,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0045047,GO:0045047,protein targeting to ER,36/317,99/12743,7.56085249659852e-33,2.71812647252717e-29,2.42583983259287e-29,RPS21/RPL13/RPS27/RPS29/SEC61G/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/HSPA5/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,36
GO:0070972,GO:0070972,protein localization to endoplasmic reticulum,38/317,118/12743,2.53793344636769e-32,4.56193536984593e-29,4.07137954975196e-29,RPS21/RPL13/RPS27/RPS29/SEC61G/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/OS9/RPS5/RPL27/PPP1R15A/RPS4Y1/HSPA5/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,38
GO:0072599,GO:0072599,establishment of protein localization to endoplasmic reticulum,36/317,103/12743,3.99654003251341e-32,4.7891871389619e-29,4.27419439266697e-29,RPS21/RPL13/RPS27/RPS29/SEC61G/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/HSPA5/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,36
GO:0006614,GO:0006614,SRP-dependent cotranslational protein targeting to membrane,34/317,94/12743,5.67456698759407e-31,5.10001708010017e-28,4.55160004689124e-28,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
GO:0006613,GO:0006613,cotranslational protein targeting to membrane,34/317,97/12743,1.97261815232033e-30,1.41831245151832e-27,1.26579792174155e-27,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
GO:0000184,GO:0000184,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,34/317,117/12743,2.6367103788515e-27,1.57982896866186e-24,1.40994618153322e-24,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
GO:0006413,GO:0006413,translational initiation,39/317,178/12743,3.95087205301708e-26,2.02905500437091e-23,1.81086586730768e-23,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/EIF4A2/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/KHDRBS1/RPS5/RPL27/PPP1R15A/RPS4Y1/EIF1B/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14/EIF3L,39
GO:0006612,GO:0006612,protein targeting to membrane,35/317,153/12743,3.32897450899313e-24,1.49595791997879e-21,1.33509398729093e-21,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/HSPA5/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,35
GO:0019083,GO:0019083,viral transcription,35/317,172/12743,2.18006064669212e-22,8.70813113873129e-20,7.77172497206733e-20,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14/JUN,35
GO:0019080,GO:0019080,viral gene expression,36/317,186/12743,3.2099544712432e-22,1.15397863241193e-19,1.02988855035255e-19,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14/EIF3L/JUN,36
GO:0000956,GO:0000956,nuclear-transcribed mRNA catabolic process,36/317,192/12743,9.96237532875872e-22,3.25588539153524e-19,2.90577224900063e-19,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/LSM3/RPS14/LSM5,36
GO:0090150,GO:0090150,establishment of protein localization to membrane,39/317,266/12743,1.77299715675104e-19,5.31160398209999e-17,4.74043450331331e-17,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/CD24/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/YWHAH/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/HSPA5/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/YWHAG/RPS14/MACF1,39
GO:0006402,GO:0006402,mRNA catabolic process,42/317,320/12743,4.56783315676796e-19,1.26318155373698e-16,1.12734862039099e-16,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/YBX1/RPS28/RPL38/HSPA1A/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/HSPA1B/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/PSMB8/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/PSMA6/LSM3/RPS14/PABPC4/LSM5,42
GO:0006401,GO:0006401,RNA catabolic process,43/317,344/12743,1.0983061778221e-18,2.82029336376461e-16,2.51702047368554e-16,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/YBX1/RPS28/RPL38/HSPA1A/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/HSPA1B/RPL39/RPL32/RPSA/RPL34/TRIR/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/PSMB8/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/PSMA6/LSM3/RPS14/PABPC4/LSM5,43
GO:0006605,GO:0006605,protein targeting,42/317,338/12743,3.59523922995946e-18,8.61659002113616e-16,7.69002748976591e-16,RPS21/RPL13/RPS27/RPS29/SEC61G/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/GABARAP/RPL39/RPL32/TOMM7/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/SLC25A6/OS9/TSPO/RPS5/RPL27/RPS4Y1/HSPA5/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/YWHAG/RPS14,42
GO:0072594,GO:0072594,establishment of protein localization to organelle,43/317,419/12743,1.71886237566815e-15,3.86206890032938e-13,3.44677139541877e-13,APOD/RPS21/RPL13/RPS27/RPS29/SEC61G/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/TOMM7/RPSA/RPL34/RPS19/YWHAH/RPL36A/RPL35A/RPLP0/SLC25A6/TSPO/RPS5/RPL27/RPS4Y1/HSPA5/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/CDKN1A/YWHAG/RPS14,43
GO:0072657,GO:0072657,protein localization to membrane,44/317,497/12743,1.61539630179579e-13,3.41608806173875e-11,3.04874794295577e-11,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/BSG/RPL38/RAMP1/RPL3/CD24/RPL15/RPL37/RPL24/RPL29/RPL14/VAMP8/RAB13/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/YWHAH/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/HSPA5/RPS3/RPLP1/RPL18A/RPL41/GRIK2/RPL27A/RPS13/YWHAG/RPS14/MACF1,44
GO:0006457,GO:0006457,protein folding,20/317,167/12743,5.9279357494481e-09,1.18394050107033e-06,1.05662854762092e-06,B2M/HSP90B1/PDIA3/HSPA1A/CALR/RGS7/GNB2/PPIB/PDIA6/HSPA1B/GNG2/GRN/HSPA6/TBCD/ERP29/PPIA/SNRNP70/HSPA5/DNAJB1/NPPA,20
GO:0002181,GO:0002181,cytoplasmic translation,13/317,67/12743,8.29381900855876e-09,1.5692778597773e-06,1.40052965861978e-06,RPS21/RPS29/RPS28/RPL38/RPL24/EEF2/RPL36/RPL39/RPL32/RPL36A/RPL18A/RPL41/EIF3L,13
GO:0043299,GO:0043299,leukocyte degranulation,29/317,416/12743,5.45900614910669e-07,9.81256355301928e-05,8.75739512761958e-05,B2M/FABP5/CHGA/RHOA/HSPA1A/EEF2/NPC2/VAMP8/CD63/PSAP/MIF/HSPA1B/DPP7/GRN/MME/S100A13/HSPA6/RAC1/PPIA/FTH1/APRT/DSP/CSTB/SVIP/ALDOA/GGH/CD47/NPPA/TUBB4B,29
GO:0002275,GO:0002275,myeloid cell activation involved in immune response,29/317,421/12743,6.98232261011351e-07,0.000119530713254086,0.000106677289802637,B2M/FABP5/CHGA/RHOA/HSPA1A/EEF2/NPC2/VAMP8/CD63/PSAP/MIF/HSPA1B/DPP7/GRN/MME/S100A13/HSPA6/RAC1/PPIA/FTH1/APRT/DSP/CSTB/SVIP/ALDOA/GGH/CD47/NPPA/TUBB4B,29
GO:0010035,GO:0010035,response to inorganic substance,29/317,423/12743,7.69514885306928e-07,0.000125745727849019,0.000112223989015097,B2M/BSG/CALR/EEF2/EEF1A2/CD9/PSAP/CYB5A/PARK7/FOS/S100A13/TSPO/RHOB/SNCB/PGAM2/DUSP1/HGF/PDCD6/AKR1B1/HSPA5/RPS3/MAP1B/IGFBP2/SYT1/ASCL1/JUN/MT2A/GGH/JUNB,29
GO:0002444,GO:0002444,myeloid leukocyte mediated immunity,29/317,433/12743,1.238288380336e-06,0.00019354985770904,0.000172736978639091,B2M/FABP5/CHGA/RHOA/HSPA1A/EEF2/NPC2/VAMP8/CD63/PSAP/MIF/HSPA1B/DPP7/GRN/MME/S100A13/HSPA6/RAC1/PPIA/FTH1/APRT/DSP/CSTB/SVIP/ALDOA/GGH/CD47/NPPA/TUBB4B,29
GO:0043312,GO:0043312,neutrophil degranulation,26/317,384/12743,3.69230950610697e-06,0.00055307719476894,0.000493603481342721,B2M/FABP5/RHOA/HSPA1A/EEF2/NPC2/VAMP8/CD63/PSAP/MIF/HSPA1B/DPP7/GRN/MME/HSPA6/RAC1/PPIA/FTH1/APRT/DSP/CSTB/SVIP/ALDOA/GGH/CD47/TUBB4B,26
GO:0002283,GO:0002283,neutrophil activation involved in immune response,26/317,385/12743,3.87145882863435e-06,0.00055671577955762,0.000496850800407474,B2M/FABP5/RHOA/HSPA1A/EEF2/NPC2/VAMP8/CD63/PSAP/MIF/HSPA1B/DPP7/GRN/MME/HSPA6/RAC1/PPIA/FTH1/APRT/DSP/CSTB/SVIP/ALDOA/GGH/CD47/TUBB4B,26
GO:0002274,GO:0002274,myeloid leukocyte activation,30/317,491/12743,5.23492677370062e-06,0.000714470953690027,0.000637642183397175,B2M/FABP5/CHGA/RHOA/HSPA1A/EEF2/NPC2/VAMP8/CD63/PSAP/MIF/HSPA1B/DPP7/GRN/MME/S100A13/HSPA6/RAC1/PPIA/FTH1/APRT/DSP/CSTB/SVIP/ALDOA/JUN/GGH/CD47/NPPA/TUBB4B,30
GO:0042119,GO:0042119,neutrophil activation,26/317,392/12743,5.36598490949395e-06,0.000714470953690027,0.000637642183397175,B2M/FABP5/RHOA/HSPA1A/EEF2/NPC2/VAMP8/CD63/PSAP/MIF/HSPA1B/DPP7/GRN/MME/HSPA6/RAC1/PPIA/FTH1/APRT/DSP/CSTB/SVIP/ALDOA/GGH/CD47/TUBB4B,26
GO:0002446,GO:0002446,neutrophil mediated immunity,26/317,396/12743,6.44057259326166e-06,0.000798408912854333,0.000712554093076643,B2M/FABP5/RHOA/HSPA1A/EEF2/NPC2/VAMP8/CD63/PSAP/MIF/HSPA1B/DPP7/GRN/MME/HSPA6/RAC1/PPIA/FTH1/APRT/DSP/CSTB/SVIP/ALDOA/GGH/CD47/TUBB4B,26
GO:0036230,GO:0036230,granulocyte activation,26/317,396/12743,6.44057259326166e-06,0.000798408912854333,0.000712554093076643,B2M/FABP5/RHOA/HSPA1A/EEF2/NPC2/VAMP8/CD63/PSAP/MIF/HSPA1B/DPP7/GRN/MME/HSPA6/RAC1/PPIA/FTH1/APRT/DSP/CSTB/SVIP/ALDOA/GGH/CD47/TUBB4B,26
GO:0010038,GO:0010038,response to metal ion,20/317,272/12743,1.53608253062372e-05,0.00184073889919743,0.00164279984327758,B2M/BSG/CALR/CYB5A/PARK7/FOS/S100A13/TSPO/SNCB/PGAM2/DUSP1/PDCD6/HSPA5/IGFBP2/SYT1/ASCL1/JUN/MT2A/GGH/JUNB,20
GO:0010592,GO:0010592,positive regulation of lamellipodium assembly,5/317,16/12743,3.2176885708073e-05,0.00373148077808137,0.00333022572625489,FSCN1/CDC42/RAC1/BRK1/AKIRIN1,5
GO:0002576,GO:0002576,platelet degranulation,11/317,100/12743,3.7437829716717e-05,0.00420590618223742,0.00375363503212347,TIMP1/TAGLN2/LGALS3BP/CD9/CD63/PSAP/HGF/ALDOA/MANF/CHID1/VEGFA,11
GO:0002479,GO:0002479,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,9/317,68/12743,4.41659951089102e-05,0.00481141673989491,0.00429403359145002,B2M/HLA-A/HLA-C/HLA-B/PDIA3/CALR/VAMP8/PSMB8/PSMA6,9
GO:0043618,GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,11/317,104/12743,5.39810904452976e-05,0.00570770647502485,0.00509394314790301,HSPA1A/CA9/TMBIM6/EGR1/PSMB8/HSPA5/RBX1/PSMA6/JUN/DNAJB1/VEGFA,11
GO:0042026,GO:0042026,protein refolding,5/317,18/12743,6.05816672445382e-05,0.00622260267840328,0.00555347133116849,B2M/HSPA1A/HSPA1B/HSPA6/SNRNP70,5
GO:0042590,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,9/317,71/12743,6.25256615740224e-05,0.00624388203773918,0.00557246247010586,B2M/HLA-A/HLA-C/HLA-B/PDIA3/CALR/VAMP8/PSMB8/PSMA6,9
GO:1903573,GO:1903573,negative regulation of response to endoplasmic reticulum stress,7/317,43/12743,8.23379633089164e-05,0.00786889757891462,0.00702273620394752,HSPA1A/PARK7/TMBIM6/OS9/PPP1R15A/HSPA5/SVIP,7
GO:0043620,GO:0043620,regulation of DNA-templated transcription in response to stress,11/317,109/12743,8.31761079273312e-05,0.00786889757891462,0.00702273620394752,HSPA1A/CA9/TMBIM6/EGR1/PSMB8/HSPA5/RBX1/PSMA6/JUN/DNAJB1/VEGFA,11
GO:0006119,GO:0006119,oxidative phosphorylation,11/317,111/12743,9.81631049610867e-05,0.0088449669537381,0.00789384650464643,RHOA/PARK7/NDUFB1/COX4I1/ATP5F1E/NDUFB4/ATP5ME/NDUFA3/NDUFA6/UQCR10/NDUFS5,11
GO:0007218,GO:0007218,neuropeptide signaling pathway,6/317,31/12743,9.84140968427049e-05,0.0088449669537381,0.00789384650464643,NPW/TAC3/GRP/PCSK1N/SCG5/NPPA,6
GO:0002685,GO:0002685,regulation of leukocyte migration,12/317,135/12743,0.000136959239036232,0.0120089869350062,0.0107176318506402,APOD/MDK/S100A14/RHOA/CALR/CD9/MIF/RAC1/DUSP1/SELENOK/AKIRIN1/VEGFA,12
GO:1905897,GO:1905897,regulation of response to endoplasmic reticulum stress,9/317,79/12743,0.000145204784511776,0.0124288381028532,0.0110923354183432,HSPA1A/PARK7/TMBIM6/OS9/ERP29/PPP1R15A/HSPA5/SVIP/MANF,9
GO:0097201,GO:0097201,negative regulation of transcription from RNA polymerase II promoter in response to stress,4/317,12/12743,0.000158827812197703,0.0132787438337382,0.0118508487534541,HSPA1A/TMBIM6/JUN/DNAJB1,4
GO:0009199,GO:0009199,ribonucleoside triphosphate metabolic process,18/317,273/12743,0.000165890295043984,0.0135539911518891,0.0120964980692359,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/NDUFA3/ALDOA/NDUFA6/UQCR10/NME4/CTPS1/NDUFS5,18
GO:0045730,GO:0045730,respiratory burst,5/317,22/12743,0.000171569656073353,0.013706509190749,0.0122326154786334,CD24/GRN/RPS19/RAC1/SELENOK,5
GO:0010591,GO:0010591,regulation of lamellipodium assembly,5/317,23/12743,0.000214794997785444,0.0167866960225798,0.0149815824542342,FSCN1/CDC42/RAC1/BRK1/AKIRIN1,5
GO:1902745,GO:1902745,positive regulation of lamellipodium organization,5/317,24/12743,0.000265836957894528,0.0200910450960891,0.0179306069695863,FSCN1/CDC42/RAC1/BRK1/AKIRIN1,5
GO:0007565,GO:0007565,female pregnancy,12/317,145/12743,0.000268253175135543,0.0200910450960891,0.0179306069695863,TAC3/TIMP1/BSG/CALR/RPL29/FOS/IGFBP5/RGS2/AKR1B1/IGFBP2/JUNB/NPPA,12
GO:0050900,GO:0050900,leukocyte migration,18/317,285/12743,0.000281785595875338,0.0206738615749355,0.0184507517986688,APOD/MDK/S100A14/CHGA/BSG/RHOA/CALR/EPCAM/CD9/MIF/RPS19/RAC1/PPIA/DUSP1/SELENOK/CD47/AKIRIN1/VEGFA,18
GO:0034976,GO:0034976,response to endoplasmic reticulum stress,16/317,237/12743,0.00029170869618641,0.0209738552558029,0.0187184864416038,HSP90B1/HSPA1A/CALR/EEF2/PDIA6/PARK7/TMBIM6/OS9/ERP29/SERP1/PPP1R15A/SELENOK/HSPA5/SVIP/MANF/JUN,16
GO:0031346,GO:0031346,positive regulation of cell projection organization,19/317,314/12743,0.000330019255064023,0.0229237291967095,0.0204586857745614,TUBB2B/MDK/FSCN1/RHOA/GRN/CDC42/RAC1/BRK1/RGS2/HGF/HSPA5/MAP1B/SNX3/SYT1/DPYSL3/CAMK2B/MACF1/AKIRIN1/VEGFA,19
GO:0002474,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,9/317,88/12743,0.000331581062094269,0.0229237291967095,0.0204586857745614,B2M/HLA-A/HLA-C/HLA-B/PDIA3/CALR/VAMP8/PSMB8/PSMA6,9
GO:0048857,GO:0048857,neural nucleus development,7/317,54/12743,0.000358177087894287,0.0241372616108471,0.0215417241460689,S100A1/RHOA/YWHAH/CDC42/BASP1/HSPA5/ASCL1,7
GO:0009141,GO:0009141,nucleoside triphosphate metabolic process,18/317,291/12743,0.000362562483167105,0.0241372616108471,0.0215417241460689,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/NDUFA3/ALDOA/NDUFA6/UQCR10/NME4/CTPS1/NDUFS5,18
GO:0009205,GO:0009205,purine ribonucleoside triphosphate metabolic process,17/317,268/12743,0.000393942399642966,0.0257495077584811,0.0229806016097944,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/NDUFA3/ALDOA/NDUFA6/UQCR10/NME4/NDUFS5,17
GO:0046034,GO:0046034,ATP metabolic process,16/317,244/12743,0.000403555015477731,0.0259067907257579,0.023120971563461,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/NDUFA3/ALDOA/NDUFA6/UQCR10/NDUFS5,16
GO:0021762,GO:0021762,substantia nigra development,6/317,40/12743,0.000425079984724032,0.0268098692119806,0.0239269398603666,S100A1/RHOA/YWHAH/CDC42/BASP1/HSPA5,6
GO:0009167,GO:0009167,purine ribonucleoside monophosphate metabolic process,17/317,272/12743,0.000467012504534036,0.0289400668093633,0.025828072215779,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/APRT/NDUFA3/ALDOA/NDUFA6/UQCR10/NDUFS5,17
GO:0031116,GO:0031116,positive regulation of microtubule polymerization,5/317,27/12743,0.000474955199374808,0.0289400668093633,0.025828072215779,HSPA1A/HSPA1B/RAC1/RPS3/MAP1B,5
GO:0009126,GO:0009126,purine nucleoside monophosphate metabolic process,17/317,273/12743,0.000487008901257985,0.0291799500003743,0.0260421601935849,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/APRT/NDUFA3/ALDOA/NDUFA6/UQCR10/NDUFS5,17
GO:0009144,GO:0009144,purine nucleoside triphosphate metabolic process,17/317,275/12743,0.000529225387142763,0.0303743718427026,0.0271081429987724,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/NDUFA3/ALDOA/NDUFA6/UQCR10/NME4/NDUFS5,17
GO:0032103,GO:0032103,positive regulation of response to external stimulus,14/317,202/12743,0.000532183994033265,0.0303743718427026,0.0271081429987724,TUBB2B/MDK/S100A14/CALR/VAMP8/MIF/PARK7/NEAT1/GRN/RPS19/RAC1/AKIRIN1/NPPA/VEGFA,14
GO:0042775,GO:0042775,mitochondrial ATP synthesis coupled electron transport,8/317,75/12743,0.000532290800025108,0.0303743718427026,0.0271081429987724,PARK7/NDUFB1/COX4I1/NDUFB4/NDUFA3/NDUFA6/UQCR10/NDUFS5,8
GO:0042773,GO:0042773,ATP synthesis coupled electron transport,8/317,76/12743,0.000582291522119899,0.0327084065940787,0.029191193411537,PARK7/NDUFB1/COX4I1/NDUFB4/NDUFA3/NDUFA6/UQCR10/NDUFS5,8
GO:0097529,GO:0097529,myeloid leukocyte migration,10/317,116/12743,0.000625157442777622,0.034546025305277,0.0308312085880929,MDK/S100A14/CHGA/CD9/MIF/RPS19/RAC1/DUSP1/CD47/AKIRIN1,10
GO:0031113,GO:0031113,regulation of microtubule polymerization,6/317,43/12743,0.000634224664853487,0.034546025305277,0.0308312085880929,HSPA1A/HSPA1B/RAC1/TBCD/RPS3/MAP1B,6
GO:0042177,GO:0042177,negative regulation of protein catabolic process,10/317,117/12743,0.000668844552390152,0.0354628927978487,0.0316494831265187,TIMP1/FHIT/PARK7/GABARAPL2/OS9/SNRNP70/SVIP/NOP53/SNX3/ATRAID,10
GO:0031112,GO:0031112,positive regulation of microtubule polymerization or depolymerization,5/317,29/12743,0.000670786289361255,0.0354628927978487,0.0316494831265187,HSPA1A/HSPA1B/RAC1/RPS3/MAP1B,5
GO:0009161,GO:0009161,ribonucleoside monophosphate metabolic process,17/317,285/12743,0.000790860268418883,0.0408113890216032,0.0364228427605143,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/APRT/NDUFA3/ALDOA/NDUFA6/UQCR10/NDUFS5,17
GO:0031102,GO:0031102,neuron projection regeneration,6/317,45/12743,0.000812786384433659,0.0408113890216032,0.0364228427605143,APOD/GRN/TSPO/HGF/MAP1B/JUN,6
GO:0071674,GO:0071674,mononuclear cell migration,6/317,45/12743,0.000812786384433659,0.0408113890216032,0.0364228427605143,MDK/S100A14/RPS19/DUSP1/CD47/AKIRIN1,6
GO:0044706,GO:0044706,multi-multicellular organism process,12/317,164/12743,0.00081736300683044,0.0408113890216032,0.0364228427605143,TAC3/TIMP1/BSG/CALR/RPL29/FOS/IGFBP5/RGS2/AKR1B1/IGFBP2/JUNB/NPPA,12
GO:0061162,GO:0061162,establishment of monopolar cell polarity,4/317,18/12743,0.000872461414004838,0.0429657367581834,0.0383455283329019,FSCN1/RHOA/CDC42/MAP1B,4
GO:0002532,GO:0002532,production of molecular mediator involved in inflammatory response,6/317,46/12743,0.000915458661825098,0.0438809851901497,0.039162357912181,APOD/VAMP8/GRN/RPS19/CHID1/NPPA,6
GO:0006120,GO:0006120,mitochondrial electron transport, NADH to ubiquinone,6/317,46/12743,0.000915458661825098,0.0438809851901497,0.039162357912181,PARK7/NDUFB1/NDUFB4/NDUFA3/NDUFA6/NDUFS5,6
GO:0022900,GO:0022900,electron transport chain,11/317,144/12743,0.000939412465409428,0.0444366817519328,0.0396582990937387,CYB5A/PARK7/NDUFB1/COX4I1/NDUFB4/AKR1B1/NDUFA3/NDUFA4L2/NDUFA6/UQCR10/NDUFS5,11
GO:0010770,GO:0010770,positive regulation of cell morphogenesis involved in differentiation,10/317,124/12743,0.00105058456272863,0.0490500195196028,0.0437755536185489,TUBB2B/MDK/RHOA/CALR/CDC42/RAC1/MAP1B/CAMK2B/MACF1/VEGFA,10
GO:0061339,GO:0061339,establishment or maintenance of monopolar cell polarity,4/317,19/12743,0.00108363734415366,0.0499445673363127,0.0445739085692354,FSCN1/RHOA/CDC42/MAP1B,4
GO:0070482,GO:0070482,response to oxygen levels,18/317,320/12743,0.00110021225631575,0.0500666210310776,0.0446828375383133,HSP90B1/RHOA/CD24/CA9/TMBIM6/EGR1/ATP6AP1/CHCHD2/PSMB8/RBX1/NOP53/PSMA6/CDKN1A/FAM162A/NPPA/VEGFA/HILPDA/MALAT1,18
GO:1900744,GO:1900744,regulation of p38MAPK cascade,5/317,33/12743,0.00123591771642536,0.0555390523818646,0.0495668052587434,GADD45G/DUSP1/HGF/GADD45B/VEGFA,5
GO:0009636,GO:0009636,response to toxic substance,20/317,379/12743,0.00129575730882775,0.0575092287066145,0.0513251238116568,RHOA/EEF2/CLDN18/SELENOW/PSAP/PARK7/FOS/PON3/EGR1/RHOB/RGS2/DUSP1/HGF/BPHL/SRSF9/RPS3/MAP1B/CDKN1A/JUN/GGH,20
GO:0034605,GO:0034605,cellular response to heat,9/317,107/12743,0.00137960455444563,0.0604463620455932,0.0539464201786013,HSPA1A/HSPA1B/HSBP1/HSPA6/PDCD6/CDKN1A/IER5/CAMK2B/DNAJB1,9
GO:1902743,GO:1902743,regulation of lamellipodium organization,5/317,34/12743,0.00141989910543308,0.0604463620455932,0.0539464201786013,FSCN1/CDC42/RAC1/BRK1/AKIRIN1,5
GO:0032387,GO:0032387,negative regulation of intracellular transport,6/317,50/12743,0.0014291907576844,0.0604463620455932,0.0539464201786013,APOD/PARK7/OS9/MAP1B/SVIP/SNX3,6
GO:1901799,GO:1901799,negative regulation of proteasomal protein catabolic process,6/317,50/12743,0.0014291907576844,0.0604463620455932,0.0539464201786013,FHIT/PARK7/GABARAPL2/OS9/SVIP/NOP53,6
GO:0045861,GO:0045861,negative regulation of proteolysis,14/317,224/12743,0.00145470522994723,0.0608100616472126,0.0542710102922784,PCSK1N/TIMP1/SPINT2/WFDC2/FHIT/SPINK7/PARK7/GABARAPL2/OS9/HGF/CSTB/SVIP/NOP53/VEGFA,14
GO:0071453,GO:0071453,cellular response to oxygen levels,13/317,200/12743,0.00150052318463465,0.0615870195662965,0.0549644200682444,CA9/TMBIM6/EGR1/ATP6AP1/CHCHD2/PSMB8/RBX1/NOP53/PSMA6/FAM162A/VEGFA/HILPDA/MALAT1,13
GO:0071456,GO:0071456,cellular response to hypoxia,12/317,176/12743,0.00150755430370907,0.0615870195662965,0.0549644200682444,CA9/TMBIM6/EGR1/CHCHD2/PSMB8/RBX1/NOP53/PSMA6/FAM162A/VEGFA/HILPDA/MALAT1,12
GO:0009123,GO:0009123,nucleoside monophosphate metabolic process,17/317,303/12743,0.00154334365229476,0.0616704141266983,0.0550388470121299,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/APRT/NDUFA3/ALDOA/NDUFA6/UQCR10/NDUFS5,17
GO:0060326,GO:0060326,cell chemotaxis,12/317,177/12743,0.00158204108758105,0.0616704141266983,0.0550388470121299,MDK/S100A14/CHGA/CALR/RAB13/MIF/RPS19/RAC1/DUSP1/HGF/AKIRIN1/VEGFA,12
GO:0036500,GO:0036500,ATF6-mediated unfolded protein response,3/317,10/12743,0.00160697896594659,0.0616704141266983,0.0550388470121299,HSP90B1/CALR/HSPA5,3
GO:0060263,GO:0060263,regulation of respiratory burst,3/317,10/12743,0.00160697896594659,0.0616704141266983,0.0550388470121299,GRN/RPS19/RAC1,3
GO:0090084,GO:0090084,negative regulation of inclusion body assembly,3/317,10/12743,0.00160697896594659,0.0616704141266983,0.0550388470121299,HSPA1A/HSPA1B/DNAJB1,3
GO:0010720,GO:0010720,positive regulation of cell development,21/317,414/12743,0.00161252265032257,0.0616704141266983,0.0550388470121299,TUBB2B/MDK/RHOA/CALR/GRN/MME/CDC42/RAC1/TSPO/ATP6AP1/RGS2/HGF/HSPA5/MAP1B/SNX3/SYT1/ASCL1/DPYSL3/CAMK2B/MACF1/VEGFA,21
GO:0002696,GO:0002696,positive regulation of leukocyte activation,13/317,202/12743,0.0016405977672876,0.0618393094438925,0.0551895806119565,MDK/RHOA/CD24/VAMP8/MIF/CDC42/RAC1/SELENOK/RPS3/IGFBP2/CDKN1A/CD47/NPPA,13
GO:0002687,GO:0002687,positive regulation of leukocyte migration,8/317,89/12743,0.00165134178209004,0.0618393094438925,0.0551895806119565,MDK/S100A14/RHOA/CALR/RAC1/SELENOK/AKIRIN1/VEGFA,8
GO:0009612,GO:0009612,response to mechanical stimulus,11/317,156/12743,0.00179724178018657,0.0666091154615538,0.0594464779816459,MDK/RHOA/CNTNAP2/FOS/RAC1/MEIS2/MAP1B/IGFBP2/SLITRK6/JUN/NPPA,11
GO:0022904,GO:0022904,respiratory electron transport chain,8/317,91/12743,0.00190407834772548,0.069848588368093,0.0623376026194122,PARK7/NDUFB1/COX4I1/NDUFB4/NDUFA3/NDUFA6/UQCR10/NDUFS5,8
GO:1905521,GO:1905521,regulation of macrophage migration,4/317,22/12743,0.00192834145134338,0.0700241163391862,0.0624942556480022,MDK/CD9/MIF/AKIRIN1,4
GO:0010976,GO:0010976,positive regulation of neuron projection development,14/317,232/12743,0.00202090517500349,0.0726515410413755,0.0648391470885331,TUBB2B/MDK/RHOA/GRN/RGS2/HGF/HSPA5/MAP1B/SNX3/SYT1/DPYSL3/CAMK2B/MACF1/VEGFA,14
GO:0050867,GO:0050867,positive regulation of cell activation,13/317,208/12743,0.00212729855528224,0.0757191911508878,0.0675769254455474,MDK/RHOA/CD24/VAMP8/MIF/CDC42/RAC1/SELENOK/RPS3/IGFBP2/CDKN1A/CD47/NPPA,13
GO:0036294,GO:0036294,cellular response to decreased oxygen levels,12/317,186/12743,0.00239909112349188,0.0845562018524834,0.0754636712528715,CA9/TMBIM6/EGR1/CHCHD2/PSMB8/RBX1/NOP53/PSMA6/FAM162A/VEGFA/HILPDA/MALAT1,12
GO:0001666,GO:0001666,response to hypoxia,16/317,290/12743,0.00248903382813655,0.0868745302150571,0.0775327042223831,HSP90B1/RHOA/CD24/CA9/TMBIM6/EGR1/CHCHD2/PSMB8/RBX1/NOP53/PSMA6/FAM162A/NPPA/VEGFA/HILPDA/MALAT1,16
GO:0051017,GO:0051017,actin filament bundle assembly,9/317,117/12743,0.00256179897422943,0.0885544933880268,0.0790320169377661,HSP90B1/FSCN1/RHOA/CDC42/RAC1/PFN2/ELN/DPYSL3/CD47,9
GO:0031103,GO:0031103,axon regeneration,5/317,39/12743,0.00265503406458015,0.0893293250299805,0.0797235290802666,APOD/GRN/TSPO/MAP1B/JUN,5
GO:0038066,GO:0038066,p38MAPK cascade,5/317,39/12743,0.00265503406458015,0.0893293250299805,0.0797235290802666,GADD45G/DUSP1/HGF/GADD45B/VEGFA,5
GO:0042274,GO:0042274,ribosomal small subunit biogenesis,4/317,24/12743,0.00269373829619514,0.0893293250299805,0.0797235290802666,RPS28/RPL38/RPS19/RPS14,4
GO:2001024,GO:2001024,negative regulation of response to drug,4/317,24/12743,0.00269373829619514,0.0893293250299805,0.0797235290802666,PSAP/PARK7/RGS2/HGF,4
GO:0061572,GO:0061572,actin filament bundle organization,9/317,118/12743,0.00271428518886585,0.0893293250299805,0.0797235290802666,HSP90B1/FSCN1/RHOA/CDC42/RAC1/PFN2/ELN/DPYSL3/CD47,9
GO:0002688,GO:0002688,regulation of leukocyte chemotaxis,7/317,76/12743,0.00277776034854365,0.0893293250299805,0.0797235290802666,MDK/S100A14/CALR/MIF/RAC1/DUSP1/AKIRIN1,7
GO:0042104,GO:0042104,positive regulation of activated T cell proliferation,3/317,12/12743,0.00283918730759808,0.0893293250299805,0.0797235290802666,CD24/RPS3/IGFBP2,3
GO:0045989,GO:0045989,positive regulation of striated muscle contraction,3/317,12/12743,0.00283918730759808,0.0893293250299805,0.0797235290802666,CHGA/RGS2/NPPA,3
GO:0051450,GO:0051450,myoblast proliferation,3/317,12/12743,0.00283918730759808,0.0893293250299805,0.0797235290802666,MEIS2/HGF/MALAT1,3
GO:0031330,GO:0031330,negative regulation of cellular catabolic process,13/317,215/12743,0.00283947083682106,0.0893293250299805,0.0797235290802666,TIMP1/YBX1/FHIT/PARK7/GABARAPL2/OS9/TSPO/SNRNP70/HGF/SVIP/NOP53/ATRAID/WDR6,13
GO:0043254,GO:0043254,regulation of protein complex assembly,18/317,349/12743,0.00285754447244722,0.0893293250299805,0.0797235290802666,FSCN1/RHOA/HSPA1A/PARK7/HSPA1B/CDC42/RAC1/BRK1/TBCD/PFN2/ELN/RPS3/MAP1B/SVIP/RBX1/NOP53/JUN/VEGFA,18
GO:0071349,GO:0071349,cellular response to interleukin-12,5/317,40/12743,0.00297359893313102,0.0908839305041498,0.0811109641099916,MIF/CDC42/RPLP0/PPIA/CD47,5
GO:1903363,GO:1903363,negative regulation of cellular protein catabolic process,7/317,77/12743,0.00299193425150503,0.0908839305041498,0.0811109641099916,FHIT/PARK7/GABARAPL2/OS9/SVIP/NOP53/ATRAID,7
GO:0030218,GO:0030218,erythrocyte differentiation,8/317,98/12743,0.0030369262421199,0.0908839305041498,0.0811109641099916,B2M/HSPA1A/HSPA1B/RPS19/P4HTM/TMEM14C/RPS14/VEGFA,8
GO:0010257,GO:0010257,NADH dehydrogenase complex assembly,6/317,58/12743,0.00308423908804069,0.0908839305041498,0.0811109641099916,NDUFB1/NDUFB4/NDUFAF3/NDUFA3/NDUFA6/NDUFS5,6
GO:0032981,GO:0032981,mitochondrial respiratory chain complex I assembly,6/317,58/12743,0.00308423908804069,0.0908839305041498,0.0811109641099916,NDUFB1/NDUFB4/NDUFAF3/NDUFA3/NDUFA6/NDUFS5,6
GO:0051781,GO:0051781,positive regulation of cell division,6/317,58/12743,0.00308423908804069,0.0908839305041498,0.0811109641099916,MDK/YBX1/RHOA/CENPV/CDC42/VEGFA,6
GO:0070059,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,6/317,58/12743,0.00308423908804069,0.0908839305041498,0.0811109641099916,HSPA1A/PARK7/TMBIM6/ERP29/PPP1R15A/SELENOK,6
GO:0042255,GO:0042255,ribosome assembly,4/317,25/12743,0.00314481514789369,0.0919155321681124,0.0820316351799741,RPL38/RPS19/NOP53/RPS14,4
GO:0030099,GO:0030099,myeloid cell differentiation,17/317,326/12743,0.00331258416421876,0.0954505924258875,0.0851865619542068,B2M/HSPA1A/CLDN18/HSPA1B/FOS/RPS19/CDC42/HIST1H4C/ATP6AP1/MEIS2/P4HTM/TMEM14C/RPS14/JUN/PABPC4/JUNB/VEGFA,17
GO:0070671,GO:0070671,response to interleukin-12,5/317,41/12743,0.00331886621786813,0.0954505924258875,0.0851865619542068,MIF/CDC42/RPLP0/PPIA/CD47,5
GO:0032273,GO:0032273,positive regulation of protein polymerization,8/317,100/12743,0.00344151835995381,0.0976680268488121,0.0871655503506857,RHOA/HSPA1A/HSPA1B/RAC1/BRK1/PFN2/RPS3/MAP1B,8
GO:1901216,GO:1901216,positive regulation of neuron death,7/317,79/12743,0.00345798470016249,0.0976680268488121,0.0871655503506857,RHOA/FOS/GRN/EGR1/GRIK2/ASCL1/JUN,7
GO:0036293,GO:0036293,response to decreased oxygen levels,16/317,300/12743,0.00347747077514547,0.0976680268488121,0.0871655503506857,HSP90B1/RHOA/CD24/CA9/TMBIM6/EGR1/CHCHD2/PSMB8/RBX1/NOP53/PSMA6/FAM162A/NPPA/VEGFA/HILPDA/MALAT1,16
GO:0006979,GO:0006979,response to oxidative stress,18/317,357/12743,0.00363095512284773,0.0989409332338859,0.0883015780680431,APOD/HSPA1A/EEF2/PSAP/PARK7/HSPA1B/FOS/NDUFB4/RHOB/DUSP1/SELENOK/HGF/PON2/RPS3/ROMO1/NDUFA6/SFPQ/JUN,18
GO:0031349,GO:0031349,positive regulation of defense response,18/317,357/12743,0.00363095512284773,0.0989409332338859,0.0883015780680431,S100A1/MDK/HSP90B1/S100A14/HSPA1A/VAMP8/PARK7/HSPA1B/NEAT1/GRN/RPS19/SLC25A6/PSMB8/NOP53/PSMA6/SFPQ/CNPY3/NPPA,18
GO:0042273,GO:0042273,ribosomal large subunit biogenesis,4/317,26/12743,0.00364478730129478,0.0989409332338859,0.0883015780680431,RPL38/RPL14/RPL35A/NOP53,4
GO:0046785,GO:0046785,microtubule polymerization,6/317,60/12743,0.00366040170239411,0.0989409332338859,0.0883015780680431,HSPA1A/HSPA1B/RAC1/TBCD/RPS3/MAP1B,6
GO:0048678,GO:0048678,response to axon injury,6/317,60/12743,0.00366040170239411,0.0989409332338859,0.0883015780680431,APOD/GRN/TSPO/MAP1B/JUN/DPYSL3,6
GO:0007568,GO:0007568,aging,14/317,250/12743,0.00397945879303328,0.106762345977273,0.0952819355943867,APOD/TIMP1/CALR/EEF2/MIF/FOS/MME/IGFBP5/TSPO/SERP1/IGFBP2/CDKN1A/ROMO1/JUN,14
GO:1904018,GO:1904018,positive regulation of vasculature development,9/317,126/12743,0.00420929930263032,0.112092081429304,0.100038551847308,S100A1/MDK/GRN/EGR1/RHOB/HGF/PDCD6/BTG1/VEGFA,9
GO:0031099,GO:0031099,regeneration,10/317,150/12743,0.00428311837034433,0.113173076253021,0.101003304712453,APOD/MDK/CD9/GRN/TSPO/HGF/MAP1B/CDKN1A/JUN/AKIRIN1,10
GO:0031110,GO:0031110,regulation of microtubule polymerization or depolymerization,6/317,62/12743,0.00431285436624863,0.113173076253021,0.101003304712453,HSPA1A/HSPA1B/RAC1/TBCD/RPS3/MAP1B,6
GO:0010226,GO:0010226,response to lithium ion,3/317,14/12743,0.00452747080337892,0.114484918294707,0.102174081242154,CALR/IGFBP2/ASCL1,3
GO:1901032,GO:1901032,negative regulation of response to reactive oxygen species,3/317,14/12743,0.00452747080337892,0.114484918294707,0.102174081242154,PSAP/PARK7/HGF,3
GO:1901841,GO:1901841,regulation of high voltage-gated calcium channel activity,3/317,14/12743,0.00452747080337892,0.114484918294707,0.102174081242154,GEM/CACNA2D1/NPPA,3
GO:1903206,GO:1903206,negative regulation of hydrogen peroxide-induced cell death,3/317,14/12743,0.00452747080337892,0.114484918294707,0.102174081242154,PSAP/PARK7/HGF,3
GO:2001039,GO:2001039,negative regulation of cellular response to drug,3/317,14/12743,0.00452747080337892,0.114484918294707,0.102174081242154,PSAP/PARK7/HGF,3
GO:0050729,GO:0050729,positive regulation of inflammatory response,7/317,83/12743,0.00455392025483813,0.114484918294707,0.102174081242154,MDK/VAMP8/PARK7/NEAT1/GRN/RPS19/NPPA,7
GO:0034101,GO:0034101,erythrocyte homeostasis,8/317,105/12743,0.00463642166084918,0.114991989370839,0.10262662575282,B2M/HSPA1A/HSPA1B/RPS19/P4HTM/TMEM14C/RPS14/VEGFA,8
GO:1903320,GO:1903320,regulation of protein modification by small protein conjugation or removal,12/317,202/12743,0.00468335137320776,0.114991989370839,0.10262662575282,RPS2/HSPA1A/PARK7/HSPA1B/SOX4/EGR1/TSPO/PDCD6/HSPA5/RPS3/NOP53/UBE2S,12
GO:0006986,GO:0006986,response to unfolded protein,10/317,152/12743,0.00470203683936394,0.114991989370839,0.10262662575282,HSP90B1/HSPA1A/CALR/PDIA6/TMBIM6/SERP1/PPP1R15A/HSPA5/MANF/DNAJB1,10
GO:1901654,GO:1901654,response to ketone,10/317,152/12743,0.00470203683936394,0.114991989370839,0.10262662575282,CALR/CA9/PARK7/FOS/GNG2/TSPO/RPL27/DUSP1/AKR1B1/CDKN1A,10
GO:0009895,GO:0009895,negative regulation of catabolic process,14/317,255/12743,0.00473714275889176,0.115067758231188,0.102694247006416,TIMP1/YBX1/FHIT/PARK7/GABARAPL2/OS9/TSPO/SNRNP70/HGF/SVIP/NOP53/SNX3/ATRAID/WDR6,14
GO:0031334,GO:0031334,positive regulation of protein complex assembly,12/317,203/12743,0.00486986989505898,0.117497867602262,0.104863040905262,FSCN1/RHOA/HSPA1A/HSPA1B/RAC1/BRK1/PFN2/RPS3/MAP1B/RBX1/JUN/VEGFA,12
GO:0030595,GO:0030595,leukocyte chemotaxis,9/317,129/12743,0.0049118598406013,0.117720907513078,0.105062096801072,MDK/S100A14/CHGA/CALR/MIF/RPS19/RAC1/DUSP1/AKIRIN1,9
GO:0051496,GO:0051496,positive regulation of stress fiber assembly,5/317,45/12743,0.00499141644314025,0.118835378232379,0.106056725818693,RHOA/CDC42/RAC1/PFN2/CD47,5
GO:1903051,GO:1903051,negative regulation of proteolysis involved in cellular protein catabolic process,6/317,64/12743,0.00504738038115278,0.119377187304239,0.10654027286533,FHIT/PARK7/GABARAPL2/OS9/SVIP/NOP53,6
GO:0010817,GO:0010817,regulation of hormone levels,18/317,369/12743,0.0051107434999406,0.120085770472461,0.107172660390911,GRP/PCSK1N/VAMP8/PARK7/SOX4/YWHAH/MME/RBP1/SLC25A6/PON3/RAC1/EGR1/TSPO/SERP1/AKR1B1/SCG5/PCLO/NPPA,18
GO:0009617,GO:0009617,response to bacterium,17/317,341/12743,0.00519427686609212,0.120874114168949,0.107876231604408,B2M/S100A14/CHGA/RHOA/CD24/TENT5A/MIF/FOS/RPL39/GRN/RPS19/TSPO/SNX3/ROMO1/MT2A/CD47/LSM5,17
GO:0043161,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,16/317,313/12743,0.00522562331477983,0.120874114168949,0.107876231604408,UCHL1/HSP90B1/HSPA1A/FHIT/PARK7/OS9/PCNP/PSMB8/HSPA5/SVIP/RBX1/NOP53/RNF187/PSMA6/UBE2S/ZFAND2A,16
GO:0046677,GO:0046677,response to antibiotic,14/317,258/12743,0.00524516322958441,0.120874114168949,0.107876231604408,RHOA/EEF2/CLDN18/PSAP/PARK7/EGR1/RHOB/RGS2/DUSP1/HGF/HSPA5/RPS3/JUN/GGH,14
GO:0051251,GO:0051251,positive regulation of lymphocyte activation,11/317,180/12743,0.00539878184685571,0.123565404033307,0.110278120633488,MDK/RHOA/CD24/MIF/CDC42/RAC1/SELENOK/RPS3/IGFBP2/CDKN1A/CD47,11
GO:0035994,GO:0035994,response to muscle stretch,3/317,15/12743,0.00555613034428207,0.123565404033307,0.110278120633488,FOS/JUN/NPPA,3
GO:0090083,GO:0090083,regulation of inclusion body assembly,3/317,15/12743,0.00555613034428207,0.123565404033307,0.110278120633488,HSPA1A/HSPA1B/DNAJB1,3
GO:0007005,GO:0007005,mitochondrion organization,20/317,431/12743,0.005630290200971,0.123565404033307,0.110278120633488,HSPA1A/PARK7/NDUFB1/TOMM7/ATP5F1E/YWHAH/SLC25A6/NDUFB4/GGCT/TSPO/ATP5ME/HGF/NDUFAF3/NDUFA3/MAP1LC3B/YWHAG/NDUFA6/JUN/FAM162A/NDUFS5,20
GO:0032271,GO:0032271,regulation of protein polymerization,10/317,156/12743,0.00563622711724455,0.123565404033307,0.110278120633488,RHOA/HSPA1A/HSPA1B/RAC1/BRK1/TBCD/PFN2/ELN/RPS3/MAP1B,10
GO:0045333,GO:0045333,cellular respiration,10/317,156/12743,0.00563622711724455,0.123565404033307,0.110278120633488,PARK7/NDUFB1/COX4I1/NDUFB4/MDH2/NDUFA3/NOP53/NDUFA6/UQCR10/NDUFS5,10
GO:0051272,GO:0051272,positive regulation of cellular component movement,19/317,402/12743,0.00568901664802852,0.123565404033307,0.110278120633488,TUBB2B/MDK/S100A14/RHOA/CALR/EPCAM/GRN/RPS19/RAC1/IGFBP5/RHOB/SELENOK/HGF/PDCD6/HSPA5/JUN/AKIRIN1/VEGFA/MALAT1,19
GO:0050870,GO:0050870,positive regulation of T cell activation,9/317,132/12743,0.00570231746112175,0.123565404033307,0.110278120633488,MDK/RHOA/CD24/CDC42/RAC1/SELENOK/RPS3/IGFBP2/CD47,9
GO:0050920,GO:0050920,regulation of chemotaxis,9/317,132/12743,0.00570231746112175,0.123565404033307,0.110278120633488,TUBB2B/MDK/S100A14/CALR/MIF/RAC1/DUSP1/AKIRIN1/VEGFA,9
GO:0052547,GO:0052547,regulation of peptidase activity,15/317,288/12743,0.00570566260626675,0.123565404033307,0.110278120633488,PCSK1N/TIMP1/SPINT2/RHOA/WFDC2/SPINK7/PARK7/GRN/HGF/PDCD6/PSMB8/RPS3/CSTB/FAM162A/VEGFA,15
GO:1902905,GO:1902905,positive regulation of supramolecular fiber organization,10/317,157/12743,0.00589101293686016,0.126815518012049,0.113178742083516,RHOA/HSPA1A/HSPA1B/CDC42/RAC1/BRK1/PFN2/RPS3/MAP1B/CD47,10
GO:0010951,GO:0010951,negative regulation of endopeptidase activity,9/317,133/12743,0.0059865392558624,0.128104813243008,0.114329396314966,PCSK1N/TIMP1/SPINT2/WFDC2/SPINK7/PARK7/HGF/CSTB/VEGFA,9
GO:0050821,GO:0050821,protein stabilization,10/317,158/12743,0.00615469978078604,0.130704634925822,0.116649652954807,HSPA1A/CALR/PPIB/PARK7/HSPA1B/SOX4/GRN/PFN2/NOP53/CDKN1A,10
GO:1901385,GO:1901385,regulation of voltage-gated calcium channel activity,4/317,30/12743,0.00618074768773009,0.130704634925822,0.116649652954807,S100A1/GEM/CACNA2D1/NPPA,4
GO:0031397,GO:0031397,negative regulation of protein ubiquitination,6/317,67/12743,0.00631575300519984,0.132778550021599,0.11850055500061,HSPA1A/PARK7/HSPA1B/SOX4/TSPO/RPS3,6
GO:0042176,GO:0042176,regulation of protein catabolic process,16/317,320/12743,0.00642931854199061,0.133801233048151,0.119413266475592,TIMP1/HSPA1A/EEF1A2/FHIT/PARK7/GABARAPL2/MYLIP/OS9/ODC1/SNRNP70/SVIP/RBX1/NOP53/SNX3/ATRAID/ZFAND2A,16
GO:0045766,GO:0045766,positive regulation of angiogenesis,8/317,111/12743,0.00646423556130196,0.133801233048151,0.119413266475592,S100A1/MDK/GRN/RHOB/HGF/PDCD6/BTG1/VEGFA,8
GO:0030032,GO:0030032,lamellipodium assembly,5/317,48/12743,0.00658567928150024,0.133801233048151,0.119413266475592,FSCN1/CDC42/RAC1/BRK1/AKIRIN1,5
GO:0043525,GO:0043525,positive regulation of neuron apoptotic process,5/317,48/12743,0.00658567928150024,0.133801233048151,0.119413266475592,RHOA/GRN/GRIK2/ASCL1/JUN,5
GO:0071248,GO:0071248,cellular response to metal ion,9/317,135/12743,0.00658765800543371,0.133801233048151,0.119413266475592,B2M/CALR/FOS/TSPO/HSPA5/SYT1/JUN/MT2A/JUNB,9
GO:0052548,GO:0052548,regulation of endopeptidase activity,14/317,265/12743,0.00660248381844767,0.133801233048151,0.119413266475592,PCSK1N/TIMP1/SPINT2/RHOA/WFDC2/SPINK7/PARK7/HGF/PDCD6/PSMB8/RPS3/CSTB/FAM162A/VEGFA,14
GO:0045666,GO:0045666,positive regulation of neuron differentiation,15/317,293/12743,0.0066560187698663,0.133801233048151,0.119413266475592,TUBB2B/MDK/RHOA/GRN/RGS2/HGF/HSPA5/MAP1B/SNX3/SYT1/ASCL1/DPYSL3/CAMK2B/MACF1/VEGFA,15
GO:0035089,GO:0035089,establishment of apical/basal cell polarity,3/317,16/12743,0.00671376398731968,0.133801233048151,0.119413266475592,FSCN1/RHOA/CDC42,3
GO:0030901,GO:0030901,midbrain development,6/317,68/12743,0.00678586294659066,0.133801233048151,0.119413266475592,S100A1/RHOA/YWHAH/CDC42/BASP1/HSPA5,6
GO:0034332,GO:0034332,adherens junction organization,8/317,112/12743,0.00681547667092489,0.133801233048151,0.119413266475592,APOD/RHOA/RAC1/TBCD/DSP/CDH18/MACF1/VEGFA,8
GO:0051051,GO:0051051,negative regulation of transport,17/317,351/12743,0.00687801323752209,0.133801233048151,0.119413266475592,APOD/FABP5/CHGA/HSPA1A/VAMP8/LRPAP1/PARK7/TMBIM6/RAC1/OS9/ERP29/GEM/RGS2/MAP1B/SVIP/SNX3/CD47,17
GO:0043303,GO:0043303,mast cell degranulation,4/317,31/12743,0.00695989724061314,0.133801233048151,0.119413266475592,CHGA/VAMP8/S100A13/NPPA,4
GO:0097352,GO:0097352,autophagosome maturation,4/317,31/12743,0.00695989724061314,0.133801233048151,0.119413266475592,VAMP8/GABARAP/GABARAPL2/MAP1LC3B,4
GO:1900026,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,4/317,31/12743,0.00695989724061314,0.133801233048151,0.119413266475592,MDK/CALR/CDC42/RAC1,4
GO:1902235,GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,4/317,31/12743,0.00695989724061314,0.133801233048151,0.119413266475592,HSPA1A/PARK7/TMBIM6/ERP29,4
GO:1905517,GO:1905517,macrophage migration,4/317,31/12743,0.00695989724061314,0.133801233048151,0.119413266475592,MDK/CD9/MIF/AKIRIN1,4
GO:0061061,GO:0061061,muscle structure development,21/317,470/12743,0.00702027531062419,0.134244094370713,0.119808505861044,UCHL1/YBX1/RHOA/CALR/EEF2/CD9/FOS/CDC42/IGFBP5/EGR1/BASP1/SERP1/RGS2/CD164/DSP/ELN/BTG1/DDX17/AKIRIN1/NPPA/VEGFA,21
GO:0035914,GO:0035914,skeletal muscle cell differentiation,5/317,49/12743,0.00718813401047593,0.13672667601937,0.122024129567979,EEF2/FOS/EGR1/DDX17/AKIRIN1,5
GO:0060333,GO:0060333,interferon-gamma-mediated signaling pathway,6/317,69/12743,0.00728083288922767,0.137500799697421,0.122715009875629,B2M/HLA-A/HLA-C/HLA-B/MT2A/CAMK2B,6
GO:0010469,GO:0010469,regulation of signaling receptor activity,16/317,325/12743,0.0074192038122818,0.137500799697421,0.122715009875629,GRP/NENF/TIMP1/MDK/BMP8B/CHGB/LRPAP1/MIF/PARK7/GRN/HGF/MANF/GNRH2/CALCB/NPPA/VEGFA,16
GO:0000302,GO:0000302,response to reactive oxygen species,11/317,188/12743,0.00742007097115431,0.137500799697421,0.122715009875629,APOD/EEF2/PSAP/PARK7/FOS/RHOB/DUSP1/HGF/RPS3/ROMO1/JUN,11
GO:0009266,GO:0009266,response to temperature stimulus,11/317,188/12743,0.00742007097115431,0.137500799697421,0.122715009875629,PCSK1N/HSPA1A/HSPA1B/FOS/HSBP1/HSPA6/PDCD6/CDKN1A/IER5/CAMK2B/DNAJB1,11
GO:0016072,GO:0016072,rRNA metabolic process,11/317,188/12743,0.00742007097115431,0.137500799697421,0.122715009875629,RPS27/RPS2/RPS28/RPL14/TRIR/RPS19/RPL35A/RPL27/NOP53/RPS14/DDX17,11
GO:0002279,GO:0002279,mast cell activation involved in immune response,4/317,32/12743,0.00780128708174216,0.140708598279297,0.125577866204611,CHGA/VAMP8/S100A13/NPPA,4
GO:0045933,GO:0045933,positive regulation of muscle contraction,4/317,32/12743,0.00780128708174216,0.140708598279297,0.125577866204611,CHGA/RHOA/RGS2/NPPA,4
GO:0071675,GO:0071675,regulation of mononuclear cell migration,4/317,32/12743,0.00780128708174216,0.140708598279297,0.125577866204611,MDK/S100A14/DUSP1/AKIRIN1,4
GO:0090184,GO:0090184,positive regulation of kidney development,4/317,32/12743,0.00780128708174216,0.140708598279297,0.125577866204611,CD24/EGR1/BASP1/VEGFA,4
GO:0051893,GO:0051893,regulation of focal adhesion assembly,5/317,50/12743,0.00782801659411945,0.140708598279297,0.125577866204611,APOD/RHOA/RAC1/MACF1/VEGFA,5
GO:0090109,GO:0090109,regulation of cell-substrate junction assembly,5/317,50/12743,0.00782801659411945,0.140708598279297,0.125577866204611,APOD/RHOA/RAC1/MACF1/VEGFA,5
GO:0032102,GO:0032102,negative regulation of response to external stimulus,12/317,216/12743,0.00787893705632177,0.140919297101874,0.125765908078915,APOD/NENF/MDK/CD9/MIF/GRN/RPS19/DUSP1/HGF/CDKN1A/CHID1/NUCB2,12
GO:0009408,GO:0009408,response to heat,9/317,139/12743,0.0079280307673786,0.141095399053099,0.12592307336618,HSPA1A/HSPA1B/HSBP1/HSPA6/PDCD6/CDKN1A/IER5/CAMK2B/DNAJB1,9
GO:0010758,GO:0010758,regulation of macrophage chemotaxis,3/317,17/12743,0.00800413262192334,0.141748062935046,0.126505554740069,MDK/MIF/AKIRIN1,3
GO:0010466,GO:0010466,negative regulation of peptidase activity,9/317,140/12743,0.00829346453819904,0.145486770735402,0.12984223034961,PCSK1N/TIMP1/SPINT2/WFDC2/SPINK7/PARK7/HGF/CSTB/VEGFA,9
GO:0009259,GO:0009259,ribonucleotide metabolic process,20/317,447/12743,0.00829618581384074,0.145486770735402,0.12984223034961,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/APRT/NDUFA3/ALDOA/NDUFA6/UQCR10/NME4/NPPA/CTPS1/NDUFS5,20
GO:0042542,GO:0042542,response to hydrogen peroxide,8/317,116/12743,0.00836648221252075,0.146007298805884,0.130306784791841,EEF2/PSAP/PARK7/RHOB/DUSP1/HGF/RPS3/JUN,8
GO:0033135,GO:0033135,regulation of peptidyl-serine phosphorylation,7/317,93/12743,0.0084281243134797,0.14637249713507,0.130632712471325,TERF2IP/MIF/PARK7/PFN2/HGF/CNKSR3/VEGFA,7
GO:0035966,GO:0035966,response to topologically incorrect protein,10/317,166/12743,0.00860954181635012,0.148346657326407,0.132394586496124,HSP90B1/HSPA1A/CALR/PDIA6/TMBIM6/SERP1/PPP1R15A/HSPA5/MANF/DNAJB1,10
GO:0002448,GO:0002448,mast cell mediated immunity,4/317,33/12743,0.00870685527006173,0.148346657326407,0.132394586496124,CHGA/VAMP8/S100A13/NPPA,4
GO:0032435,GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,4/317,33/12743,0.00870685527006173,0.148346657326407,0.132394586496124,FHIT/PARK7/SVIP/NOP53,4
GO:0072595,GO:0072595,maintenance of protein localization in organelle,4/317,33/12743,0.00870685527006173,0.148346657326407,0.132394586496124,PARK7/OS9/TSPO/HSPA5,4
GO:0034620,GO:0034620,cellular response to unfolded protein,8/317,117/12743,0.00879251400982652,0.148399473546133,0.132441723261434,HSP90B1/HSPA1A/CALR/PDIA6/TMBIM6/SERP1/PPP1R15A/HSPA5,8
GO:1902600,GO:1902600,proton transmembrane transport,8/317,117/12743,0.00879251400982652,0.148399473546133,0.132441723261434,CYB5A/PARK7/COX4I1/ATP5F1E/ATP6AP1/ATP5ME/ATP6V0E2/NDUFA4L2,8
GO:0010498,GO:0010498,proteasomal protein catabolic process,17/317,361/12743,0.00897880717380158,0.150835569111293,0.1346158596446,UCHL1/HSP90B1/HSPA1A/FHIT/PARK7/GABARAPL2/OS9/PCNP/PSMB8/HSPA5/SVIP/RBX1/NOP53/RNF187/PSMA6/UBE2S/ZFAND2A,17
GO:0042445,GO:0042445,hormone metabolic process,9/317,142/12743,0.00906262952537417,0.151393142208021,0.135113475572813,PCSK1N/YWHAH/MME/RBP1/PON3/EGR1/TSPO/AKR1B1/SCG5,9
GO:0010975,GO:0010975,regulation of neuron projection development,18/317,391/12743,0.00909622217439016,0.151393142208021,0.135113475572813,B2M/TUBB2B/MDK/RHOA/GRN/YWHAH/MYLIP/RGS2/HGF/HSPA5/MAP1B/SNX3/SYT1/ARC/DPYSL3/CAMK2B/MACF1/VEGFA,18
GO:0032233,GO:0032233,positive regulation of actin filament bundle assembly,5/317,52/12743,0.00922451485321016,0.151935336893769,0.135597366767355,RHOA/CDC42/RAC1/PFN2/CD47,5
GO:0006941,GO:0006941,striated muscle contraction,8/317,118/12743,0.00923456701498731,0.151935336893769,0.135597366767355,CHGA/EEF2/RGS2/PGAM2/DSP/ALDOA/CACNA2D1/NPPA,8
GO:0006163,GO:0006163,purine nucleotide metabolic process,20/317,452/12743,0.00931322682520591,0.151935336893769,0.135597366767355,RHOA/HSPA1A/FHIT/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/APRT/NDUFA3/ALDOA/NDUFA6/UQCR10/NME4/NPPA/NDUFS5,20
GO:0031290,GO:0031290,retinal ganglion cell axon guidance,3/317,18/12743,0.00943046686350704,0.151935336893769,0.135597366767355,RPL24/ALCAM/VEGFA,3
GO:0031640,GO:0031640,killing of cells of other organism,3/317,18/12743,0.00943046686350704,0.151935336893769,0.135597366767355,CHGA/RPS19/ROMO1,3
GO:0033687,GO:0033687,osteoblast proliferation,3/317,18/12743,0.00943046686350704,0.151935336893769,0.135597366767355,RHOA/ATRAID/JUNB,3
GO:0044364,GO:0044364,disruption of cells of other organism,3/317,18/12743,0.00943046686350704,0.151935336893769,0.135597366767355,CHGA/RPS19/ROMO1,3
GO:1903039,GO:1903039,positive regulation of leukocyte cell-cell adhesion,9/317,143/12743,0.00946690277168409,0.151935336893769,0.135597366767355,MDK/RHOA/CD24/CDC42/RAC1/SELENOK/RPS3/IGFBP2/CD47,9
GO:0071622,GO:0071622,regulation of granulocyte chemotaxis,4/317,34/12743,0.00967844942534555,0.154640114151632,0.138011292858261,MDK/S100A14/RAC1/AKIRIN1,4
GO:0050769,GO:0050769,positive regulation of neurogenesis,17/317,365/12743,0.00995109126055874,0.157737283651763,0.140775416315226,TUBB2B/MDK/RHOA/GRN/MME/TSPO/RGS2/HGF/HSPA5/MAP1B/SNX3/SYT1/ASCL1/DPYSL3/CAMK2B/MACF1/VEGFA,17
GO:0050921,GO:0050921,positive regulation of chemotaxis,7/317,96/12743,0.00996004544894304,0.157737283651763,0.140775416315226,TUBB2B/MDK/S100A14/CALR/RAC1/AKIRIN1/VEGFA,7
GO:0061418,GO:0061418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,6/317,74/12743,0.0101534172500783,0.160094451815927,0.142879112549578,CA9/EGR1/PSMB8/RBX1/PSMA6/VEGFA,6
GO:0022613,GO:0022613,ribonucleoprotein complex biogenesis,16/317,337/12743,0.0102991250063133,0.161682770295618,0.144296635344716,RPS27/RPS2/RPS28/RPL38/RPL14/SNRPF/RPS19/RPL35A/RPL27/SRSF9/SNRPE/NOP53/TXNL4A/RPS14/EIF3L/DDX17,16
GO:0051271,GO:0051271,negative regulation of cellular component movement,12/317,225/12743,0.0107025880633733,0.163342203087591,0.145777625360069,APOD/TIMP1/SPINT2/RHOA/CALR/CD9/MIF/IGFBP5/RHOB/PFN2/DUSP1/DPYSL3,12
GO:0033574,GO:0033574,response to testosterone,4/317,35/12743,0.0107178245165624,0.163342203087591,0.145777625360069,CALR/CA9/TSPO/DUSP1,4
GO:0090317,GO:0090317,negative regulation of intracellular protein transport,4/317,35/12743,0.0107178245165624,0.163342203087591,0.145777625360069,APOD/PARK7/OS9/SVIP,4
GO:0042254,GO:0042254,ribosome biogenesis,11/317,198/12743,0.0107266857235286,0.163342203087591,0.145777625360069,RPS27/RPS2/RPS28/RPL38/RPL14/RPS19/RPL35A/RPL27/NOP53/RPS14/DDX17,11
GO:0042246,GO:0042246,tissue regeneration,5/317,54/12743,0.0107838474814568,0.163342203087591,0.145777625360069,APOD/MDK/CD9/CDKN1A/AKIRIN1,5
GO:0071277,GO:0071277,cellular response to calcium ion,5/317,54/12743,0.0107838474814568,0.163342203087591,0.145777625360069,FOS/HSPA5/SYT1/JUN/JUNB,5
GO:0006935,GO:0006935,chemotaxis,18/317,398/12743,0.0107905617716106,0.163342203087591,0.145777625360069,TUBB2B/MDK/S100A14/CHGA/RHOA/CALR/RPL24/TUBB3/RAB13/MIF/RPS19/RAC1/PLP2/DUSP1/HGF/ALCAM/AKIRIN1/VEGFA,18
GO:1903321,GO:1903321,negative regulation of protein modification by small protein conjugation or removal,6/317,75/12743,0.0108123625662128,0.163342203087591,0.145777625360069,HSPA1A/PARK7/HSPA1B/SOX4/TSPO/RPS3,6
GO:0001558,GO:0001558,regulation of cell growth,16/317,339/12743,0.0108553088183339,0.163342203087591,0.145777625360069,RHOA/HSPA1A/HSPA1B/CDC42/IGFBP5/RGS2/SGK1/MEG3/MAP1B/CDKN1A/SYT1/BTG1/CCDC85B/MACF1/NPPA/VEGFA,16
GO:0006700,GO:0006700,C21-steroid hormone biosynthetic process,3/317,19/12743,0.0109954973983858,0.163342203087591,0.145777625360069,EGR1/TSPO/AKR1B1,3
GO:0007263,GO:0007263,nitric oxide mediated signal transduction,3/317,19/12743,0.0109954973983858,0.163342203087591,0.145777625360069,RASD1/MT2A/VEGFA,3
GO:0032069,GO:0032069,regulation of nuclease activity,3/317,19/12743,0.0109954973983858,0.163342203087591,0.145777625360069,HSPA1A/TMBIM6/RPS3,3
GO:1902236,GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,3/317,19/12743,0.0109954973983858,0.163342203087591,0.145777625360069,HSPA1A/PARK7/TMBIM6,3
GO:0051258,GO:0051258,protein polymerization,11/317,199/12743,0.0111110323308384,0.16437926431837,0.146703168916592,RHOA/HSPA1A/HSPA1B/RAC1/BRK1/TBCD/PFN2/ELN/RPS3/MAP1B/UBE2S,11
GO:0042330,GO:0042330,taxis,18/317,400/12743,0.0113182656429233,0.16675887289471,0.148826892491934,TUBB2B/MDK/S100A14/CHGA/RHOA/CALR/RPL24/TUBB3/RAB13/MIF/RPS19/RAC1/PLP2/DUSP1/HGF/ALCAM/AKIRIN1/VEGFA,18
GO:0048259,GO:0048259,regulation of receptor-mediated endocytosis,6/317,76/12743,0.0115010427562988,0.168760198811812,0.15061301104704,B2M/LRPAP1/CD63/RAC1/ARC/VEGFA,6
GO:0009991,GO:0009991,response to extracellular stimulus,18/317,401/12743,0.0115897107968155,0.169369960628259,0.151157203717131,PCSK1N/NENF/HSP90B1/EEF2/FOS/TMBIM6/COX4I1/RPS19/TSPO/HSPA5/MAP1B/WIPI2/MAP1LC3B/IGFBP2/CDKN1A/ASCL1/JUN/NUCB2,18
GO:0019693,GO:0019693,ribose phosphate metabolic process,20/317,462/12743,0.0116492215108643,0.169550410249219,0.151318249158808,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/APRT/NDUFA3/ALDOA/NDUFA6/UQCR10/NME4/NPPA/CTPS1/NDUFS5,20
GO:0034248,GO:0034248,regulation of cellular amide metabolic process,16/317,343/12743,0.0120388310360561,0.173968545216609,0.155261291507276,RPL38/RHOA/CALR/EIF4A2/EEF2/EEF1A2/SOX4/IGFBP5/KHDRBS1/SNRNP70/SERP1/RGS2/PPP1R15A/EIF1B/RPS3/RPS14,16
GO:0009150,GO:0009150,purine ribonucleotide metabolic process,19/317,433/12743,0.0120624064585277,0.173968545216609,0.155261291507276,RHOA/HSPA1A/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/APRT/NDUFA3/ALDOA/NDUFA6/UQCR10/NME4/NPPA/NDUFS5,19
GO:0051495,GO:0051495,positive regulation of cytoskeleton organization,10/317,175/12743,0.0122024665009036,0.173968545216609,0.155261291507276,RHOA/HSPA1A/HSPA1B/CDC42/RAC1/BRK1/PFN2/RPS3/MAP1B/CD47,10
GO:0034333,GO:0034333,adherens junction assembly,6/317,77/12743,0.0122201223482531,0.173968545216609,0.155261291507276,APOD/RHOA/RAC1/TBCD/MACF1/VEGFA,6
GO:0048010,GO:0048010,vascular endothelial growth factor receptor signaling pathway,6/317,77/12743,0.0122201223482531,0.173968545216609,0.155261291507276,RHOA/CDC42/RAC1/BRK1/PDCD6/VEGFA,6
GO:0060538,GO:0060538,skeletal muscle organ development,8/317,124/12743,0.0122431271042565,0.173968545216609,0.155261291507276,RHOA/EEF2/FOS/EGR1/BASP1/ELN/DDX17/AKIRIN1,8
GO:0032434,GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,7/317,100/12743,0.0123063315253365,0.174178196195216,0.155448398214777,HSPA1A/FHIT/PARK7/SVIP/RBX1/NOP53/ZFAND2A,7
GO:1903391,GO:1903391,regulation of adherens junction organization,5/317,56/12743,0.0125142927863744,0.175622442230584,0.156737341020077,APOD/RHOA/RAC1/MACF1/VEGFA,5
GO:0010769,GO:0010769,regulation of cell morphogenesis involved in differentiation,12/317,230/12743,0.012578229223765,0.175622442230584,0.156737341020077,TUBB2B/MDK/RHOA/CALR/YWHAH/CDC42/RAC1/MAP1B/ARC/CAMK2B/MACF1/VEGFA,12
GO:0016486,GO:0016486,peptide hormone processing,3/317,20/12743,0.0127014839999866,0.175622442230584,0.156737341020077,PCSK1N/MME/SCG5,3
GO:0030325,GO:0030325,adrenal gland development,3/317,20/12743,0.0127014839999866,0.175622442230584,0.156737341020077,MDK/TSPO/ASCL1,3
GO:0071624,GO:0071624,positive regulation of granulocyte chemotaxis,3/317,20/12743,0.0127014839999866,0.175622442230584,0.156737341020077,MDK/S100A14/RAC1,3
GO:1903205,GO:1903205,regulation of hydrogen peroxide-induced cell death,3/317,20/12743,0.0127014839999866,0.175622442230584,0.156737341020077,PSAP/PARK7/HGF,3
GO:0002262,GO:0002262,myeloid cell homeostasis,8/317,125/12743,0.0128072068365527,0.176405779990065,0.157436444596946,B2M/HSPA1A/HSPA1B/RPS19/P4HTM/TMEM14C/RPS14/VEGFA,8
GO:0007610,GO:0007610,behavior,19/317,436/12743,0.0129006970176096,0.176621473999733,0.157628944513927,NPW/GRP/MDK/UCHL1/PSAP/PARK7/CNTNAP2/FOS/MME/EGR1/TSPO/SGK1/MEIS2/APRT/CSTB/GRIK2/SLITRK6/ARC/JUN,19
GO:0050671,GO:0050671,positive regulation of lymphocyte proliferation,6/317,78/12743,0.0129702556706341,0.176621473999733,0.157628944513927,CD24/MIF/SELENOK/RPS3/IGFBP2/CDKN1A,6
GO:1900034,GO:1900034,regulation of cellular response to heat,6/317,78/12743,0.0129702556706341,0.176621473999733,0.157628944513927,HSPA1A/HSPA1B/HSBP1/IER5/CAMK2B/DNAJB1,6
GO:0031396,GO:0031396,regulation of protein ubiquitination,10/317,177/12743,0.013135394668587,0.178195259749321,0.159033497318185,RPS2/HSPA1A/PARK7/HSPA1B/SOX4/TSPO/PDCD6/HSPA5/RPS3/UBE2S,10
GO:0051592,GO:0051592,response to calcium ion,7/317,102/12743,0.0136181329583572,0.184049578892083,0.164258287523042,FOS/DUSP1/PDCD6/HSPA5/SYT1/JUN/JUNB,7
GO:0061136,GO:0061136,regulation of proteasomal protein catabolic process,9/317,152/12743,0.0137449275959379,0.184472946828661,0.164636129692924,HSPA1A/FHIT/PARK7/GABARAPL2/OS9/SVIP/RBX1/NOP53/ZFAND2A,9
GO:0032946,GO:0032946,positive regulation of mononuclear cell proliferation,6/317,79/12743,0.0137520861613578,0.184472946828661,0.164636129692924,CD24/MIF/SELENOK/RPS3/IGFBP2/CDKN1A,6
GO:0007566,GO:0007566,embryo implantation,4/317,38/12743,0.0142587600539683,0.188952709195153,0.168634172498888,TIMP1/BSG/CALR/RPL29,4
GO:0035722,GO:0035722,interleukin-12-mediated signaling pathway,4/317,38/12743,0.0142587600539683,0.188952709195153,0.168634172498888,MIF/CDC42/RPLP0/PPIA,4
GO:0045576,GO:0045576,mast cell activation,4/317,38/12743,0.0142587600539683,0.188952709195153,0.168634172498888,CHGA/VAMP8/S100A13/NPPA,4
GO:0006364,GO:0006364,rRNA processing,9/317,153/12743,0.0142962828653913,0.188952709195153,0.168634172498888,RPS27/RPS2/RPS28/RPL14/RPS19/RPL35A/RPL27/RPS14/DDX17,9
GO:0046006,GO:0046006,regulation of activated T cell proliferation,3/317,21/12743,0.0145502432670414,0.190459880854254,0.169979274385116,CD24/RPS3/IGFBP2,3
GO:0070841,GO:0070841,inclusion body assembly,3/317,21/12743,0.0145502432670414,0.190459880854254,0.169979274385116,HSPA1A/HSPA1B/DNAJB1,3
GO:1902903,GO:1902903,regulation of supramolecular fiber organization,13/317,263/12743,0.0145692537510208,0.190459880854254,0.169979274385116,RHOA/HSPA1A/PARK7/HSPA1B/CDC42/RAC1/BRK1/TBCD/PFN2/ELN/RPS3/MAP1B/CD47,13
GO:0006417,GO:0006417,regulation of translation,14/317,292/12743,0.014658264689482,0.19092920854597,0.170398134147754,RPL38/RHOA/CALR/EIF4A2/EEF2/SOX4/IGFBP5/KHDRBS1/SERP1/RGS2/PPP1R15A/EIF1B/RPS3/RPS14,14
GO:0051962,GO:0051962,positive regulation of nervous system development,18/317,412/12743,0.014930145789564,0.193768498604631,0.172932108556303,TUBB2B/MDK/RHOA/GRN/MME/TSPO/RGS2/HGF/HSPA5/MAP1B/SNX3/SLITRK6/SYT1/ASCL1/DPYSL3/CAMK2B/MACF1/VEGFA,18
GO:0035967,GO:0035967,cellular response to topologically incorrect protein,8/317,129/12743,0.0152552448789173,0.195545391016934,0.17451792747811,HSP90B1/HSPA1A/CALR/PDIA6/TMBIM6/SERP1/PPP1R15A/HSPA5,8
GO:0072521,GO:0072521,purine-containing compound metabolic process,20/317,475/12743,0.0153622312917047,0.195545391016934,0.17451792747811,RHOA/HSPA1A/FHIT/PARK7/HSPA1B/NDUFB1/COX4I1/ATP5F1E/NDUFB4/TSPO/ATP5ME/PGAM2/APRT/NDUFA3/ALDOA/NDUFA6/UQCR10/NME4/NPPA/NDUFS5,20
GO:0030038,GO:0030038,contractile actin filament bundle assembly,6/317,81/12743,0.015413353954503,0.195545391016934,0.17451792747811,RHOA/CDC42/RAC1/PFN2/ELN/CD47,6
GO:0033108,GO:0033108,mitochondrial respiratory chain complex assembly,6/317,81/12743,0.015413353954503,0.195545391016934,0.17451792747811,NDUFB1/NDUFB4/NDUFAF3/NDUFA3/NDUFA6/NDUFS5,6
GO:0043149,GO:0043149,stress fiber assembly,6/317,81/12743,0.015413353954503,0.195545391016934,0.17451792747811,RHOA/CDC42/RAC1/PFN2/ELN/CD47,6
GO:0010959,GO:0010959,regulation of metal ion transport,13/317,265/12743,0.0154255557180341,0.195545391016934,0.17451792747811,S100A1/B2M/RHOA/CD63/TSPAN13/TMBIM6/YWHAH/TSPO/GEM/CACNA2D1/CAMK2B/CNKSR3/NPPA,13
GO:1901264,GO:1901264,carbohydrate derivative transport,5/317,59/12743,0.0154478139217828,0.195545391016934,0.17451792747811,MFSD2A/NPC2/VAMP8/PSAP/SLC25A6,5
GO:1903362,GO:1903362,regulation of cellular protein catabolic process,11/317,209/12743,0.0155592036197218,0.19626434039614,0.175159566511217,HSPA1A/FHIT/PARK7/GABARAPL2/MYLIP/OS9/SVIP/RBX1/NOP53/ATRAID/ZFAND2A,11
GO:0040017,GO:0040017,positive regulation of locomotion,18/317,415/12743,0.0159610335948654,0.200169383493658,0.178644690985629,TUBB2B/MDK/S100A14/RHOA/CALR/EPCAM/GRN/RAC1/IGFBP5/RHOB/SELENOK/HGF/PDCD6/HSPA5/JUN/AKIRIN1/VEGFA/MALAT1,18
GO:0002478,GO:0002478,antigen processing and presentation of exogenous peptide antigen,9/317,156/12743,0.0160485294273144,0.200169383493658,0.178644690985629,B2M/HLA-A/HLA-C/HLA-B/PDIA3/CALR/VAMP8/PSMB8/PSMA6,9
GO:2000146,GO:2000146,negative regulation of cell motility,11/317,210/12743,0.0160683789897801,0.200169383493658,0.178644690985629,APOD/TIMP1/SPINT2/RHOA/CALR/MIF/IGFBP5/RHOB/PFN2/DUSP1/DPYSL3,11
GO:0034330,GO:0034330,cell junction organization,12/317,238/12743,0.0160915025951787,0.200169383493658,0.178644690985629,APOD/FSCN1/RHOA/CD9/RAB13/CDC42/RAC1/TBCD/DSP/CDH18/MACF1/VEGFA,12
GO:0031623,GO:0031623,receptor internalization,6/317,82/12743,0.0162940177720102,0.200244830309687,0.178712024825101,RAMP1/CD9/LRPAP1/CD63/ARC/VEGFA,6
GO:0120034,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,6/317,82/12743,0.0162940177720102,0.200244830309687,0.178712024825101,FSCN1/CDC42/RAC1/BRK1/DPYSL3/AKIRIN1,6
GO:0002690,GO:0002690,positive regulation of leukocyte chemotaxis,5/317,60/12743,0.0165193968508182,0.200244830309687,0.178712024825101,MDK/S100A14/CALR/RAC1/AKIRIN1,5
GO:0010996,GO:0010996,response to auditory stimulus,3/317,22/12743,0.0165431751326779,0.200244830309687,0.178712024825101,MDK/CNTNAP2/SLITRK6,3
GO:0043496,GO:0043496,regulation of protein homodimerization activity,3/317,22/12743,0.0165431751326779,0.200244830309687,0.178712024825101,PARK7/HSPA5/PCBD1,3
GO:0051385,GO:0051385,response to mineralocorticoid,3/317,22/12743,0.0165431751326779,0.200244830309687,0.178712024825101,FOS/RPL27/CDKN1A,3
GO:0061844,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,3/317,22/12743,0.0165431751326779,0.200244830309687,0.178712024825101,RPL39/RPS19/ROMO1,3
GO:2001038,GO:2001038,regulation of cellular response to drug,3/317,22/12743,0.0165431751326779,0.200244830309687,0.178712024825101,PSAP/PARK7/HGF,3
GO:0010810,GO:0010810,regulation of cell-substrate adhesion,9/317,157/12743,0.016666216240923,0.201057205993686,0.179437043809019,APOD/MDK/RHOA/CALR/CDC42/RAC1/TBCD/MACF1/VEGFA,9
GO:0050728,GO:0050728,negative regulation of inflammatory response,6/317,83/12743,0.0172088305655561,0.205963287367007,0.183815562519475,APOD/MDK/GRN/RPS19/HGF/CHID1,6
GO:0070665,GO:0070665,positive regulation of leukocyte proliferation,6/317,83/12743,0.0172088305655561,0.205963287367007,0.183815562519475,CD24/MIF/SELENOK/RPS3/IGFBP2/CDKN1A,6
GO:0019884,GO:0019884,antigen processing and presentation of exogenous antigen,9/317,158/12743,0.0173011400539514,0.205963287367007,0.183815562519475,B2M/HLA-A/HLA-C/HLA-B/PDIA3/CALR/VAMP8/PSMB8/PSMA6,9
GO:0034614,GO:0034614,cellular response to reactive oxygen species,8/317,132/12743,0.0173020619707471,0.205963287367007,0.183815562519475,PSAP/PARK7/FOS/RHOB/HGF/RPS3/ROMO1/JUN,8
GO:2000147,GO:2000147,positive regulation of cell motility,17/317,389/12743,0.0176755102394685,0.209714387164651,0.187163297585201,MDK/S100A14/RHOA/CALR/EPCAM/GRN/RAC1/IGFBP5/RHOB/SELENOK/HGF/PDCD6/HSPA5/JUN/AKIRIN1/VEGFA/MALAT1,17
GO:0006091,GO:0006091,generation of precursor metabolites and energy,18/317,420/12743,0.0178019299172872,0.210519533067919,0.187881864224,RHOA/CYB5A/PARK7/NDUFB1/COX4I1/ATP5F1E/NDUFB4/ATP5ME/PGAM2/MDH2/AKR1B1/NDUFA3/NOP53/ALDOA/NDUFA4L2/NDUFA6/UQCR10/NDUFS5,18
GO:0043484,GO:0043484,regulation of RNA splicing,7/317,108/12743,0.0181518635875402,0.213953933105597,0.19094695501233,HSPA1A/TMBIM6/KHDRBS1/SNRNP70/SRSF9/RPS13/DDX17,7
GO:0071241,GO:0071241,cellular response to inorganic substance,9/317,160/12743,0.0186237286318576,0.217343789802039,0.193972292311431,B2M/CALR/FOS/TSPO/HSPA5/SYT1/JUN/MT2A/JUNB,9
GO:1903706,GO:1903706,regulation of hemopoiesis,16/317,361/12743,0.0186711679774301,0.217343789802039,0.193972292311431,B2M/MDK/RHOA/HSPA1A/CLDN18/HSPA1B/FOS/HIST1H4C/ATP6AP1/MEIS2/PSMB8/P4HTM/TMEM176B/PSMA6/TMEM176A/JUN,16
GO:1900745,GO:1900745,positive regulation of p38MAPK cascade,3/317,23/12743,0.0186812881916078,0.217343789802039,0.193972292311431,GADD45G/GADD45B/VEGFA,3
GO:1903427,GO:1903427,negative regulation of reactive oxygen species biosynthetic process,3/317,23/12743,0.0186812881916078,0.217343789802039,0.193972292311431,RHOA/PARK7/TSPO,3
GO:0051899,GO:0051899,membrane depolarization,5/317,62/12743,0.0188082622206277,0.218115169945667,0.194660724103475,PARK7/YWHAH/TSPO/CACNA2D1/JUN,5
GO:0008637,GO:0008637,apoptotic mitochondrial changes,7/317,109/12743,0.0189993279344514,0.219622456348401,0.196005928394679,HSPA1A/YWHAH/GGCT/HGF/YWHAG/JUN/FAM162A,7
GO:0050865,GO:0050865,regulation of cell activation,16/317,363/12743,0.0195535927910625,0.224711920689794,0.200548110464093,MDK/RHOA/CD24/VAMP8/CD9/MIF/GRN/CDC42/RAC1/SELENOK/MAD1L1/RPS3/IGFBP2/CDKN1A/CD47/NPPA,16
GO:0030155,GO:0030155,regulation of cell adhesion,20/317,487/12743,0.0195646261963576,0.224711920689794,0.200548110464093,APOD/MDK/SPINT2/RHOA/CALR/CD24/EPCAM/CD9/CDC42/RAC1/TBCD/CD164/DUSP1/SELENOK/MAD1L1/RPS3/IGFBP2/MACF1/CD47/VEGFA,20
GO:0060537,GO:0060537,muscle tissue development,13/317,274/12743,0.0197629446369278,0.226266834298584,0.201935820493986,RHOA/CALR/EEF2/FOS/IGFBP5/EGR1/RGS2/DSP/ELN/DDX17/AKIRIN1/NPPA/VEGFA,13
GO:0034329,GO:0034329,cell junction assembly,10/317,189/12743,0.0198983215358358,0.227024930647794,0.202612396929793,APOD/FSCN1/RHOA/CD9/RAB13/CDC42/RAC1/TBCD/MACF1/VEGFA,10
GO:0045646,GO:0045646,regulation of erythrocyte differentiation,4/317,42/12743,0.0200186100181782,0.227024930647794,0.202612396929793,B2M/HSPA1A/HSPA1B/P4HTM,4
GO:0060563,GO:0060563,neuroepithelial cell differentiation,4/317,42/12743,0.0200186100181782,0.227024930647794,0.202612396929793,MYCL/SOX4/SLITRK6/ASCL1,4
GO:0031109,GO:0031109,microtubule polymerization or depolymerization,6/317,86/12743,0.0201638836075132,0.227953338267327,0.20344097065773,HSPA1A/HSPA1B/RAC1/TBCD/RPS3/MAP1B,6
GO:0006898,GO:0006898,receptor-mediated endocytosis,10/317,190/12743,0.0205589229448646,0.231690683344164,0.206776430080671,B2M/HSP90B1/RAMP1/CALR/CD9/LRPAP1/CD63/RAC1/ARC/VEGFA,10
GO:0022407,GO:0022407,regulation of cell-cell adhesion,13/317,276/12743,0.020840352309613,0.23262339471597,0.207608844768107,MDK/SPINT2/RHOA/CD24/EPCAM/CD9/CDC42/RAC1/SELENOK/MAD1L1/RPS3/IGFBP2/CD47,13
GO:0033119,GO:0033119,negative regulation of RNA splicing,3/317,24/12743,0.0209652238909525,0.23262339471597,0.207608844768107,TMBIM6/SRSF9/RPS13,3
GO:0036474,GO:0036474,cell death in response to hydrogen peroxide,3/317,24/12743,0.0209652238909525,0.23262339471597,0.207608844768107,PSAP/PARK7/HGF,3
GO:0048246,GO:0048246,macrophage chemotaxis,3/317,24/12743,0.0209652238909525,0.23262339471597,0.207608844768107,MDK/MIF/AKIRIN1,3
GO:0071353,GO:0071353,cellular response to interleukin-4,3/317,24/12743,0.0209652238909525,0.23262339471597,0.207608844768107,RPS2/RPL3/HSPA5,3
GO:0097581,GO:0097581,lamellipodium organization,5/317,64/12743,0.021296590992682,0.235573060365205,0.210241325816015,FSCN1/CDC42/RAC1/BRK1/AKIRIN1,5
GO:0002694,GO:0002694,regulation of leukocyte activation,15/317,337/12743,0.0216040182772593,0.23803804810776,0.212441247531646,MDK/RHOA/CD24/VAMP8/MIF/GRN/CDC42/RAC1/SELENOK/MAD1L1/RPS3/IGFBP2/CDKN1A/CD47/NPPA,15
GO:0071806,GO:0071806,protein transmembrane transport,4/317,43/12743,0.0216518613995098,0.23803804810776,0.212441247531646,SEC61G/TOMM7/HSPA5/AZGP1,4
GO:0051402,GO:0051402,neuron apoptotic process,10/317,192/12743,0.0219279913662806,0.240119862175365,0.214299199153946,MDK/RHOA/PARK7/GRN/SNCB/HSPA5/GRIK2/ASCL1/JUN/FAM162A,10
GO:0044089,GO:0044089,positive regulation of cellular component biogenesis,18/317,430/12743,0.0219748079709861,0.240119862175365,0.214299199153946,FSCN1/CHGA/RHOA/HSPA1A/HSPA1B/CDC42/RAC1/BRK1/PFN2/RPS3/MAP1B/RBX1/SLITRK6/JUN/DPYSL3/CD47/AKIRIN1/VEGFA,18
GO:0032411,GO:0032411,positive regulation of transporter activity,6/317,88/12743,0.022314888245767,0.241610382400368,0.215629440174606,S100A1/PARK7/SGK1/CACNA2D1/CNKSR3/NPPA,6
GO:0046718,GO:0046718,viral entry into host cell,6/317,88/12743,0.022314888245767,0.241610382400368,0.215629440174606,HSPA1A/VAMP8/HSPA1B/RPSA/PPIA/SNX3,6
GO:0016049,GO:0016049,cell growth,17/317,400/12743,0.0224864240912288,0.241610382400368,0.215629440174606,RHOA/HSPA1A/HSPA1B/CDC42/IGFBP5/RGS2/SGK1/MEG3/MAP1B/CDKN1A/SYT1/ALCAM/BTG1/CCDC85B/MACF1/NPPA/VEGFA,17
GO:0050772,GO:0050772,positive regulation of axonogenesis,5/317,65/12743,0.0226173706784667,0.241610382400368,0.215629440174606,TUBB2B/RHOA/MAP1B/MACF1/VEGFA,5
GO:2000177,GO:2000177,regulation of neural precursor cell proliferation,5/317,65/12743,0.0226173706784667,0.241610382400368,0.215629440174606,MDK/SPINT2/RHOA/ASCL1/VEGFA,5
GO:0030308,GO:0030308,negative regulation of cell growth,8/317,139/12743,0.0228339441894528,0.241610382400368,0.215629440174606,HSPA1A/HSPA1B/RGS2/MEG3/CDKN1A/BTG1/CCDC85B/NPPA,8
GO:0048002,GO:0048002,antigen processing and presentation of peptide antigen,9/317,166/12743,0.0230315526580221,0.241610382400368,0.215629440174606,B2M/HLA-A/HLA-C/HLA-B/PDIA3/CALR/VAMP8/PSMB8/PSMA6,9
GO:0097435,GO:0097435,supramolecular fiber organization,19/317,464/12743,0.0231444661656565,0.241610382400368,0.215629440174606,HSP90B1/FSCN1/RHOA/HSPA1A/PARK7/HSPA1B/CDC42/RAC1/BRK1/TBCD/PFN2/DSP/ELN/RPS3/MAP1B/TMSB15A/ALDOA/DPYSL3/CD47,19
GO:0031647,GO:0031647,regulation of protein stability,12/317,251/12743,0.0233196361367186,0.241610382400368,0.215629440174606,HSPA1A/CALR/PPIB/PARK7/HSPA1B/SOX4/TOMM7/GRN/MYLIP/PFN2/NOP53/CDKN1A,12
GO:0007162,GO:0007162,negative regulation of cell adhesion,10/317,194/12743,0.023362207832817,0.241610382400368,0.215629440174606,APOD/MDK/SPINT2/RHOA/EPCAM/CD9/TBCD/CD164/DUSP1/MAD1L1,10
GO:0002090,GO:0002090,regulation of receptor internalization,4/317,44/12743,0.0233643351180213,0.241610382400368,0.215629440174606,LRPAP1/CD63/ARC/VEGFA,4
GO:0019730,GO:0019730,antimicrobial humoral response,4/317,44/12743,0.0233643351180213,0.241610382400368,0.215629440174606,CHGA/RPL39/RPS19/ROMO1,4
GO:0048146,GO:0048146,positive regulation of fibroblast proliferation,4/317,44/12743,0.0233643351180213,0.241610382400368,0.215629440174606,MIF/S100A6/CDKN1A/JUN,4
GO:0090183,GO:0090183,regulation of kidney development,4/317,44/12743,0.0233643351180213,0.241610382400368,0.215629440174606,CD24/EGR1/BASP1/VEGFA,4
GO:1900024,GO:1900024,regulation of substrate adhesion-dependent cell spreading,4/317,44/12743,0.0233643351180213,0.241610382400368,0.215629440174606,MDK/CALR/CDC42/RAC1,4
GO:0050798,GO:0050798,activated T cell proliferation,3/317,25/12743,0.0233952796286423,0.241610382400368,0.215629440174606,CD24/RPS3/IGFBP2,3
GO:0046683,GO:0046683,response to organophosphorus,6/317,89/12743,0.0234462351999674,0.241610382400368,0.215629440174606,HSP90B1/BSG/FOS/IGFBP5/DUSP1/HSPA5,6
GO:0043524,GO:0043524,negative regulation of neuron apoptotic process,7/317,114/12743,0.0236550197500475,0.241610382400368,0.215629440174606,MDK/RHOA/PARK7/GRN/SNCB/GRIK2/JUN,7
GO:0022604,GO:0022604,regulation of cell morphogenesis,16/317,372/12743,0.0239251581473371,0.241610382400368,0.215629440174606,TUBB2B/MDK/RHOA/CALR/YWHAH/S100A13/CDC42/RAC1/MAP1B/ALDOA/SYT1/CFDP1/ARC/CAMK2B/MACF1/VEGFA,16
GO:0033138,GO:0033138,positive regulation of peptidyl-serine phosphorylation,5/317,66/12743,0.0239901236643244,0.241610382400368,0.215629440174606,TERF2IP/MIF/PARK7/PFN2/VEGFA,5
GO:0045637,GO:0045637,regulation of myeloid cell differentiation,10/317,195/12743,0.0241042371828251,0.241610382400368,0.215629440174606,B2M/HSPA1A/CLDN18/HSPA1B/FOS/HIST1H4C/ATP6AP1/MEIS2/P4HTM/JUN,10
GO:0045926,GO:0045926,negative regulation of growth,10/317,195/12743,0.0241042371828251,0.241610382400368,0.215629440174606,HSPA1A/HSPA1B/IGFBP5/RGS2/MEG3/CDKN1A/MT2A/BTG1/CCDC85B/NPPA,10
GO:0006000,GO:0006000,fructose metabolic process,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,AKR1B1/ALDOA,2
GO:0010642,GO:0010642,negative regulation of platelet-derived growth factor receptor signaling pathway,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,APOD/PHF14,2
GO:0019372,GO:0019372,lipoxygenase pathway,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,PON3/PON2,2
GO:0031223,GO:0031223,auditory behavior,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,CNTNAP2/SLITRK6,2
GO:0050746,GO:0050746,regulation of lipoprotein metabolic process,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,APOD/SVIP,2
GO:0051593,GO:0051593,response to folic acid,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,EEF2/ASCL1,2
GO:0070431,GO:0070431,nucleotide-binding oligomerization domain containing 2 signaling pathway,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,HSPA1A/HSPA1B,2
GO:0070862,GO:0070862,negative regulation of protein exit from endoplasmic reticulum,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,OS9/SVIP,2
GO:0072216,GO:0072216,positive regulation of metanephros development,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,EGR1/BASP1,2
GO:0086069,GO:0086069,bundle of His cell to Purkinje myocyte communication,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,DSP/CACNA2D1,2
GO:1903265,GO:1903265,positive regulation of tumor necrosis factor-mediated signaling pathway,2/317,10/12743,0.0243290565866296,0.241610382400368,0.215629440174606,HSPA1A/HSPA1B,2
GO:0097193,GO:0097193,intrinsic apoptotic signaling pathway,12/317,253/12743,0.0246152429860634,0.243492486642058,0.217309157246173,HSPA1A/CD24/FHIT/MIF/PARK7/TMBIM6/ERP29/PPP1R15A/SELENOK/RPS3/CDKN1A/SFPQ,12
GO:0022618,GO:0022618,ribonucleoprotein complex assembly,9/317,168/12743,0.0246540375904615,0.243492486642058,0.217309157246173,RPL38/SNRPF/RPS19/SRSF9/SNRPE/NOP53/TXNL4A/RPS14/EIF3L,9
GO:0006826,GO:0006826,iron ion transport,4/317,45/12743,0.0251568149887413,0.245910614281995,0.219467257838085,B2M/ATP6AP1/FTH1/ATP6V0E2,4
GO:0006984,GO:0006984,ER-nucleus signaling pathway,4/317,45/12743,0.0251568149887413,0.245910614281995,0.219467257838085,HSP90B1/CALR/PPP1R15A/HSPA5,4
GO:2000059,GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,4/317,45/12743,0.0251568149887413,0.245910614281995,0.219467257838085,FHIT/PARK7/SVIP/NOP53,4
GO:0045639,GO:0045639,positive regulation of myeloid cell differentiation,5/317,67/12743,0.0254154761368345,0.245910614281995,0.219467257838085,HSPA1A/HSPA1B/FOS/ATP6AP1/JUN,5
GO:0051492,GO:0051492,regulation of stress fiber assembly,5/317,67/12743,0.0254154761368345,0.245910614281995,0.219467257838085,RHOA/CDC42/RAC1/PFN2/CD47,5
GO:0051591,GO:0051591,response to cAMP,5/317,67/12743,0.0254154761368345,0.245910614281995,0.219467257838085,BSG/FOS/IGFBP5/DUSP1/HSPA5,5
GO:1903426,GO:1903426,regulation of reactive oxygen species biosynthetic process,5/317,67/12743,0.0254154761368345,0.245910614281995,0.219467257838085,RHOA/PARK7/RAC1/TSPO/CD47,5
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,9/317,169/12743,0.0254950716847022,0.245910614281995,0.219467257838085,MDK/RHOA/CD24/CDC42/RAC1/SELENOK/RPS3/IGFBP2/CD47,9
GO:0031667,GO:0031667,response to nutrient levels,16/317,375/12743,0.0255350787687911,0.245910614281995,0.219467257838085,PCSK1N/NENF/HSP90B1/EEF2/TMBIM6/COX4I1/TSPO/HSPA5/MAP1B/WIPI2/MAP1LC3B/IGFBP2/CDKN1A/ASCL1/JUN/NUCB2,16
GO:0070997,GO:0070997,neuron death,13/317,284/12743,0.0255941560774099,0.245910614281995,0.219467257838085,MDK/CHGA/RHOA/PARK7/FOS/GRN/EGR1/SNCB/HSPA5/GRIK2/ASCL1/JUN/FAM162A,13
GO:0007519,GO:0007519,skeletal muscle tissue development,7/317,116/12743,0.0257197193240695,0.245910614281995,0.219467257838085,RHOA/EEF2/FOS/EGR1/ELN/DDX17/AKIRIN1,7
GO:0031960,GO:0031960,response to corticosteroid,7/317,116/12743,0.0257197193240695,0.245910614281995,0.219467257838085,MDK/RHOA/FOS/RPL27/DUSP1/IGFBP2/CDKN1A,7
GO:0070670,GO:0070670,response to interleukin-4,3/317,26/12743,0.0259714308017746,0.247658604064668,0.221027282099146,RPS2/RPL3/HSPA5,3
GO:0002683,GO:0002683,negative regulation of immune system process,14/317,315/12743,0.0262161495897419,0.249330840674926,0.222519699107583,APOD/MDK/CLDN18/MIF/TMBIM6/GRN/RPS19/HIST1H4C/MEIS2/DUSP1/MAD1L1/TMEM176B/TMEM176A/CD47,14
GO:1903037,GO:1903037,regulation of leukocyte cell-cell adhesion,10/317,198/12743,0.0264323150026846,0.250723410117813,0.223762522227976,MDK/RHOA/CD24/CDC42/RAC1/SELENOK/MAD1L1/RPS3/IGFBP2/CD47,10
GO:1901342,GO:1901342,regulation of vasculature development,11/317,227/12743,0.0267623571322916,0.252438617843491,0.225293289565027,S100A1/MDK/RHOA/GRN/EGR1/RHOB/HGF/PDCD6/GTF2I/BTG1/VEGFA,11
GO:0007045,GO:0007045,cell-substrate adherens junction assembly,5/317,68/12743,0.0268940168662189,0.252438617843491,0.225293289565027,APOD/RHOA/RAC1/MACF1/VEGFA,5
GO:0048041,GO:0048041,focal adhesion assembly,5/317,68/12743,0.0268940168662189,0.252438617843491,0.225293289565027,APOD/RHOA/RAC1/MACF1/VEGFA,5
GO:0051651,GO:0051651,maintenance of location in cell,5/317,68/12743,0.0268940168662189,0.252438617843491,0.225293289565027,PARK7/OS9/TSPO/FTH1/HSPA5,5
GO:0071236,GO:0071236,cellular response to antibiotic,7/317,118/12743,0.0279044399520432,0.255879084122633,0.228363794277369,PSAP/PARK7/EGR1/RHOB/HGF/HSPA5/RPS3,7
GO:0071346,GO:0071346,cellular response to interferon-gamma,7/317,118/12743,0.0279044399520432,0.255879084122633,0.228363794277369,B2M/HLA-A/HLA-C/HLA-B/MT2A/CAMK2B/CD47,7
GO:0030336,GO:0030336,negative regulation of cell migration,10/317,200/12743,0.0280712344594142,0.255879084122633,0.228363794277369,APOD/TIMP1/RHOA/CALR/MIF/IGFBP5/RHOB/PFN2/DUSP1/DPYSL3,10
GO:2000377,GO:2000377,regulation of reactive oxygen species metabolic process,8/317,145/12743,0.0284815830081466,0.255879084122633,0.228363794277369,RHOA/PARK7/PON3/RAC1/TSPO/CDKN1A/ROMO1/CD47,8
GO:0002548,GO:0002548,monocyte chemotaxis,3/317,27/12743,0.0286933518458146,0.255879084122633,0.228363794277369,S100A14/RPS19/DUSP1,3
GO:0032467,GO:0032467,positive regulation of cytokinesis,3/317,27/12743,0.0286933518458146,0.255879084122633,0.228363794277369,RHOA/CENPV/CDC42,3
GO:0051491,GO:0051491,positive regulation of filopodium assembly,3/317,27/12743,0.0286933518458146,0.255879084122633,0.228363794277369,FSCN1/CDC42/DPYSL3,3
GO:0051924,GO:0051924,regulation of calcium ion transport,9/317,173/12743,0.0290630876923859,0.255879084122633,0.228363794277369,S100A1/RHOA/TSPAN13/TMBIM6/TSPO/GEM/CACNA2D1/CAMK2B/NPPA,9
GO:0000027,GO:0000027,ribosomal large subunit assembly,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,RPL38/NOP53,2
GO:0000185,GO:0000185,activation of MAPKKK activity,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,GADD45G/GADD45B,2
GO:0002689,GO:0002689,negative regulation of leukocyte chemotaxis,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,MIF/DUSP1,2
GO:0010421,GO:0010421,hydrogen peroxide-mediated programmed cell death,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,PARK7/HGF,2
GO:0010759,GO:0010759,positive regulation of macrophage chemotaxis,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,MDK/AKIRIN1,2
GO:0032105,GO:0032105,negative regulation of response to extracellular stimulus,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,NENF/NUCB2,2
GO:0032108,GO:0032108,negative regulation of response to nutrient levels,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,NENF/NUCB2,2
GO:0033008,GO:0033008,positive regulation of mast cell activation involved in immune response,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,VAMP8/NPPA,2
GO:0043306,GO:0043306,positive regulation of mast cell degranulation,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,VAMP8/NPPA,2
GO:0060004,GO:0060004,reflex,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,SLITRK6/ASCL1,2
GO:0061577,GO:0061577,calcium ion transmembrane transport via high voltage-gated calcium channel,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,CACNA2D1/NPPA,2
GO:0090085,GO:0090085,regulation of protein deubiquitination,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,PARK7/NOP53,2
GO:0090399,GO:0090399,replicative senescence,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,MME/CDKN1A,2
GO:0097468,GO:0097468,programmed cell death in response to reactive oxygen species,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,PARK7/HGF,2
GO:0098885,GO:0098885,modification of postsynaptic actin cytoskeleton,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,RHOA/PFN2,2
GO:1900037,GO:1900037,regulation of cellular response to hypoxia,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,TMBIM6/CHCHD2,2
GO:1900102,GO:1900102,negative regulation of endoplasmic reticulum unfolded protein response,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,PPP1R15A/HSPA5,2
GO:1901387,GO:1901387,positive regulation of voltage-gated calcium channel activity,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,S100A1/CACNA2D1,2
GO:1903209,GO:1903209,positive regulation of oxidative stress-induced cell death,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,PARK7/SFPQ,2
GO:1904996,GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,2/317,11/12743,0.0292534919539366,0.255879084122633,0.228363794277369,MDK/RHOA,2
GO:0042110,GO:0042110,T cell activation,14/317,320/12743,0.0294387431958237,0.256874470361617,0.22925214425363,B2M/MDK/RHOA/CD24/SOX4/CDC42/RAC1/EGR1/SELENOK/MAD1L1/RPS3/IGFBP2/CD47/CTPS1,14
GO:0048545,GO:0048545,response to steroid hormone,13/317,290/12743,0.0296527311413565,0.258115177852728,0.230359435501095,MDK/RHOA/CALR/PARK7/FOS/YWHAH/TSPO/RPL27/DUSP1/IGFBP2/CDKN1A/SCGB2A1/DDX17,13
GO:0060337,GO:0060337,type I interferon signaling pathway,5/317,70/12743,0.0300128291088791,0.259990652160049,0.232033235570992,HLA-A/HLA-C/HLA-B/EGR1/PSMB8,5
GO:0071357,GO:0071357,cellular response to type I interferon,5/317,70/12743,0.0300128291088791,0.259990652160049,0.232033235570992,HLA-A/HLA-C/HLA-B/EGR1/PSMB8,5
GO:0001764,GO:0001764,neuron migration,7/317,120/12743,0.0302118721421053,0.261085770074203,0.233010592836885,TUBB2B/MDK/RAC1/MAP1B/ASCL1/CAMK2B/VEGFA,7
GO:0032642,GO:0032642,regulation of chemokine production,4/317,48/12743,0.0310207041516169,0.266156160919004,0.237535752428409,APOD/MIF/EGR1/SELENOK,4
GO:0045806,GO:0045806,negative regulation of endocytosis,4/317,48/12743,0.0310207041516169,0.266156160919004,0.237535752428409,LRPAP1/RAC1/SNX3/CD47,4
GO:2000378,GO:2000378,negative regulation of reactive oxygen species metabolic process,4/317,48/12743,0.0310207041516169,0.266156160919004,0.237535752428409,RHOA/PARK7/PON3/TSPO,4
GO:0008207,GO:0008207,C21-steroid hormone metabolic process,3/317,28/12743,0.0315604363040749,0.266368299700003,0.237725079418962,EGR1/TSPO/AKR1B1,3
GO:0030970,GO:0030970,retrograde protein transport, ER to cytosol,3/317,28/12743,0.0315604363040749,0.266368299700003,0.237725079418962,HSP90B1/OS9/SVIP,3
GO:0050829,GO:0050829,defense response to Gram-negative bacterium,3/317,28/12743,0.0315604363040749,0.266368299700003,0.237725079418962,CHGA/RPS19/ROMO1,3
GO:0071480,GO:0071480,cellular response to gamma radiation,3/317,28/12743,0.0315604363040749,0.266368299700003,0.237725079418962,EGR1/HSPA5/CDKN1A,3
GO:1901031,GO:1901031,regulation of response to reactive oxygen species,3/317,28/12743,0.0315604363040749,0.266368299700003,0.237725079418962,PSAP/PARK7/HGF,3
GO:1903513,GO:1903513,endoplasmic reticulum to cytosol transport,3/317,28/12743,0.0315604363040749,0.266368299700003,0.237725079418962,HSP90B1/OS9/SVIP,3
GO:0045765,GO:0045765,regulation of angiogenesis,10/317,204/12743,0.0315640878086791,0.266368299700003,0.237725079418962,S100A1/MDK/RHOA/GRN/RHOB/HGF/PDCD6/GTF2I/BTG1/VEGFA,10
GO:0048145,GO:0048145,regulation of fibroblast proliferation,5/317,71/12743,0.0316540883299407,0.266502219077604,0.237844598125624,MIF/S100A6/FTH1/CDKN1A/JUN,5
GO:0014706,GO:0014706,striated muscle tissue development,12/317,263/12743,0.031896895944864,0.267919020845294,0.239109047810982,RHOA/CALR/EEF2/FOS/EGR1/RGS2/DSP/ELN/DDX17/AKIRIN1/NPPA/VEGFA,12
GO:0097305,GO:0097305,response to alcohol,9/317,177/12743,0.0329676553765423,0.276190396435551,0.246490982603194,RHOA/EEF2/CLDN18/FOS/GNG2/RGS2/RPL27/CDKN1A/GGH,9
GO:0046686,GO:0046686,response to cadmium ion,4/317,49/12743,0.0331391548308294,0.276190396435551,0.246490982603194,B2M/CYB5A/FOS/JUN,4
GO:0060135,GO:0060135,maternal process involved in female pregnancy,4/317,49/12743,0.0331391548308294,0.276190396435551,0.246490982603194,BSG/RGS2/AKR1B1/JUNB,4
GO:0048144,GO:0048144,fibroblast proliferation,5/317,72/12743,0.0333505108598513,0.276190396435551,0.246490982603194,MIF/S100A6/FTH1/CDKN1A/JUN,5
GO:0007638,GO:0007638,mechanosensory behavior,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,CNTNAP2/SLITRK6,2
GO:0009415,GO:0009415,response to water,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,CD9/AKR1B1,2
GO:0010984,GO:0010984,regulation of lipoprotein particle clearance,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,LRPAP1/MYLIP,2
GO:0014733,GO:0014733,regulation of skeletal muscle adaptation,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,IGFBP5/CAMK2B,2
GO:0032095,GO:0032095,regulation of response to food,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,NENF/NUCB2,2
GO:0044849,GO:0044849,estrous cycle,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,MDK/EGR1,2
GO:0045198,GO:0045198,establishment of epithelial cell apical/basal polarity,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,RHOA/CDC42,2
GO:0048569,GO:0048569,post-embryonic animal organ development,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,MFAP2/VEGFA,2
GO:0055119,GO:0055119,relaxation of cardiac muscle,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,CHGA/RGS2,2
GO:0061318,GO:0061318,renal filtration cell differentiation,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,CD24/BASP1,2
GO:0071801,GO:0071801,regulation of podosome assembly,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,FSCN1/RHOA,2
GO:0071850,GO:0071850,mitotic cell cycle arrest,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,DUSP1/CDKN1A,2
GO:0072112,GO:0072112,glomerular visceral epithelial cell differentiation,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,CD24/BASP1,2
GO:1900016,GO:1900016,negative regulation of cytokine production involved in inflammatory response,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,APOD/CHID1,2
GO:1900409,GO:1900409,positive regulation of cellular response to oxidative stress,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,PARK7/SFPQ,2
GO:1905523,GO:1905523,positive regulation of macrophage migration,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,MDK/AKIRIN1,2
GO:2001044,GO:2001044,regulation of integrin-mediated signaling pathway,2/317,12/12743,0.0345363528832043,0.276190396435551,0.246490982603194,TIMP1/CD63,2
GO:0000413,GO:0000413,protein peptidyl-prolyl isomerization,3/317,29/12743,0.034571815965507,0.276190396435551,0.246490982603194,PPIB/PPIA/NKTR,3
GO:1903050,GO:1903050,regulation of proteolysis involved in cellular protein catabolic process,9/317,179/12743,0.0350502334649353,0.277959180342789,0.248069564946876,HSPA1A/FHIT/PARK7/GABARAPL2/OS9/SVIP/RBX1/NOP53/ZFAND2A,9
GO:0034599,GO:0034599,cellular response to oxidative stress,11/317,237/12743,0.0350577817382003,0.277959180342789,0.248069564946876,HSPA1A/PSAP/PARK7/HSPA1B/FOS/RHOB/HGF/RPS3/ROMO1/SFPQ/JUN,11
GO:0040013,GO:0040013,negative regulation of locomotion,11/317,237/12743,0.0350577817382003,0.277959180342789,0.248069564946876,APOD/TIMP1/SPINT2/RHOA/CALR/MIF/IGFBP5/RHOB/PFN2/DUSP1/DPYSL3,11
GO:0034340,GO:0034340,response to type I interferon,5/317,73/12743,0.0351024945412033,0.277959180342789,0.248069564946876,HLA-A/HLA-C/HLA-B/EGR1/PSMB8,5
GO:2000058,GO:2000058,regulation of ubiquitin-dependent protein catabolic process,7/317,124/12743,0.0352048114327918,0.278156696925026,0.248245842098669,HSPA1A/FHIT/PARK7/SVIP/RBX1/NOP53/ZFAND2A,7
GO:1903201,GO:1903201,regulation of oxidative stress-induced cell death,4/317,50/12743,0.035340123373152,0.278613472645793,0.248653499633812,PSAP/PARK7/HGF/SFPQ,4
GO:0071826,GO:0071826,ribonucleoprotein complex subunit organization,9/317,180/12743,0.0361247698074285,0.284176252642681,0.253618100594361,RPL38/SNRPF/RPS19/SRSF9/SNRPE/NOP53/TXNL4A/RPS14/EIF3L,9
GO:0002764,GO:0002764,immune response-regulating signaling pathway,17/317,424/12743,0.0363749219177808,0.285519310686511,0.254816736394842,S100A1/HSP90B1/S100A14/HSPA1A/CD24/HSPA1B/FOS/CDC42/RAC1/BRK1/PSMB8/RPS3/NOP53/PSMA6/JUN/CNPY3/CD47,17
GO:0030855,GO:0030855,epithelial cell differentiation,19/317,489/12743,0.0367452566530622,0.287797816269627,0.256850228823607,TAGLN2/SPINT2/RHOA/CD24/MYCL/RAB13/PSAP/SOX4/CDC42/BASP1/DSP/KRT12/KRT10/SLITRK6/CDKN1A/ASCL1/JUN/BTG1/VEGFA,19
GO:0110020,GO:0110020,regulation of actomyosin structure organization,5/317,74/12743,0.0369103986927341,0.288462789783433,0.257443696145203,RHOA/CDC42/RAC1/PFN2/CD47,5
GO:0050863,GO:0050863,regulation of T cell activation,10/317,210/12743,0.0373614461304569,0.29104363281416,0.259747014952803,MDK/RHOA/CD24/CDC42/RAC1/SELENOK/MAD1L1/RPS3/IGFBP2/CD47,10
GO:0030521,GO:0030521,androgen receptor signaling pathway,4/317,51/12743,0.0376238406971549,0.29104363281416,0.259747014952803,RHOA/PARK7/SCGB2A1/DDX17,4
GO:1903524,GO:1903524,positive regulation of blood circulation,4/317,51/12743,0.0376238406971549,0.29104363281416,0.259747014952803,CHGA/RHOA/RGS2/NPPA,4
GO:0006734,GO:0006734,NADH metabolic process,3/317,30/12743,0.0377263791074822,0.29104363281416,0.259747014952803,PGAM2/MDH2/ALDOA,3
GO:0014888,GO:0014888,striated muscle adaptation,3/317,30/12743,0.0377263791074822,0.29104363281416,0.259747014952803,IGFBP5/CAMK2B/NPPA,3
GO:0032757,GO:0032757,positive regulation of interleukin-8 production,3/317,30/12743,0.0377263791074822,0.29104363281416,0.259747014952803,HSPA1A/PARK7/HSPA1B,3
GO:0030260,GO:0030260,entry into host cell,6/317,100/12743,0.0384850339054643,0.29436956785137,0.262715304241557,HSPA1A/VAMP8/HSPA1B/RPSA/PPIA/SNX3,6
GO:0044409,GO:0044409,entry into host,6/317,100/12743,0.0384850339054643,0.29436956785137,0.262715304241557,HSPA1A/VAMP8/HSPA1B/RPSA/PPIA/SNX3,6
GO:0051806,GO:0051806,entry into cell of other organism involved in symbiotic interaction,6/317,100/12743,0.0384850339054643,0.29436956785137,0.262715304241557,HSPA1A/VAMP8/HSPA1B/RPSA/PPIA/SNX3,6
GO:0051828,GO:0051828,entry into other organism involved in symbiotic interaction,6/317,100/12743,0.0384850339054643,0.29436956785137,0.262715304241557,HSPA1A/VAMP8/HSPA1B/RPSA/PPIA/SNX3,6
GO:0010632,GO:0010632,regulation of epithelial cell migration,9/317,183/12743,0.0394835396722698,0.295222858672845,0.263476838660371,RHOA/CALR/GRN/RHOB/PFN2/PDCD6/JUN/MACF1/VEGFA,9
GO:0071900,GO:0071900,regulation of protein serine/threonine kinase activity,16/317,397/12743,0.0399265473985087,0.295222858672845,0.263476838660371,UCHL1/RHOA/CD24/DIRAS3/GADD45G/MIF/ERP29/RGS2/DUSP1/HGF/GADD45B/RPS3/CDKN1A/YWHAG/SERTAD1/VEGFA,16
GO:0042102,GO:0042102,positive regulation of T cell proliferation,4/317,52/12743,0.0399904511841503,0.295222858672845,0.263476838660371,CD24/SELENOK/RPS3/IGFBP2,4
GO:0014074,GO:0014074,response to purine-containing compound,6/317,101/12743,0.0400977545259952,0.295222858672845,0.263476838660371,HSP90B1/BSG/FOS/IGFBP5/DUSP1/HSPA5,6
GO:0046887,GO:0046887,positive regulation of hormone secretion,6/317,101/12743,0.0400977545259952,0.295222858672845,0.263476838660371,GRP/VAMP8/SOX4/RAC1/SERP1/NPPA,6
GO:0006241,GO:0006241,CTP biosynthetic process,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,NME4/CTPS1,2
GO:0009209,GO:0009209,pyrimidine ribonucleoside triphosphate biosynthetic process,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,NME4/CTPS1,2
GO:0010042,GO:0010042,response to manganese ion,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,TSPO/HSPA5,2
GO:0030490,GO:0030490,maturation of SSU-rRNA,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,RPS19/RPS14,2
GO:0033005,GO:0033005,positive regulation of mast cell activation,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,VAMP8/NPPA,2
GO:0036035,GO:0036035,osteoclast development,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,CLDN18/ATP6AP1,2
GO:0042447,GO:0042447,hormone catabolic process,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,YWHAH/PON3,2
GO:0046036,GO:0046036,CTP metabolic process,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,NME4/CTPS1,2
GO:0048012,GO:0048012,hepatocyte growth factor receptor signaling pathway,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,RAC1/HGF,2
GO:0061548,GO:0061548,ganglion development,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,TUBB3/ASCL1,2
GO:0072311,GO:0072311,glomerular epithelial cell differentiation,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,CD24/BASP1,2
GO:1903010,GO:1903010,regulation of bone development,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,CLDN18/ATP6AP1,2
GO:1904152,GO:1904152,regulation of retrograde protein transport, ER to cytosol,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,OS9/SVIP,2
GO:1904293,GO:1904293,negative regulation of ERAD pathway,2/317,13/12743,0.0401568784119669,0.295222858672845,0.263476838660371,OS9/SVIP,2
GO:0050727,GO:0050727,regulation of inflammatory response,11/317,243/12743,0.0408273085641382,0.299141830476191,0.266974394053563,APOD/MDK/VAMP8/PARK7/NEAT1/GRN/RPS19/HGF/PSMA6/CHID1/NPPA,11
GO:0035088,GO:0035088,establishment or maintenance of apical/basal cell polarity,3/317,31/12743,0.0410227878789324,0.299141830476191,0.266974394053563,FSCN1/RHOA/CDC42,3
GO:0042455,GO:0042455,ribonucleoside biosynthetic process,3/317,31/12743,0.0410227878789324,0.299141830476191,0.266974394053563,APRT/NME4/CTPS1,3
GO:0061245,GO:0061245,establishment or maintenance of bipolar cell polarity,3/317,31/12743,0.0410227878789324,0.299141830476191,0.266974394053563,FSCN1/RHOA/CDC42,3
GO:1905330,GO:1905330,regulation of morphogenesis of an epithelium,8/317,156/12743,0.0412097718962228,0.299897024224536,0.267648380012118,MDK/RHOA/CDC42/RAC1/HGF/PSMB8/PSMA6/VEGFA,8
GO:0042742,GO:0042742,defense response to bacterium,6/317,102/12743,0.0417527308739726,0.30323447978168,0.270626950991746,S100A14/CHGA/RPL39/GRN/RPS19/ROMO1,6
GO:0032507,GO:0032507,maintenance of protein location in cell,4/317,53/12743,0.0424400145733068,0.306816354281956,0.273823657961028,PARK7/OS9/TSPO/HSPA5,4
GO:0032602,GO:0032602,chemokine production,4/317,53/12743,0.0424400145733068,0.306816354281956,0.273823657961028,APOD/MIF/EGR1/SELENOK,4
GO:0007015,GO:0007015,actin filament organization,12/317,275/12743,0.0425372504124046,0.306816354281956,0.273823657961028,HSP90B1/FSCN1/RHOA/CDC42/RAC1/BRK1/PFN2/ELN/TMSB15A/ALDOA/DPYSL3/CD47,12
GO:0032231,GO:0032231,regulation of actin filament bundle assembly,5/317,77/12743,0.0426726501087561,0.306816354281956,0.273823657961028,RHOA/CDC42/RAC1/PFN2/CD47,5
GO:0070301,GO:0070301,cellular response to hydrogen peroxide,5/317,77/12743,0.0426726501087561,0.306816354281956,0.273823657961028,PSAP/PARK7/RHOB/HGF/RPS3,5
GO:0035821,GO:0035821,modification of morphology or physiology of other organism,6/317,103/12743,0.0434501999618752,0.310321968695069,0.276952305272695,CHGA/PPIB/RPS19/SLC25A6/ROMO1/JUN,6
GO:0045727,GO:0045727,positive regulation of translation,6/317,103/12743,0.0434501999618752,0.310321968695069,0.276952305272695,RHOA/EEF2/SOX4/KHDRBS1/SERP1/PPP1R15A,6
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,7/317,130/12743,0.0436720941573756,0.310321968695069,0.276952305272695,CD24/MIF/SELENOK/MAD1L1/RPS3/IGFBP2/CDKN1A,7
GO:0061564,GO:0061564,axon development,15/317,370/12743,0.0438169882561194,0.310321968695069,0.276952305272695,APOD/TUBB2B/UCHL1/RHOA/RPL24/TUBB3/GRN/S100A6/TSPO/MAP1B/NCAM2/ALCAM/JUN/MACF1/VEGFA,15
GO:0002686,GO:0002686,negative regulation of leukocyte migration,3/317,32/12743,0.0444594948579521,0.310321968695069,0.276952305272695,APOD/MIF/DUSP1,3
GO:0010043,GO:0010043,response to zinc ion,3/317,32/12743,0.0444594948579521,0.310321968695069,0.276952305272695,TSPO/MT2A/GGH,3
GO:0014009,GO:0014009,glial cell proliferation,3/317,32/12743,0.0444594948579521,0.310321968695069,0.276952305272695,EEF2/SOX4/TSPO,3
GO:0032722,GO:0032722,positive regulation of chemokine production,3/317,32/12743,0.0444594948579521,0.310321968695069,0.276952305272695,MIF/EGR1/SELENOK,3
GO:0045823,GO:0045823,positive regulation of heart contraction,3/317,32/12743,0.0444594948579521,0.310321968695069,0.276952305272695,CHGA/RGS2/NPPA,3
GO:0048662,GO:0048662,negative regulation of smooth muscle cell proliferation,3/317,32/12743,0.0444594948579521,0.310321968695069,0.276952305272695,APOD/IGFBP5/CDKN1A,3
GO:0051590,GO:0051590,positive regulation of neurotransmitter transport,3/317,32/12743,0.0444594948579521,0.310321968695069,0.276952305272695,VAMP8/SYT1/NPPA,3
GO:0051346,GO:0051346,negative regulation of hydrolase activity,13/317,308/12743,0.0446230172338884,0.310321968695069,0.276952305272695,PCSK1N/TIMP1/SPINT2/WFDC2/BOD1/SPINK7/PARK7/TMBIM6/RGS2/PPP1R15A/HGF/CSTB/VEGFA,13
GO:0001906,GO:0001906,cell killing,5/317,78/12743,0.0447070606867096,0.310321968695069,0.276952305272695,B2M/CHGA/RPS19/ROMO1/TUBB4B,5
GO:1901888,GO:1901888,regulation of cell junction assembly,5/317,78/12743,0.0447070606867096,0.310321968695069,0.276952305272695,APOD/RHOA/RAC1/MACF1/VEGFA,5
GO:1903409,GO:1903409,reactive oxygen species biosynthetic process,5/317,78/12743,0.0447070606867096,0.310321968695069,0.276952305272695,RHOA/PARK7/RAC1/TSPO/CD47,5
GO:0000422,GO:0000422,autophagy of mitochondrion,4/317,54/12743,0.0449725079406548,0.310321968695069,0.276952305272695,PARK7/TOMM7/TSPO/MAP1LC3B,4
GO:0001836,GO:0001836,release of cytochrome c from mitochondria,4/317,54/12743,0.0449725079406548,0.310321968695069,0.276952305272695,GGCT/HGF/JUN/FAM162A,4
GO:0032418,GO:0032418,lysosome localization,4/317,54/12743,0.0449725079406548,0.310321968695069,0.276952305272695,CHGA/VAMP8/S100A13/NPPA,4
GO:0061726,GO:0061726,mitochondrion disassembly,4/317,54/12743,0.0449725079406548,0.310321968695069,0.276952305272695,PARK7/TOMM7/TSPO/MAP1LC3B,4
GO:1901224,GO:1901224,positive regulation of NIK/NF-kappaB signaling,4/317,54/12743,0.0449725079406548,0.310321968695069,0.276952305272695,RHOA/CALR/TERF2IP/RPS3,4
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,7/317,131/12743,0.0452004113270348,0.310321968695069,0.276952305272695,CD24/MIF/SELENOK/MAD1L1/RPS3/IGFBP2/CDKN1A,7
GO:0006914,GO:0006914,autophagy,17/317,436/12743,0.0453040097085894,0.310321968695069,0.276952305272695,UCHL1/VAMP8/EEF1A2/PSAP/PARK7/GABARAP/GABARAPL2/TMBIM6/TOMM7/TSPO/SNRNP70/HGF/SVIP/WIPI2/MAP1LC3B/ATP6V0E2/WDR6,17
GO:0061919,GO:0061919,process utilizing autophagic mechanism,17/317,436/12743,0.0453040097085894,0.310321968695069,0.276952305272695,UCHL1/VAMP8/EEF1A2/PSAP/PARK7/GABARAP/GABARAPL2/TMBIM6/TOMM7/TSPO/SNRNP70/HGF/SVIP/WIPI2/MAP1LC3B/ATP6V0E2/WDR6,17
GO:0007035,GO:0007035,vacuolar acidification,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,GRN/ATP6V0E2,2
GO:0009208,GO:0009208,pyrimidine ribonucleoside triphosphate metabolic process,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,NME4/CTPS1,2
GO:0010224,GO:0010224,response to UV-B,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,MME/CDKN1A,2
GO:0032098,GO:0032098,regulation of appetite,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,NENF/NUCB2,2
GO:0043567,GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,IGFBP5/IGFBP2,2
GO:0048485,GO:0048485,sympathetic nervous system development,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,SOX4/ASCL1,2
GO:0050765,GO:0050765,negative regulation of phagocytosis,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,SNX3/CD47,2
GO:0051412,GO:0051412,response to corticosterone,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,FOS/CDKN1A,2
GO:0070262,GO:0070262,peptidyl-serine dephosphorylation,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,PPP1R15A/DUSP1,2
GO:0071875,GO:0071875,adrenergic receptor signaling pathway,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,CHGA/RGS2,2
GO:1902884,GO:1902884,positive regulation of response to oxidative stress,2/317,14/12743,0.0460951130133983,0.310321968695069,0.276952305272695,PARK7/SFPQ,2
GO:0034341,GO:0034341,response to interferon-gamma,7/317,132/12743,0.0467627188909869,0.314227989557192,0.280438302370346,B2M/HLA-A/HLA-C/HLA-B/MT2A/CAMK2B/CD47,7
GO:0019935,GO:0019935,cyclic-nucleotide-mediated signaling,6/317,105/12743,0.046973462702444,0.31446852591301,0.280652973276584,CHGA/RAMP1/GNG2/RGS2/PCLO/NPPA,6
GO:0051384,GO:0051384,response to glucocorticoid,6/317,105/12743,0.046973462702444,0.31446852591301,0.280652973276584,MDK/RHOA/FOS/DUSP1/IGFBP2/CDKN1A,6
GO:0006521,GO:0006521,regulation of cellular amino acid metabolic process,4/317,55/12743,0.047587827751966,0.317663442989676,0.283504333279418,PARK7/ODC1/PSMB8/PSMA6,4
GO:1903532,GO:1903532,positive regulation of secretion by cell,12/317,280/12743,0.0476274258056843,0.317663442989676,0.283504333279418,GRP/MDK/VAMP8/MIF/SOX4/RAC1/ATP6AP1/PPIA/SERP1/SELENOK/SYT1/NPPA,12
GO:2000404,GO:2000404,regulation of T cell migration,3/317,33/12743,0.0480347588167412,0.319474250066437,0.285120419940707,APOD/RHOA/SELENOK,3
GO:0007584,GO:0007584,response to nutrient,8/317,161/12743,0.0480766534870494,0.319474250066437,0.285120419940707,HSP90B1/EEF2/TMBIM6/COX4I1/TSPO/MAP1B/IGFBP2/ASCL1,8
GO:0030335,GO:0030335,positive regulation of cell migration,15/317,375/12743,0.0482368635252739,0.319947461943468,0.285542746212924,MDK/S100A14/RHOA/CALR/GRN/RAC1/IGFBP5/RHOB/SELENOK/HGF/PDCD6/HSPA5/JUN/AKIRIN1/VEGFA,15
GO:1903708,GO:1903708,positive regulation of hemopoiesis,7/317,133/12743,0.0483591890835695,0.320168111888458,0.28573966914165,MDK/RHOA/HSPA1A/HSPA1B/FOS/ATP6AP1/JUN,7
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,10/317,220/12743,0.048594019029829,0.321131430904844,0.286599400160446,MDK/RHOA/CD24/CDC42/RAC1/SELENOK/MAD1L1/RPS3/IGFBP2/CD47,10
GO:0030968,GO:0030968,endoplasmic reticulum unfolded protein response,6/317,106/12743,0.0487996284910845,0.321308909204119,0.286757793793764,HSP90B1/CALR/PDIA6/SERP1/PPP1R15A/HSPA5,6
GO:0048660,GO:0048660,regulation of smooth muscle cell proliferation,6/317,106/12743,0.0487996284910845,0.321308909204119,0.286757793793764,APOD/IGFBP5/AKR1B1/ELN/CDKN1A/JUN,6
GO:0019882,GO:0019882,antigen processing and presentation,9/317,191/12743,0.0494602404917732,0.325063189338071,0.290108367206629,B2M/HLA-A/HLA-C/HLA-B/PDIA3/CALR/VAMP8/PSMB8/PSMA6,9
GO:0055117,GO:0055117,regulation of cardiac muscle contraction,4/317,56/12743,0.0502857919800885,0.328330029812339,0.293023916512118,CHGA/RGS2/DSP/NPPA,4
GO:2001023,GO:2001023,regulation of response to drug,4/317,56/12743,0.0502857919800885,0.328330029812339,0.293023916512118,PSAP/PARK7/RGS2/HGF,4
GO:0031333,GO:0031333,negative regulation of protein complex assembly,6/317,107/12743,0.0506690312179059,0.328330029812339,0.293023916512118,PARK7/CDC42/TBCD/PFN2/SVIP/NOP53,6
GO:0048659,GO:0048659,smooth muscle cell proliferation,6/317,107/12743,0.0506690312179059,0.328330029812339,0.293023916512118,APOD/IGFBP5/AKR1B1/ELN/CDKN1A/JUN,6
GO:0005996,GO:0005996,monosaccharide metabolic process,10/317,222/12743,0.0510857837467134,0.328330029812339,0.293023916512118,APOD/FABP5/TFF3/CYB5A/IGFBP5/SERP1/PGAM2/MDH2/AKR1B1/ALDOA,10
GO:0002065,GO:0002065,columnar/cuboidal epithelial cell differentiation,5/317,81/12743,0.0511536272150015,0.328330029812339,0.293023916512118,MYCL/SOX4/SLITRK6/CDKN1A/ASCL1,5
GO:0051224,GO:0051224,negative regulation of protein transport,7/317,135/12743,0.0516552444478709,0.328330029812339,0.293023916512118,APOD/PARK7/TMBIM6/OS9/ERP29/SVIP/SNX3,7
GO:2000242,GO:2000242,negative regulation of reproductive process,3/317,34/12743,0.0517466597255859,0.328330029812339,0.293023916512118,TIMP1/CALR/DUSP1,3
GO:1901214,GO:1901214,regulation of neuron death,11/317,253/12743,0.0518519570167281,0.328330029812339,0.293023916512118,MDK/CHGA/RHOA/PARK7/FOS/GRN/EGR1/SNCB/GRIK2/ASCL1/JUN,11
GO:0051249,GO:0051249,regulation of lymphocyte activation,12/317,284/12743,0.0519903827257589,0.328330029812339,0.293023916512118,MDK/RHOA/CD24/MIF/CDC42/RAC1/SELENOK/MAD1L1/RPS3/IGFBP2/CDKN1A/CD47,12
GO:0001817,GO:0001817,regulation of cytokine production,18/317,477/12743,0.0521934444866691,0.328330029812339,0.293023916512118,APOD/B2M/MDK/HSPA1A/CD24/MIF/PARK7/HSPA1B/RAC1/EGR1/TSPO/SELENOK/HGF/RPS3/NOP53/CHID1/CD47/HILPDA,18
GO:0003081,GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,RHOA/MME,2
GO:0003159,GO:0003159,morphogenesis of an endothelium,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,RHOA/RHOB,2
GO:0021544,GO:0021544,subpallium development,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,CNTNAP2/ASCL1,2
GO:0042474,GO:0042474,middle ear morphogenesis,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,RPL38/TSHZ1,2
GO:0042921,GO:0042921,glucocorticoid receptor signaling pathway,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,CALR/YWHAH,2
GO:0045056,GO:0045056,transcytosis,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,MFSD2A/LRPAP1,2
GO:0045663,GO:0045663,positive regulation of myoblast differentiation,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,BTG1/AKIRIN1,2
GO:0045672,GO:0045672,positive regulation of osteoclast differentiation,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,FOS/ATP6AP1,2
GO:0051953,GO:0051953,negative regulation of amine transport,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,CHGA/RGS2,2
GO:0061154,GO:0061154,endothelial tube morphogenesis,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,RHOA/RHOB,2
GO:0061684,GO:0061684,chaperone-mediated autophagy,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,EEF1A2/SNRNP70,2
GO:0071800,GO:0071800,podosome assembly,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,FSCN1/RHOA,2
GO:0099010,GO:0099010,modification of postsynaptic structure,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,RHOA/PFN2,2
GO:1904994,GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,MDK/RHOA,2
GO:2000269,GO:2000269,regulation of fibroblast apoptotic process,2/317,15/12743,0.0523318795778777,0.328330029812339,0.293023916512118,CFDP1/BTG1,2
GO:0010821,GO:0010821,regulation of mitochondrion organization,8/317,164/12743,0.0525347396323472,0.328456328657893,0.293136634140768,HSPA1A/PARK7/TOMM7/YWHAH/TSPO/HGF/YWHAG/FAM162A,8
GO:1901215,GO:1901215,negative regulation of neuron death,8/317,164/12743,0.0525347396323472,0.328456328657893,0.293136634140768,MDK/CHGA/RHOA/PARK7/GRN/SNCB/GRIK2/JUN,8
GO:0030433,GO:0030433,ubiquitin-dependent ERAD pathway,4/317,57/12743,0.0530661422778857,0.331202745640623,0.295587722337346,HSP90B1/OS9/HSPA5/SVIP,4
GO:0010595,GO:0010595,positive regulation of endothelial cell migration,5/317,82/12743,0.0534172382177932,0.332816241582264,0.29702771520174,CALR/GRN/RHOB/PDCD6/VEGFA,5
GO:0001837,GO:0001837,epithelial to mesenchymal transition,6/317,109/12743,0.0545380666300259,0.339211677396096,0.302735434507957,MDK/S100A4/HNRNPAB/HGF/PDCD6/DDX17,6
GO:0048639,GO:0048639,positive regulation of developmental growth,7/317,137/12743,0.0550897069395724,0.34205094377852,0.305269387786232,PPIB/BASP1/SERP1/MAP1B/SYT1/MACF1/VEGFA,7
GO:0046651,GO:0046651,lymphocyte proliferation,8/317,166/12743,0.0556498980586254,0.344876712836209,0.307791295139379,CD24/MIF/SELENOK/MAD1L1/RPS3/IGFBP2/CDKN1A/CTPS1,8
GO:0007044,GO:0007044,cell-substrate junction assembly,5/317,83/12743,0.0557382899903726,0.344876712836209,0.307791295139379,APOD/RHOA/RAC1/MACF1/VEGFA,5
GO:0043462,GO:0043462,regulation of ATPase activity,4/317,58/12743,0.0559285461984728,0.344876712836209,0.307791295139379,GABARAPL2/SNRNP70/PFN2/DNAJB1,4
GO:1900407,GO:1900407,regulation of cellular response to oxidative stress,4/317,58/12743,0.0559285461984728,0.344876712836209,0.307791295139379,PSAP/PARK7/HGF/SFPQ,4
GO:0048872,GO:0048872,homeostasis of number of cells,9/317,196/12743,0.056473561009693,0.346849451221136,0.309551900248012,B2M/HSPA1A/MIF/HSPA1B/RPS19/P4HTM/TMEM14C/RPS14/VEGFA,9
GO:0030518,GO:0030518,intracellular steroid hormone receptor signaling pathway,6/317,110/12743,0.0565379077651142,0.346849451221136,0.309551900248012,RHOA/CALR/PARK7/YWHAH/SCGB2A1/DDX17,6
GO:0045216,GO:0045216,cell-cell junction organization,6/317,110/12743,0.0565379077651142,0.346849451221136,0.309551900248012,FSCN1/RHOA/CD9/RAB13/TBCD/DSP,6
GO:0031589,GO:0031589,cell-substrate adhesion,11/317,257/12743,0.056774918332186,0.347043471458478,0.309725057025237,APOD/MDK/RHOA/CALR/BCAM/CD63/CDC42/RAC1/TBCD/MACF1/VEGFA,11
GO:0048167,GO:0048167,regulation of synaptic plasticity,7/317,138/12743,0.0568591389955614,0.347043471458478,0.309725057025237,YWHAH/MME/MAP1B/GRIK2/YWHAG/ARC/CAMK2B,7
GO:0070663,GO:0070663,regulation of leukocyte proliferation,7/317,138/12743,0.0568591389955614,0.347043471458478,0.309725057025237,CD24/MIF/SELENOK/MAD1L1/RPS3/IGFBP2/CDKN1A,7
GO:0043523,GO:0043523,regulation of neuron apoptotic process,8/317,167/12743,0.0572507512137543,0.348841441717706,0.311329687242681,MDK/RHOA/PARK7/GRN/SNCB/GRIK2/ASCL1/JUN,8
GO:0048771,GO:0048771,tissue remodeling,6/317,111/12743,0.0585814028225197,0.350456473323235,0.312771050637353,TIMP1/MDK/CLDN18/RAC1/IGFBP5/ATP6AP1,6
GO:1904950,GO:1904950,negative regulation of establishment of protein localization,7/317,139/12743,0.0586635053867945,0.350456473323235,0.312771050637353,APOD/PARK7/TMBIM6/OS9/ERP29/SVIP/SNX3,7
GO:0009148,GO:0009148,pyrimidine nucleoside triphosphate biosynthetic process,2/317,16/12743,0.0588487532336717,0.350456473323235,0.312771050637353,NME4/CTPS1,2
GO:0030859,GO:0030859,polarized epithelial cell differentiation,2/317,16/12743,0.0588487532336717,0.350456473323235,0.312771050637353,RHOA/CDC42,2
GO:0031958,GO:0031958,corticosteroid receptor signaling pathway,2/317,16/12743,0.0588487532336717,0.350456473323235,0.312771050637353,CALR/YWHAH,2
GO:0033688,GO:0033688,regulation of osteoblast proliferation,2/317,16/12743,0.0588487532336717,0.350456473323235,0.312771050637353,RHOA/ATRAID,2
GO:0043501,GO:0043501,skeletal muscle adaptation,2/317,16/12743,0.0588487532336717,0.350456473323235,0.312771050637353,IGFBP5/CAMK2B,2
GO:0071294,GO:0071294,cellular response to zinc ion,2/317,16/12743,0.0588487532336717,0.350456473323235,0.312771050637353,TSPO/MT2A,2
GO:0072010,GO:0072010,glomerular epithelium development,2/317,16/12743,0.0588487532336717,0.350456473323235,0.312771050637353,CD24/BASP1,2
GO:2001014,GO:2001014,regulation of skeletal muscle cell differentiation,2/317,16/12743,0.0588487532336717,0.350456473323235,0.312771050637353,DDX17/AKIRIN1,2
GO:0008344,GO:0008344,adult locomotory behavior,4/317,59/12743,0.0588725994549593,0.350456473323235,0.312771050637353,UCHL1/PARK7/CSTB/SLITRK6,4
GO:0032943,GO:0032943,mononuclear cell proliferation,8/317,168/12743,0.058880586894919,0.350456473323235,0.312771050637353,CD24/MIF/SELENOK/MAD1L1/RPS3/IGFBP2/CDKN1A/CTPS1,8
GO:0038093,GO:0038093,Fc receptor signaling pathway,8/317,168/12743,0.058880586894919,0.350456473323235,0.312771050637353,FOS/CDC42/RAC1/BRK1/PSMB8/PSMA6/JUN/CD47,8
GO:0051701,GO:0051701,interaction with host,8/317,168/12743,0.058880586894919,0.350456473323235,0.312771050637353,HSPA1A/VAMP8/HSPA1B/RPSA/SLC25A6/PPIA/THOC7/SNX3,8
GO:1904062,GO:1904062,regulation of cation transmembrane transport,10/317,228/12743,0.0590676662080517,0.350988859533795,0.313246188085501,S100A1/CD63/TSPAN13/PARK7/YWHAH/GEM/RGS2/CACNA2D1/CNKSR3/NPPA,10
GO:0042769,GO:0042769,DNA damage response, detection of DNA damage,3/317,36/12743,0.0595718832054982,0.351659967362506,0.31384513008445,SOX4/RPS3/RBX1,3
GO:0046850,GO:0046850,regulation of bone remodeling,3/317,36/12743,0.0595718832054982,0.351659967362506,0.31384513008445,MDK/CLDN18/ATP6AP1,3
GO:1900408,GO:1900408,negative regulation of cellular response to oxidative stress,3/317,36/12743,0.0595718832054982,0.351659967362506,0.31384513008445,PSAP/PARK7/HGF,3
GO:1903202,GO:1903202,negative regulation of oxidative stress-induced cell death,3/317,36/12743,0.0595718832054982,0.351659967362506,0.31384513008445,PSAP/PARK7/HGF,3
GO:0015980,GO:0015980,energy derivation by oxidation of organic compounds,10/317,229/12743,0.0604728251905,0.355697132091813,0.317448168835619,PARK7/NDUFB1/COX4I1/NDUFB4/MDH2/NDUFA3/NOP53/NDUFA6/UQCR10/NDUFS5,10
GO:0030522,GO:0030522,intracellular receptor signaling pathway,10/317,229/12743,0.0604728251905,0.355697132091813,0.317448168835619,FABP5/RHOA/HSPA1A/CALR/PARK7/HSPA1B/YWHAH/NOP53/SCGB2A1/DDX17,10
GO:0021782,GO:0021782,glial cell development,5/317,85/12743,0.0605526133074241,0.355697132091813,0.317448168835619,MDK/CD9/SOX4/GRN/ASCL1,5
GO:0060627,GO:0060627,regulation of vesicle-mediated transport,15/317,388/12743,0.0611730094261469,0.358755251039149,0.320177440939119,B2M/CALR/VAMP8/LRPAP1/CD63/RAC1/ATP6AP1/PFN2/SNX3/SYT1/PCLO/ARC/CD47/NPPA/VEGFA,15
GO:0002521,GO:0002521,leukocyte differentiation,14/317,356/12743,0.0616513958372095,0.360971934910046,0.322155759492224,B2M/MDK/RHOA/CLDN18/SOX4/FOS/CDC42/EGR1/ATP6AP1/TMEM176B/TMEM176A/JUN/JUNB/VEGFA,14
GO:0032436,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,4/317,60/12743,0.061897828212398,0.361825516135888,0.32291755308753,HSPA1A/RBX1/NOP53/ZFAND2A,4
GO:0120032,GO:0120032,regulation of plasma membrane bounded cell projection assembly,7/317,141/12743,0.0623773666552749,0.364036742087197,0.324891000624193,FSCN1/CDC42/RAC1/BRK1/PFN2/DPYSL3/AKIRIN1,7
GO:0007043,GO:0007043,cell-cell junction assembly,5/317,86/12743,0.0630457447703816,0.366746686811524,0.327309538511537,FSCN1/RHOA/CD9/RAB13/TBCD,5
GO:0010811,GO:0010811,positive regulation of cell-substrate adhesion,5/317,86/12743,0.0630457447703816,0.366746686811524,0.327309538511537,MDK/CALR/CDC42/RAC1/VEGFA,5
GO:0002763,GO:0002763,positive regulation of myeloid leukocyte differentiation,3/317,37/12743,0.0636805966933165,0.366877796654604,0.327426549799644,FOS/ATP6AP1/JUN,3
GO:0031295,GO:0031295,T cell costimulation,3/317,37/12743,0.0636805966933165,0.366877796654604,0.327426549799644,CD24/CDC42/RAC1,3
GO:0044764,GO:0044764,multi-organism cellular process,3/317,37/12743,0.0636805966933165,0.366877796654604,0.327426549799644,PPIA/NOP53/ROMO1,3
GO:0045773,GO:0045773,positive regulation of axon extension,3/317,37/12743,0.0636805966933165,0.366877796654604,0.327426549799644,MAP1B/MACF1/VEGFA,3
GO:0048260,GO:0048260,positive regulation of receptor-mediated endocytosis,3/317,37/12743,0.0636805966933165,0.366877796654604,0.327426549799644,B2M/CD63/VEGFA,3
GO:0051489,GO:0051489,regulation of filopodium assembly,3/317,37/12743,0.0636805966933165,0.366877796654604,0.327426549799644,FSCN1/CDC42/DPYSL3,3
GO:0007517,GO:0007517,muscle organ development,12/317,294/12743,0.0640656764722925,0.368126017558598,0.328540546524736,RHOA/EEF2/FOS/EGR1/BASP1/SERP1/RGS2/CD164/DSP/ELN/DDX17/AKIRIN1,12
GO:0019318,GO:0019318,hexose metabolic process,9/317,201/12743,0.0641020547960173,0.368126017558598,0.328540546524736,APOD/FABP5/TFF3/IGFBP5/SERP1/PGAM2/MDH2/AKR1B1/ALDOA,9
GO:0043405,GO:0043405,regulation of MAP kinase activity,11/317,263/12743,0.0647266568707962,0.371120145854087,0.331212709044215,UCHL1/CD24/GADD45G/MIF/ERP29/RGS2/DUSP1/HGF/GADD45B/RPS3/VEGFA,11
GO:0008380,GO:0008380,RNA splicing,15/317,392/12743,0.0655876071761295,0.371906515211397,0.331914518223947,YBX1/HSPA1A/TMBIM6/SNRPF/KHDRBS1/SNRNP70/SRSF9/THOC7/SNRPE/RPS13/TXNL4A/LSM3/SFPQ/LSM5/DDX17,15
GO:0032091,GO:0032091,negative regulation of protein binding,5/317,87/12743,0.0655960378505417,0.371906515211397,0.331914518223947,B2M/LRPAP1/PARK7/TMBIM6/HSPA5,5
GO:0018195,GO:0018195,peptidyl-arginine modification,2/317,17/12743,0.0656280359819049,0.371906515211397,0.331914518223947,PARK7/KRTCAP2,2
GO:0042776,GO:0042776,mitochondrial ATP synthesis coupled proton transport,2/317,17/12743,0.0656280359819049,0.371906515211397,0.331914518223947,ATP5F1E/ATP5ME,2
GO:0043302,GO:0043302,positive regulation of leukocyte degranulation,2/317,17/12743,0.0656280359819049,0.371906515211397,0.331914518223947,VAMP8/NPPA,2
GO:0045117,GO:0045117,azole transport,2/317,17/12743,0.0656280359819049,0.371906515211397,0.331914518223947,VAMP8/NPPA,2
GO:0090025,GO:0090025,regulation of monocyte chemotaxis,2/317,17/12743,0.0656280359819049,0.371906515211397,0.331914518223947,S100A14/DUSP1,2
GO:0006006,GO:0006006,glucose metabolic process,8/317,172/12743,0.0656914150651563,0.371906515211397,0.331914518223947,APOD/FABP5/TFF3/IGFBP5/SERP1/PGAM2/MDH2/ALDOA,8
GO:0060491,GO:0060491,regulation of cell projection assembly,7/317,143/12743,0.0662318150020622,0.373644289619343,0.333465425593955,FSCN1/CDC42/RAC1/BRK1/PFN2/DPYSL3/AKIRIN1,7
GO:0010631,GO:0010631,epithelial cell migration,10/317,233/12743,0.0663101687836274,0.373644289619343,0.333465425593955,RHOA/CALR/RAB13/GRN/RHOB/PFN2/PDCD6/JUN/MACF1/VEGFA,10
GO:0090132,GO:0090132,epithelium migration,10/317,233/12743,0.0663101687836274,0.373644289619343,0.333465425593955,RHOA/CALR/RAB13/GRN/RHOB/PFN2/PDCD6/JUN/MACF1/VEGFA,10
GO:0031400,GO:0031400,negative regulation of protein modification process,18/317,493/12743,0.0672007509578353,0.37678988214728,0.336272765034744,UCHL1/HSPA1A/BOD1/TERF2IP/PARK7/HSPA1B/SOX4/TSPO/RGS2/PPP1R15A/DUSP1/HGF/GADD45B/RPS3/CDKN1A/YWHAG/JUN/CNKSR3,18
GO:0001101,GO:0001101,response to acid chemical,11/317,265/12743,0.0675307532453705,0.37678988214728,0.336272765034744,RHOA/EEF2/CD9/TMBIM6/GNG2/EGR1/DUSP1/AKR1B1/IGFBP2/ASCL1/VEGFA,11
GO:0006936,GO:0006936,muscle contraction,10/317,234/12743,0.0678240057193073,0.37678988214728,0.336272765034744,CHGA/RHOA/EEF2/HSBP1/RGS2/PGAM2/DSP/ALDOA/CACNA2D1/NPPA,10
GO:0048667,GO:0048667,cell morphogenesis involved in neuron differentiation,16/317,427/12743,0.0679055306558656,0.37678988214728,0.336272765034744,TUBB2B/UCHL1/RHOA/RPL24/TUBB3/YWHAH/CDC42/S100A6/TBCD/MAP1B/SLITRK6/ALCAM/ARC/CAMK2B/MACF1/VEGFA,16
GO:0006584,GO:0006584,catecholamine metabolic process,3/317,38/12743,0.0679167541195465,0.37678988214728,0.336272765034744,PARK7/SNCB/AKR1B1,3
GO:0009163,GO:0009163,nucleoside biosynthetic process,3/317,38/12743,0.0679167541195465,0.37678988214728,0.336272765034744,APRT/NME4/CTPS1,3
GO:0009712,GO:0009712,catechol-containing compound metabolic process,3/317,38/12743,0.0679167541195465,0.37678988214728,0.336272765034744,PARK7/SNCB/AKR1B1,3
GO:0031294,GO:0031294,lymphocyte costimulation,3/317,38/12743,0.0679167541195465,0.37678988214728,0.336272765034744,CD24/CDC42/RAC1,3
GO:1902883,GO:1902883,negative regulation of response to oxidative stress,3/317,38/12743,0.0679167541195465,0.37678988214728,0.336272765034744,PSAP/PARK7/HGF,3
GO:2000179,GO:2000179,positive regulation of neural precursor cell proliferation,3/317,38/12743,0.0679167541195465,0.37678988214728,0.336272765034744,MDK/ASCL1/VEGFA,3
GO:0003012,GO:0003012,muscle system process,12/317,297/12743,0.0680213166936259,0.37678988214728,0.336272765034744,CHGA/RHOA/EEF2/HSBP1/IGFBP5/RGS2/PGAM2/DSP/ALDOA/CACNA2D1/CAMK2B/NPPA,12
GO:0030100,GO:0030100,regulation of endocytosis,9/317,204/12743,0.0689786630860087,0.38091903808633,0.339957902960877,B2M/CALR/LRPAP1/CD63/RAC1/SNX3/ARC/CD47/VEGFA,9
GO:2000027,GO:2000027,regulation of animal organ morphogenesis,9/317,204/12743,0.0689786630860087,0.38091903808633,0.339957902960877,MDK/RHOA/CDC42/RAC1/BASP1/HGF/PSMB8/PSMA6/VEGFA,9
GO:1903707,GO:1903707,negative regulation of hemopoiesis,6/317,116/12743,0.0694548479566516,0.382960396325402,0.341779749066635,MDK/CLDN18/HIST1H4C/MEIS2/TMEM176B/TMEM176A,6
GO:0043269,GO:0043269,regulation of ion transport,17/317,462/12743,0.069814226065091,0.384097899966953,0.342794934221293,S100A1/B2M/RHOA/VAMP8/CD63/TSPAN13/MIF/PARK7/TMBIM6/YWHAH/TSPO/GEM/RGS2/CACNA2D1/CAMK2B/CNKSR3/NPPA,17
GO:0033002,GO:0033002,muscle cell proliferation,7/317,145/12743,0.070227172035154,0.384097899966953,0.342794934221293,APOD/IGFBP5/AKR1B1/ELN/CDKN1A/JUN/AKIRIN1,7
GO:0051047,GO:0051047,positive regulation of secretion,12/317,299/12743,0.0707452423399075,0.384097899966953,0.342794934221293,GRP/MDK/VAMP8/MIF/SOX4/RAC1/ATP6AP1/PPIA/SERP1/SELENOK/SYT1/NPPA,12
GO:0090130,GO:0090130,tissue migration,10/317,236/12743,0.0709174713517038,0.384097899966953,0.342794934221293,RHOA/CALR/RAB13/GRN/RHOB/PFN2/PDCD6/JUN/MACF1/VEGFA,10
GO:0006942,GO:0006942,regulation of striated muscle contraction,4/317,63/12743,0.071454834710928,0.384097899966953,0.342794934221293,CHGA/RGS2/DSP/NPPA,4
GO:0046849,GO:0046849,bone remodeling,4/317,63/12743,0.071454834710928,0.384097899966953,0.342794934221293,MDK/CLDN18/RAC1/ATP6AP1,4
GO:0071479,GO:0071479,cellular response to ionizing radiation,4/317,63/12743,0.071454834710928,0.384097899966953,0.342794934221293,EGR1/RHOB/HSPA5/CDKN1A,4
GO:0071621,GO:0071621,granulocyte chemotaxis,4/317,63/12743,0.071454834710928,0.384097899966953,0.342794934221293,MDK/S100A14/RAC1/AKIRIN1,4
GO:2001242,GO:2001242,regulation of intrinsic apoptotic signaling pathway,7/317,146/12743,0.0722777365222356,0.384097899966953,0.342794934221293,HSPA1A/MIF/PARK7/TMBIM6/ERP29/RPS3/SFPQ,7
GO:0018208,GO:0018208,peptidyl-proline modification,3/317,39/12743,0.0722777419489219,0.384097899966953,0.342794934221293,PPIB/PPIA/NKTR,3
GO:1901659,GO:1901659,glycosyl compound biosynthetic process,3/317,39/12743,0.0722777419489219,0.384097899966953,0.342794934221293,APRT/NME4/CTPS1,3
GO:1901862,GO:1901862,negative regulation of muscle tissue development,3/317,39/12743,0.0722777419489219,0.384097899966953,0.342794934221293,IGFBP5/RGS2/AKIRIN1,3
GO:0046879,GO:0046879,hormone secretion,10/317,237/12743,0.0724971933611094,0.384097899966953,0.342794934221293,GRP/VAMP8/PARK7/SOX4/SLC25A6/RAC1/SERP1/SCG5/PCLO/NPPA,10
GO:0001516,GO:0001516,prostaglandin biosynthetic process,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,FABP5/MIF,2
GO:0009147,GO:0009147,pyrimidine nucleoside triphosphate metabolic process,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,NME4/CTPS1,2
GO:0015985,GO:0015985,energy coupled proton transport, down electrochemical gradient,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,ATP5F1E/ATP5ME,2
GO:0015986,GO:0015986,ATP synthesis coupled proton transport,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,ATP5F1E/ATP5ME,2
GO:0032104,GO:0032104,regulation of response to extracellular stimulus,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,NENF/NUCB2,2
GO:0032107,GO:0032107,regulation of response to nutrient levels,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,NENF/NUCB2,2
GO:0034389,GO:0034389,lipid droplet organization,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,PPIA/HILPDA,2
GO:0044346,GO:0044346,fibroblast apoptotic process,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,CFDP1/BTG1,2
GO:0046457,GO:0046457,prostanoid biosynthetic process,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,FABP5/MIF,2
GO:0061213,GO:0061213,positive regulation of mesonephros development,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,BASP1/VEGFA,2
GO:0072215,GO:0072215,regulation of metanephros development,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,EGR1/BASP1,2
GO:0090023,GO:0090023,positive regulation of neutrophil chemotaxis,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,MDK/RAC1,2
GO:0090075,GO:0090075,relaxation of muscle,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,CHGA/RGS2,2
GO:0099623,GO:0099623,regulation of cardiac muscle cell membrane repolarization,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,CACNA2D1/NPPA,2
GO:1902667,GO:1902667,regulation of axon guidance,2/317,18/12743,0.0726527321217046,0.384097899966953,0.342794934221293,TUBB2B/VEGFA,2
GO:0019933,GO:0019933,cAMP-mediated signaling,5/317,90/12743,0.0735881541846669,0.387902366999821,0.346190297815812,CHGA/RAMP1/GNG2/RGS2/PCLO,5
GO:0060048,GO:0060048,cardiac muscle contraction,5/317,90/12743,0.0735881541846669,0.387902366999821,0.346190297815812,CHGA/RGS2/DSP/CACNA2D1/NPPA,5
GO:0051656,GO:0051656,establishment of organelle localization,15/317,399/12743,0.073819734850699,0.388553362793943,0.346771290475349,UCHL1/CHGA/VAMP8/BOD1/S100A13/CDC42/ATP6AP1/GEM/PFN2/MAD1L1/PDCD6/MAP1B/SYT1/PCLO/NPPA,15
GO:0010721,GO:0010721,negative regulation of cell development,10/317,238/12743,0.0740989626956457,0.389452881419366,0.347574081711801,B2M/RHOA/CALR/CLDN18/YWHAH/MYLIP/TSPO/RGS2/ASCL1/DPYSL3,10
GO:0001819,GO:0001819,positive regulation of cytokine production,12/317,302/12743,0.0749622819012914,0.393415187496559,0.351110311540739,B2M/MDK/HSPA1A/MIF/PARK7/HSPA1B/EGR1/SELENOK/HGF/RPS3/NOP53/HILPDA,12
GO:0001667,GO:0001667,ameboidal-type cell migration,12/317,303/12743,0.0764030907788634,0.399654361832504,0.356678572539484,TIMP1/RHOA/CALR/RAB13/GRN/CENPV/RHOB/PFN2/PDCD6/JUN/MACF1/VEGFA,12
GO:0002221,GO:0002221,pattern recognition receptor signaling pathway,7/317,148/12743,0.0764846177860258,0.399654361832504,0.356678572539484,S100A1/HSP90B1/S100A14/HSPA1A/HSPA1B/NOP53/CNPY3,7
GO:0002573,GO:0002573,myeloid leukocyte differentiation,7/317,148/12743,0.0764846177860258,0.399654361832504,0.356678572539484,CLDN18/FOS/CDC42/ATP6AP1/JUN/JUNB/VEGFA,7
GO:0006839,GO:0006839,mitochondrial transport,9/317,209/12743,0.0776102152804124,0.404947349685171,0.361402392750282,HSPA1A/TOMM7/ATP5F1E/YWHAH/SLC25A6/TSPO/ATP5ME/TMEM14C/YWHAG,9
GO:0043112,GO:0043112,receptor metabolic process,7/317,149/12743,0.0786408891822761,0.409730429869975,0.365671136884176,RAMP1/CD9/LRPAP1/CD63/MYLIP/ARC/VEGFA,7
GO:0010634,GO:0010634,positive regulation of epithelial cell migration,6/317,120/12743,0.07893946698145,0.409791662438419,0.365725784968099,CALR/GRN/RHOB/PDCD6/JUN/VEGFA,6
GO:0045471,GO:0045471,response to ethanol,5/317,92/12743,0.0791982863140621,0.409791662438419,0.365725784968099,RHOA/EEF2/CLDN18/RGS2/GGH,5
GO:0002092,GO:0002092,positive regulation of receptor internalization,2/317,19/12743,0.079906524442095,0.409791662438419,0.365725784968099,CD63/VEGFA,2
GO:0010640,GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway,2/317,19/12743,0.079906524442095,0.409791662438419,0.365725784968099,APOD/PHF14,2
GO:0034643,GO:0034643,establishment of mitochondrion localization, microtubule-mediated,2/317,19/12743,0.079906524442095,0.409791662438419,0.365725784968099,UCHL1/MAP1B,2
GO:0042451,GO:0042451,purine nucleoside biosynthetic process,2/317,19/12743,0.079906524442095,0.409791662438419,0.365725784968099,APRT/NME4,2
GO:0046129,GO:0046129,purine ribonucleoside biosynthetic process,2/317,19/12743,0.079906524442095,0.409791662438419,0.365725784968099,APRT/NME4,2
GO:0046823,GO:0046823,negative regulation of nucleocytoplasmic transport,2/317,19/12743,0.079906524442095,0.409791662438419,0.365725784968099,APOD/PARK7,2
GO:0047497,GO:0047497,mitochondrion transport along microtubule,2/317,19/12743,0.079906524442095,0.409791662438419,0.365725784968099,UCHL1/MAP1B,2
GO:0048261,GO:0048261,negative regulation of receptor-mediated endocytosis,2/317,19/12743,0.079906524442095,0.409791662438419,0.365725784968099,LRPAP1/RAC1,2
GO:0086010,GO:0086010,membrane depolarization during action potential,2/317,19/12743,0.079906524442095,0.409791662438419,0.365725784968099,YWHAH/CACNA2D1,2
GO:0070661,GO:0070661,leukocyte proliferation,8/317,180/12743,0.0807232442167318,0.41261297292149,0.36824371318782,CD24/MIF/SELENOK/MAD1L1/RPS3/IGFBP2/CDKN1A/CTPS1,8
GO:0009914,GO:0009914,hormone transport,10/317,242/12743,0.0807271456056514,0.41261297292149,0.36824371318782,GRP/VAMP8/PARK7/SOX4/SLC25A6/RAC1/SERP1/SCG5/PCLO/NPPA,10
GO:0034381,GO:0034381,plasma lipoprotein particle clearance,3/317,41/12743,0.0813632495372408,0.41261297292149,0.36824371318782,NPC2/LRPAP1/MYLIP,3
GO:0072678,GO:0072678,T cell migration,3/317,41/12743,0.0813632495372408,0.41261297292149,0.36824371318782,APOD/RHOA/SELENOK,3
GO:1903146,GO:1903146,regulation of autophagy of mitochondrion,3/317,41/12743,0.0813632495372408,0.41261297292149,0.36824371318782,PARK7/TOMM7/TSPO,3
GO:1904705,GO:1904705,regulation of vascular smooth muscle cell proliferation,3/317,41/12743,0.0813632495372408,0.41261297292149,0.36824371318782,IGFBP5/CDKN1A/JUN,3
GO:1990874,GO:1990874,vascular smooth muscle cell proliferation,3/317,41/12743,0.0813632495372408,0.41261297292149,0.36824371318782,IGFBP5/CDKN1A/JUN,3
GO:0042098,GO:0042098,T cell proliferation,6/317,121/12743,0.0814191399634616,0.41261297292149,0.36824371318782,CD24/SELENOK/MAD1L1/RPS3/IGFBP2/CTPS1,6
GO:0006446,GO:0006446,regulation of translational initiation,4/317,66/12743,0.081719175721864,0.41261297292149,0.36824371318782,EIF4A2/KHDRBS1/PPP1R15A/EIF1B,4
GO:0036473,GO:0036473,cell death in response to oxidative stress,4/317,66/12743,0.081719175721864,0.41261297292149,0.36824371318782,PSAP/PARK7/HGF/SFPQ,4
GO:1901019,GO:1901019,regulation of calcium ion transmembrane transporter activity,4/317,66/12743,0.081719175721864,0.41261297292149,0.36824371318782,S100A1/GEM/CACNA2D1/NPPA,4
GO:0045927,GO:0045927,positive regulation of growth,9/317,212/12743,0.0830927630373511,0.418960004374863,0.373908233170217,RHOA/PPIB/CDC42/BASP1/SERP1/MAP1B/SYT1/MACF1/VEGFA,9
GO:0019932,GO:0019932,second-messenger-mediated signaling,10/317,244/12743,0.0841742122666966,0.423818337673354,0.378244138270517,CHGA/RAMP1/GNG2/RGS2/SELENOK/PCLO/RASD1/MT2A/NPPA/VEGFA,10
GO:0001952,GO:0001952,regulation of cell-matrix adhesion,5/317,94/12743,0.0850313121971222,0.42447112893594,0.378826733327501,APOD/RHOA/RAC1/MACF1/VEGFA,5
GO:0007569,GO:0007569,cell aging,5/317,94/12743,0.0850313121971222,0.42447112893594,0.378826733327501,CALR/MIF/MME/CDKN1A/ROMO1,5
GO:0006690,GO:0006690,icosanoid metabolic process,4/317,67/12743,0.0852940137907547,0.42447112893594,0.378826733327501,FABP5/MIF/PON3/PON2,4
GO:0030316,GO:0030316,osteoclast differentiation,4/317,67/12743,0.0852940137907547,0.42447112893594,0.378826733327501,CLDN18/FOS/ATP6AP1/JUNB,4
GO:1902882,GO:1902882,regulation of response to oxidative stress,4/317,67/12743,0.0852940137907547,0.42447112893594,0.378826733327501,PSAP/PARK7/HGF/SFPQ,4
GO:0002931,GO:0002931,response to ischemia,3/317,42/12743,0.0860820679617841,0.42447112893594,0.378826733327501,UCHL1/EEF2/EGR1,3
GO:0032527,GO:0032527,protein exit from endoplasmic reticulum,3/317,42/12743,0.0860820679617841,0.42447112893594,0.378826733327501,HSP90B1/OS9/SVIP,3
GO:0032781,GO:0032781,positive regulation of ATPase activity,3/317,42/12743,0.0860820679617841,0.42447112893594,0.378826733327501,GABARAPL2/PFN2/DNAJB1,3
GO:0050830,GO:0050830,defense response to Gram-positive bacterium,3/317,42/12743,0.0860820679617841,0.42447112893594,0.378826733327501,CHGA/RPL39/ROMO1,3
GO:1901028,GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,3/317,42/12743,0.0860820679617841,0.42447112893594,0.378826733327501,HSPA1A/YWHAH/YWHAG,3
GO:0002082,GO:0002082,regulation of oxidative phosphorylation,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,RHOA/PARK7,2
GO:0007020,GO:0007020,microtubule nucleation,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,HSPA1A/HSPA1B,2
GO:0018149,GO:0018149,peptide cross-linking,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,DSP/KRT10,2
GO:0032770,GO:0032770,positive regulation of monooxygenase activity,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,S100A1/PARK7,2
GO:0033233,GO:0033233,regulation of protein sumoylation,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,PARK7/EGR1,2
GO:0036499,GO:0036499,PERK-mediated unfolded protein response,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,PPP1R15A/HSPA5,2
GO:0043304,GO:0043304,regulation of mast cell degranulation,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,VAMP8/NPPA,2
GO:0045745,GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,GRP/CHGA,2
GO:0046132,GO:0046132,pyrimidine ribonucleoside biosynthetic process,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,NME4/CTPS1,2
GO:0046697,GO:0046697,decidualization,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,BSG/JUNB,2
GO:0048846,GO:0048846,axon extension involved in axon guidance,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,ALCAM/VEGFA,2
GO:0071157,GO:0071157,negative regulation of cell cycle arrest,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,CALR/MIF,2
GO:0099563,GO:0099563,modification of synaptic structure,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,RHOA/PFN2,2
GO:1901673,GO:1901673,regulation of mitotic spindle assembly,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,HSPA1A/HSPA1B,2
GO:1902284,GO:1902284,neuron projection extension involved in neuron projection guidance,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,ALCAM/VEGFA,2
GO:1903599,GO:1903599,positive regulation of autophagy of mitochondrion,2/317,20/12743,0.0873737511578848,0.42447112893594,0.378826733327501,PARK7/TOMM7,2
GO:0045785,GO:0045785,positive regulation of cell adhesion,11/317,278/12743,0.0876613900056568,0.425293788219077,0.379560930090549,MDK/RHOA/CALR/CD24/CDC42/RAC1/SELENOK/RPS3/IGFBP2/CD47/VEGFA,11
GO:0033273,GO:0033273,response to vitamin,4/317,68/12743,0.0889440135985383,0.4303663468809,0.384088024388546,EEF2/TSPO/MAP1B/ASCL1,4
GO:0051146,GO:0051146,striated muscle cell differentiation,8/317,184/12743,0.0889463687712124,0.4303663468809,0.384088024388546,UCHL1/YBX1/CALR/CD9/IGFBP5/RGS2/NPPA/VEGFA,8
GO:0034250,GO:0034250,positive regulation of cellular amide metabolic process,6/317,124/12743,0.0891164035304425,0.4306095036182,0.38430503390038,RHOA/EEF2/SOX4/KHDRBS1/SERP1/PPP1R15A,6
GO:0006954,GO:0006954,inflammatory response,16/317,445/12743,0.0898756366559264,0.433695186279269,0.387058905725558,APOD/TIMP1/MDK/VAMP8/MIF/PARK7/FOS/NEAT1/GRN/RPS19/RAC1/HGF/PSMA6/JUN/CHID1/NPPA,16
GO:0032677,GO:0032677,regulation of interleukin-8 production,3/317,43/12743,0.0909143334539547,0.436364524388474,0.389441203524213,HSPA1A/PARK7/HSPA1B,3
GO:0045428,GO:0045428,regulation of nitric oxide biosynthetic process,3/317,43/12743,0.0909143334539547,0.436364524388474,0.389441203524213,RAC1/TSPO/CD47,3
GO:0045851,GO:0045851,pH reduction,3/317,43/12743,0.0909143334539547,0.436364524388474,0.389441203524213,GRN/ATP6AP1/ATP6V0E2,3
GO:1903307,GO:1903307,positive regulation of regulated secretory pathway,3/317,43/12743,0.0909143334539547,0.436364524388474,0.389441203524213,VAMP8/SYT1/NPPA,3
GO:0042129,GO:0042129,regulation of T cell proliferation,5/317,96/12743,0.0910843259442209,0.436597535692632,0.389649158565593,CD24/SELENOK/MAD1L1/RPS3/IGFBP2,5
GO:0009611,GO:0009611,response to wounding,17/317,480/12743,0.0912536081369382,0.436633166492965,0.389680957900756,APOD/TIMP1/MDK/RHOA/CD9/GNG2/GRN/CDC42/RAC1/TSPO/MAP1B/CDKN1A/JUN/DPYSL3/PABPC4/MACF1/AKIRIN1,17
GO:0002218,GO:0002218,activation of innate immune response,10/317,248/12743,0.0913346707100723,0.436633166492965,0.389680957900756,S100A1/HSP90B1/S100A14/HSPA1A/HSPA1B/PSMB8/NOP53/PSMA6/SFPQ/CNPY3,10
GO:0001938,GO:0001938,positive regulation of endothelial cell proliferation,4/317,69/12743,0.0926681807821762,0.441429694993505,0.393961704220834,MDK/PDCD6/JUN/VEGFA,4
GO:0045089,GO:0045089,positive regulation of innate immune response,11/317,281/12743,0.0927794860137758,0.441429694993505,0.393961704220834,S100A1/HSP90B1/S100A14/HSPA1A/HSPA1B/RPS19/PSMB8/NOP53/PSMA6/SFPQ/CNPY3,11
GO:0032355,GO:0032355,response to estradiol,5/317,97/12743,0.094192292929218,0.441429694993505,0.393961704220834,CALR/EEF2/DUSP1/MAP1B/IGFBP2,5
GO:0060071,GO:0060071,Wnt signaling pathway, planar cell polarity pathway,5/317,97/12743,0.094192292929218,0.441429694993505,0.393961704220834,RHOA/CDC42/RAC1/PSMB8/PSMA6,5
GO:0045665,GO:0045665,negative regulation of neuron differentiation,7/317,156/12743,0.0947156796742281,0.441429694993505,0.393961704220834,B2M/RHOA/CALR/YWHAH/MYLIP/ASCL1/DPYSL3,7
GO:0015672,GO:0015672,monovalent inorganic cation transport,13/317,348/12743,0.0950255238758126,0.441429694993505,0.393961704220834,CD63/CYB5A/PARK7/COX4I1/ATP5F1E/YWHAH/ATP6AP1/ATP5ME/SGK1/ATP6V0E2/NDUFA4L2/CNKSR3/NPPA,13
GO:0001990,GO:0001990,regulation of systemic arterial blood pressure by hormone,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,RHOA/MME,2
GO:0002888,GO:0002888,positive regulation of myeloid leukocyte mediated immunity,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,VAMP8/NPPA,2
GO:0003298,GO:0003298,physiological muscle hypertrophy,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,RGS2/NPPA,2
GO:0003301,GO:0003301,physiological cardiac muscle hypertrophy,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,RGS2/NPPA,2
GO:0006783,GO:0006783,heme biosynthetic process,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,TSPO/TMEM14C,2
GO:0009220,GO:0009220,pyrimidine ribonucleotide biosynthetic process,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,NME4/CTPS1,2
GO:0010737,GO:0010737,protein kinase A signaling,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,RAB13/MIF,2
GO:0014741,GO:0014741,negative regulation of muscle hypertrophy,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,IGFBP5/RGS2,2
GO:0033006,GO:0033006,regulation of mast cell activation involved in immune response,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,VAMP8/NPPA,2
GO:0035767,GO:0035767,endothelial cell chemotaxis,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,RAB13/VEGFA,2
GO:0051894,GO:0051894,positive regulation of focal adhesion assembly,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,RAC1/VEGFA,2
GO:0061049,GO:0061049,cell growth involved in cardiac muscle cell development,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,RGS2/NPPA,2
GO:0061217,GO:0061217,regulation of mesonephros development,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,BASP1/VEGFA,2
GO:0090659,GO:0090659,walking behavior,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,UCHL1/PSAP,2
GO:1902624,GO:1902624,positive regulation of neutrophil migration,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,MDK/RAC1,2
GO:1903579,GO:1903579,negative regulation of ATP metabolic process,2/317,21/12743,0.0950393835674473,0.441429694993505,0.393961704220834,RHOA/TSPO,2
GO:0032886,GO:0032886,regulation of microtubule-based process,8/317,187/12743,0.0954218525657261,0.442063865945599,0.394527681253843,RHOA/HSPA1A/HSPA1B/RAC1/TBCD/RPS3/MAP1B/MACF1,8
GO:1902105,GO:1902105,regulation of leukocyte differentiation,8/317,187/12743,0.0954218525657261,0.442063865945599,0.394527681253843,MDK/RHOA/CLDN18/FOS/ATP6AP1/TMEM176B/TMEM176A/JUN,8
GO:0045670,GO:0045670,regulation of osteoclast differentiation,3/317,44/12743,0.0958570162590229,0.442938269217465,0.395308057850767,CLDN18/FOS/ATP6AP1,3
GO:0050918,GO:0050918,positive chemotaxis,3/317,44/12743,0.0958570162590229,0.442938269217465,0.395308057850767,MIF/HGF/VEGFA,3
GO:0048024,GO:0048024,regulation of mRNA splicing, via spliceosome,4/317,70/12743,0.0964654748229821,0.445177640550219,0.3973066242287,KHDRBS1/SNRNP70/SRSF9/DDX17,4
GO:1903828,GO:1903828,negative regulation of cellular protein localization,5/317,98/12743,0.0973539586392445,0.448701899112928,0.400451910839969,APOD/CLDN18/PARK7/OS9/SVIP,5
GO:2001233,GO:2001233,regulation of apoptotic signaling pathway,13/317,350/12743,0.0982121674033637,0.45207777441113,0.403464770194019,PDIA3/HSPA1A/MIF/PARK7/HSPA1B/TMBIM6/YWHAH/ERP29/HGF/RPS3/YWHAG/SFPQ/FAM162A,13
GO:0090257,GO:0090257,regulation of muscle system process,7/317,158/12743,0.0996209748586866,0.457213303236593,0.408048063323369,CHGA/RHOA/IGFBP5/RGS2/DSP/CAMK2B/NPPA,7
GO:0002793,GO:0002793,positive regulation of peptide secretion,8/317,189/12743,0.0998846748824911,0.457213303236593,0.408048063323369,GRP/MDK/MIF/SOX4/RAC1/PPIA/SERP1/SELENOK,8
GO:0010594,GO:0010594,regulation of endothelial cell migration,6/317,128/12743,0.0999748142980323,0.457213303236593,0.408048063323369,RHOA/CALR/GRN/RHOB/PDCD6/VEGFA,6
GO:0035567,GO:0035567,non-canonical Wnt signaling pathway,6/317,128/12743,0.0999748142980323,0.457213303236593,0.408048063323369,RHOA/GNG2/CDC42/RAC1/PSMB8/PSMA6,6
GO:0051302,GO:0051302,regulation of cell division,6/317,128/12743,0.0999748142980323,0.457213303236593,0.408048063323369,MDK/YBX1/RHOA/CENPV/CDC42/VEGFA,6
GO:0033238,GO:0033238,regulation of cellular amine metabolic process,4/317,71/12743,0.100334811330029,0.457213303236593,0.408048063323369,PARK7/ODC1/PSMB8/PSMA6,4
GO:0034754,GO:0034754,cellular hormone metabolic process,4/317,71/12743,0.100334811330029,0.457213303236593,0.408048063323369,RBP1/EGR1/TSPO/AKR1B1,4
GO:0090175,GO:0090175,regulation of establishment of planar polarity,5/317,99/12743,0.100568833473106,0.457213303236593,0.408048063323369,RHOA/CDC42/RAC1/PSMB8/PSMA6,5
GO:0032835,GO:0032835,glomerulus development,3/317,45/12743,0.100907030635472,0.457213303236593,0.408048063323369,CD24/EGR1/BASP1,3
GO:0042100,GO:0042100,B cell proliferation,3/317,45/12743,0.100907030635472,0.457213303236593,0.408048063323369,MIF/CDKN1A/CTPS1,3
GO:0045453,GO:0045453,bone resorption,3/317,45/12743,0.100907030635472,0.457213303236593,0.408048063323369,CLDN18/RAC1/ATP6AP1,3
GO:0048844,GO:0048844,artery morphogenesis,3/317,45/12743,0.100907030635472,0.457213303236593,0.408048063323369,MDK/SOX4/VEGFA,3
GO:0048514,GO:0048514,blood vessel morphogenesis,15/317,419/12743,0.100981185749612,0.457213303236593,0.408048063323369,S100A1/APOD/MDK/RHOA/RAMP1/SOX4/GRN/RHOB/HGF/PDCD6/GTF2I/JUN/BTG1/JUNB/VEGFA,15
GO:0070507,GO:0070507,regulation of microtubule cytoskeleton organization,7/317,159/12743,0.102125077801828,0.458346927952011,0.409059786662098,RHOA/HSPA1A/HSPA1B/RAC1/TBCD/RPS3/MAP1B,7
GO:0007157,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,CD164/ALCAM,2
GO:0015988,GO:0015988,energy coupled proton transmembrane transport, against electrochemical gradient,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,ATP6AP1/ATP6V0E2,2
GO:0015991,GO:0015991,ATP hydrolysis coupled proton transport,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,ATP6AP1/ATP6V0E2,2
GO:0030947,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,PDCD6/VEGFA,2
GO:0032094,GO:0032094,response to food,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,NENF/NUCB2,2
GO:0033137,GO:0033137,negative regulation of peptidyl-serine phosphorylation,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,HGF/CNKSR3,2
GO:0036296,GO:0036296,response to increased oxygen levels,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,ATP6AP1/CDKN1A,2
GO:0045948,GO:0045948,positive regulation of translational initiation,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,KHDRBS1/PPP1R15A,2
GO:0051654,GO:0051654,establishment of mitochondrion localization,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,UCHL1/MAP1B,2
GO:0070207,GO:0070207,protein homotrimerization,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,MIF/BRK1,2
GO:1902175,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,PARK7/SFPQ,2
GO:2000406,GO:2000406,positive regulation of T cell migration,2/317,22/12743,0.102889004410924,0.458346927952011,0.409059786662098,RHOA/SELENOK,2
GO:0043434,GO:0043434,response to peptide hormone,12/317,320/12743,0.103608113946412,0.460227804624643,0.410738408168044,TIMP1/BSG/RAB13/IGFBP5/EGR1/ATP6AP1/APRT/MAP1B/ATP6V0E2/YWHAG/GGH/NPPA,12
GO:1902107,GO:1902107,positive regulation of leukocyte differentiation,5/317,100/12743,0.103836401871403,0.460227804624643,0.410738408168044,MDK/RHOA/FOS/ATP6AP1/JUN,5
GO:0010507,GO:0010507,negative regulation of autophagy,4/317,72/12743,0.104275064298863,0.460227804624643,0.410738408168044,TSPO/SNRNP70/HGF/WDR6,4
GO:0045921,GO:0045921,positive regulation of exocytosis,4/317,72/12743,0.104275064298863,0.460227804624643,0.410738408168044,VAMP8/ATP6AP1/SYT1/NPPA,4
GO:0097530,GO:0097530,granulocyte migration,4/317,72/12743,0.104275064298863,0.460227804624643,0.410738408168044,MDK/S100A14/RAC1/AKIRIN1,4
GO:1902106,GO:1902106,negative regulation of leukocyte differentiation,4/317,72/12743,0.104275064298863,0.460227804624643,0.410738408168044,MDK/CLDN18/TMEM176B/TMEM176A,4
GO:2000060,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,4/317,72/12743,0.104275064298863,0.460227804624643,0.410738408168044,HSPA1A/RBX1/NOP53/ZFAND2A,4
GO:0007611,GO:0007611,learning or memory,8/317,191/12743,0.104463390423841,0.460227804624643,0.410738408168044,MDK/CNTNAP2/FOS/MME/SGK1/MEIS2/ARC/JUN,8
GO:0032409,GO:0032409,regulation of transporter activity,8/317,191/12743,0.104463390423841,0.460227804624643,0.410738408168044,S100A1/PARK7/YWHAH/GEM/SGK1/CACNA2D1/CNKSR3/NPPA,8
GO:0001822,GO:0001822,kidney development,9/317,223/12743,0.10514132012564,0.462647546942076,0.41289794980732,CD24/EPCAM/SOX4/MME/ODC1/EGR1/BASP1/AKR1B1/VEGFA,9
GO:1901652,GO:1901652,response to peptide,14/317,388/12743,0.105378991417751,0.463126496512,0.413325396784592,TIMP1/BSG/RAB13/IGFBP5/EGR1/ATP6AP1/APRT/AKR1B1/MAP1B/ATP6V0E2/CACNA2D1/YWHAG/GGH/NPPA,14
GO:0000245,GO:0000245,spliceosomal complex assembly,3/317,46/12743,0.106061242819971,0.464421641824356,0.414481272024197,SRSF9/SNRPE/TXNL4A,3
GO:0010324,GO:0010324,membrane invagination,3/317,46/12743,0.106061242819971,0.464421641824356,0.414481272024197,RHOA/CDC42/SNX3,3
GO:0032637,GO:0032637,interleukin-8 production,3/317,46/12743,0.106061242819971,0.464421641824356,0.414481272024197,HSPA1A/PARK7/HSPA1B,3
GO:0001525,GO:0001525,angiogenesis,13/317,355/12743,0.106461751838139,0.465608269900378,0.415540299145408,S100A1/APOD/MDK/RHOA/RAMP1/GRN/RHOB/HGF/PDCD6/GTF2I/JUN/BTG1/VEGFA,13
GO:2001235,GO:2001235,positive regulation of apoptotic signaling pathway,7/317,161/12743,0.10723539367774,0.467551716615335,0.417274762387392,PDIA3/PARK7/YWHAH/RPS3/YWHAG/SFPQ/FAM162A,7
GO:0010506,GO:0010506,regulation of autophagy,11/317,289/12743,0.107295251027958,0.467551716615335,0.417274762387392,UCHL1/EEF1A2/PSAP/PARK7/TOMM7/TSPO/SNRNP70/HGF/SVIP/ATP6V0E2/WDR6,11
GO:0000086,GO:0000086,G2/M transition of mitotic cell cycle,9/317,224/12743,0.107296291017427,0.467551716615335,0.417274762387392,TUBA1A/KHDRBS1/PSMB8/RBX1/NOP53/PSMA6/CDKN1A/YWHAG/TUBB4B,9
GO:0019319,GO:0019319,hexose biosynthetic process,4/317,73/12743,0.108285068342786,0.470719251139437,0.420101684349024,PGAM2/MDH2/AKR1B1/ALDOA,4
GO:2000379,GO:2000379,positive regulation of reactive oxygen species metabolic process,4/317,73/12743,0.108285068342786,0.470719251139437,0.420101684349024,PARK7/TSPO/CDKN1A/ROMO1,4
GO:0031032,GO:0031032,actomyosin structure organization,6/317,131/12743,0.108556755367433,0.470761804036096,0.420139661430941,RHOA/CDC42/RAC1/PFN2/ELN/CD47,6
GO:0031345,GO:0031345,negative regulation of cell projection organization,6/317,131/12743,0.108556755367433,0.470761804036096,0.420139661430941,B2M/RHOA/YWHAH/MYLIP/PFN2/DPYSL3,6
GO:1904064,GO:1904064,positive regulation of cation transmembrane transport,5/317,102/12743,0.110527431964285,0.47080322399474,0.420176627402376,S100A1/PARK7/CACNA2D1/CNKSR3/NPPA,5
GO:0048858,GO:0048858,cell projection morphogenesis,17/317,494/12743,0.110571773092606,0.47080322399474,0.420176627402376,TUBB2B/MDK/UCHL1/RHOA/RPL24/TUBB3/CNTNAP2/YWHAH/CDC42/S100A6/MAP1B/SYT1/ALCAM/ARC/CAMK2B/MACF1/VEGFA,17
GO:0071214,GO:0071214,cellular response to abiotic stimulus,10/317,258/12743,0.110784095395103,0.47080322399474,0.420176627402376,MME/RAC1/EGR1/TSPO/RHOB/AKR1B1/HSPA5/CDKN1A/ASCL1/NPPA,10
GO:0104004,GO:0104004,cellular response to environmental stimulus,10/317,258/12743,0.110784095395103,0.47080322399474,0.420176627402376,MME/RAC1/EGR1/TSPO/RHOB/AKR1B1/HSPA5/CDKN1A/ASCL1/NPPA,10
GO:0001569,GO:0001569,branching involved in blood vessel morphogenesis,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,MDK/VEGFA,2
GO:0006735,GO:0006735,NADH regeneration,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,PGAM2/ALDOA,2
GO:0009218,GO:0009218,pyrimidine ribonucleotide metabolic process,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,NME4/CTPS1,2
GO:0036003,GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,HSPA5/VEGFA,2
GO:0045980,GO:0045980,negative regulation of nucleotide metabolic process,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,RHOA/TSPO,2
GO:0048169,GO:0048169,regulation of long-term neuronal synaptic plasticity,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,GRIK2/CAMK2B,2
GO:0060306,GO:0060306,regulation of membrane repolarization,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,CACNA2D1/NPPA,2
GO:0061621,GO:0061621,canonical glycolysis,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,PGAM2/ALDOA,2
GO:0061718,GO:0061718,glucose catabolic process to pyruvate,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,PGAM2/ALDOA,2
GO:0070861,GO:0070861,regulation of protein exit from endoplasmic reticulum,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,OS9/SVIP,2
GO:0090022,GO:0090022,regulation of neutrophil chemotaxis,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,MDK/RAC1,2
GO:0099131,GO:0099131,ATP hydrolysis coupled ion transmembrane transport,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,ATP6AP1/ATP6V0E2,2
GO:1900543,GO:1900543,negative regulation of purine nucleotide metabolic process,2/317,23/12743,0.110908786908002,0.47080322399474,0.420176627402376,RHOA/TSPO,2
GO:0051438,GO:0051438,regulation of ubiquitin-protein transferase activity,3/317,47/12743,0.111316478552303,0.47080322399474,0.420176627402376,RPS2/PARK7/UBE2S,3
GO:0060688,GO:0060688,regulation of morphogenesis of a branching structure,3/317,47/12743,0.111316478552303,0.47080322399474,0.420176627402376,MDK/HGF/VEGFA,3
GO:0099132,GO:0099132,ATP hydrolysis coupled cation transmembrane transport,3/317,47/12743,0.111316478552303,0.47080322399474,0.420176627402376,ATP5F1E/ATP6AP1/ATP6V0E2,3
GO:2000401,GO:2000401,regulation of lymphocyte migration,3/317,47/12743,0.111316478552303,0.47080322399474,0.420176627402376,APOD/RHOA/SELENOK,3
GO:0038061,GO:0038061,NIK/NF-kappaB signaling,6/317,132/12743,0.111499328532979,0.471022427821455,0.420372259717384,RHOA/CALR/TERF2IP/PSMB8/RPS3/PSMA6,6
GO:0051588,GO:0051588,regulation of neurotransmitter transport,5/317,103/12743,0.11394973971951,0.48080905433291,0.429106506875546,VAMP8/RGS2/PFN2/SYT1/NPPA,5
GO:0045088,GO:0045088,regulation of innate immune response,12/317,326/12743,0.114434011695747,0.482286368166718,0.430424961619839,S100A1/HSP90B1/S100A14/HSPA1A/HSPA1B/GRN/RPS19/PSMB8/NOP53/PSMA6/SFPQ/CNPY3,12
GO:0043542,GO:0043542,endothelial cell migration,7/317,164/12743,0.11515340632057,0.484749994991157,0.432623668760134,RHOA/CALR/RAB13/GRN/RHOB/PDCD6/VEGFA,7
GO:0006511,GO:0006511,ubiquitin-dependent protein catabolic process,16/317,463/12743,0.115942063987341,0.484838369949885,0.432702540548203,UCHL1/HSP90B1/HSPA1A/FHIT/PARK7/OS9/PCNP/PSMB8/HSPA5/SVIP/RBX1/NOP53/RNF187/PSMA6/UBE2S/ZFAND2A,16
GO:0043270,GO:0043270,positive regulation of ion transport,8/317,196/12743,0.116411584871798,0.484838369949885,0.432702540548203,S100A1/VAMP8/MIF/PARK7/TSPO/CACNA2D1/CNKSR3/NPPA,8
GO:0034446,GO:0034446,substrate adhesion-dependent cell spreading,4/317,75/12743,0.116509484373872,0.484838369949885,0.432702540548203,MDK/CALR/CDC42/RAC1,4
GO:0090277,GO:0090277,positive regulation of peptide hormone secretion,4/317,75/12743,0.116509484373872,0.484838369949885,0.432702540548203,GRP/SOX4/RAC1/SERP1,4
GO:0120162,GO:0120162,positive regulation of cold-induced thermogenesis,4/317,75/12743,0.116509484373872,0.484838369949885,0.432702540548203,FABP5/GADD45G/MFAP2/VEGFA,4
GO:0010823,GO:0010823,negative regulation of mitochondrion organization,3/317,48/12743,0.116669530179015,0.484838369949885,0.432702540548203,HSPA1A/TSPO/HGF,3
GO:0033555,GO:0033555,multicellular organismal response to stress,3/317,48/12743,0.116669530179015,0.484838369949885,0.432702540548203,MDK/TSPO/GRIK2,3
GO:0048008,GO:0048008,platelet-derived growth factor receptor signaling pathway,3/317,48/12743,0.116669530179015,0.484838369949885,0.432702540548203,APOD/PHF14/VEGFA,3
GO:0006937,GO:0006937,regulation of muscle contraction,5/317,104/12743,0.117422434731866,0.484838369949885,0.432702540548203,CHGA/RHOA/RGS2/DSP/NPPA,5
GO:0030534,GO:0030534,adult behavior,5/317,104/12743,0.117422434731866,0.484838369949885,0.432702540548203,UCHL1/PARK7/CNTNAP2/CSTB/SLITRK6,5
GO:0031348,GO:0031348,negative regulation of defense response,6/317,134/12743,0.117505405940647,0.484838369949885,0.432702540548203,APOD/MDK/GRN/RPS19/HGF/CHID1,6
GO:0001894,GO:0001894,tissue homeostasis,7/317,165/12743,0.117859281871234,0.484838369949885,0.432702540548203,B2M/CLDN18/RAC1/ATP6AP1/AKR1B1/AZGP1/VEGFA,7
GO:0072593,GO:0072593,reactive oxygen species metabolic process,8/317,197/12743,0.11888616290841,0.484838369949885,0.432702540548203,RHOA/PARK7/PON3/RAC1/TSPO/CDKN1A/ROMO1/CD47,8
GO:0006517,GO:0006517,protein deglycosylation,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,PARK7/OS9,2
GO:0006779,GO:0006779,porphyrin-containing compound biosynthetic process,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,TSPO/TMEM14C,2
GO:0008334,GO:0008334,histone mRNA metabolic process,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,SNRPF/SNRPE,2
GO:0043457,GO:0043457,regulation of cellular respiration,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,PARK7/NOP53,2
GO:0046688,GO:0046688,response to copper ion,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,PARK7/S100A13,2
GO:0061615,GO:0061615,glycolytic process through fructose-6-phosphate,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,PGAM2/ALDOA,2
GO:0061620,GO:0061620,glycolytic process through glucose-6-phosphate,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,PGAM2/ALDOA,2
GO:0061756,GO:0061756,leukocyte adhesion to vascular endothelial cell,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,MDK/RHOA,2
GO:0070570,GO:0070570,regulation of neuron projection regeneration,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,GRN/HGF,2
GO:0090662,GO:0090662,ATP hydrolysis coupled transmembrane transport,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,ATP6AP1/ATP6V0E2,2
GO:0097242,GO:0097242,amyloid-beta clearance,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,LRPAP1/MME,2
GO:1900101,GO:1900101,regulation of endoplasmic reticulum unfolded protein response,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,PPP1R15A/HSPA5,2
GO:1900739,GO:1900739,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,YWHAH/YWHAG,2
GO:1900740,GO:1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,YWHAH/YWHAG,2
GO:1901099,GO:1901099,negative regulation of signal transduction in absence of ligand,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,HSPA1A/HSPA1B,2
GO:2001240,GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,2/317,24/12743,0.119085474455006,0.484838369949885,0.432702540548203,HSPA1A/HSPA1B,2
GO:0055080,GO:0055080,cation homeostasis,15/317,431/12743,0.119902620669562,0.4876130331528,0.435178837581358,B2M/HSP90B1/S100A14/CALR/CD24/TMBIM6/GRN/ATP6AP1/FTH1/GTF2I/GRIK2/ATP6V0E2/CACNA2D1/MT2A/CALCB,15
GO:0000041,GO:0000041,transition metal ion transport,4/317,76/12743,0.120721388325687,0.488731296205908,0.436176851134063,B2M/ATP6AP1/FTH1/ATP6V0E2,4
GO:0010972,GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,4/317,76/12743,0.120721388325687,0.488731296205908,0.436176851134063,PSMB8/RBX1/NOP53/PSMA6,4
GO:0043500,GO:0043500,muscle adaptation,4/317,76/12743,0.120721388325687,0.488731296205908,0.436176851134063,IGFBP5/RGS2/CAMK2B/NPPA,4
GO:1901222,GO:1901222,regulation of NIK/NF-kappaB signaling,4/317,76/12743,0.120721388325687,0.488731296205908,0.436176851134063,RHOA/CALR/TERF2IP/RPS3,4
GO:1903169,GO:1903169,regulation of calcium ion transmembrane transport,5/317,105/12743,0.120944883333336,0.489085326865404,0.436492812030086,S100A1/TSPAN13/GEM/CACNA2D1/NPPA,5
GO:1901991,GO:1901991,negative regulation of mitotic cell cycle phase transition,8/317,198/12743,0.121388716900248,0.490328581186955,0.437602376241224,SOX4/DUSP1/MAD1L1/PSMB8/RBX1/NOP53/PSMA6/CDKN1A,8
GO:0042698,GO:0042698,ovulation cycle,3/317,49/12743,0.122117163353897,0.492165024952085,0.439241342816471,MDK/EGR1/HSPA5,3
GO:0045669,GO:0045669,positive regulation of osteoblast differentiation,3/317,49/12743,0.122117163353897,0.492165024952085,0.439241342816471,ATP6AP1/HGF/ATRAID,3
GO:0046649,GO:0046649,lymphocyte activation,16/317,467/12743,0.122293953606752,0.492325602705795,0.439384653260307,B2M/MDK/RHOA/CD24/MIF/SOX4/CDC42/RAC1/EGR1/SELENOK/MAD1L1/RPS3/IGFBP2/CDKN1A/CD47/CTPS1,16
GO:0043281,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,7/317,167/12743,0.123369504524485,0.496099965062107,0.442753149406135,RHOA/PARK7/HGF/PDCD6/RPS3/FAM162A/VEGFA,7
GO:0019941,GO:0019941,modification-dependent protein catabolic process,16/317,468/12743,0.123913517734602,0.497197676886415,0.44373282165282,UCHL1/HSP90B1/HSPA1A/FHIT/PARK7/OS9/PCNP/PSMB8/HSPA5/SVIP/RBX1/NOP53/RNF187/PSMA6/UBE2S/ZFAND2A,16
GO:0046883,GO:0046883,regulation of hormone secretion,8/317,199/12743,0.123919087201732,0.497197676886415,0.44373282165282,GRP/VAMP8/SOX4/SLC25A6/RAC1/SERP1/SCG5/NPPA,8
GO:0036503,GO:0036503,ERAD pathway,4/317,77/12743,0.124998031515656,0.499853084870728,0.446102687266226,HSP90B1/OS9/HSPA5/SVIP,4
GO:0046364,GO:0046364,monosaccharide biosynthetic process,4/317,77/12743,0.124998031515656,0.499853084870728,0.446102687266226,PGAM2/MDH2/AKR1B1/ALDOA,4
GO:1903008,GO:1903008,organelle disassembly,4/317,77/12743,0.124998031515656,0.499853084870728,0.446102687266226,PARK7/TOMM7/TSPO/MAP1LC3B,4
GO:0002758,GO:0002758,innate immune response-activating signal transduction,9/317,232/12743,0.125422459272452,0.500437004533258,0.446623816651012,S100A1/HSP90B1/S100A14/HSPA1A/HSPA1B/PSMB8/NOP53/PSMA6/CNPY3,9
GO:0031098,GO:0031098,stress-activated protein kinase signaling cascade,9/317,232/12743,0.125422459272452,0.500437004533258,0.446623816651012,RHOA/GADD45G/DUSP1/HGF/AKR1B1/GADD45B/RPS3/GRIK2/VEGFA,9
GO:0051100,GO:0051100,negative regulation of binding,6/317,137/12743,0.12681144487461,0.501008475385197,0.447133835875582,B2M/LRPAP1/PARK7/TMBIM6/HSPA5/JUN,6
GO:0001662,GO:0001662,behavioral fear response,2/317,25/12743,0.127406360961647,0.501008475385197,0.447133835875582,MDK/GRIK2,2
GO:0001774,GO:0001774,microglial cell activation,2/317,25/12743,0.127406360961647,0.501008475385197,0.447133835875582,GRN/JUN,2
GO:0002269,GO:0002269,leukocyte activation involved in inflammatory response,2/317,25/12743,0.127406360961647,0.501008475385197,0.447133835875582,GRN/JUN,2
GO:0030224,GO:0030224,monocyte differentiation,2/317,25/12743,0.127406360961647,0.501008475385197,0.447133835875582,JUN/VEGFA,2
GO:0033003,GO:0033003,regulation of mast cell activation,2/317,25/12743,0.127406360961647,0.501008475385197,0.447133835875582,VAMP8/NPPA,2
GO:0048009,GO:0048009,insulin-like growth factor receptor signaling pathway,2/317,25/12743,0.127406360961647,0.501008475385197,0.447133835875582,IGFBP5/IGFBP2,2
GO:0090322,GO:0090322,regulation of superoxide metabolic process,2/317,25/12743,0.127406360961647,0.501008475385197,0.447133835875582,PARK7/PON3,2
GO:0099622,GO:0099622,cardiac muscle cell membrane repolarization,2/317,25/12743,0.127406360961647,0.501008475385197,0.447133835875582,CACNA2D1/NPPA,2
GO:1900181,GO:1900181,negative regulation of protein localization to nucleus,2/317,25/12743,0.127406360961647,0.501008475385197,0.447133835875582,APOD/CLDN18,2
GO:1903131,GO:1903131,mononuclear cell differentiation,2/317,25/12743,0.127406360961647,0.501008475385197,0.447133835875582,JUN/VEGFA,2
GO:0006809,GO:0006809,nitric oxide biosynthetic process,3/317,50/12743,0.127656123352668,0.501008475385197,0.447133835875582,RAC1/TSPO/CD47,3
GO:0007189,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,3/317,50/12743,0.127656123352668,0.501008475385197,0.447133835875582,CHGA/RAMP1/GNG2,3
GO:0010332,GO:0010332,response to gamma radiation,3/317,50/12743,0.127656123352668,0.501008475385197,0.447133835875582,EGR1/HSPA5/CDKN1A,3
GO:0060997,GO:0060997,dendritic spine morphogenesis,3/317,50/12743,0.127656123352668,0.501008475385197,0.447133835875582,CDC42/ARC/CAMK2B,3
GO:0072001,GO:0072001,renal system development,9/317,233/12743,0.127797506658164,0.501016397422136,0.447140906036943,CD24/EPCAM/SOX4/MME/ODC1/EGR1/BASP1/AKR1B1/VEGFA,9
GO:0038095,GO:0038095,Fc-epsilon receptor signaling pathway,5/317,107/12743,0.128136401160836,0.501251754268993,0.447350954399207,FOS/RAC1/PSMB8/PSMA6/JUN,5
GO:0071901,GO:0071901,negative regulation of protein serine/threonine kinase activity,5/317,107/12743,0.128136401160836,0.501251754268993,0.447350954399207,UCHL1/RGS2/DUSP1/CDKN1A/YWHAG,5
GO:0002757,GO:0002757,immune response-activating signal transduction,14/317,402/12743,0.129258572880398,0.504306303638247,0.450077040769893,S100A1/HSP90B1/S100A14/HSPA1A/HSPA1B/CDC42/RAC1/BRK1/PSMB8/RPS3/NOP53/PSMA6/CNPY3/CD47,14
GO:0002698,GO:0002698,negative regulation of immune effector process,4/317,78/12743,0.129338083992897,0.504306303638247,0.450077040769893,TMBIM6/GRN/RPS19/CD47,4
GO:0009119,GO:0009119,ribonucleoside metabolic process,4/317,78/12743,0.129338083992897,0.504306303638247,0.450077040769893,RHOA/APRT/NME4/CTPS1,4
GO:0009201,GO:0009201,ribonucleoside triphosphate biosynthetic process,6/317,138/12743,0.129991095141839,0.505755397223931,0.451370309856831,ATP5F1E/ATP5ME/PGAM2/ALDOA/NME4/CTPS1,6
GO:0010565,GO:0010565,regulation of cellular ketone metabolic process,6/317,138/12743,0.129991095141839,0.505755397223931,0.451370309856831,FABP5/PARK7/ODC1/EGR1/PSMB8/PSMA6,6
GO:0000377,GO:0000377,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,11/317,301/12743,0.131407386915237,0.510161507516496,0.455302620572515,YBX1/SNRPF/KHDRBS1/SNRNP70/SRSF9/SNRPE/TXNL4A/LSM3/SFPQ/LSM5/DDX17,11
GO:0000398,GO:0000398,mRNA splicing, via spliceosome,11/317,301/12743,0.131407386915237,0.510161507516496,0.455302620572515,YBX1/SNRPF/KHDRBS1/SNRNP70/SRSF9/SNRPE/TXNL4A/LSM3/SFPQ/LSM5/DDX17,11
GO:0098662,GO:0098662,inorganic cation transmembrane transport,16/317,473/12743,0.132199870805108,0.512684504362851,0.457554313534286,S100A1/CD63/CYB5A/TSPAN13/PARK7/COX4I1/ATP5F1E/YWHAH/ATP6AP1/ATP5ME/GEM/ATP6V0E2/CACNA2D1/NDUFA4L2/CNKSR3/NPPA,16
GO:0046847,GO:0046847,filopodium assembly,3/317,51/12743,0.133283141018637,0.513579476499315,0.458353047176609,FSCN1/CDC42/DPYSL3,3
GO:0090307,GO:0090307,mitotic spindle assembly,3/317,51/12743,0.133283141018637,0.513579476499315,0.458353047176609,RHOA/HSPA1A/HSPA1B,3
GO:0097345,GO:0097345,mitochondrial outer membrane permeabilization,3/317,51/12743,0.133283141018637,0.513579476499315,0.458353047176609,HSPA1A/YWHAH/YWHAG,3
GO:0098771,GO:0098771,inorganic ion homeostasis,15/317,439/12743,0.13360426562651,0.513579476499315,0.458353047176609,B2M/HSP90B1/S100A14/CALR/CD24/TMBIM6/GRN/ATP6AP1/FTH1/GTF2I/GRIK2/ATP6V0E2/CACNA2D1/MT2A/CALCB,15
GO:0002433,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,4/317,79/12743,0.133740189111478,0.513579476499315,0.458353047176609,CDC42/RAC1/BRK1/CD47,4
GO:0038094,GO:0038094,Fc-gamma receptor signaling pathway,4/317,79/12743,0.133740189111478,0.513579476499315,0.458353047176609,CDC42/RAC1/BRK1/CD47,4
GO:0038096,GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,4/317,79/12743,0.133740189111478,0.513579476499315,0.458353047176609,CDC42/RAC1/BRK1/CD47,4
GO:0045185,GO:0045185,maintenance of protein location,4/317,79/12743,0.133740189111478,0.513579476499315,0.458353047176609,PARK7/OS9/TSPO/HSPA5,4
GO:0021700,GO:0021700,developmental maturation,8/317,203/12743,0.134315280764052,0.513579476499315,0.458353047176609,RHOA/CD63/CNTNAP2/MAP1B/CDKN1A/ASCL1/CAMK2B/VEGFA,8
GO:0050768,GO:0050768,negative regulation of neurogenesis,8/317,203/12743,0.134315280764052,0.513579476499315,0.458353047176609,B2M/RHOA/CALR/YWHAH/MYLIP/TSPO/ASCL1/DPYSL3,8
GO:0010822,GO:0010822,positive regulation of mitochondrion organization,5/317,109/12743,0.135518813106647,0.513579476499315,0.458353047176609,PARK7/TOMM7/YWHAH/YWHAG/FAM162A,5
GO:0043632,GO:0043632,modification-dependent macromolecule catabolic process,16/317,475/12743,0.135601930172259,0.513579476499315,0.458353047176609,UCHL1/HSP90B1/HSPA1A/FHIT/PARK7/OS9/PCNP/PSMB8/HSPA5/SVIP/RBX1/NOP53/RNF187/PSMA6/UBE2S/ZFAND2A,16
GO:0002209,GO:0002209,behavioral defense response,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,MDK/GRIK2,2
GO:0003044,GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,RHOA/MME,2
GO:0038084,GO:0038084,vascular endothelial growth factor signaling pathway,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,CD63/VEGFA,2
GO:0042168,GO:0042168,heme metabolic process,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,TSPO/TMEM14C,2
GO:0042407,GO:0042407,cristae formation,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,ATP5F1E/ATP5ME,2
GO:0042491,GO:0042491,inner ear auditory receptor cell differentiation,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,MYCL/SLITRK6,2
GO:0046039,GO:0046039,GTP metabolic process,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,RHOA/NME4,2
GO:0050690,GO:0050690,regulation of defense response to virus by virus,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,B2M/RAC1,2
GO:0051154,GO:0051154,negative regulation of striated muscle cell differentiation,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,YBX1/RGS2,2
GO:0086091,GO:0086091,regulation of heart rate by cardiac conduction,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,DSP/CACNA2D1,2
GO:1902622,GO:1902622,regulation of neutrophil migration,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,MDK/RAC1,2
GO:2000403,GO:2000403,positive regulation of lymphocyte migration,2/317,26/12743,0.135859271808303,0.513579476499315,0.458353047176609,RHOA/SELENOK,2
GO:0007160,GO:0007160,cell-matrix adhesion,7/317,172/12743,0.137707790963979,0.520020492138135,0.46410144500023,APOD/RHOA/BCAM/CD63/RAC1/MACF1/VEGFA,7
GO:0032414,GO:0032414,positive regulation of ion transmembrane transporter activity,4/317,80/12743,0.138202965511684,0.520796290371596,0.464793819794342,S100A1/CACNA2D1/CNKSR3/NPPA,4
GO:0055007,GO:0055007,cardiac muscle cell differentiation,4/317,80/12743,0.138202965511684,0.520796290371596,0.464793819794342,CALR/RGS2/NPPA/VEGFA,4
GO:0051493,GO:0051493,regulation of cytoskeleton organization,14/317,407/12743,0.138479473143965,0.52114642463826,0.465106303285972,MDK/FSCN1/RHOA/HSPA1A/HSPA1B/CDC42/RAC1/BRK1/TBCD/PFN2/ELN/RPS3/MAP1B/CD47,14
GO:0010812,GO:0010812,negative regulation of cell-substrate adhesion,3/317,52/12743,0.138994938355443,0.52114642463826,0.465106303285972,APOD/RHOA/TBCD,3
GO:0070268,GO:0070268,cornification,3/317,52/12743,0.138994938355443,0.52114642463826,0.465106303285972,DSP/KRT12/KRT10,3
GO:0048812,GO:0048812,neuron projection morphogenesis,16/317,477/12743,0.139053657204321,0.52114642463826,0.465106303285972,TUBB2B/UCHL1/RHOA/RPL24/TUBB3/CNTNAP2/YWHAH/CDC42/S100A6/MAP1B/SYT1/ALCAM/ARC/CAMK2B/MACF1/VEGFA,16
GO:0010977,GO:0010977,negative regulation of neuron projection development,5/317,110/12743,0.139279808599101,0.52114642463826,0.465106303285972,B2M/RHOA/YWHAH/MYLIP/DPYSL3,5
GO:0034767,GO:0034767,positive regulation of ion transmembrane transport,5/317,110/12743,0.139279808599101,0.52114642463826,0.465106303285972,S100A1/PARK7/CACNA2D1/CNKSR3/NPPA,5
GO:0002697,GO:0002697,regulation of immune effector process,10/317,271/12743,0.139310629785081,0.52114642463826,0.465106303285972,B2M/VAMP8/MIF/TMBIM6/GRN/RPS19/SELENOK/NOP53/CD47/NPPA,10
GO:0043406,GO:0043406,positive regulation of MAP kinase activity,8/317,205/12743,0.139675588183779,0.521968544200297,0.465840018365422,CD24/GADD45G/MIF/ERP29/HGF/GADD45B/RPS3/VEGFA,8
GO:0000375,GO:0000375,RNA splicing, via transesterification reactions,11/317,305/12743,0.14005446330655,0.522604116915285,0.466407246426407,YBX1/SNRPF/KHDRBS1/SNRNP70/SRSF9/SNRPE/TXNL4A/LSM3/SFPQ/LSM5/DDX17,11
GO:0002431,GO:0002431,Fc receptor mediated stimulatory signaling pathway,4/317,81/12743,0.142725009059563,0.522604116915285,0.466407246426407,CDC42/RAC1/BRK1/CD47,4
GO:0007229,GO:0007229,integrin-mediated signaling pathway,4/317,81/12743,0.142725009059563,0.522604116915285,0.466407246426407,TIMP1/CD63/CDC42/CD47,4
GO:0055088,GO:0055088,lipid homeostasis,4/317,81/12743,0.142725009059563,0.522604116915285,0.466407246426407,CD24/NPC2/RBP1/MYLIP,4
GO:0001736,GO:0001736,establishment of planar polarity,5/317,111/12743,0.143086337173468,0.522604116915285,0.466407246426407,RHOA/CDC42/RAC1/PSMB8/PSMA6,5
GO:0007006,GO:0007006,mitochondrial membrane organization,5/317,111/12743,0.143086337173468,0.522604116915285,0.466407246426407,HSPA1A/ATP5F1E/YWHAH/ATP5ME/YWHAG,5
GO:0007164,GO:0007164,establishment of tissue polarity,5/317,111/12743,0.143086337173468,0.522604116915285,0.466407246426407,RHOA/CDC42/RAC1/PSMB8/PSMA6,5
GO:0007093,GO:0007093,mitotic cell cycle checkpoint,6/317,142/12743,0.143086693952551,0.522604116915285,0.466407246426407,RPL24/SOX4/DUSP1/MAD1L1/NOP53/CDKN1A,6
GO:0090090,GO:0090090,negative regulation of canonical Wnt signaling pathway,6/317,142/12743,0.143086693952551,0.522604116915285,0.466407246426407,MDK/EGR1/PSMB8/RBX1/IGFBP2/PSMA6,6
GO:0010389,GO:0010389,regulation of G2/M transition of mitotic cell cycle,7/317,174/12743,0.143662430512563,0.522604116915285,0.466407246426407,TUBA1A/PSMB8/RBX1/NOP53/PSMA6/YWHAG/TUBB4B,7
GO:0050714,GO:0050714,positive regulation of protein secretion,7/317,174/12743,0.143662430512563,0.522604116915285,0.466407246426407,MDK/MIF/SOX4/RAC1/PPIA/SERP1/SELENOK,7
GO:0032970,GO:0032970,regulation of actin filament-based process,10/317,273/12743,0.144014550819502,0.522604116915285,0.466407246426407,MDK/FSCN1/RHOA/CDC42/RAC1/BRK1/PFN2/DSP/ELN/CD47,10
GO:0007616,GO:0007616,long-term memory,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,SGK1/ARC,2
GO:0015949,GO:0015949,nucleobase-containing small molecule interconversion,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,NME4/CTPS1,2
GO:0033014,GO:0033014,tetrapyrrole biosynthetic process,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,TSPO/TMEM14C,2
GO:0033120,GO:0033120,positive regulation of RNA splicing,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,HSPA1A/SNRNP70,2
GO:0042596,GO:0042596,fear response,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,MDK/GRIK2,2
GO:0045197,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,RHOA/CDC42,2
GO:0045648,GO:0045648,positive regulation of erythrocyte differentiation,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,HSPA1A/HSPA1B,2
GO:0046134,GO:0046134,pyrimidine nucleoside biosynthetic process,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,NME4/CTPS1,2
GO:0090162,GO:0090162,establishment of epithelial cell polarity,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,RHOA/CDC42,2
GO:0090169,GO:0090169,regulation of spindle assembly,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,HSPA1A/HSPA1B,2
GO:0097028,GO:0097028,dendritic cell differentiation,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,TMEM176B/TMEM176A,2
GO:1900015,GO:1900015,regulation of cytokine production involved in inflammatory response,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,APOD/CHID1,2
GO:1902895,GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,FOS/JUN,2
GO:1903393,GO:1903393,positive regulation of adherens junction organization,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,RAC1/VEGFA,2
GO:2000249,GO:2000249,regulation of actin cytoskeleton reorganization,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,MDK/CDC42,2
GO:2000648,GO:2000648,positive regulation of stem cell proliferation,2/317,27/12743,0.144432545405302,0.522604116915285,0.466407246426407,EPCAM/VEGFA,2
GO:0000380,GO:0000380,alternative mRNA splicing, via spliceosome,3/317,53/12743,0.144788233782371,0.522604116915285,0.466407246426407,KHDRBS1/SFPQ/DDX17,3
GO:0022617,GO:0022617,extracellular matrix disassembly,3/317,53/12743,0.144788233782371,0.522604116915285,0.466407246426407,TIMP1/FSCN1/BSG,3
GO:0042632,GO:0042632,cholesterol homeostasis,3/317,53/12743,0.144788233782371,0.522604116915285,0.466407246426407,CD24/NPC2/MYLIP,3
GO:0051310,GO:0051310,metaphase plate congression,3/317,53/12743,0.144788233782371,0.522604116915285,0.466407246426407,BOD1/GEM/MAD1L1,3
GO:0055013,GO:0055013,cardiac muscle cell development,3/317,53/12743,0.144788233782371,0.522604116915285,0.466407246426407,RGS2/NPPA/VEGFA,3
GO:1902110,GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,3/317,53/12743,0.144788233782371,0.522604116915285,0.466407246426407,HSPA1A/YWHAH/YWHAG,3
GO:0051091,GO:0051091,positive regulation of DNA-binding transcription factor activity,8/317,207/12743,0.145141874794927,0.523355105203374,0.467077479147905,HSPA1A/TERF2IP/PARK7/HSPA1B/RPS3/PSMA6/BEX1/VEGFA,8
GO:0098542,GO:0098542,defense response to other organism,10/317,274/12743,0.146397161112589,0.526497100810237,0.469881608453145,S100A14/CHGA/RPL39/GRN/RPS19/SELENOK/WIPI2/NOP53/ROMO1/DDX17,10
GO:0007179,GO:0007179,transforming growth factor beta receptor signaling pathway,6/317,143/12743,0.146452601059871,0.526497100810237,0.469881608453145,RHOA/HSPA1A/PEG10/FOS/HSPA5/JUN,6
GO:0030307,GO:0030307,positive regulation of cell growth,6/317,143/12743,0.146452601059871,0.526497100810237,0.469881608453145,RHOA/CDC42/MAP1B/SYT1/MACF1/VEGFA,6
GO:1901800,GO:1901800,positive regulation of proteasomal protein catabolic process,4/317,82/12743,0.147304894743757,0.528504088426951,0.471672779891764,HSPA1A/RBX1/NOP53/ZFAND2A,4
GO:2001237,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,4/317,82/12743,0.147304894743757,0.528504088426951,0.471672779891764,HSPA1A/PARK7/HSPA1B/HGF,4
GO:0032868,GO:0032868,response to insulin,8/317,208/12743,0.147914215725279,0.530161122165879,0.473151628829983,RAB13/EGR1/ATP6AP1/APRT/ATP6V0E2/YWHAG/GGH/NPPA,8
GO:0032386,GO:0032386,regulation of intracellular transport,12/317,343/12743,0.148503452144286,0.531742938703893,0.474563348852783,APOD/VAMP8/PARK7/TOMM7/OS9/KHDRBS1/PFN2/MAP1B/SVIP/SNX3/SYT1/NPPA,12
GO:0030003,GO:0030003,cellular cation homeostasis,13/317,378/12743,0.149543182083393,0.534933074218703,0.477410441466542,HSP90B1/CALR/CD24/TMBIM6/GRN/ATP6AP1/FTH1/GTF2I/GRIK2/ATP6V0E2/CACNA2D1/MT2A/CALCB,13
GO:0043401,GO:0043401,steroid hormone mediated signaling pathway,6/317,144/12743,0.149854372073896,0.535455719974237,0.477876885874086,RHOA/CALR/PARK7/YWHAH/SCGB2A1/DDX17,6
GO:0034103,GO:0034103,regulation of tissue remodeling,3/317,54/12743,0.150659747067178,0.535455719974237,0.477876885874086,MDK/CLDN18/ATP6AP1,3
GO:0043407,GO:0043407,negative regulation of MAP kinase activity,3/317,54/12743,0.150659747067178,0.535455719974237,0.477876885874086,UCHL1/RGS2/DUSP1,3
GO:0055092,GO:0055092,sterol homeostasis,3/317,54/12743,0.150659747067178,0.535455719974237,0.477876885874086,CD24/NPC2/MYLIP,3
GO:0008217,GO:0008217,regulation of blood pressure,5/317,113/12743,0.15083291478928,0.535455719974237,0.477876885874086,CHGA/RHOA/MME/SGK1/NPPA,5
GO:1901657,GO:1901657,glycosyl compound metabolic process,5/317,113/12743,0.15083291478928,0.535455719974237,0.477876885874086,RHOA/APRT/AKR1B1/NME4/CTPS1,5
GO:0001508,GO:0001508,action potential,4/317,83/12743,0.151941178528738,0.535455719974237,0.477876885874086,YWHAH/DSP/GRIK2/CACNA2D1,4
GO:0097237,GO:0097237,cellular response to toxic substance,7/317,177/12743,0.152821827357279,0.535455719974237,0.477876885874086,SELENOW/PSAP/PARK7/EGR1/RHOB/HGF/RPS3,7
GO:0032956,GO:0032956,regulation of actin cytoskeleton organization,9/317,243/12743,0.152838420314323,0.535455719974237,0.477876885874086,MDK/FSCN1/RHOA/CDC42/RAC1/BRK1/PFN2/ELN/CD47,9
GO:0044839,GO:0044839,cell cycle G2/M phase transition,9/317,243/12743,0.152838420314323,0.535455719974237,0.477876885874086,TUBA1A/KHDRBS1/PSMB8/RBX1/NOP53/PSMA6/CDKN1A/YWHAG/TUBB4B,9
GO:0001844,GO:0001844,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,YWHAH/YWHAG,2
GO:0001893,GO:0001893,maternal placenta development,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,BSG/JUNB,2
GO:0002534,GO:0002534,cytokine production involved in inflammatory response,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,APOD/CHID1,2
GO:0010458,GO:0010458,exit from mitosis,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,RPL24/UBE2S,2
GO:0010464,GO:0010464,regulation of mesenchymal cell proliferation,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,PHF14/VEGFA,2
GO:0030890,GO:0030890,positive regulation of B cell proliferation,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,MIF/CDKN1A,2
GO:0031111,GO:0031111,negative regulation of microtubule polymerization or depolymerization,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,TBCD/MAP1B,2
GO:0032653,GO:0032653,regulation of interleukin-10 production,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,HGF/CD47,2
GO:0033144,GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,RHOA/CALR,2
GO:0051443,GO:0051443,positive regulation of ubiquitin-protein transferase activity,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,RPS2/UBE2S,2
GO:0061082,GO:0061082,myeloid leukocyte cytokine production,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,CHGA/MIF,2
GO:1902042,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,PARK7/HGF,2
GO:1904292,GO:1904292,regulation of ERAD pathway,2/317,28/12743,0.153115015336166,0.535455719974237,0.477876885874086,OS9/SVIP,2
GO:0007612,GO:0007612,learning,5/317,114/12743,0.154771385936138,0.540197215961568,0.48210851745871,CNTNAP2/FOS/MEIS2/ARC/JUN,5
GO:0061351,GO:0061351,neural precursor cell proliferation,5/317,114/12743,0.154771385936138,0.540197215961568,0.48210851745871,MDK/SPINT2/RHOA/ASCL1/VEGFA,5
GO:0023061,GO:0023061,signal release,12/317,346/12743,0.155021507217284,0.540545410714,0.482419269996713,GRP/VAMP8/PARK7/SOX4/SLC25A6/RAC1/SERP1/PFN2/SCG5/SYT1/PCLO/NPPA,12
GO:0032872,GO:0032872,regulation of stress-activated MAPK cascade,7/317,178/12743,0.155934305782441,0.541889340388675,0.483618683699489,GADD45G/DUSP1/HGF/GADD45B/RPS3/GRIK2/VEGFA,7
GO:0046209,GO:0046209,nitric oxide metabolic process,3/317,55/12743,0.156606203950748,0.541889340388675,0.483618683699489,RAC1/TSPO/CD47,3
GO:1902686,GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,3/317,55/12743,0.156606203950748,0.541889340388675,0.483618683699489,HSPA1A/YWHAH/YWHAG,3
GO:1903749,GO:1903749,positive regulation of establishment of protein localization to mitochondrion,3/317,55/12743,0.156606203950748,0.541889340388675,0.483618683699489,TOMM7/YWHAH/YWHAG,3
GO:0002761,GO:0002761,regulation of myeloid leukocyte differentiation,4/317,84/12743,0.156632399163743,0.541889340388675,0.483618683699489,CLDN18/FOS/ATP6AP1/JUN,4
GO:0035150,GO:0035150,regulation of tube size,4/317,84/12743,0.156632399163743,0.541889340388675,0.483618683699489,CHGA/RHOA/RGS2/NPPA,4
GO:0050880,GO:0050880,regulation of blood vessel size,4/317,84/12743,0.156632399163743,0.541889340388675,0.483618683699489,CHGA/RHOA/RGS2/NPPA,4
GO:2001243,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,4/317,84/12743,0.156632399163743,0.541889340388675,0.483618683699489,HSPA1A/MIF/PARK7/TMBIM6,4
GO:0060541,GO:0060541,respiratory system development,6/317,146/12743,0.156763536579756,0.541889340388675,0.483618683699489,PHF14/MME/IGFBP5/BASP1/ASCL1/VEGFA,6
GO:0001568,GO:0001568,blood vessel development,16/317,487/12743,0.157047350541123,0.542348919496002,0.484028843166332,S100A1/APOD/MDK/RHOA/RAMP1/SOX4/GRN/EGR1/RHOB/HGF/PDCD6/GTF2I/JUN/BTG1/JUNB/VEGFA,16
GO:0050801,GO:0050801,ion homeostasis,16/317,488/12743,0.158913122577231,0.548112106340298,0.489172300746718,B2M/HSP90B1/S100A14/CALR/CD24/TMBIM6/GRN/TSPO/ATP6AP1/FTH1/GTF2I/GRIK2/ATP6V0E2/CACNA2D1/MT2A/CALCB,16
GO:0022898,GO:0022898,regulation of transmembrane transporter activity,7/317,179/12743,0.159075890153879,0.548112106340298,0.489172300746718,S100A1/PARK7/YWHAH/GEM/CACNA2D1/CNKSR3/NPPA,7
GO:0022406,GO:0022406,membrane docking,6/317,147/12743,0.160269918678522,0.548112106340298,0.489172300746718,TUBA1A/VAMP8/SNX3/SYT1/YWHAG/TUBB4B,6
GO:0042692,GO:0042692,muscle cell differentiation,9/317,246/12743,0.160793744700456,0.548112106340298,0.489172300746718,UCHL1/YBX1/CALR/CD9/CDC42/IGFBP5/RGS2/NPPA/VEGFA,9
GO:0002253,GO:0002253,activation of immune response,15/317,454/12743,0.161579925900454,0.548112106340298,0.489172300746718,S100A1/HSP90B1/S100A14/HSPA1A/HSPA1B/CDC42/RAC1/BRK1/PSMB8/RPS3/NOP53/PSMA6/SFPQ/CNPY3/CD47,15
GO:0002833,GO:0002833,positive regulation of response to biotic stimulus,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,MIF/GRN,2
GO:0006692,GO:0006692,prostanoid metabolic process,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,FABP5/MIF,2
GO:0006693,GO:0006693,prostaglandin metabolic process,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,FABP5/MIF,2
GO:0008608,GO:0008608,attachment of spindle microtubules to kinetochore,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,BOD1/CDC42,2
GO:0034383,GO:0034383,low-density lipoprotein particle clearance,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,NPC2/MYLIP,2
GO:0042417,GO:0042417,dopamine metabolic process,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,PARK7/SNCB,2
GO:0046131,GO:0046131,pyrimidine ribonucleoside metabolic process,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,NME4/CTPS1,2
GO:0050922,GO:0050922,negative regulation of chemotaxis,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,MIF/DUSP1,2
GO:0071276,GO:0071276,cellular response to cadmium ion,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,FOS/JUN,2
GO:0098751,GO:0098751,bone cell development,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,CLDN18/ATP6AP1,2
GO:1901890,GO:1901890,positive regulation of cell junction assembly,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,RAC1/VEGFA,2
GO:1904707,GO:1904707,positive regulation of vascular smooth muscle cell proliferation,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,IGFBP5/JUN,2
GO:1905332,GO:1905332,positive regulation of morphogenesis of an epithelium,2/317,29/12743,0.161895993067326,0.548112106340298,0.489172300746718,MDK/VEGFA,2
GO:0006873,GO:0006873,cellular ion homeostasis,13/317,384/12743,0.162124967905332,0.548112106340298,0.489172300746718,HSP90B1/CALR/CD24/TMBIM6/GRN/ATP6AP1/FTH1/GTF2I/GRIK2/ATP6V0E2/CACNA2D1/MT2A/CALCB,13
GO:1901988,GO:1901988,negative regulation of cell cycle phase transition,8/317,213/12743,0.162158539434164,0.548112106340298,0.489172300746718,SOX4/DUSP1/MAD1L1/PSMB8/RBX1/NOP53/PSMA6/CDKN1A,8
GO:0070302,GO:0070302,regulation of stress-activated protein kinase signaling cascade,7/317,180/12743,0.162246228428792,0.548112106340298,0.489172300746718,GADD45G/DUSP1/HGF/GADD45B/RPS3/GRIK2/VEGFA,7
GO:0002753,GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,3/317,56/12743,0.162624340477389,0.548112106340298,0.489172300746718,HSPA1A/HSPA1B/NOP53,3
GO:1903670,GO:1903670,regulation of sprouting angiogenesis,3/317,56/12743,0.162624340477389,0.548112106340298,0.489172300746718,S100A1/RHOA/VEGFA,3
GO:2001244,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,3/317,56/12743,0.162624340477389,0.548112106340298,0.489172300746718,PARK7/RPS3/SFPQ,3
GO:2001259,GO:2001259,positive regulation of cation channel activity,3/317,56/12743,0.162624340477389,0.548112106340298,0.489172300746718,S100A1/CACNA2D1/NPPA,3
GO:0120039,GO:0120039,plasma membrane bounded cell projection morphogenesis,16/317,490/12743,0.16268028302228,0.548112106340298,0.489172300746718,TUBB2B/UCHL1/RHOA/RPL24/TUBB3/CNTNAP2/YWHAH/CDC42/S100A6/MAP1B/SYT1/ALCAM/ARC/CAMK2B/MACF1/VEGFA,16
GO:0002790,GO:0002790,peptide secretion,14/317,420/12743,0.164106715363923,0.552400413607961,0.492999476078491,GRP/MDK/MIF/PARK7/SOX4/TMBIM6/S100A13/SLC25A6/RAC1/ERP29/PPIA/SERP1/SELENOK/PCLO,14
GO:0055065,GO:0055065,metal ion homeostasis,13/317,385/12743,0.16427369544208,0.55244521526125,0.493039460102859,B2M/HSP90B1/S100A14/CALR/CD24/TMBIM6/ATP6AP1/FTH1/GTF2I/GRIK2/CACNA2D1/MT2A/CALCB,13
GO:0003014,GO:0003014,renal system process,4/317,86/12743,0.16617373044318,0.556398144008837,0.496567320968871,RHOA/PSAP/SGK1/AKR1B1,4
GO:0051225,GO:0051225,spindle assembly,4/317,86/12743,0.16617373044318,0.556398144008837,0.496567320968871,RHOA/HSPA1A/HSPA1B/RPS3,4
GO:0072655,GO:0072655,establishment of protein localization to mitochondrion,5/317,117/12743,0.166837763919673,0.556398144008837,0.496567320968871,TOMM7/YWHAH/SLC25A6/TSPO/YWHAG,5
GO:0007626,GO:0007626,locomotory behavior,6/317,149/12743,0.167383677770844,0.556398144008837,0.496567320968871,UCHL1/PSAP/PARK7/EGR1/CSTB/SLITRK6,6
GO:0009142,GO:0009142,nucleoside triphosphate biosynthetic process,6/317,149/12743,0.167383677770844,0.556398144008837,0.496567320968871,ATP5F1E/ATP5ME/PGAM2/ALDOA/NME4/CTPS1,6
GO:0042063,GO:0042063,gliogenesis,8/317,215/12743,0.168030170686008,0.556398144008837,0.496567320968871,MDK/RHOA/EEF2/CD9/SOX4/GRN/TSPO/ASCL1,8
GO:0003151,GO:0003151,outflow tract morphogenesis,3/317,57/12743,0.168710907044028,0.556398144008837,0.496567320968871,ELN/JUN/VEGFA,3
GO:0006220,GO:0006220,pyrimidine nucleotide metabolic process,3/317,57/12743,0.168710907044028,0.556398144008837,0.496567320968871,NTHL1/NME4/CTPS1,3
GO:0009593,GO:0009593,detection of chemical stimulus,3/317,57/12743,0.168710907044028,0.556398144008837,0.496567320968871,OR51E1/SYT1/AZGP1,3
GO:0015696,GO:0015696,ammonium transport,3/317,57/12743,0.168710907044028,0.556398144008837,0.496567320968871,VAMP8/PARK7/NPPA,3
GO:0035794,GO:0035794,positive regulation of mitochondrial membrane permeability,3/317,57/12743,0.168710907044028,0.556398144008837,0.496567320968871,HSPA1A/YWHAH/YWHAG,3
GO:0042116,GO:0042116,macrophage activation,3/317,57/12743,0.168710907044028,0.556398144008837,0.496567320968871,MIF/GRN/JUN,3
GO:0061515,GO:0061515,myeloid cell development,3/317,57/12743,0.168710907044028,0.556398144008837,0.496567320968871,CLDN18/ATP6AP1/PABPC4,3
GO:1902108,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,3/317,57/12743,0.168710907044028,0.556398144008837,0.496567320968871,HSPA1A/YWHAH/YWHAG,3
GO:0048638,GO:0048638,regulation of developmental growth,9/317,249/12743,0.168944901909472,0.556398144008837,0.496567320968871,PPIB/BASP1/SERP1/RGS2/MAP1B/CDKN1A/SYT1/MACF1/VEGFA,9
GO:0099177,GO:0099177,regulation of trans-synaptic signaling,11/317,318/12743,0.170170391144041,0.556398144008837,0.496567320968871,TUBB2B/FABP5/YWHAH/MME/PFN2/MAP1B/GRIK2/SYT1/YWHAG/ARC/CAMK2B,11
GO:0001504,GO:0001504,neurotransmitter uptake,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,PARK7/RGS2,2
GO:0006007,GO:0006007,glucose catabolic process,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,PGAM2/ALDOA,2
GO:0006778,GO:0006778,porphyrin-containing compound metabolic process,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,TSPO/TMEM14C,2
GO:0007094,GO:0007094,mitotic spindle assembly checkpoint,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,DUSP1/MAD1L1,2
GO:0008038,GO:0008038,neuron recognition,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,CNTNAP2/NCAM2,2
GO:0030866,GO:0030866,cortical actin cytoskeleton organization,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,CALR/RAB13,2
GO:0031577,GO:0031577,spindle checkpoint,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,DUSP1/MAD1L1,2
GO:0035036,GO:0035036,sperm-egg recognition,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,CD9/ALDOA,2
GO:0045124,GO:0045124,regulation of bone resorption,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,CLDN18/ATP6AP1,2
GO:0050873,GO:0050873,brown fat cell differentiation,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,RGS2/ARL4A,2
GO:0051204,GO:0051204,protein insertion into mitochondrial membrane,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,YWHAH/YWHAG,2
GO:0051602,GO:0051602,response to electrical stimulus,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,EEF1A2/S100A13,2
GO:0061900,GO:0061900,glial cell activation,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,GRN/JUN,2
GO:0071173,GO:0071173,spindle assembly checkpoint,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,DUSP1/MAD1L1,2
GO:0071174,GO:0071174,mitotic spindle checkpoint,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,DUSP1/MAD1L1,2
GO:0098760,GO:0098760,response to interleukin-7,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,PDIA3/YBX1,2
GO:0098761,GO:0098761,cellular response to interleukin-7,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,PDIA3/YBX1,2
GO:1903672,GO:1903672,positive regulation of sprouting angiogenesis,2/317,30/12743,0.170765251207314,0.556398144008837,0.496567320968871,S100A1/VEGFA,2
GO:0050890,GO:0050890,cognition,8/317,216/12743,0.171002200820055,0.556398144008837,0.496567320968871,MDK/CNTNAP2/FOS/MME/SGK1/MEIS2/ARC/JUN,8
GO:0051983,GO:0051983,regulation of chromosome segregation,4/317,87/12743,0.171020848158488,0.556398144008837,0.496567320968871,CDC42/DUSP1/MAD1L1/SFPQ,4
GO:0048588,GO:0048588,developmental cell growth,7/317,183/12743,0.171926134262106,0.558837660644008,0.498744510546207,RGS2/MAP1B/SYT1/ALCAM/MACF1/NPPA/VEGFA,7
GO:0017157,GO:0017157,regulation of exocytosis,6/317,151/12743,0.17462851207246,0.563794893713815,0.503168680488898,VAMP8/ATP6AP1/PFN2/SYT1/PCLO/NPPA,6
GO:0019674,GO:0019674,NAD metabolic process,3/317,58/12743,0.174862672181058,0.563794893713815,0.503168680488898,PGAM2/MDH2/ALDOA,3
GO:0032024,GO:0032024,positive regulation of insulin secretion,3/317,58/12743,0.174862672181058,0.563794893713815,0.503168680488898,SOX4/RAC1/SERP1,3
GO:0043627,GO:0043627,response to estrogen,3/317,58/12743,0.174862672181058,0.563794893713815,0.503168680488898,CITED4/CD24/IGFBP2,3
GO:0046128,GO:0046128,purine ribonucleoside metabolic process,3/317,58/12743,0.174862672181058,0.563794893713815,0.503168680488898,RHOA/APRT/NME4,3
GO:0055006,GO:0055006,cardiac cell development,3/317,58/12743,0.174862672181058,0.563794893713815,0.503168680488898,RGS2/NPPA/VEGFA,3
GO:1901983,GO:1901983,regulation of protein acetylation,3/317,58/12743,0.174862672181058,0.563794893713815,0.503168680488898,TERF2IP/PARK7/SOX4,3
GO:1905710,GO:1905710,positive regulation of membrane permeability,3/317,58/12743,0.174862672181058,0.563794893713815,0.503168680488898,HSPA1A/YWHAH/YWHAG,3
GO:2001057,GO:2001057,reactive nitrogen species metabolic process,3/317,58/12743,0.174862672181058,0.563794893713815,0.503168680488898,RAC1/TSPO/CD47,3
GO:1903322,GO:1903322,positive regulation of protein modification by small protein conjugation or removal,5/317,119/12743,0.175082759876003,0.563998675407017,0.50335054904929,RPS2/PDCD6/HSPA5/NOP53/UBE2S,5
GO:0007338,GO:0007338,single fertilization,4/317,88/12743,0.175916920165106,0.565672028616778,0.504843962586616,CD9/PARK7/SLIRP/ALDOA,4
GO:1902750,GO:1902750,negative regulation of cell cycle G2/M phase transition,4/317,88/12743,0.175916920165106,0.565672028616778,0.504843962586616,PSMB8/RBX1/NOP53/PSMA6,4
GO:0090066,GO:0090066,regulation of anatomical structure size,12/317,356/12743,0.17778973843204,0.570315056357857,0.508987714450991,CHGA/RHOA/RAC1/BRK1/RGS2/PPP1R15A/PFN2/ELN/MAP1B/MACF1/NPPA/VEGFA,12
GO:0006469,GO:0006469,negative regulation of protein kinase activity,7/317,185/12743,0.178516390239492,0.570315056357857,0.508987714450991,UCHL1/PARK7/RGS2/DUSP1/GADD45B/CDKN1A/YWHAG,7
GO:0034470,GO:0034470,ncRNA processing,10/317,287/12743,0.179163296475603,0.570315056357857,0.508987714450991,RPS27/TRIT1/RPS2/RPS28/RPL14/RPS19/RPL35A/RPL27/RPS14/DDX17,10
GO:0022408,GO:0022408,negative regulation of cell-cell adhesion,5/317,120/12743,0.179262903045332,0.570315056357857,0.508987714450991,MDK/SPINT2/EPCAM/CD9/MAD1L1,5
GO:0006369,GO:0006369,termination of RNA polymerase II transcription,2/317,31/12743,0.179713007298927,0.570315056357857,0.508987714450991,SNRPF/SNRPE,2
GO:0014003,GO:0014003,oligodendrocyte development,2/317,31/12743,0.179713007298927,0.570315056357857,0.508987714450991,CD9/ASCL1,2
GO:0032613,GO:0032613,interleukin-10 production,2/317,31/12743,0.179713007298927,0.570315056357857,0.508987714450991,HGF/CD47,2
GO:0042743,GO:0042743,hydrogen peroxide metabolic process,2/317,31/12743,0.179713007298927,0.570315056357857,0.508987714450991,PARK7/RAC1,2
GO:0043300,GO:0043300,regulation of leukocyte degranulation,2/317,31/12743,0.179713007298927,0.570315056357857,0.508987714450991,VAMP8/NPPA,2
GO:0045740,GO:0045740,positive regulation of DNA replication,2/317,31/12743,0.179713007298927,0.570315056357857,0.508987714450991,RAC1/JUN,2
GO:0046685,GO:0046685,response to arsenic-containing substance,2/317,31/12743,0.179713007298927,0.570315056357857,0.508987714450991,CDKN1A/ZFAND2A,2
GO:0048483,GO:0048483,autonomic nervous system development,2/317,31/12743,0.179713007298927,0.570315056357857,0.508987714450991,SOX4/ASCL1,2
GO:0086009,GO:0086009,membrane repolarization,2/317,31/12743,0.179713007298927,0.570315056357857,0.508987714450991,CACNA2D1/NPPA,2
GO:1901797,GO:1901797,negative regulation of signal transduction by p53 class mediator,2/317,31/12743,0.179713007298927,0.570315056357857,0.508987714450991,MIF/NOP53,2
GO:0045936,GO:0045936,negative regulation of phosphate metabolic process,15/317,463/12743,0.179740461433505,0.570315056357857,0.508987714450991,UCHL1/RHOA/BOD1/TERF2IP/PARK7/TSPO/RGS2/PPP1R15A/DUSP1/HGF/GADD45B/CDKN1A/YWHAG/JUN/CNKSR3,15
GO:0048589,GO:0048589,developmental growth,16/317,499/12743,0.180209458907623,0.571298946007852,0.50986580409397,APOD/MDK/PPIB/CD9/BASP1/SERP1/RGS2/MAP1B/SLITRK6/CDKN1A/SYT1/ALCAM/MACF1/AKIRIN1/NPPA/VEGFA,16
GO:0008037,GO:0008037,cell recognition,4/317,89/12743,0.180860424682828,0.572532763190124,0.510966945963984,CD9/CNTNAP2/NCAM2/ALDOA,4
GO:0043297,GO:0043297,apical junction assembly,3/317,59/12743,0.181076426077099,0.572532763190124,0.510966945963984,RHOA/RAB13/TBCD,3
GO:0140029,GO:0140029,exocytic process,3/317,59/12743,0.181076426077099,0.572532763190124,0.510966945963984,VAMP8/SYT1/NPPA,3
GO:0010563,GO:0010563,negative regulation of phosphorus metabolic process,15/317,464/12743,0.181819395087944,0.572967543231706,0.511354973067928,UCHL1/RHOA/BOD1/TERF2IP/PARK7/TSPO/RGS2/PPP1R15A/DUSP1/HGF/GADD45B/CDKN1A/YWHAG/JUN/CNKSR3,15
GO:0034404,GO:0034404,nucleobase-containing small molecule biosynthetic process,7/317,186/12743,0.18185145113418,0.572967543231706,0.511354973067928,PGAM2/APRT/NUDT3/ALDOA/NTHL1/NME4/CTPS1,7
GO:0042180,GO:0042180,cellular ketone metabolic process,7/317,186/12743,0.18185145113418,0.572967543231706,0.511354973067928,FABP5/PARK7/ODC1/EGR1/PSMB8/AKR1B1/PSMA6,7
GO:2000116,GO:2000116,regulation of cysteine-type endopeptidase activity,7/317,186/12743,0.18185145113418,0.572967543231706,0.511354973067928,RHOA/PARK7/HGF/PDCD6/RPS3/FAM162A/VEGFA,7
GO:0051961,GO:0051961,negative regulation of nervous system development,8/317,220/12743,0.183125237197872,0.57618065715458,0.51422257316658,B2M/RHOA/CALR/YWHAH/MYLIP/TSPO/ASCL1/DPYSL3,8
GO:0016055,GO:0016055,Wnt signaling pathway,14/317,429/12743,0.183191791690594,0.57618065715458,0.51422257316658,MDK/RHOA/CD24/SOX4/GNG2/CDC42/RAC1/EGR1/PSMB8/RBX1/SNX3/IGFBP2/PSMA6/MACF1,14
GO:0070585,GO:0070585,protein localization to mitochondrion,5/317,121/12743,0.183480306626447,0.57658365587594,0.514582236471668,TOMM7/YWHAH/SLC25A6/TSPO/YWHAG,5
GO:0009306,GO:0009306,protein secretion,13/317,394/12743,0.184256994226036,0.577433208273471,0.515340434468206,MDK/MIF/PARK7/SOX4/TMBIM6/S100A13/SLC25A6/RAC1/ERP29/PPIA/SERP1/SELENOK/PCLO,13
GO:0198738,GO:0198738,cell-cell signaling by wnt,14/317,430/12743,0.185377307133545,0.577433208273471,0.515340434468206,MDK/RHOA/CD24/SOX4/GNG2/CDC42/RAC1/EGR1/PSMB8/RBX1/SNX3/IGFBP2/PSMA6/MACF1,14
GO:0048762,GO:0048762,mesenchymal cell differentiation,6/317,154/12743,0.185731811752262,0.577433208273471,0.515340434468206,MDK/S100A4/HNRNPAB/HGF/PDCD6/DDX17,6
GO:0045667,GO:0045667,regulation of osteoblast differentiation,4/317,90/12743,0.185849832612975,0.577433208273471,0.515340434468206,IGFBP5/ATP6AP1/HGF/ATRAID,4
GO:0140014,GO:0140014,mitotic nuclear division,8/317,221/12743,0.186213277282517,0.577433208273471,0.515340434468206,RHOA/HSPA1A/RPL24/BOD1/HSPA1B/DUSP1/MAD1L1/UBE2S,8
GO:0042326,GO:0042326,negative regulation of phosphorylation,12/317,360/12743,0.18732881049305,0.577433208273471,0.515340434468206,UCHL1/RHOA/TERF2IP/PARK7/RGS2/DUSP1/HGF/GADD45B/CDKN1A/YWHAG/JUN/CNKSR3,12
GO:0036498,GO:0036498,IRE1-mediated unfolded protein response,3/317,60/12743,0.187348983859452,0.577433208273471,0.515340434468206,PDIA6/SERP1/HSPA5,3
GO:0045445,GO:0045445,myoblast differentiation,3/317,60/12743,0.187348983859452,0.577433208273471,0.515340434468206,BTG1/DDX17/AKIRIN1,3
GO:0097006,GO:0097006,regulation of plasma lipoprotein particle levels,3/317,60/12743,0.187348983859452,0.577433208273471,0.515340434468206,NPC2/LRPAP1/MYLIP,3
GO:0006836,GO:0006836,neurotransmitter transport,7/317,188/12743,0.188599436966179,0.577433208273471,0.515340434468206,VAMP8/PARK7/RGS2/PFN2/SYT1/PCLO/NPPA,7
GO:0007608,GO:0007608,sensory perception of smell,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,OR51E1/NCAM2,2
GO:0014911,GO:0014911,positive regulation of smooth muscle cell migration,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,MDK/IGFBP5,2
GO:0015682,GO:0015682,ferric iron transport,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,ATP6AP1/ATP6V0E2,2
GO:0030225,GO:0030225,macrophage differentiation,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,CDC42/VEGFA,2
GO:0032655,GO:0032655,regulation of interleukin-12 production,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,MDK/CD47,2
GO:0033572,GO:0033572,transferrin transport,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,ATP6AP1/ATP6V0E2,2
GO:0043403,GO:0043403,skeletal muscle tissue regeneration,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,CD9/AKIRIN1,2
GO:0045661,GO:0045661,regulation of myoblast differentiation,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,BTG1/AKIRIN1,2
GO:0045841,GO:0045841,negative regulation of mitotic metaphase/anaphase transition,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,DUSP1/MAD1L1,2
GO:0046456,GO:0046456,icosanoid biosynthetic process,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,FABP5/MIF,2
GO:0048286,GO:0048286,lung alveolus development,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,PHF14/IGFBP5,2
GO:0050907,GO:0050907,detection of chemical stimulus involved in sensory perception,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,OR51E1/AZGP1,2
GO:0051445,GO:0051445,regulation of meiotic cell cycle,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,CALR/DUSP1,2
GO:0070423,GO:0070423,nucleotide-binding oligomerization domain containing signaling pathway,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,HSPA1A/HSPA1B,2
GO:0072512,GO:0072512,trivalent inorganic cation transport,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,ATP6AP1/ATP6V0E2,2
GO:1901021,GO:1901021,positive regulation of calcium ion transmembrane transporter activity,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,S100A1/CACNA2D1,2
GO:1901985,GO:1901985,positive regulation of protein acetylation,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,TERF2IP/SOX4,2
GO:1902100,GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,DUSP1/MAD1L1,2
GO:1905819,GO:1905819,negative regulation of chromosome separation,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,DUSP1/MAD1L1,2
GO:2000649,GO:2000649,regulation of sodium ion transmembrane transporter activity,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,YWHAH/CNKSR3,2
GO:2000816,GO:2000816,negative regulation of mitotic sister chromatid separation,2/317,32/12743,0.188729908128325,0.577433208273471,0.515340434468206,DUSP1/MAD1L1,2
GO:0043410,GO:0043410,positive regulation of MAPK cascade,12/317,361/12743,0.189750669368577,0.58006263297622,0.517687110844453,NENF/CD24/PSAP/GADD45G/MIF/ATP6AP1/ERP29/HGF/GADD45B/RPS3/JUN/VEGFA,12
GO:0007041,GO:0007041,lysosomal transport,4/317,91/12743,0.190883609026202,0.582041199702458,0.519452917558917,HSPA1A/PSAP/GRN/RHOB,4
GO:0035270,GO:0035270,endocrine system development,4/317,91/12743,0.190883609026202,0.582041199702458,0.519452917558917,MDK/SOX4/TSPO/ASCL1,4
GO:0070498,GO:0070498,interleukin-1-mediated signaling pathway,4/317,91/12743,0.190883609026202,0.582041199702458,0.519452917558917,EGR1/PSMB8/RBX1/PSMA6,4
GO:1903311,GO:1903311,regulation of mRNA metabolic process,9/317,257/12743,0.19159602734052,0.583718405329805,0.520949769254153,YBX1/HSPA1A/KHDRBS1/SNRNP70/PSMB8/SRSF9/PSMA6/PABPC4/DDX17,9
GO:0030041,GO:0030041,actin filament polymerization,5/317,123/12743,0.192023332118824,0.584524876348157,0.521669518515242,RHOA/RAC1/BRK1/PFN2/ELN,5
GO:0097164,GO:0097164,ammonium ion metabolic process,6/317,156/12743,0.193284687359845,0.586579185481427,0.523502922874574,FABP5/MFSD2A/PARK7/ODC1/SNCB/AKR1B1,6
GO:0006487,GO:0006487,protein N-linked glycosylation,3/317,61/12743,0.193677188641573,0.586579185481427,0.523502922874574,TMEM258/KRTCAP2/RPN1,3
GO:0030512,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,3/317,61/12743,0.193677188641573,0.586579185481427,0.523502922874574,HSPA1A/PEG10/HSPA5,3
GO:0042278,GO:0042278,purine nucleoside metabolic process,3/317,61/12743,0.193677188641573,0.586579185481427,0.523502922874574,RHOA/APRT/NME4,3
GO:0042446,GO:0042446,hormone biosynthetic process,3/317,61/12743,0.193677188641573,0.586579185481427,0.523502922874574,EGR1/TSPO/AKR1B1,3
GO:1990542,GO:1990542,mitochondrial transmembrane transport,3/317,61/12743,0.193677188641573,0.586579185481427,0.523502922874574,TOMM7/ATP5F1E/ATP5ME,3
GO:0099537,GO:0099537,trans-synaptic signaling,15/317,470/12743,0.194541356972602,0.587699353103479,0.524502636193369,TUBB2B/FABP5/PARK7/GABARAP/YWHAH/MME/SNCB/PFN2/MAP1B/GRIK2/SYT1/PCLO/YWHAG/ARC/CAMK2B,15
GO:0006816,GO:0006816,calcium ion transport,10/317,293/12743,0.195348314309079,0.587699353103479,0.524502636193369,S100A1/RHOA/RAMP1/TSPAN13/TMBIM6/TSPO/GEM/CACNA2D1/CAMK2B/NPPA,10
GO:0010948,GO:0010948,negative regulation of cell cycle process,10/317,293/12743,0.195348314309079,0.587699353103479,0.524502636193369,CALR/MIF/SOX4/DUSP1/MAD1L1/PSMB8/RBX1/NOP53/PSMA6/CDKN1A,10
GO:0007188,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,4/317,92/12743,0.195960214604027,0.587699353103479,0.524502636193369,CHGA/RAMP1/GNG2/RGS2,4
GO:0055076,GO:0055076,transition metal ion homeostasis,4/317,92/12743,0.195960214604027,0.587699353103479,0.524502636193369,B2M/ATP6AP1/FTH1/MT2A,4
GO:0034249,GO:0034249,negative regulation of cellular amide metabolic process,5/317,124/12743,0.196347152647748,0.587699353103479,0.524502636193369,CALR/IGFBP5/SNRNP70/RGS2/RPS3,5
GO:0030036,GO:0030036,actin cytoskeleton organization,15/317,471/12743,0.196702331988683,0.587699353103479,0.524502636193369,MDK/HSP90B1/FSCN1/RHOA/CALR/RAB13/CDC42/RAC1/BRK1/PFN2/ELN/TMSB15A/ALDOA/DPYSL3/CD47,15
GO:0001825,GO:0001825,blastocyst formation,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,TM4SF1/JUNB,2
GO:0007007,GO:0007007,inner mitochondrial membrane organization,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,ATP5F1E/ATP5ME,2
GO:0019226,GO:0019226,transmission of nerve impulse,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,CNTNAP2/GRIK2,2
GO:0030865,GO:0030865,cortical cytoskeleton organization,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,CALR/RAB13,2
GO:0032615,GO:0032615,interleukin-12 production,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,MDK/CD47,2
GO:0035315,GO:0035315,hair cell differentiation,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,MYCL/SLITRK6,2
GO:0035850,GO:0035850,epithelial cell differentiation involved in kidney development,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,CD24/BASP1,2
GO:0035872,GO:0035872,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,HSPA1A/HSPA1B,2
GO:0043928,GO:0043928,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,LSM3/LSM5,2
GO:0045070,GO:0045070,positive regulation of viral genome replication,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,PPIB/PPIA,2
GO:0048641,GO:0048641,regulation of skeletal muscle tissue development,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,DDX17/AKIRIN1,2
GO:0061077,GO:0061077,chaperone-mediated protein folding,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,PPIB/DNAJB1,2
GO:0071470,GO:0071470,cellular response to osmotic stress,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,TSPO/AKR1B1,2
GO:0090049,GO:0090049,regulation of cell migration involved in sprouting angiogenesis,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,RHOA/VEGFA,2
GO:0097178,GO:0097178,ruffle assembly,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,RAC1/PFN2,2
GO:1901030,GO:1901030,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,2/317,33/12743,0.197807014535524,0.587699353103479,0.524502636193369,YWHAH/YWHAG,2
GO:0060485,GO:0060485,mesenchyme development,7/317,191/12743,0.198909893175357,0.589514481422431,0.526122579423342,MDK/S100A4/BASP1/HNRNPAB/HGF/PDCD6/DDX17,7
GO:0110053,GO:0110053,regulation of actin filament organization,7/317,191/12743,0.198909893175357,0.589514481422431,0.526122579423342,RHOA/CDC42/RAC1/BRK1/PFN2/ELN/CD47,7
GO:1902749,GO:1902749,regulation of cell cycle G2/M phase transition,7/317,191/12743,0.198909893175357,0.589514481422431,0.526122579423342,TUBA1A/PSMB8/RBX1/NOP53/PSMA6/YWHAG/TUBB4B,7
GO:0006885,GO:0006885,regulation of pH,3/317,62/12743,0.200057914348449,0.590482924534215,0.526986883531305,GRN/ATP6AP1/ATP6V0E2,3
GO:0009060,GO:0009060,aerobic respiration,3/317,62/12743,0.200057914348449,0.590482924534215,0.526986883531305,COX4I1/MDH2/NOP53,3
GO:0055072,GO:0055072,iron ion homeostasis,3/317,62/12743,0.200057914348449,0.590482924534215,0.526986883531305,B2M/ATP6AP1/FTH1,3
GO:0110110,GO:0110110,positive regulation of animal organ morphogenesis,3/317,62/12743,0.200057914348449,0.590482924534215,0.526986883531305,MDK/BASP1/VEGFA,3
GO:1903845,GO:1903845,negative regulation of cellular response to transforming growth factor beta stimulus,3/317,62/12743,0.200057914348449,0.590482924534215,0.526986883531305,HSPA1A/PEG10/HSPA5,3
GO:0001655,GO:0001655,urogenital system development,9/317,260/12743,0.200415837156471,0.590936243066375,0.5273914556376,CD24/EPCAM/SOX4/MME/ODC1/EGR1/BASP1/AKR1B1/VEGFA,9
GO:0001738,GO:0001738,morphogenesis of a polarized epithelium,5/317,125/12743,0.200704632206966,0.590936243066375,0.5273914556376,RHOA/CDC42/RAC1/PSMB8/PSMA6,5
GO:0051092,GO:0051092,positive regulation of NF-kappaB transcription factor activity,5/317,125/12743,0.200704632206966,0.590936243066375,0.5273914556376,HSPA1A/TERF2IP/HSPA1B/RPS3/PSMA6,5
GO:0051896,GO:0051896,regulation of protein kinase B signaling,6/317,158/12743,0.200952600387427,0.591067698109602,0.527508775005657,PARK7/RAC1/IGFBP5/HGF/PDCD6/NOP53,6
GO:0001936,GO:0001936,regulation of endothelial cell proliferation,4/317,93/12743,0.201078107034226,0.591067698109602,0.527508775005657,MDK/PDCD6/JUN/VEGFA,4
GO:0001933,GO:0001933,negative regulation of protein phosphorylation,11/317,331/12743,0.203161601051551,0.596165668368884,0.532058548331266,UCHL1/TERF2IP/PARK7/RGS2/DUSP1/HGF/GADD45B/CDKN1A/YWHAG/JUN/CNKSR3,11
GO:0099536,GO:0099536,synaptic signaling,15/317,474/12743,0.203253264738349,0.596165668368884,0.532058548331266,TUBB2B/FABP5/PARK7/GABARAP/YWHAH/MME/SNCB/PFN2/MAP1B/GRIK2/SYT1/PCLO/YWHAG/ARC/CAMK2B,15
GO:0033674,GO:0033674,positive regulation of kinase activity,14/317,438/12743,0.203309905262935,0.596165668368884,0.532058548331266,RHOA/CD24/EEF1A2/GADD45G/MIF/PARK7/EGR1/ERP29/HGF/GADD45B/RPS3/RPLP1/CDKN1A/VEGFA,14
GO:0002768,GO:0002768,immune response-regulating cell surface receptor signaling pathway,10/317,296/12743,0.203674698071443,0.596748606003941,0.532578801288343,CD24/FOS/CDC42/RAC1/BRK1/PSMB8/RPS3/PSMA6/JUN/CD47,10
GO:0051348,GO:0051348,negative regulation of transferase activity,8/317,227/12743,0.205199263434007,0.599016509421635,0.534602831627888,UCHL1/EIF4A2/PARK7/RGS2/DUSP1/GADD45B/CDKN1A/YWHAG,8
GO:0016999,GO:0016999,antibiotic metabolic process,4/317,94/12743,0.20623574236032,0.599016509421635,0.534602831627888,PARK7/RAC1/MDH2/AKR1B1,4
GO:0021987,GO:0021987,cerebral cortex development,4/317,94/12743,0.20623574236032,0.599016509421635,0.534602831627888,MDK/RHOA/CNTNAP2/ASCL1,4
GO:0042136,GO:0042136,neurotransmitter biosynthetic process,3/317,63/12743,0.206488068330325,0.599016509421635,0.534602831627888,RAC1/TSPO/CD47,3
GO:0050000,GO:0050000,chromosome localization,3/317,63/12743,0.206488068330325,0.599016509421635,0.534602831627888,BOD1/GEM/MAD1L1,3
GO:0051303,GO:0051303,establishment of chromosome localization,3/317,63/12743,0.206488068330325,0.599016509421635,0.534602831627888,BOD1/GEM/MAD1L1,3
GO:0060840,GO:0060840,artery development,3/317,63/12743,0.206488068330325,0.599016509421635,0.534602831627888,MDK/SOX4/VEGFA,3
GO:0072676,GO:0072676,lymphocyte migration,3/317,63/12743,0.206488068330325,0.599016509421635,0.534602831627888,APOD/RHOA/SELENOK,3
GO:0000291,GO:0000291,nuclear-transcribed mRNA catabolic process, exonucleolytic,2/317,34/12743,0.206935786711145,0.599016509421635,0.534602831627888,LSM3/LSM5,2
GO:0021517,GO:0021517,ventral spinal cord development,2/317,34/12743,0.206935786711145,0.599016509421635,0.534602831627888,SOX4/ASCL1,2
GO:1900271,GO:1900271,regulation of long-term synaptic potentiation,2/317,34/12743,0.206935786711145,0.599016509421635,0.534602831627888,MME/ARC,2
GO:2001239,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,2/317,34/12743,0.206935786711145,0.599016509421635,0.534602831627888,HSPA1A/HSPA1B,2
GO:0030324,GO:0030324,lung development,5/317,127/12743,0.209516892775825,0.599016509421635,0.534602831627888,PHF14/MME/IGFBP5/ASCL1/VEGFA,5
GO:0045860,GO:0045860,positive regulation of protein kinase activity,13/317,405/12743,0.210179841630823,0.599016509421635,0.534602831627888,RHOA/CD24/GADD45G/MIF/PARK7/EGR1/ERP29/HGF/GADD45B/RPS3/RPLP1/CDKN1A/VEGFA,13
GO:0032680,GO:0032680,regulation of tumor necrosis factor production,4/317,95/12743,0.211431576285403,0.599016509421635,0.534602831627888,MIF/TSPO/SELENOK/CD47,4
GO:0048675,GO:0048675,axon extension,4/317,95/12743,0.211431576285403,0.599016509421635,0.534602831627888,MAP1B/ALCAM/MACF1/VEGFA,4
GO:1903052,GO:1903052,positive regulation of proteolysis involved in cellular protein catabolic process,4/317,95/12743,0.211431576285403,0.599016509421635,0.534602831627888,HSPA1A/RBX1/NOP53/ZFAND2A,4
GO:0045930,GO:0045930,negative regulation of mitotic cell cycle,9/317,264/12743,0.212434887215882,0.599016509421635,0.534602831627888,RPL24/SOX4/DUSP1/MAD1L1/PSMB8/RBX1/NOP53/PSMA6/CDKN1A,9
GO:0007631,GO:0007631,feeding behavior,3/317,64/12743,0.212964593774826,0.599016509421635,0.534602831627888,NPW/UCHL1/FOS,3
GO:0050764,GO:0050764,regulation of phagocytosis,3/317,64/12743,0.212964593774826,0.599016509421635,0.534602831627888,CALR/SNX3/CD47,3
GO:1903035,GO:1903035,negative regulation of response to wounding,3/317,64/12743,0.212964593774826,0.599016509421635,0.534602831627888,MDK/CD9/CDKN1A,3
GO:0018105,GO:0018105,peptidyl-serine phosphorylation,7/317,195/12743,0.212991115618926,0.599016509421635,0.534602831627888,TERF2IP/MIF/PARK7/PFN2/HGF/CNKSR3/VEGFA,7
GO:0009267,GO:0009267,cellular response to starvation,5/317,128/12743,0.213969822795248,0.599016509421635,0.534602831627888,HSPA5/WIPI2/MAP1LC3B/CDKN1A/JUN,5
GO:2001236,GO:2001236,regulation of extrinsic apoptotic signaling pathway,5/317,128/12743,0.213969822795248,0.599016509421635,0.534602831627888,PDIA3/HSPA1A/PARK7/HSPA1B/HGF,5
GO:0000387,GO:0000387,spliceosomal snRNP assembly,2/317,35/12743,0.216108069964764,0.599016509421635,0.534602831627888,SNRPF/SNRPE,2
GO:0006656,GO:0006656,phosphatidylcholine biosynthetic process,2/317,35/12743,0.216108069964764,0.599016509421635,0.534602831627888,FABP5/MFSD2A,2
GO:0021515,GO:0021515,cell differentiation in spinal cord,2/317,35/12743,0.216108069964764,0.599016509421635,0.534602831627888,SOX4/ASCL1,2
GO:0031952,GO:0031952,regulation of protein autophosphorylation,2/317,35/12743,0.216108069964764,0.599016509421635,0.534602831627888,JUN/VEGFA,2
GO:0032570,GO:0032570,response to progesterone,2/317,35/12743,0.216108069964764,0.599016509421635,0.534602831627888,FOS/TSPO,2
GO:0033048,GO:0033048,negative regulation of mitotic sister chromatid segregation,2/317,35/12743,0.216108069964764,0.599016509421635,0.534602831627888,DUSP1/MAD1L1,2
GO:0060711,GO:0060711,labyrinthine layer development,2/317,35/12743,0.216108069964764,0.599016509421635,0.534602831627888,SPINT2/JUNB,2
GO:0065002,GO:0065002,intracellular protein transmembrane transport,2/317,35/12743,0.216108069964764,0.599016509421635,0.534602831627888,TOMM7/HSPA5,2
GO:2001222,GO:2001222,regulation of neuron migration,2/317,35/12743,0.216108069964764,0.599016509421635,0.534602831627888,MDK/CAMK2B,2
GO:0006875,GO:0006875,cellular metal ion homeostasis,11/317,336/12743,0.216548461894519,0.599016509421635,0.534602831627888,HSP90B1/CALR/CD24/TMBIM6/ATP6AP1/FTH1/GTF2I/GRIK2/CACNA2D1/MT2A/CALCB,11
GO:0030072,GO:0030072,peptide hormone secretion,7/317,196/12743,0.216568135276227,0.599016509421635,0.534602831627888,GRP/PARK7/SOX4/SLC25A6/RAC1/SERP1/PCLO,7
GO:0071156,GO:0071156,regulation of cell cycle arrest,4/317,96/12743,0.216664065430672,0.599016509421635,0.534602831627888,CALR/MIF/SOX4/CDKN1A,4
GO:0007606,GO:0007606,sensory perception of chemical stimulus,3/317,65/12743,0.219484471927117,0.599016509421635,0.534602831627888,OR51E1/NCAM2/AZGP1,3
GO:0051235,GO:0051235,maintenance of location,8/317,232/12743,0.221584976562547,0.599016509421635,0.534602831627888,HSP90B1/CALR/PARK7/OS9/TSPO/FTH1/HSPA5/HILPDA,8
GO:0071902,GO:0071902,positive regulation of protein serine/threonine kinase activity,9/317,267/12743,0.221634616160684,0.599016509421635,0.534602831627888,RHOA/CD24/GADD45G/MIF/ERP29/HGF/GADD45B/RPS3/VEGFA,9
GO:1903555,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,4/317,97/12743,0.221931668549014,0.599016509421635,0.534602831627888,MIF/TSPO/SELENOK/CD47,4
GO:0002328,GO:0002328,pro-B cell differentiation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,SOX4,1
GO:0002903,GO:0002903,negative regulation of B cell apoptotic process,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,MIF,1
GO:0003334,GO:0003334,keratinocyte development,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,PSAP,1
GO:0006285,GO:0006285,base-excision repair, AP site formation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,NTHL1,1
GO:0006596,GO:0006596,polyamine biosynthetic process,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,ODC1,1
GO:0006878,GO:0006878,cellular copper ion homeostasis,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,MT2A,1
GO:0007351,GO:0007351,tripartite regional subdivision,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,BASP1,1
GO:0008595,GO:0008595,anterior/posterior axis specification, embryo,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,BASP1,1
GO:0009886,GO:0009886,post-embryonic animal morphogenesis,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,MFAP2,1
GO:0010752,GO:0010752,regulation of cGMP-mediated signaling,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,NPPA,1
GO:0014067,GO:0014067,negative regulation of phosphatidylinositol 3-kinase signaling,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,NOP53,1
GO:0014841,GO:0014841,skeletal muscle satellite cell proliferation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,AKIRIN1,1
GO:0014842,GO:0014842,regulation of skeletal muscle satellite cell proliferation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,AKIRIN1,1
GO:0014856,GO:0014856,skeletal muscle cell proliferation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,AKIRIN1,1
GO:0014857,GO:0014857,regulation of skeletal muscle cell proliferation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,AKIRIN1,1
GO:0015732,GO:0015732,prostaglandin transport,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,MIF,1
GO:0015867,GO:0015867,ATP transport,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,SLC25A6,1
GO:0016075,GO:0016075,rRNA catabolic process,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,TRIR,1
GO:0018158,GO:0018158,protein oxidation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,PARK7,1
GO:0030948,GO:0030948,negative regulation of vascular endothelial growth factor receptor signaling pathway,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,PDCD6,1
GO:0030949,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,VEGFA,1
GO:0031115,GO:0031115,negative regulation of microtubule polymerization,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,TBCD,1
GO:0031507,GO:0031507,heterochromatin assembly,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,CENPV,1
GO:0031629,GO:0031629,synaptic vesicle fusion to presynaptic active zone membrane,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,SYT1,1
GO:0032070,GO:0032070,regulation of deoxyribonuclease activity,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,RPS3,1
GO:0032305,GO:0032305,positive regulation of icosanoid secretion,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,MIF,1
GO:0033033,GO:0033033,negative regulation of myeloid cell apoptotic process,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,MIF,1
GO:0033189,GO:0033189,response to vitamin A,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,MAP1B,1
GO:0035358,GO:0035358,regulation of peroxisome proliferator activated receptor signaling pathway,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,FABP5,1
GO:0035627,GO:0035627,ceramide transport,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,PSAP,1
GO:0038007,GO:0038007,netrin-activated signaling pathway,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,TUBB3,1
GO:0042573,GO:0042573,retinoic acid metabolic process,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,RBP1,1
GO:0043031,GO:0043031,negative regulation of macrophage activation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,GRN,1
GO:0043476,GO:0043476,pigment accumulation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,CD63,1
GO:0043482,GO:0043482,cellular pigment accumulation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,CD63,1
GO:0043922,GO:0043922,negative regulation by host of viral transcription,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,JUN,1
GO:0045116,GO:0045116,protein neddylation,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,RBX1,1
GO:0045161,GO:0045161,neuronal ion channel clustering,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,CNTNAP2,1
GO:0045779,GO:0045779,negative regulation of bone resorption,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,CLDN18,1
GO:0046479,GO:0046479,glycosphingolipid catabolic process,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,PSAP,1
GO:0048266,GO:0048266,behavioral response to pain,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,TSPO,1
GO:0048875,GO:0048875,chemical homeostasis within a tissue,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,VEGFA,1
GO:0051238,GO:0051238,sequestering of metal ion,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,FTH1,1
GO:0051315,GO:0051315,attachment of mitotic spindle microtubules to kinetochore,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,BOD1,1
GO:0051409,GO:0051409,response to nitrosative stress,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,PARK7,1
GO:0060123,GO:0060123,regulation of growth hormone secretion,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,SERP1,1
GO:0061029,GO:0061029,eyelid development in camera-type eye,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,JUN,1
GO:0070525,GO:0070525,tRNA threonylcarbamoyladenosine metabolic process,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,TRIT1,1
GO:0071281,GO:0071281,cellular response to iron ion,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,B2M,1
GO:0071472,GO:0071472,cellular response to salt stress,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,AKR1B1,1
GO:0071545,GO:0071545,inositol phosphate catabolic process,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,NUDT3,1
GO:0071880,GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,CHGA,1
GO:0090197,GO:0090197,positive regulation of chemokine secretion,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,SELENOK,1
GO:0098814,GO:0098814,spontaneous synaptic transmission,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,SYT1,1
GO:0099149,GO:0099149,regulation of postsynaptic neurotransmitter receptor internalization,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,ARC,1
GO:0099500,GO:0099500,vesicle fusion to plasma membrane,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,SYT1,1
GO:0150065,GO:0150065,regulation of deacetylase activity,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,VEGFA,1
GO:1900452,GO:1900452,regulation of long-term synaptic depression,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,ARC,1
GO:1901526,GO:1901526,positive regulation of mitophagy,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,TOMM7,1
GO:1902805,GO:1902805,positive regulation of synaptic vesicle transport,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,SYT1,1
GO:1903587,GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,VEGFA,1
GO:1904181,GO:1904181,positive regulation of membrane depolarization,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,TSPO,1
GO:1905244,GO:1905244,regulation of modification of synaptic structure,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,RHOA,1
GO:1905245,GO:1905245,regulation of aspartic-type peptidase activity,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,GRN,1
GO:1990440,GO:1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,HSPA5,1
GO:2000341,GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,1/317,10/12743,0.222755751307896,0.599016509421635,0.534602831627888,MIF,1
GO:0030323,GO:0030323,respiratory tube development,5/317,130/12743,0.222964622079258,0.599016509421635,0.534602831627888,PHF14/MME/IGFBP5/ASCL1/VEGFA,5
GO:0055074,GO:0055074,calcium ion homeostasis,9/317,268/12743,0.224735092689522,0.599016509421635,0.534602831627888,HSP90B1/S100A14/CALR/CD24/TMBIM6/GTF2I/GRIK2/CACNA2D1/CALCB,9
GO:0002886,GO:0002886,regulation of myeloid leukocyte mediated immunity,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,VAMP8/NPPA,2
GO:0006749,GO:0006749,glutathione metabolic process,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,PARK7/GGCT,2
GO:0006940,GO:0006940,regulation of smooth muscle contraction,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,RHOA/RGS2,2
GO:0008631,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,PARK7/SFPQ,2
GO:0009409,GO:0009409,response to cold,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,PCSK1N/FOS,2
GO:0010463,GO:0010463,mesenchymal cell proliferation,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,PHF14/VEGFA,2
GO:0035176,GO:0035176,social behavior,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,GRP/CNTNAP2,2
GO:0043030,GO:0043030,regulation of macrophage activation,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,MIF/GRN,2
GO:0051703,GO:0051703,intraspecies interaction between organisms,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,GRP/CNTNAP2,2
GO:0051937,GO:0051937,catecholamine transport,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,CHGA/PARK7,2
GO:0086002,GO:0086002,cardiac muscle cell action potential involved in contraction,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,DSP/CACNA2D1,2
GO:0090102,GO:0090102,cochlea development,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,PSAP/SLITRK6,2
GO:0150076,GO:0150076,neuroinflammatory response,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,GRN/JUN,2
GO:1902893,GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II,2/317,36/12743,0.225316080950603,0.599016509421635,0.534602831627888,FOS/JUN,2
GO:0001656,GO:0001656,metanephros development,3/317,66/12743,0.226044724127368,0.599016509421635,0.534602831627888,EGR1/BASP1/AKR1B1,3
GO:0014812,GO:0014812,muscle cell migration,3/317,66/12743,0.226044724127368,0.599016509421635,0.534602831627888,MDK/IGFBP5/AKIRIN1,3
GO:0019233,GO:0019233,sensory perception of pain,3/317,66/12743,0.226044724127368,0.599016509421635,0.534602831627888,FABP5/UCHL1/MME,3
GO:0043502,GO:0043502,regulation of muscle adaptation,3/317,66/12743,0.226044724127368,0.599016509421635,0.534602831627888,IGFBP5/RGS2/CAMK2B,3
GO:1901861,GO:1901861,regulation of muscle tissue development,4/317,98/12743,0.227232847694111,0.599016509421635,0.534602831627888,IGFBP5/RGS2/DDX17/AKIRIN1,4
GO:0002791,GO:0002791,regulation of peptide secretion,11/317,340/12743,0.227514959642685,0.599016509421635,0.534602831627888,GRP/MDK/MIF/SOX4/TMBIM6/SLC25A6/RAC1/ERP29/PPIA/SERP1/SELENOK,11
GO:0051090,GO:0051090,regulation of DNA-binding transcription factor activity,11/317,341/12743,0.230290773717872,0.599016509421635,0.534602831627888,HSPA1A/TERF2IP/PARK7/HSPA1B/FOS/SGK1/RPS3/PSMA6/BEX1/JUN/VEGFA,11
GO:0071496,GO:0071496,cellular response to external stimulus,9/317,270/12743,0.230985254027541,0.599016509421635,0.534602831627888,HSP90B1/FOS/RAC1/HSPA5/WIPI2/MAP1LC3B/CDKN1A/JUN/NPPA,9
GO:0033673,GO:0033673,negative regulation of kinase activity,7/317,200/12743,0.231089545527881,0.599016509421635,0.534602831627888,UCHL1/PARK7/RGS2/DUSP1/GADD45B/CDKN1A/YWHAG,7
GO:1903522,GO:1903522,regulation of blood circulation,7/317,200/12743,0.231089545527881,0.599016509421635,0.534602831627888,S100A1/CHGA/RHOA/RGS2/DSP/CACNA2D1/NPPA,7
GO:0050770,GO:0050770,regulation of axonogenesis,5/317,132/12743,0.232071754123,0.599016509421635,0.534602831627888,TUBB2B/RHOA/MAP1B/MACF1/VEGFA,5
GO:0007034,GO:0007034,vacuolar transport,4/317,99/12743,0.232566069345522,0.599016509421635,0.534602831627888,HSPA1A/PSAP/GRN/RHOB,4
GO:0032640,GO:0032640,tumor necrosis factor production,4/317,99/12743,0.232566069345522,0.599016509421635,0.534602831627888,MIF/TSPO/SELENOK/CD47,4
GO:0035051,GO:0035051,cardiocyte differentiation,4/317,99/12743,0.232566069345522,0.599016509421635,0.534602831627888,CALR/RGS2/NPPA/VEGFA,4
GO:0002027,GO:0002027,regulation of heart rate,3/317,67/12743,0.232642413674396,0.599016509421635,0.534602831627888,DSP/CACNA2D1/NPPA,3
GO:0014897,GO:0014897,striated muscle hypertrophy,3/317,67/12743,0.232642413674396,0.599016509421635,0.534602831627888,IGFBP5/RGS2/NPPA,3
GO:0031146,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,3/317,67/12743,0.232642413674396,0.599016509421635,0.534602831627888,PSMB8/RBX1/PSMA6,3
GO:0043154,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3/317,67/12743,0.232642413674396,0.599016509421635,0.534602831627888,PARK7/HGF/VEGFA,3
GO:0046902,GO:0046902,regulation of mitochondrial membrane permeability,3/317,67/12743,0.232642413674396,0.599016509421635,0.534602831627888,HSPA1A/YWHAH/YWHAG,3
GO:0060419,GO:0060419,heart growth,3/317,67/12743,0.232642413674396,0.599016509421635,0.534602831627888,BASP1/RGS2/NPPA,3
GO:1903747,GO:1903747,regulation of establishment of protein localization to mitochondrion,3/317,67/12743,0.232642413674396,0.599016509421635,0.534602831627888,TOMM7/YWHAH/YWHAG,3
GO:0030178,GO:0030178,negative regulation of Wnt signaling pathway,6/317,166/12743,0.232676711270465,0.599016509421635,0.534602831627888,MDK/EGR1/PSMB8/RBX1/IGFBP2/PSMA6,6
GO:0006284,GO:0006284,base-excision repair,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,RPS3/NTHL1,2
GO:0006296,GO:0006296,nucleotide-excision repair, DNA incision, 5'-to lesion,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,RBX1/NTHL1,2
GO:0007200,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,GRP/CHGA,2
GO:0021545,GO:0021545,cranial nerve development,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,RPL24/SLITRK6,2
GO:0033046,GO:0033046,negative regulation of sister chromatid segregation,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,DUSP1/MAD1L1,2
GO:0045824,GO:0045824,negative regulation of innate immune response,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,GRN/RPS19,2
GO:0045843,GO:0045843,negative regulation of striated muscle tissue development,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,RGS2/AKIRIN1,2
GO:0046622,GO:0046622,positive regulation of organ growth,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,BASP1/SERP1,2
GO:0051966,GO:0051966,regulation of synaptic transmission, glutamatergic,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,GRIK2/SYT1,2
GO:0051985,GO:0051985,negative regulation of chromosome segregation,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,DUSP1/MAD1L1,2
GO:0060236,GO:0060236,regulation of mitotic spindle organization,2/317,37/12743,0.234552394336734,0.599016509421635,0.534602831627888,HSPA1A/HSPA1B,2
GO:0002699,GO:0002699,positive regulation of immune effector process,5/317,133/12743,0.236665091110338,0.599016509421635,0.534602831627888,B2M/VAMP8/MIF/RPS19/NPPA,5
GO:0009206,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,5/317,133/12743,0.236665091110338,0.599016509421635,0.534602831627888,ATP5F1E/ATP5ME/PGAM2/ALDOA/NME4,5
GO:0035637,GO:0035637,multicellular organismal signaling,5/317,133/12743,0.236665091110338,0.599016509421635,0.534602831627888,CNTNAP2/DSP/GRIK2/CACNA2D1/NPPA,5
GO:0009755,GO:0009755,hormone-mediated signaling pathway,6/317,167/12743,0.236750271770315,0.599016509421635,0.534602831627888,RHOA/CALR/PARK7/YWHAH/SCGB2A1/DDX17,6
GO:0010001,GO:0010001,glial cell differentiation,6/317,167/12743,0.236750271770315,0.599016509421635,0.534602831627888,MDK/RHOA/CD9/SOX4/GRN/ASCL1,6
GO:0008360,GO:0008360,regulation of cell shape,4/317,100/12743,0.237929805490277,0.599016509421635,0.534602831627888,S100A13/ALDOA/CFDP1/VEGFA,4
GO:0009116,GO:0009116,nucleoside metabolic process,4/317,100/12743,0.237929805490277,0.599016509421635,0.534602831627888,RHOA/APRT/NME4/CTPS1,4
GO:0055002,GO:0055002,striated muscle cell development,4/317,100/12743,0.237929805490277,0.599016509421635,0.534602831627888,UCHL1/RGS2/NPPA/VEGFA,4
GO:0061025,GO:0061025,membrane fusion,4/317,100/12743,0.237929805490277,0.599016509421635,0.534602831627888,CALR/CD9/PPIA/SYT1,4
GO:0007589,GO:0007589,body fluid secretion,3/317,68/12743,0.239274647524051,0.599016509421635,0.534602831627888,VAMP8/APRT/VEGFA,3
GO:0014896,GO:0014896,muscle hypertrophy,3/317,68/12743,0.239274647524051,0.599016509421635,0.534602831627888,IGFBP5/RGS2/NPPA,3
GO:0033143,GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,3/317,68/12743,0.239274647524051,0.599016509421635,0.534602831627888,RHOA/CALR/PARK7,3
GO:0097061,GO:0097061,dendritic spine organization,3/317,68/12743,0.239274647524051,0.599016509421635,0.534602831627888,CDC42/ARC/CAMK2B,3
GO:0045862,GO:0045862,positive regulation of proteolysis,9/317,273/12743,0.240479324698699,0.599016509421635,0.534602831627888,RHOA/HSPA1A/GRN/PDCD6/RPS3/RBX1/NOP53/ZFAND2A/FAM162A,9
GO:0030073,GO:0030073,insulin secretion,6/317,168/12743,0.240845712557794,0.599016509421635,0.534602831627888,PARK7/SOX4/SLC25A6/RAC1/SERP1/PCLO,6
GO:0001659,GO:0001659,temperature homeostasis,5/317,134/12743,0.241283683558776,0.599016509421635,0.534602831627888,FABP5/GADD45G/MFAP2/EGR1/VEGFA,5
GO:0009145,GO:0009145,purine nucleoside triphosphate biosynthetic process,5/317,134/12743,0.241283683558776,0.599016509421635,0.534602831627888,ATP5F1E/ATP5ME/PGAM2/ALDOA/NME4,5
GO:0001696,GO:0001696,gastric acid secretion,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,SGK1,1
GO:0002091,GO:0002091,negative regulation of receptor internalization,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,LRPAP1,1
GO:0002093,GO:0002093,auditory receptor cell morphogenesis,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,SLITRK6,1
GO:0002227,GO:0002227,innate immune response in mucosa,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,RPL39,1
GO:0002363,GO:0002363,alpha-beta T cell lineage commitment,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,RHOA,1
GO:0002483,GO:0002483,antigen processing and presentation of endogenous peptide antigen,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,B2M,1
GO:0002693,GO:0002693,positive regulation of cellular extravasation,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,MDK,1
GO:0002861,GO:0002861,regulation of inflammatory response to antigenic stimulus,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,PARK7,1
GO:0005513,GO:0005513,detection of calcium ion,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,SYT1,1
GO:0006089,GO:0006089,lactate metabolic process,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,PARK7,1
GO:0006122,GO:0006122,mitochondrial electron transport, ubiquinol to cytochrome c,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,UQCR10,1
GO:0009223,GO:0009223,pyrimidine deoxyribonucleotide catabolic process,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,NTHL1,1
GO:0014029,GO:0014029,neural crest formation,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,PDCD6,1
GO:0019042,GO:0019042,viral latency,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,PPIA,1
GO:0021514,GO:0021514,ventral spinal cord interneuron differentiation,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,ASCL1,1
GO:0021554,GO:0021554,optic nerve development,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,RPL24,1
GO:0021681,GO:0021681,cerebellar granular layer development,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,MDK,1
GO:0031269,GO:0031269,pseudopodium assembly,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,CDC42,1
GO:0031953,GO:0031953,negative regulation of protein autophosphorylation,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,JUN,1
GO:0032352,GO:0032352,positive regulation of hormone metabolic process,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,EGR1,1
GO:0035751,GO:0035751,regulation of lysosomal lumen pH,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,GRN,1
GO:0042308,GO:0042308,negative regulation of protein import into nucleus,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,APOD,1
GO:0043247,GO:0043247,telomere maintenance in response to DNA damage,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,TERF2IP,1
GO:0046033,GO:0046033,AMP metabolic process,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,APRT,1
GO:0046068,GO:0046068,cGMP metabolic process,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,NPPA,1
GO:0046831,GO:0046831,regulation of RNA export from nucleus,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,KHDRBS1,1
GO:0046851,GO:0046851,negative regulation of bone remodeling,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,CLDN18,1
GO:0048172,GO:0048172,regulation of short-term neuronal synaptic plasticity,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,GRIK2,1
GO:0050862,GO:0050862,positive regulation of T cell receptor signaling pathway,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,RPS3,1
GO:0051023,GO:0051023,regulation of immunoglobulin secretion,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,TMBIM6,1
GO:0060192,GO:0060192,negative regulation of lipase activity,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,RGS2,1
GO:0060253,GO:0060253,negative regulation of glial cell proliferation,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,TSPO,1
GO:0060575,GO:0060575,intestinal epithelial cell differentiation,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,CDKN1A,1
GO:0060856,GO:0060856,establishment of blood-brain barrier,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,MFSD2A,1
GO:0071318,GO:0071318,cellular response to ATP,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,HSP90B1,1
GO:0071679,GO:0071679,commissural neuron axon guidance,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,VEGFA,1
GO:0072075,GO:0072075,metanephric mesenchyme development,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,BASP1,1
GO:0072182,GO:0072182,regulation of nephron tubule epithelial cell differentiation,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,CD24,1
GO:0072224,GO:0072224,metanephric glomerulus development,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,EGR1,1
GO:0090073,GO:0090073,positive regulation of protein homodimerization activity,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,PARK7,1
GO:0090196,GO:0090196,regulation of chemokine secretion,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,SELENOK,1
GO:0090494,GO:0090494,dopamine uptake,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,PARK7,1
GO:0099171,GO:0099171,presynaptic modulation of chemical synaptic transmission,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,SYT1,1
GO:0099640,GO:0099640,axo-dendritic protein transport,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,SFPQ,1
GO:1900119,GO:1900119,positive regulation of execution phase of apoptosis,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,RPS3,1
GO:1900221,GO:1900221,regulation of amyloid-beta clearance,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,LRPAP1,1
GO:1900424,GO:1900424,regulation of defense response to bacterium,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,GRN,1
GO:1902065,GO:1902065,response to L-glutamate,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,TMBIM6,1
GO:1902259,GO:1902259,regulation of delayed rectifier potassium channel activity,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,NPPA,1
GO:1902414,GO:1902414,protein localization to cell junction,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,DSP,1
GO:1903818,GO:1903818,positive regulation of voltage-gated potassium channel activity,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,NPPA,1
GO:1903894,GO:1903894,regulation of IRE1-mediated unfolded protein response,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,HSPA5,1
GO:1904590,GO:1904590,negative regulation of protein import,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,APOD,1
GO:2000251,GO:2000251,positive regulation of actin cytoskeleton reorganization,1/317,11/12743,0.242105977243292,0.599016509421635,0.534602831627888,CDC42,1
GO:0031398,GO:0031398,positive regulation of protein ubiquitination,4/317,101/12743,0.243322534661533,0.599109157898946,0.534685517392867,RPS2/PDCD6/HSPA5/UBE2S,4
GO:0007595,GO:0007595,lactation,2/317,38/12743,0.243809929904356,0.599109157898946,0.534685517392867,APRT/VEGFA,2
GO:0030888,GO:0030888,regulation of B cell proliferation,2/317,38/12743,0.243809929904356,0.599109157898946,0.534685517392867,MIF/CDKN1A,2
GO:0048635,GO:0048635,negative regulation of muscle organ development,2/317,38/12743,0.243809929904356,0.599109157898946,0.534685517392867,RGS2/AKIRIN1,2
GO:0048747,GO:0048747,muscle fiber development,2/317,38/12743,0.243809929904356,0.599109157898946,0.534685517392867,UCHL1/VEGFA,2
GO:0050879,GO:0050879,multicellular organismal movement,2/317,38/12743,0.243809929904356,0.599109157898946,0.534685517392867,EEF2/ASCL1,2
GO:0050881,GO:0050881,musculoskeletal movement,2/317,38/12743,0.243809929904356,0.599109157898946,0.534685517392867,EEF2/ASCL1,2
GO:0071320,GO:0071320,cellular response to cAMP,2/317,38/12743,0.243809929904356,0.599109157898946,0.534685517392867,IGFBP5/HSPA5,2
GO:0099024,GO:0099024,plasma membrane invagination,2/317,38/12743,0.243809929904356,0.599109157898946,0.534685517392867,RHOA/CDC42,2
GO:1902229,GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,2/317,38/12743,0.243809929904356,0.599109157898946,0.534685517392867,MIF/RPS3,2
GO:0055082,GO:0055082,cellular chemical homeostasis,15/317,492/12743,0.244572260525093,0.600571910237507,0.53599097647432,HSP90B1/CALR/CD24/SOX4/TMBIM6/GRN/RAC1/ATP6AP1/FTH1/GTF2I/GRIK2/ATP6V0E2/CACNA2D1/MT2A/CALCB,15
GO:0051262,GO:0051262,protein tetramerization,5/317,135/12743,0.245926586612975,0.601462032177312,0.536785381473229,RPS19/HIST1H4C/ALDOA/KRT10/PCBD1,5
GO:0071347,GO:0071347,cellular response to interleukin-1,5/317,135/12743,0.245926586612975,0.601462032177312,0.536785381473229,EGR1/PSMB8/RBX1/PSMA6/CD47,5
GO:0030838,GO:0030838,positive regulation of actin filament polymerization,3/317,69/12743,0.2459385778305,0.601462032177312,0.536785381473229,RHOA/BRK1/PFN2,3
GO:0033045,GO:0033045,regulation of sister chromatid segregation,3/317,69/12743,0.2459385778305,0.601462032177312,0.536785381473229,DUSP1/MAD1L1/SFPQ,3
GO:0048661,GO:0048661,positive regulation of smooth muscle cell proliferation,3/317,69/12743,0.2459385778305,0.601462032177312,0.536785381473229,IGFBP5/AKR1B1/JUN,3
GO:0072332,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,3/317,69/12743,0.2459385778305,0.601462032177312,0.536785381473229,FHIT/MIF/CDKN1A,3
GO:0007187,GO:0007187,G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,4/317,102/12743,0.24874274293489,0.604016076648731,0.539064783434692,CHGA/RAMP1/GNG2/RGS2,4
GO:0042157,GO:0042157,lipoprotein metabolic process,4/317,102/12743,0.24874274293489,0.604016076648731,0.539064783434692,APOD/SELENOK/SVIP/WIPI2,4
GO:0043280,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,4/317,102/12743,0.24874274293489,0.604016076648731,0.539064783434692,RHOA/PDCD6/RPS3/FAM162A,4
GO:0044106,GO:0044106,cellular amine metabolic process,4/317,102/12743,0.24874274293489,0.604016076648731,0.539064783434692,PARK7/ODC1/PSMB8/PSMA6,4
GO:0071706,GO:0071706,tumor necrosis factor superfamily cytokine production,4/317,102/12743,0.24874274293489,0.604016076648731,0.539064783434692,MIF/TSPO/SELENOK/CD47,4
GO:0008016,GO:0008016,regulation of heart contraction,6/317,170/12743,0.24909964456927,0.604016076648731,0.539064783434692,S100A1/CHGA/RGS2/DSP/CACNA2D1/NPPA,6
GO:0043687,GO:0043687,post-translational protein modification,10/317,312/12743,0.250453213881835,0.604016076648731,0.539064783434692,TIMP1/HSP90B1/CHGB/RAB13/PDIA6/IGFBP5/PSMB8/WIPI2/RBX1/PSMA6,10
GO:1990138,GO:1990138,neuron projection extension,5/317,136/12743,0.250592855305727,0.604016076648731,0.539064783434692,MAP1B/SYT1/ALCAM/MACF1/VEGFA,5
GO:0006094,GO:0006094,gluconeogenesis,3/317,70/12743,0.252631403338299,0.604016076648731,0.539064783434692,PGAM2/MDH2/ALDOA,3
GO:0006720,GO:0006720,isoprenoid metabolic process,3/317,70/12743,0.252631403338299,0.604016076648731,0.539064783434692,NPC2/RBP1/AKR1B1,3
GO:0008625,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,3/317,70/12743,0.252631403338299,0.604016076648731,0.539064783434692,PARK7/GABARAP/HGF,3
GO:0030516,GO:0030516,regulation of axon extension,3/317,70/12743,0.252631403338299,0.604016076648731,0.539064783434692,MAP1B/MACF1/VEGFA,3
GO:0006636,GO:0006636,unsaturated fatty acid biosynthetic process,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,FABP5/MIF,2
GO:0007588,GO:0007588,excretion,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,MDK/PSAP,2
GO:0021695,GO:0021695,cerebellar cortex development,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,MDK/HSPA5,2
GO:0033683,GO:0033683,nucleotide-excision repair, DNA incision,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,RBX1/NTHL1,2
GO:0051148,GO:0051148,negative regulation of muscle cell differentiation,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,YBX1/RGS2,2
GO:0051926,GO:0051926,negative regulation of calcium ion transport,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,TMBIM6/GEM,2
GO:0061001,GO:0061001,regulation of dendritic spine morphogenesis,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,ARC/CAMK2B,2
GO:0061005,GO:0061005,cell differentiation involved in kidney development,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,CD24/BASP1,2
GO:0070206,GO:0070206,protein trimerization,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,MIF/BRK1,2
GO:0098900,GO:0098900,regulation of action potential,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,DSP/CACNA2D1,2
GO:1990868,GO:1990868,response to chemokine,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,RHOA/DUSP1,2
GO:1990869,GO:1990869,cellular response to chemokine,2/317,39/12743,0.253081940064109,0.604016076648731,0.539064783434692,RHOA/DUSP1,2
GO:0051606,GO:0051606,detection of stimulus,6/317,171/12743,0.253256835573794,0.604016076648731,0.539064783434692,OR51E1/SOX4/RPS3/RBX1/SYT1/AZGP1,6
GO:0050684,GO:0050684,regulation of mRNA processing,4/317,103/12743,0.254188924882986,0.604016076648731,0.539064783434692,KHDRBS1/SNRNP70/SRSF9/DDX17,4
GO:0021543,GO:0021543,pallium development,5/317,137/12743,0.255281545094785,0.604016076648731,0.539064783434692,MDK/MFSD2A/RHOA/CNTNAP2/ASCL1,5
GO:0033209,GO:0033209,tumor necrosis factor-mediated signaling pathway,5/317,137/12743,0.255281545094785,0.604016076648731,0.539064783434692,HSPA1A/CLDN18/HSPA1B/PSMB8/PSMA6,5
GO:0045787,GO:0045787,positive regulation of cell cycle,10/317,314/12743,0.256553162942091,0.604016076648731,0.539064783434692,RHOA/CALR/MIF/SOX4/CENPV/CDC42/MEIS2/CDKN1A/ASCL1/SFPQ,10
GO:0006897,GO:0006897,endocytosis,15/317,497/12743,0.256611924354055,0.604016076648731,0.539064783434692,B2M/HSP90B1/RAMP1/CALR/CD9/LRPAP1/CD63/CDC42/RAC1/BRK1/SNCB/SNX3/ARC/CD47/VEGFA,15
GO:0009791,GO:0009791,post-embryonic development,3/317,71/12743,0.259350370632782,0.604016076648731,0.539064783434692,MFAP2/SERP1/VEGFA,3
GO:0018958,GO:0018958,phenol-containing compound metabolic process,3/317,71/12743,0.259350370632782,0.604016076648731,0.539064783434692,PARK7/SNCB/AKR1B1,3
GO:0072384,GO:0072384,organelle transport along microtubule,3/317,71/12743,0.259350370632782,0.604016076648731,0.539064783434692,UCHL1/CDC42/MAP1B,3
GO:0043900,GO:0043900,regulation of multi-organism process,10/317,315/12743,0.259621959056406,0.604016076648731,0.539064783434692,TIMP1/CALR/PPIB/MIF/GRN/PPIA/SELENOK/NOP53/SNX3/JUN,10
GO:0003018,GO:0003018,vascular process in circulatory system,4/317,104/12743,0.259659584489031,0.604016076648731,0.539064783434692,CHGA/RHOA/RGS2/NPPA,4
GO:0003215,GO:0003215,cardiac right ventricle morphogenesis,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,SOX4,1
GO:0006244,GO:0006244,pyrimidine nucleotide catabolic process,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,NTHL1,1
GO:0006983,GO:0006983,ER overload response,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,HSPA5,1
GO:0007625,GO:0007625,grooming behavior,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,APRT,1
GO:0010566,GO:0010566,regulation of ketone biosynthetic process,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,EGR1,1
GO:0010715,GO:0010715,regulation of extracellular matrix disassembly,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,FSCN1,1
GO:0010829,GO:0010829,negative regulation of glucose transmembrane transport,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,FABP5,1
GO:0016137,GO:0016137,glycoside metabolic process,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,AKR1B1,1
GO:0019377,GO:0019377,glycolipid catabolic process,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,PSAP,1
GO:0030728,GO:0030728,ovulation,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,RGS2,1
GO:0031268,GO:0031268,pseudopodium organization,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,CDC42,1
GO:0031643,GO:0031643,positive regulation of myelination,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,HGF,1
GO:0032303,GO:0032303,regulation of icosanoid secretion,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,MIF,1
GO:0032530,GO:0032530,regulation of microvillus organization,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,FSCN1,1
GO:0034111,GO:0034111,negative regulation of homotypic cell-cell adhesion,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,CD9,1
GO:0042401,GO:0042401,cellular biogenic amine biosynthetic process,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,ODC1,1
GO:0042559,GO:0042559,pteridine-containing compound biosynthetic process,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,PCBD1,1
GO:0043173,GO:0043173,nucleotide salvage,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,APRT,1
GO:0043584,GO:0043584,nose development,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,ASCL1,1
GO:0043931,GO:0043931,ossification involved in bone maturation,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,RHOA,1
GO:0045019,GO:0045019,negative regulation of nitric oxide biosynthetic process,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,TSPO,1
GO:0045603,GO:0045603,positive regulation of endothelial cell differentiation,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,BTG1,1
GO:0051349,GO:0051349,positive regulation of lyase activity,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,PARK7,1
GO:0051645,GO:0051645,Golgi localization,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,CDC42,1
GO:0051988,GO:0051988,regulation of attachment of spindle microtubules to kinetochore,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,CDC42,1
GO:0060252,GO:0060252,positive regulation of glial cell proliferation,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,TSPO,1
GO:0060413,GO:0060413,atrial septum morphogenesis,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,SOX4,1
GO:0060713,GO:0060713,labyrinthine layer morphogenesis,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,SPINT2,1
GO:0060841,GO:0060841,venous blood vessel development,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,VEGFA,1
GO:0060977,GO:0060977,coronary vasculature morphogenesis,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,VEGFA,1
GO:0072567,GO:0072567,chemokine (C-X-C motif) ligand 2 production,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,MIF,1
GO:0090128,GO:0090128,regulation of synapse maturation,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,CAMK2B,1
GO:0090493,GO:0090493,catecholamine uptake,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,PARK7,1
GO:1901070,GO:1901070,guanosine-containing compound biosynthetic process,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,NME4,1
GO:1901386,GO:1901386,negative regulation of voltage-gated calcium channel activity,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,GEM,1
GO:1904406,GO:1904406,negative regulation of nitric oxide metabolic process,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,TSPO,1
GO:1904668,GO:1904668,positive regulation of ubiquitin protein ligase activity,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,UBE2S,1
GO:1904706,GO:1904706,negative regulation of vascular smooth muscle cell proliferation,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,CDKN1A,1
GO:1990173,GO:1990173,protein localization to nucleoplasm,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,NOP53,1
GO:2000193,GO:2000193,positive regulation of fatty acid transport,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,MIF,1
GO:2000345,GO:2000345,regulation of hepatocyte proliferation,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,MDK,1
GO:2000402,GO:2000402,negative regulation of lymphocyte migration,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,APOD,1
GO:2001028,GO:2001028,positive regulation of endothelial cell chemotaxis,1/317,12/12743,0.260975943094209,0.604016076648731,0.539064783434692,VEGFA,1
GO:0000381,GO:0000381,regulation of alternative mRNA splicing, via spliceosome,2/317,40/12743,0.262361997776761,0.604016076648731,0.539064783434692,KHDRBS1/DDX17,2
GO:0001961,GO:0001961,positive regulation of cytokine-mediated signaling pathway,2/317,40/12743,0.262361997776761,0.604016076648731,0.539064783434692,HSPA1A/HSPA1B,2
GO:0002720,GO:0002720,positive regulation of cytokine production involved in immune response,2/317,40/12743,0.262361997776761,0.604016076648731,0.539064783434692,B2M/MIF,2
GO:0042398,GO:0042398,cellular modified amino acid biosynthetic process,2/317,40/12743,0.262361997776761,0.604016076648731,0.539064783434692,PARK7/GGCT,2
GO:0046173,GO:0046173,polyol biosynthetic process,2/317,40/12743,0.262361997776761,0.604016076648731,0.539064783434692,AKR1B1/PCBD1,2
GO:0051205,GO:0051205,protein insertion into membrane,2/317,40/12743,0.262361997776761,0.604016076648731,0.539064783434692,YWHAH/YWHAG,2
GO:0051646,GO:0051646,mitochondrion localization,2/317,40/12743,0.262361997776761,0.604016076648731,0.539064783434692,UCHL1/MAP1B,2
GO:0051898,GO:0051898,negative regulation of protein kinase B signaling,2/317,40/12743,0.262361997776761,0.604016076648731,0.539064783434692,PDCD6/NOP53,2
GO:1902305,GO:1902305,regulation of sodium ion transmembrane transport,2/317,40/12743,0.262361997776761,0.604016076648731,0.539064783434692,YWHAH/CNKSR3,2
GO:0032535,GO:0032535,regulation of cellular component size,9/317,280/12743,0.263146530783537,0.604016076648731,0.539064783434692,RHOA/RAC1/BRK1/PPP1R15A/PFN2/ELN/MAP1B/MACF1/VEGFA,9
GO:0140056,GO:0140056,organelle localization by membrane tethering,5/317,139/12743,0.264722415044474,0.604016076648731,0.539064783434692,TUBA1A/VAMP8/SYT1/YWHAG/TUBB4B,5
GO:0007050,GO:0007050,cell cycle arrest,7/317,209/12743,0.264883451465772,0.604016076648731,0.539064783434692,CALR/MIF/SOX4/PPP1R15A/DUSP1/CDKN1A/WDR6,7
GO:0017148,GO:0017148,negative regulation of translation,4/317,105/12743,0.26515323601995,0.604016076648731,0.539064783434692,CALR/IGFBP5/RGS2/RPS3,4
GO:0050804,GO:0050804,modulation of chemical synaptic transmission,10/317,317/12743,0.265795974290512,0.604016076648731,0.539064783434692,TUBB2B/YWHAH/MME/PFN2/MAP1B/GRIK2/SYT1/YWHAG/ARC/CAMK2B,10
GO:0032412,GO:0032412,regulation of ion transmembrane transporter activity,6/317,174/12743,0.265841475887626,0.604016076648731,0.539064783434692,S100A1/YWHAH/GEM/CACNA2D1/CNKSR3/NPPA,6
GO:0045778,GO:0045778,positive regulation of ossification,3/317,72/12743,0.266092775255996,0.604016076648731,0.539064783434692,ATP6AP1/HGF/ATRAID,3
GO:0046620,GO:0046620,regulation of organ growth,3/317,72/12743,0.266092775255996,0.604016076648731,0.539064783434692,BASP1/SERP1/RGS2,3
GO:2000117,GO:2000117,negative regulation of cysteine-type endopeptidase activity,3/317,72/12743,0.266092775255996,0.604016076648731,0.539064783434692,PARK7/HGF/VEGFA,3
GO:0006913,GO:0006913,nucleocytoplasmic transport,9/317,281/12743,0.266439185966111,0.604016076648731,0.539064783434692,APOD/CALR/PARK7/SNRPF/KHDRBS1/SRSF9/THOC7/SNRPE/CDKN1A,9
GO:0002237,GO:0002237,response to molecule of bacterial origin,7/317,210/12743,0.268723013698525,0.604016076648731,0.539064783434692,B2M/S100A14/RHOA/CD24/MIF/FOS/TSPO,7
GO:0042060,GO:0042060,wound healing,12/317,392/12743,0.271347158693253,0.604016076648731,0.539064783434692,APOD/TIMP1/MDK/RHOA/CD9/GNG2/CDC42/RAC1/CDKN1A/PABPC4/MACF1/AKIRIN1,12
GO:0006221,GO:0006221,pyrimidine nucleotide biosynthetic process,2/317,41/12743,0.271643984865967,0.604016076648731,0.539064783434692,NME4/CTPS1,2
GO:0032890,GO:0032890,regulation of organic acid transport,2/317,41/12743,0.271643984865967,0.604016076648731,0.539064783434692,MIF/RGS2,2
GO:0042771,GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,2/317,41/12743,0.271643984865967,0.604016076648731,0.539064783434692,MIF/CDKN1A,2
GO:0048168,GO:0048168,regulation of neuronal synaptic plasticity,2/317,41/12743,0.271643984865967,0.604016076648731,0.539064783434692,GRIK2/CAMK2B,2
GO:0051353,GO:0051353,positive regulation of oxidoreductase activity,2/317,41/12743,0.271643984865967,0.604016076648731,0.539064783434692,S100A1/PARK7,2
GO:0051452,GO:0051452,intracellular pH reduction,2/317,41/12743,0.271643984865967,0.604016076648731,0.539064783434692,GRN/ATP6V0E2,2
GO:0090224,GO:0090224,regulation of spindle organization,2/317,41/12743,0.271643984865967,0.604016076648731,0.539064783434692,HSPA1A/HSPA1B,2
GO:1990090,GO:1990090,cellular response to nerve growth factor stimulus,2/317,41/12743,0.271643984865967,0.604016076648731,0.539064783434692,EEF2/HSPA5,2
GO:0050708,GO:0050708,regulation of protein secretion,10/317,319/12743,0.272016909972124,0.604016076648731,0.539064783434692,MDK/MIF/SOX4/TMBIM6/SLC25A6/RAC1/ERP29/PPIA/SERP1/SELENOK,10
GO:0031532,GO:0031532,actin cytoskeleton reorganization,3/317,73/12743,0.272855962695134,0.604016076648731,0.539064783434692,MDK/RHOA/CDC42,3
GO:0032465,GO:0032465,regulation of cytokinesis,3/317,73/12743,0.272855962695134,0.604016076648731,0.539064783434692,RHOA/CENPV/CDC42,3
GO:0045638,GO:0045638,negative regulation of myeloid cell differentiation,3/317,73/12743,0.272855962695134,0.604016076648731,0.539064783434692,CLDN18/HIST1H4C/MEIS2,3
GO:0046916,GO:0046916,cellular transition metal ion homeostasis,3/317,73/12743,0.272855962695134,0.604016076648731,0.539064783434692,ATP6AP1/FTH1/MT2A,3
GO:0048709,GO:0048709,oligodendrocyte differentiation,3/317,73/12743,0.272855962695134,0.604016076648731,0.539064783434692,MDK/CD9/ASCL1,3
GO:0009260,GO:0009260,ribonucleotide biosynthetic process,8/317,247/12743,0.273369983076008,0.604016076648731,0.539064783434692,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA/NME4/NPPA/CTPS1,8
GO:0008361,GO:0008361,regulation of cell size,5/317,141/12743,0.274241668174531,0.604016076648731,0.539064783434692,RHOA/RAC1/MAP1B/MACF1/VEGFA,5
GO:0007268,GO:0007268,chemical synaptic transmission,14/317,467/12743,0.274274152476788,0.604016076648731,0.539064783434692,TUBB2B/PARK7/GABARAP/YWHAH/MME/SNCB/PFN2/MAP1B/GRIK2/SYT1/PCLO/YWHAG/ARC/CAMK2B,14
GO:0098916,GO:0098916,anterograde trans-synaptic signaling,14/317,467/12743,0.274274152476788,0.604016076648731,0.539064783434692,TUBB2B/PARK7/GABARAP/YWHAH/MME/SNCB/PFN2/MAP1B/GRIK2/SYT1/PCLO/YWHAG/ARC/CAMK2B,14
GO:0001935,GO:0001935,endothelial cell proliferation,4/317,107/12743,0.276203628304461,0.604016076648731,0.539064783434692,MDK/PDCD6/JUN/VEGFA,4
GO:0002831,GO:0002831,regulation of response to biotic stimulus,4/317,107/12743,0.276203628304461,0.604016076648731,0.539064783434692,MIF/GRN/SELENOK/NOP53,4
GO:0009308,GO:0009308,amine metabolic process,4/317,107/12743,0.276203628304461,0.604016076648731,0.539064783434692,PARK7/ODC1/PSMB8/PSMA6,4
GO:0051291,GO:0051291,protein heterooligomerization,4/317,107/12743,0.276203628304461,0.604016076648731,0.539064783434692,HIST1H4C/KRT10/SYT1/PCBD1,4
GO:0051169,GO:0051169,nuclear transport,9/317,284/12743,0.27639229046647,0.604016076648731,0.539064783434692,APOD/CALR/PARK7/SNRPF/KHDRBS1/SRSF9/THOC7/SNRPE/CDKN1A,9
GO:0018209,GO:0018209,peptidyl-serine modification,7/317,212/12743,0.276447144756403,0.604016076648731,0.539064783434692,TERF2IP/MIF/PARK7/PFN2/HGF/CNKSR3/VEGFA,7
GO:0002009,GO:0002009,morphogenesis of an epithelium,13/317,431/12743,0.277111904034672,0.604016076648731,0.539064783434692,MDK/SPINT2/RHOA/CA9/SOX4/CDC42/RAC1/IGFBP5/RHOB/HGF/PSMB8/PSMA6/VEGFA,13
GO:0000963,GO:0000963,mitochondrial RNA processing,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,TRIT1,1
GO:0001580,GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,AZGP1,1
GO:0001732,GO:0001732,formation of cytoplasmic translation initiation complex,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,EIF3L,1
GO:0001829,GO:0001829,trophectodermal cell differentiation,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,JUNB,1
GO:0001916,GO:0001916,positive regulation of T cell mediated cytotoxicity,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,B2M,1
GO:0002070,GO:0002070,epithelial cell maturation,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,CDKN1A,1
GO:0002902,GO:0002902,regulation of B cell apoptotic process,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,MIF,1
GO:0006349,GO:0006349,regulation of gene expression by genetic imprinting,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,DIRAS3,1
GO:0006474,GO:0006474,N-terminal protein amino acid acetylation,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,SOX4,1
GO:0007158,GO:0007158,neuron cell-cell adhesion,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,NCAM2,1
GO:0009309,GO:0009309,amine biosynthetic process,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,ODC1,1
GO:0009404,GO:0009404,toxin metabolic process,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,PON3,1
GO:0009713,GO:0009713,catechol-containing compound biosynthetic process,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,PARK7,1
GO:0010738,GO:0010738,regulation of protein kinase A signaling,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,MIF,1
GO:0017085,GO:0017085,response to insecticide,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,MAP1B,1
GO:0019883,GO:0019883,antigen processing and presentation of endogenous antigen,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,B2M,1
GO:0021516,GO:0021516,dorsal spinal cord development,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,ASCL1,1
GO:0021756,GO:0021756,striatum development,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,CNTNAP2,1
GO:0021781,GO:0021781,glial cell fate commitment,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,ASCL1,1
GO:0030252,GO:0030252,growth hormone secretion,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,SERP1,1
GO:0032239,GO:0032239,regulation of nucleobase-containing compound transport,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,KHDRBS1,1
GO:0032793,GO:0032793,positive regulation of CREB transcription factor activity,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,VEGFA,1
GO:0032802,GO:0032802,low-density lipoprotein particle receptor catabolic process,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,MYLIP,1
GO:0032891,GO:0032891,negative regulation of organic acid transport,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,RGS2,1
GO:0035809,GO:0035809,regulation of urine volume,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,AKR1B1,1
GO:0036295,GO:0036295,cellular response to increased oxygen levels,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,ATP6AP1,1
GO:0042423,GO:0042423,catecholamine biosynthetic process,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,PARK7,1
GO:0042448,GO:0042448,progesterone metabolic process,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,EGR1,1
GO:0042537,GO:0042537,benzene-containing compound metabolic process,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,PON3,1
GO:0042790,GO:0042790,nucleolar large rRNA transcription by RNA polymerase I,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,NOP53,1
GO:0044090,GO:0044090,positive regulation of vacuole organization,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,GRN,1
GO:0044794,GO:0044794,positive regulation by host of viral process,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,PPIB,1
GO:0045475,GO:0045475,locomotor rhythm,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,EGR1,1
GO:0045655,GO:0045655,regulation of monocyte differentiation,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,JUN,1
GO:0045780,GO:0045780,positive regulation of bone resorption,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,ATP6AP1,1
GO:0046597,GO:0046597,negative regulation of viral entry into host cell,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,SNX3,1
GO:0046852,GO:0046852,positive regulation of bone remodeling,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,ATP6AP1,1
GO:0048305,GO:0048305,immunoglobulin secretion,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,TMBIM6,1
GO:0048385,GO:0048385,regulation of retinoic acid receptor signaling pathway,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,CALR,1
GO:0050774,GO:0050774,negative regulation of dendrite morphogenesis,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,YWHAH,1
GO:0051085,GO:0051085,chaperone cofactor-dependent protein refolding,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,DNAJB1,1
GO:0051127,GO:0051127,positive regulation of actin nucleation,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,BRK1,1
GO:0055070,GO:0055070,copper ion homeostasis,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,MT2A,1
GO:0060049,GO:0060049,regulation of protein glycosylation,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,RAMP1,1
GO:0060080,GO:0060080,inhibitory postsynaptic potential,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,GRIK2,1
GO:0060487,GO:0060487,lung epithelial cell differentiation,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,ASCL1,1
GO:0060749,GO:0060749,mammary gland alveolus development,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,VEGFA,1
GO:0061377,GO:0061377,mammary gland lobule development,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,VEGFA,1
GO:0070293,GO:0070293,renal absorption,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,SGK1,1
GO:0071380,GO:0071380,cellular response to prostaglandin E stimulus,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,GNG2,1
GO:0072160,GO:0072160,nephron tubule epithelial cell differentiation,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,CD24,1
GO:0090026,GO:0090026,positive regulation of monocyte chemotaxis,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,S100A14,1
GO:0090195,GO:0090195,chemokine secretion,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,SELENOK,1
GO:0090330,GO:0090330,regulation of platelet aggregation,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,CD9,1
GO:0098884,GO:0098884,postsynaptic neurotransmitter receptor internalization,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,ARC,1
GO:0098911,GO:0098911,regulation of ventricular cardiac muscle cell action potential,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,DSP,1
GO:0140239,GO:0140239,postsynaptic endocytosis,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,ARC,1
GO:1901836,GO:1901836,regulation of transcription of nucleolar large rRNA by RNA polymerase I,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,NOP53,1
GO:1902570,GO:1902570,protein localization to nucleolus,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,NOP53,1
GO:1902644,GO:1902644,tertiary alcohol metabolic process,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,AKR1B1,1
GO:1903960,GO:1903960,negative regulation of anion transmembrane transport,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,RGS2,1
GO:1904925,GO:1904925,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,TOMM7,1
GO:1905048,GO:1905048,regulation of metallopeptidase activity,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,TIMP1,1
GO:2000651,GO:2000651,positive regulation of sodium ion transmembrane transporter activity,1/317,13/12743,0.27937753181773,0.604016076648731,0.539064783434692,CNKSR3,1
GO:0002367,GO:0002367,cytokine production involved in immune response,3/317,74/12743,0.279637329250102,0.604016076648731,0.539064783434692,B2M/CHGA/MIF,3
GO:0006497,GO:0006497,protein lipidation,3/317,74/12743,0.279637329250102,0.604016076648731,0.539064783434692,SELENOK/SVIP/WIPI2,3
GO:0048814,GO:0048814,regulation of dendrite morphogenesis,3/317,74/12743,0.279637329250102,0.604016076648731,0.539064783434692,YWHAH/ARC/CAMK2B,3
GO:0050715,GO:0050715,positive regulation of cytokine secretion,3/317,74/12743,0.279637329250102,0.604016076648731,0.539064783434692,MDK/MIF/SELENOK,3
GO:0060993,GO:0060993,kidney morphogenesis,3/317,74/12743,0.279637329250102,0.604016076648731,0.539064783434692,SOX4/BASP1/VEGFA,3
GO:1901655,GO:1901655,cellular response to ketone,3/317,74/12743,0.279637329250102,0.604016076648731,0.539064783434692,PARK7/GNG2/AKR1B1,3
GO:0003179,GO:0003179,heart valve morphogenesis,2/317,42/12743,0.280922080711176,0.604016076648731,0.539064783434692,SOX4/ELN,2
GO:0006213,GO:0006213,pyrimidine nucleoside metabolic process,2/317,42/12743,0.280922080711176,0.604016076648731,0.539064783434692,NME4/CTPS1,2
GO:0019748,GO:0019748,secondary metabolic process,2/317,42/12743,0.280922080711176,0.604016076648731,0.539064783434692,PON3/AKR1B1,2
GO:0031529,GO:0031529,ruffle organization,2/317,42/12743,0.280922080711176,0.604016076648731,0.539064783434692,RAC1/PFN2,2
GO:0035924,GO:0035924,cellular response to vascular endothelial growth factor stimulus,2/317,42/12743,0.280922080711176,0.604016076648731,0.539064783434692,CD63/VEGFA,2
GO:0061614,GO:0061614,pri-miRNA transcription by RNA polymerase II,2/317,42/12743,0.280922080711176,0.604016076648731,0.539064783434692,FOS/JUN,2
GO:0086065,GO:0086065,cell communication involved in cardiac conduction,2/317,42/12743,0.280922080711176,0.604016076648731,0.539064783434692,DSP/CACNA2D1,2
GO:1901068,GO:1901068,guanosine-containing compound metabolic process,2/317,42/12743,0.280922080711176,0.604016076648731,0.539064783434692,RHOA/NME4,2
GO:0090288,GO:0090288,negative regulation of cellular response to growth factor stimulus,4/317,108/12743,0.281757456317498,0.605088444122702,0.540021836669643,HSPA1A/PEG10/PDCD6/HSPA5,4
GO:1903305,GO:1903305,regulation of regulated secretory pathway,4/317,108/12743,0.281757456317498,0.605088444122702,0.540021836669643,VAMP8/PFN2/SYT1/NPPA,4
GO:0001505,GO:0001505,regulation of neurotransmitter levels,8/317,250/12743,0.284124510240827,0.60749516207883,0.542169754488331,PARK7/RAC1/TSPO/RGS2/PFN2/SYT1/PCLO/CD47,8
GO:0090559,GO:0090559,regulation of membrane permeability,3/317,75/12743,0.286434322786611,0.60749516207883,0.542169754488331,HSPA1A/YWHAH/YWHAG,3
GO:0106027,GO:0106027,neuron projection organization,3/317,75/12743,0.286434322786611,0.60749516207883,0.542169754488331,CDC42/ARC/CAMK2B,3
GO:0009566,GO:0009566,fertilization,4/317,109/12743,0.287328452249339,0.60749516207883,0.542169754488331,CD9/PARK7/SLIRP/ALDOA,4
GO:0030833,GO:0030833,regulation of actin filament polymerization,4/317,109/12743,0.287328452249339,0.60749516207883,0.542169754488331,RHOA/BRK1/PFN2/ELN,4
GO:0030856,GO:0030856,regulation of epithelial cell differentiation,4/317,109/12743,0.287328452249339,0.60749516207883,0.542169754488331,CD24/MYCL/ASCL1/BTG1,4
GO:0072006,GO:0072006,nephron development,4/317,109/12743,0.287328452249339,0.60749516207883,0.542169754488331,CD24/EGR1/BASP1/VEGFA,4
GO:0046390,GO:0046390,ribose phosphate biosynthetic process,8/317,251/12743,0.287734037603438,0.60749516207883,0.542169754488331,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA/NME4/NPPA/CTPS1,8
GO:0002066,GO:0002066,columnar/cuboidal epithelial cell development,2/317,43/12743,0.290190751309089,0.60749516207883,0.542169754488331,SLITRK6/CDKN1A,2
GO:0015844,GO:0015844,monoamine transport,2/317,43/12743,0.290190751309089,0.60749516207883,0.542169754488331,CHGA/PARK7,2
GO:0032768,GO:0032768,regulation of monooxygenase activity,2/317,43/12743,0.290190751309089,0.60749516207883,0.542169754488331,S100A1/PARK7,2
GO:0034113,GO:0034113,heterotypic cell-cell adhesion,2/317,43/12743,0.290190751309089,0.60749516207883,0.542169754488331,DSP/CD47,2
GO:0045123,GO:0045123,cellular extravasation,2/317,43/12743,0.290190751309089,0.60749516207883,0.542169754488331,MDK/CD47,2
GO:0060395,GO:0060395,SMAD protein signal transduction,2/317,43/12743,0.290190751309089,0.60749516207883,0.542169754488331,FOS/JUN,2
GO:0090199,GO:0090199,regulation of release of cytochrome c from mitochondria,2/317,43/12743,0.290190751309089,0.60749516207883,0.542169754488331,HGF/FAM162A,2
GO:0022411,GO:0022411,cellular component disassembly,13/317,436/12743,0.290743209590332,0.60749516207883,0.542169754488331,TIMP1/FSCN1/BSG/VAMP8/PARK7/GABARAP/GABARAPL2/TOMM7/MRPS24/TSPO/MRPL33/MAP1B/MAP1LC3B,13
GO:0043491,GO:0043491,protein kinase B signaling,6/317,180/12743,0.291460625421302,0.60749516207883,0.542169754488331,PARK7/RAC1/IGFBP5/HGF/PDCD6/NOP53,6
GO:0071560,GO:0071560,cellular response to transforming growth factor beta stimulus,6/317,180/12743,0.291460625421302,0.60749516207883,0.542169754488331,RHOA/HSPA1A/PEG10/FOS/HSPA5/JUN,6
GO:0002224,GO:0002224,toll-like receptor signaling pathway,4/317,110/12743,0.29291519351916,0.60749516207883,0.542169754488331,S100A1/HSP90B1/S100A14/CNPY3,4
GO:0051170,GO:0051170,import into nucleus,4/317,110/12743,0.29291519351916,0.60749516207883,0.542169754488331,APOD/SNRPF/SNRPE/CDKN1A,4
GO:0030111,GO:0030111,regulation of Wnt signaling pathway,9/317,289/12743,0.293212977060154,0.60749516207883,0.542169754488331,MDK/SOX4/EGR1/PSMB8/RBX1/SNX3/IGFBP2/PSMA6/MACF1,9
GO:0000079,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,3/317,76/12743,0.293244443380896,0.60749516207883,0.542169754488331,DIRAS3/CDKN1A/SERTAD1,3
GO:0015748,GO:0015748,organophosphate ester transport,3/317,76/12743,0.293244443380896,0.60749516207883,0.542169754488331,MFSD2A/NPC2/SLC25A6,3
GO:0098754,GO:0098754,detoxification,3/317,76/12743,0.293244443380896,0.60749516207883,0.542169754488331,SELENOW/PARK7/PON3,3
GO:0034764,GO:0034764,positive regulation of transmembrane transport,5/317,145/12743,0.293485420076422,0.60749516207883,0.542169754488331,S100A1/PARK7/CACNA2D1/CNKSR3/NPPA,5
GO:0050808,GO:0050808,synapse organization,10/317,326/12743,0.294130779512688,0.60749516207883,0.542169754488331,RHOA/TUBA1A/CDC42/SNCB/PFN2/MAP1B/SLITRK6/PCLO/ARC/CAMK2B,10
GO:0031668,GO:0031668,cellular response to extracellular stimulus,7/317,217/12743,0.295997221991009,0.60749516207883,0.542169754488331,HSP90B1/FOS/HSPA5/WIPI2/MAP1LC3B/CDKN1A/JUN,7
GO:0072507,GO:0072507,divalent inorganic cation homeostasis,9/317,290/12743,0.296609175276526,0.60749516207883,0.542169754488331,HSP90B1/S100A14/CALR/CD24/TMBIM6/GTF2I/GRIK2/CACNA2D1/CALCB,9
GO:0002052,GO:0002052,positive regulation of neuroblast proliferation,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,VEGFA,1
GO:0006123,GO:0006123,mitochondrial electron transport, cytochrome c to oxygen,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,COX4I1,1
GO:0006595,GO:0006595,polyamine metabolic process,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,ODC1,1
GO:0007350,GO:0007350,blastoderm segmentation,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,BASP1,1
GO:0010523,GO:0010523,negative regulation of calcium ion transport into cytosol,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,TMBIM6,1
GO:0016338,GO:0016338,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,CLDN18,1
GO:0019081,GO:0019081,viral translation,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,EIF3L,1
GO:0019228,GO:0019228,neuronal action potential,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,GRIK2,1
GO:0019430,GO:0019430,removal of superoxide radicals,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,PARK7,1
GO:0019646,GO:0019646,aerobic electron transport chain,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,COX4I1,1
GO:0021513,GO:0021513,spinal cord dorsal/ventral patterning,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,ASCL1,1
GO:0032682,GO:0032682,negative regulation of chemokine production,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,APOD,1
GO:0034315,GO:0034315,regulation of Arp2/3 complex-mediated actin nucleation,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,BRK1,1
GO:0035025,GO:0035025,positive regulation of Rho protein signal transduction,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,RAC1,1
GO:0036303,GO:0036303,lymph vessel morphogenesis,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,VEGFA,1
GO:0038083,GO:0038083,peptidyl-tyrosine autophosphorylation,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,VEGFA,1
GO:0042754,GO:0042754,negative regulation of circadian rhythm,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,SFPQ,1
GO:0043101,GO:0043101,purine-containing compound salvage,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,APRT,1
GO:0043518,GO:0043518,negative regulation of DNA damage response, signal transduction by p53 class mediator,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,MIF,1
GO:0043558,GO:0043558,regulation of translational initiation in response to stress,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,PPP1R15A,1
GO:0044827,GO:0044827,modulation by host of viral genome replication,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,PPIB,1
GO:0045932,GO:0045932,negative regulation of muscle contraction,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,RGS2,1
GO:0046174,GO:0046174,polyol catabolic process,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,NUDT3,1
GO:0046514,GO:0046514,ceramide catabolic process,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,PSAP,1
GO:0048026,GO:0048026,positive regulation of mRNA splicing, via spliceosome,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,SNRNP70,1
GO:0048841,GO:0048841,regulation of axon extension involved in axon guidance,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,VEGFA,1
GO:0050832,GO:0050832,defense response to fungus,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,CHGA,1
GO:0050911,GO:0050911,detection of chemical stimulus involved in sensory perception of smell,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,OR51E1,1
GO:0051503,GO:0051503,adenine nucleotide transport,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,SLC25A6,1
GO:0051895,GO:0051895,negative regulation of focal adhesion assembly,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,APOD,1
GO:0060009,GO:0060009,Sertoli cell development,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,RAB13,1
GO:0060117,GO:0060117,auditory receptor cell development,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,SLITRK6,1
GO:0060231,GO:0060231,mesenchymal to epithelial transition,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,BASP1,1
GO:0060479,GO:0060479,lung cell differentiation,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,ASCL1,1
GO:0070977,GO:0070977,bone maturation,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,RHOA,1
GO:0071474,GO:0071474,cellular hyperosmotic response,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,AKR1B1,1
GO:0071625,GO:0071625,vocalization behavior,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,CNTNAP2,1
GO:0072111,GO:0072111,cell proliferation involved in kidney development,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,EGR1,1
GO:0080182,GO:0080182,histone H3-K4 trimethylation,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,HIST1H1C,1
GO:0090036,GO:0090036,regulation of protein kinase C signaling,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,VEGFA,1
GO:0090231,GO:0090231,regulation of spindle checkpoint,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,DUSP1,1
GO:0090266,GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,DUSP1,1
GO:0097091,GO:0097091,synaptic vesicle clustering,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,PCLO,1
GO:0098840,GO:0098840,protein transport along microtubule,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,SFPQ,1
GO:0099118,GO:0099118,microtubule-based protein transport,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,SFPQ,1
GO:0099558,GO:0099558,maintenance of synapse structure,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,PCLO,1
GO:0099590,GO:0099590,neurotransmitter receptor internalization,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,ARC,1
GO:1900746,GO:1900746,regulation of vascular endothelial growth factor signaling pathway,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,CD63,1
GO:1903504,GO:1903504,regulation of mitotic spindle checkpoint,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,DUSP1,1
GO:1904923,GO:1904923,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,TOMM7,1
GO:1905564,GO:1905564,positive regulation of vascular endothelial cell proliferation,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,MDK,1
GO:2000726,GO:2000726,negative regulation of cardiac muscle cell differentiation,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,RGS2,1
GO:2001224,GO:2001224,positive regulation of neuron migration,1/317,14/12743,0.297322333264217,0.60749516207883,0.542169754488331,MDK,1
GO:0070838,GO:0070838,divalent metal ion transport,10/317,327/12743,0.297329774666447,0.60749516207883,0.542169754488331,S100A1/RHOA/RAMP1/TSPAN13/TMBIM6/TSPO/GEM/CACNA2D1/CAMK2B/NPPA,10
GO:0010952,GO:0010952,positive regulation of peptidase activity,5/317,146/12743,0.298333713817439,0.60749516207883,0.542169754488331,RHOA/GRN/PDCD6/RPS3/FAM162A,5
GO:0043488,GO:0043488,regulation of mRNA stability,5/317,146/12743,0.298333713817439,0.60749516207883,0.542169754488331,YBX1/HSPA1A/PSMB8/PSMA6/PABPC4,5
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,5/317,146/12743,0.298333713817439,0.60749516207883,0.542169754488331,MDK/GRN/PDCD6/JUN/VEGFA,5
GO:0008277,GO:0008277,regulation of G protein-coupled receptor signaling pathway,4/317,111/12743,0.298516272261055,0.60749516207883,0.542169754488331,GRP/CHGA/RAMP1/RGS2,4
GO:0001954,GO:0001954,positive regulation of cell-matrix adhesion,2/317,44/12743,0.299444738692426,0.60749516207883,0.542169754488331,RAC1/VEGFA,2
GO:0006801,GO:0006801,superoxide metabolic process,2/317,44/12743,0.299444738692426,0.60749516207883,0.542169754488331,PARK7/PON3,2
GO:0009988,GO:0009988,cell-cell recognition,2/317,44/12743,0.299444738692426,0.60749516207883,0.542169754488331,CD9/ALDOA,2
GO:0019320,GO:0019320,hexose catabolic process,2/317,44/12743,0.299444738692426,0.60749516207883,0.542169754488331,PGAM2/ALDOA,2
GO:0030071,GO:0030071,regulation of mitotic metaphase/anaphase transition,2/317,44/12743,0.299444738692426,0.60749516207883,0.542169754488331,DUSP1/MAD1L1,2
GO:0031055,GO:0031055,chromatin remodeling at centromere,2/317,44/12743,0.299444738692426,0.60749516207883,0.542169754488331,CENPV/HIST1H4C,2
GO:0033013,GO:0033013,tetrapyrrole metabolic process,2/317,44/12743,0.299444738692426,0.60749516207883,0.542169754488331,TSPO/TMEM14C,2
GO:0045839,GO:0045839,negative regulation of mitotic nuclear division,2/317,44/12743,0.299444738692426,0.60749516207883,0.542169754488331,DUSP1/MAD1L1,2
GO:0086003,GO:0086003,cardiac muscle cell contraction,2/317,44/12743,0.299444738692426,0.60749516207883,0.542169754488331,DSP/CACNA2D1,2
GO:1990089,GO:1990089,response to nerve growth factor,2/317,44/12743,0.299444738692426,0.60749516207883,0.542169754488331,EEF2/HSPA5,2
GO:0001503,GO:0001503,ossification,9/317,291/12743,0.300015338458024,0.60749516207883,0.542169754488331,MDK/BMP8B/RPL38/RHOA/IGFBP5/ATP6AP1/HGF/ATRAID/JUNB,9
GO:0035296,GO:0035296,regulation of tube diameter,3/317,77/12743,0.300065243861919,0.60749516207883,0.542169754488331,CHGA/RHOA/RGS2,3
GO:0042158,GO:0042158,lipoprotein biosynthetic process,3/317,77/12743,0.300065243861919,0.60749516207883,0.542169754488331,SELENOK/SVIP/WIPI2,3
GO:0046717,GO:0046717,acid secretion,3/317,77/12743,0.300065243861919,0.60749516207883,0.542169754488331,MIF/SGK1/SYT1,3
GO:0097746,GO:0097746,regulation of blood vessel diameter,3/317,77/12743,0.300065243861919,0.60749516207883,0.542169754488331,CHGA/RHOA/RGS2,3
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,6/317,182/12743,0.300114438901809,0.60749516207883,0.542169754488331,PDIA3/HSPA1A/PARK7/HSPA1B/GABARAP/HGF,6
GO:0008154,GO:0008154,actin polymerization or depolymerization,5/317,147/12743,0.303195115054724,0.611775046879938,0.54598941304152,RHOA/RAC1/BRK1/PFN2/ELN,5
GO:0030278,GO:0030278,regulation of ossification,5/317,147/12743,0.303195115054724,0.611775046879938,0.54598941304152,MDK/IGFBP5/ATP6AP1/HGF/ATRAID,5
GO:0048738,GO:0048738,cardiac muscle tissue development,5/317,147/12743,0.303195115054724,0.611775046879938,0.54598941304152,CALR/RGS2/DSP/NPPA/VEGFA,5
GO:0048871,GO:0048871,multicellular organismal homeostasis,11/317,366/12743,0.303493545743143,0.611775046879938,0.54598941304152,B2M/FABP5/CLDN18/GADD45G/RAC1/MFAP2/EGR1/ATP6AP1/AKR1B1/AZGP1/VEGFA,11
GO:0072511,GO:0072511,divalent inorganic cation transport,10/317,329/12743,0.30375510752629,0.611775046879938,0.54598941304152,S100A1/RHOA/RAMP1/TSPAN13/TMBIM6/TSPO/GEM/CACNA2D1/CAMK2B/NPPA,10
GO:0055001,GO:0055001,muscle cell development,4/317,112/12743,0.30413029593504,0.611775046879938,0.54598941304152,UCHL1/RGS2/NPPA/VEGFA,4
GO:1901568,GO:1901568,fatty acid derivative metabolic process,4/317,112/12743,0.30413029593504,0.611775046879938,0.54598941304152,FABP5/MIF/PON3/PON2,4
GO:0035690,GO:0035690,cellular response to drug,9/317,293/12743,0.306856316359745,0.611775046879938,0.54598941304152,HSP90B1/PSAP/PARK7/EGR1/RHOB/HGF/HSPA5/RPS3/MT2A,9
GO:0031145,GO:0031145,anaphase-promoting complex-dependent catabolic process,3/317,78/12743,0.30689433025668,0.611775046879938,0.54598941304152,PSMB8/PSMA6/UBE2S,3
GO:0009127,GO:0009127,purine nucleoside monophosphate biosynthetic process,5/317,148/12743,0.30806871548811,0.611775046879938,0.54598941304152,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA,5
GO:0009168,GO:0009168,purine ribonucleoside monophosphate biosynthetic process,5/317,148/12743,0.30806871548811,0.611775046879938,0.54598941304152,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA,5
GO:0043902,GO:0043902,positive regulation of multi-organism process,5/317,148/12743,0.30806871548811,0.611775046879938,0.54598941304152,PPIB/MIF/GRN/PPIA/JUN,5
GO:0044057,GO:0044057,regulation of system process,12/317,405/12743,0.308629872317892,0.611775046879938,0.54598941304152,S100A1/FABP5/CHGA/RHOA/IGFBP5/RGS2/SGK1/HGF/DSP/CACNA2D1/CAMK2B/NPPA,12
GO:0007405,GO:0007405,neuroblast proliferation,2/317,45/12743,0.308679050695075,0.611775046879938,0.54598941304152,ASCL1/VEGFA,2
GO:0009435,GO:0009435,NAD biosynthetic process,2/317,45/12743,0.308679050695075,0.611775046879938,0.54598941304152,PGAM2/ALDOA,2
GO:0046148,GO:0046148,pigment biosynthetic process,2/317,45/12743,0.308679050695075,0.611775046879938,0.54598941304152,TSPO/TMEM14C,2
GO:0051290,GO:0051290,protein heterotetramerization,2/317,45/12743,0.308679050695075,0.611775046879938,0.54598941304152,HIST1H4C/KRT10,2
GO:0060760,GO:0060760,positive regulation of response to cytokine stimulus,2/317,45/12743,0.308679050695075,0.611775046879938,0.54598941304152,HSPA1A/HSPA1B,2
GO:0061912,GO:0061912,selective autophagy,2/317,45/12743,0.308679050695075,0.611775046879938,0.54598941304152,TOMM7/WIPI2,2
GO:1902041,GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/317,45/12743,0.308679050695075,0.611775046879938,0.54598941304152,PARK7/HGF,2
GO:1902099,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,2/317,45/12743,0.308679050695075,0.611775046879938,0.54598941304152,DUSP1/MAD1L1,2
GO:0045807,GO:0045807,positive regulation of endocytosis,4/317,113/12743,0.309755887903692,0.611775046879938,0.54598941304152,B2M/CALR/CD63/VEGFA,4
GO:0072073,GO:0072073,kidney epithelium development,4/317,113/12743,0.309755887903692,0.611775046879938,0.54598941304152,CD24/EPCAM/BASP1/VEGFA,4
GO:1903364,GO:1903364,positive regulation of cellular protein catabolic process,4/317,113/12743,0.309755887903692,0.611775046879938,0.54598941304152,HSPA1A/RBX1/NOP53/ZFAND2A,4
GO:0071417,GO:0071417,cellular response to organonitrogen compound,13/317,444/12743,0.312958609317413,0.611775046879938,0.54598941304152,HSP90B1/RAB13/GNG2/IGFBP5/EGR1/ATP6AP1/APRT/AKR1B1/HSPA5/MAP1B/ATP6V0E2/CACNA2D1/YWHAG,13
GO:0071559,GO:0071559,response to transforming growth factor beta,6/317,185/12743,0.313184218906688,0.611775046879938,0.54598941304152,RHOA/HSPA1A/PEG10/FOS/HSPA5/JUN,6
GO:0006874,GO:0006874,cellular calcium ion homeostasis,8/317,258/12743,0.313307020780696,0.611775046879938,0.54598941304152,HSP90B1/CALR/CD24/TMBIM6/GTF2I/GRIK2/CACNA2D1/CALCB,8
GO:0001657,GO:0001657,ureteric bud development,3/317,79/12743,0.313729362143991,0.611775046879938,0.54598941304152,EPCAM/BASP1/VEGFA,3
GO:0002043,GO:0002043,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,VEGFA,1
GO:0002360,GO:0002360,T cell lineage commitment,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,RHOA,1
GO:0002407,GO:0002407,dendritic cell chemotaxis,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,CALR,1
GO:0002675,GO:0002675,positive regulation of acute inflammatory response,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,PARK7,1
GO:0002726,GO:0002726,positive regulation of T cell cytokine production,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,B2M,1
GO:0006450,GO:0006450,regulation of translational fidelity,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,RPS5,1
GO:0006750,GO:0006750,glutathione biosynthetic process,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,GGCT,1
GO:0008299,GO:0008299,isoprenoid biosynthetic process,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,RBP1,1
GO:0009190,GO:0009190,cyclic nucleotide biosynthetic process,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,NPPA,1
GO:0010544,GO:0010544,negative regulation of platelet activation,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,CD9,1
GO:0015868,GO:0015868,purine ribonucleotide transport,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,SLC25A6,1
GO:0019400,GO:0019400,alditol metabolic process,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,AKR1B1,1
GO:0019433,GO:0019433,triglyceride catabolic process,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,FABP5,1
GO:0023019,GO:0023019,signal transduction involved in regulation of gene expression,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,EPCAM,1
GO:0032516,GO:0032516,positive regulation of phosphoprotein phosphatase activity,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,PPP1R15A,1
GO:0034312,GO:0034312,diol biosynthetic process,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,PCBD1,1
GO:0035729,GO:0035729,cellular response to hepatocyte growth factor stimulus,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,HGF,1
GO:0042572,GO:0042572,retinol metabolic process,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,AKR1B1,1
GO:0043090,GO:0043090,amino acid import,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,RGS2,1
GO:0043174,GO:0043174,nucleoside salvage,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,APRT,1
GO:0043951,GO:0043951,negative regulation of cAMP-mediated signaling,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,RGS2,1
GO:0045653,GO:0045653,negative regulation of megakaryocyte differentiation,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,HIST1H4C,1
GO:0048143,GO:0048143,astrocyte activation,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,GRN,1
GO:0048532,GO:0048532,anatomical structure arrangement,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,HSPA5,1
GO:0050857,GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,RPS3,1
GO:0050912,GO:0050912,detection of chemical stimulus involved in sensory perception of taste,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,AZGP1,1
GO:0050927,GO:0050927,positive regulation of positive chemotaxis,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,VEGFA,1
GO:0051131,GO:0051131,chaperone-mediated protein complex assembly,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,HSPA1A,1
GO:0051580,GO:0051580,regulation of neurotransmitter uptake,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,RGS2,1
GO:0052652,GO:0052652,cyclic purine nucleotide metabolic process,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,NPPA,1
GO:0055093,GO:0055093,response to hyperoxia,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,CDKN1A,1
GO:0060307,GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,CACNA2D1,1
GO:0061050,GO:0061050,regulation of cell growth involved in cardiac muscle cell development,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,RGS2,1
GO:0071379,GO:0071379,cellular response to prostaglandin stimulus,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,GNG2,1
GO:0072012,GO:0072012,glomerulus vasculature development,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,EGR1,1
GO:0072074,GO:0072074,kidney mesenchyme development,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,BASP1,1
GO:0089718,GO:0089718,amino acid import across plasma membrane,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,RGS2,1
GO:0090051,GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,RHOA,1
GO:0098810,GO:0098810,neurotransmitter reuptake,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,PARK7,1
GO:1902074,GO:1902074,response to salt,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,HSPA5,1
GO:1902176,GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,PARK7,1
GO:1902547,GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,CD63,1
GO:1903392,GO:1903392,negative regulation of adherens junction organization,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,APOD,1
GO:2000047,GO:2000047,regulation of cell-cell adhesion mediated by cadherin,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,EPCAM,1
GO:2000696,GO:2000696,regulation of epithelial cell differentiation involved in kidney development,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,CD24,1
GO:2001026,GO:2001026,regulation of endothelial cell chemotaxis,1/317,15/12743,0.314821651384669,0.611775046879938,0.54598941304152,VEGFA,1
GO:0046165,GO:0046165,alcohol biosynthetic process,4/317,114/12743,0.315391687975239,0.612220906193837,0.546387328037132,CNBP/PARK7/AKR1B1/PCBD1,4
GO:2001056,GO:2001056,positive regulation of cysteine-type endopeptidase activity,4/317,114/12743,0.315391687975239,0.612220906193837,0.546387328037132,RHOA/PDCD6/RPS3/FAM162A,4
GO:0007409,GO:0007409,axonogenesis,10/317,333/12743,0.316707908545774,0.614444107513253,0.548371463201931,TUBB2B/UCHL1/RHOA/RPL24/TUBB3/S100A6/MAP1B/ALCAM/MACF1/VEGFA,10
GO:0009913,GO:0009913,epidermal cell differentiation,6/317,186/12743,0.317561977832439,0.614744905344625,0.548639915523144,MYCL/PSAP/DSP/KRT12/KRT10/SLITRK6,6
GO:0002042,GO:0002042,cell migration involved in sprouting angiogenesis,2/317,46/12743,0.317888951053034,0.614744905344625,0.548639915523144,RHOA/VEGFA,2
GO:0007062,GO:0007062,sister chromatid cohesion,2/317,46/12743,0.317888951053034,0.614744905344625,0.548639915523144,BOD1/SFPQ,2
GO:0030593,GO:0030593,neutrophil chemotaxis,2/317,46/12743,0.317888951053034,0.614744905344625,0.548639915523144,MDK/RAC1,2
GO:0051784,GO:0051784,negative regulation of nuclear division,2/317,46/12743,0.317888951053034,0.614744905344625,0.548639915523144,DUSP1/MAD1L1,2
GO:0060113,GO:0060113,inner ear receptor cell differentiation,2/317,46/12743,0.317888951053034,0.614744905344625,0.548639915523144,MYCL/SLITRK6,2
GO:1901990,GO:1901990,regulation of mitotic cell cycle phase transition,11/317,371/12743,0.318851657530939,0.616275112270821,0.550005575639108,TUBA1A/SOX4/DUSP1/MAD1L1/PSMB8/RBX1/NOP53/PSMA6/CDKN1A/YWHAG/TUBB4B,11
GO:0034765,GO:0034765,regulation of ion transmembrane transport,10/317,334/12743,0.319965874237517,0.617243666831216,0.550869979211346,S100A1/CD63/TSPAN13/PARK7/YWHAH/GEM/RGS2/CACNA2D1/CNKSR3/NPPA,10
GO:0048013,GO:0048013,ephrin receptor signaling pathway,3/317,80/12743,0.320568052921873,0.617243666831216,0.550869979211346,RHOA/CDC42/RAC1,3
GO:0072163,GO:0072163,mesonephric epithelium development,3/317,80/12743,0.320568052921873,0.617243666831216,0.550869979211346,EPCAM/BASP1/VEGFA,3
GO:0072164,GO:0072164,mesonephric tubule development,3/317,80/12743,0.320568052921873,0.617243666831216,0.550869979211346,EPCAM/BASP1/VEGFA,3
GO:1904029,GO:1904029,regulation of cyclin-dependent protein kinase activity,3/317,80/12743,0.320568052921873,0.617243666831216,0.550869979211346,DIRAS3/CDKN1A/SERTAD1,3
GO:0030010,GO:0030010,establishment of cell polarity,4/317,115/12743,0.321036352913904,0.617243666831216,0.550869979211346,FSCN1/RHOA/CDC42/MAP1B,4
GO:0051897,GO:0051897,positive regulation of protein kinase B signaling,4/317,115/12743,0.321036352913904,0.617243666831216,0.550869979211346,PARK7/RAC1/IGFBP5/HGF,4
GO:0106106,GO:0106106,cold-induced thermogenesis,4/317,115/12743,0.321036352913904,0.617243666831216,0.550869979211346,FABP5/GADD45G/MFAP2/VEGFA,4
GO:0120161,GO:0120161,regulation of cold-induced thermogenesis,4/317,115/12743,0.321036352913904,0.617243666831216,0.550869979211346,FABP5/GADD45G/MFAP2/VEGFA,4
GO:0030705,GO:0030705,cytoskeleton-dependent intracellular transport,5/317,151/12743,0.322753718326858,0.617243666831216,0.550869979211346,UCHL1/TUBA1A/CDC42/MAP1B/SFPQ,5
GO:0043487,GO:0043487,regulation of RNA stability,5/317,151/12743,0.322753718326858,0.617243666831216,0.550869979211346,YBX1/HSPA1A/PSMB8/PSMA6/PABPC4,5
GO:0016236,GO:0016236,macroautophagy,8/317,261/12743,0.324409838647341,0.617243666831216,0.550869979211346,UCHL1/VAMP8/GABARAP/GABARAPL2/TOMM7/WIPI2/MAP1LC3B/ATP6V0E2,8
GO:0001818,GO:0001818,negative regulation of cytokine production,6/317,188/12743,0.326345397634086,0.617243666831216,0.550869979211346,APOD/CD24/RAC1/TSPO/HGF/CHID1,6
GO:0006959,GO:0006959,humoral immune response,4/317,116/12743,0.3266885569183,0.617243666831216,0.550869979211346,CHGA/RPL39/RPS19/ROMO1,4
GO:0007091,GO:0007091,metaphase/anaphase transition of mitotic cell cycle,2/317,47/12743,0.327069949830844,0.617243666831216,0.550869979211346,DUSP1/MAD1L1,2
GO:0010965,GO:0010965,regulation of mitotic sister chromatid separation,2/317,47/12743,0.327069949830844,0.617243666831216,0.550869979211346,DUSP1/MAD1L1,2
GO:0030858,GO:0030858,positive regulation of epithelial cell differentiation,2/317,47/12743,0.327069949830844,0.617243666831216,0.550869979211346,CD24/BTG1,2
GO:0035249,GO:0035249,synaptic transmission, glutamatergic,2/317,47/12743,0.327069949830844,0.617243666831216,0.550869979211346,GRIK2/SYT1,2
GO:0050805,GO:0050805,negative regulation of synaptic transmission,2/317,47/12743,0.327069949830844,0.617243666831216,0.550869979211346,GRIK2/ARC,2
GO:0051705,GO:0051705,multi-organism behavior,2/317,47/12743,0.327069949830844,0.617243666831216,0.550869979211346,GRP/CNTNAP2,2
GO:1903036,GO:1903036,positive regulation of response to wounding,2/317,47/12743,0.327069949830844,0.617243666831216,0.550869979211346,MDK/GRN,2
GO:0001823,GO:0001823,mesonephros development,3/317,81/12743,0.3274081699935,0.617243666831216,0.550869979211346,EPCAM/BASP1/VEGFA,3
GO:0006626,GO:0006626,protein targeting to mitochondrion,3/317,81/12743,0.3274081699935,0.617243666831216,0.550869979211346,TOMM7/SLC25A6/TSPO,3
GO:0032526,GO:0032526,response to retinoic acid,3/317,81/12743,0.3274081699935,0.617243666831216,0.550869979211346,DUSP1/IGFBP2/ASCL1,3
GO:0050905,GO:0050905,neuromuscular process,3/317,81/12743,0.3274081699935,0.617243666831216,0.550869979211346,UCHL1/PSAP/SLITRK6,3
GO:0051783,GO:0051783,regulation of nuclear division,5/317,152/12743,0.327667154167787,0.617243666831216,0.550869979211346,HSPA1A/CALR/HSPA1B/DUSP1/MAD1L1,5
GO:0099003,GO:0099003,vesicle-mediated transport in synapse,5/317,152/12743,0.327667154167787,0.617243666831216,0.550869979211346,SNCB/PFN2/SYT1/PCLO/ARC,5
GO:0010876,GO:0010876,lipid localization,8/317,263/12743,0.331851697118259,0.617243666831216,0.550869979211346,APOD/MFSD2A/NPC2/PSAP/MIF/TSPO/NME4/HILPDA,8
GO:0051403,GO:0051403,stress-activated MAPK cascade,7/317,226/12743,0.331886166419763,0.617243666831216,0.550869979211346,GADD45G/DUSP1/HGF/GADD45B/RPS3/GRIK2/VEGFA,7
GO:0060828,GO:0060828,regulation of canonical Wnt signaling pathway,7/317,226/12743,0.331886166419763,0.617243666831216,0.550869979211346,MDK/SOX4/EGR1/PSMB8/RBX1/IGFBP2/PSMA6,7
GO:0003299,GO:0003299,muscle hypertrophy in response to stress,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,NPPA,1
GO:0006677,GO:0006677,glycosylceramide metabolic process,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,PSAP,1
GO:0009219,GO:0009219,pyrimidine deoxyribonucleotide metabolic process,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,NTHL1,1
GO:0010310,GO:0010310,regulation of hydrogen peroxide metabolic process,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,RAC1,1
GO:0010884,GO:0010884,positive regulation of lipid storage,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,HILPDA,1
GO:0014887,GO:0014887,cardiac muscle adaptation,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,NPPA,1
GO:0014898,GO:0014898,cardiac muscle hypertrophy in response to stress,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,NPPA,1
GO:0015865,GO:0015865,purine nucleotide transport,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,SLC25A6,1
GO:0021511,GO:0021511,spinal cord patterning,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,ASCL1,1
GO:0030033,GO:0030033,microvillus assembly,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,FSCN1,1
GO:0031065,GO:0031065,positive regulation of histone deacetylation,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,VEGFA,1
GO:0031069,GO:0031069,hair follicle morphogenesis,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,IGFBP5,1
GO:0033145,GO:0033145,positive regulation of intracellular steroid hormone receptor signaling pathway,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,PARK7,1
GO:0034104,GO:0034104,negative regulation of tissue remodeling,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,CLDN18,1
GO:0034695,GO:0034695,response to prostaglandin E,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,GNG2,1
GO:0035357,GO:0035357,peroxisome proliferator activated receptor signaling pathway,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,FABP5,1
GO:0035970,GO:0035970,peptidyl-threonine dephosphorylation,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,DUSP1,1
GO:0042311,GO:0042311,vasodilation,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,RGS2,1
GO:0043923,GO:0043923,positive regulation by host of viral transcription,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,JUN,1
GO:0045109,GO:0045109,intermediate filament organization,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,DSP,1
GO:0045907,GO:0045907,positive regulation of vasoconstriction,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,RHOA,1
GO:0046716,GO:0046716,muscle cell cellular homeostasis,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,ALDOA,1
GO:0048714,GO:0048714,positive regulation of oligodendrocyte differentiation,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,MDK,1
GO:0050482,GO:0050482,arachidonic acid secretion,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,MIF,1
GO:0050926,GO:0050926,regulation of positive chemotaxis,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,VEGFA,1
GO:0051000,GO:0051000,positive regulation of nitric-oxide synthase activity,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,S100A1,1
GO:0051444,GO:0051444,negative regulation of ubiquitin-protein transferase activity,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,PARK7,1
GO:0060669,GO:0060669,embryonic placenta morphogenesis,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,SPINT2,1
GO:0060965,GO:0060965,negative regulation of gene silencing by miRNA,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,NEAT1,1
GO:0070828,GO:0070828,heterochromatin organization,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,CENPV,1
GO:0071404,GO:0071404,cellular response to low-density lipoprotein particle stimulus,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,CD9,1
GO:0071450,GO:0071450,cellular response to oxygen radical,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,PARK7,1
GO:0071451,GO:0071451,cellular response to superoxide,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,PARK7,1
GO:0072574,GO:0072574,hepatocyte proliferation,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,MDK,1
GO:0072575,GO:0072575,epithelial cell proliferation involved in liver morphogenesis,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,MDK,1
GO:0086012,GO:0086012,membrane depolarization during cardiac muscle cell action potential,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,CACNA2D1,1
GO:1902166,GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,MIF,1
GO:1902307,GO:1902307,positive regulation of sodium ion transmembrane transport,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,CNKSR3,1
GO:1903963,GO:1903963,arachidonate transport,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,MIF,1
GO:1903978,GO:1903978,regulation of microglial cell activation,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,GRN,1
GO:1904380,GO:1904380,endoplasmic reticulum mannose trimming,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,OS9,1
GO:1904754,GO:1904754,positive regulation of vascular associated smooth muscle cell migration,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,IGFBP5,1
GO:2000641,GO:2000641,regulation of early endosome to late endosome transport,1/317,16/12743,0.331886511261402,0.617243666831216,0.550869979211346,SNX3,1
GO:0050806,GO:0050806,positive regulation of synaptic transmission,4/317,117/12743,0.332346992068693,0.617780473881567,0.551349062115809,MME/GRIK2/SYT1/ARC,4
GO:0071478,GO:0071478,cellular response to radiation,5/317,153/12743,0.332588341953677,0.617909606885514,0.551464309139023,MME/EGR1/RHOB/HSPA5/CDKN1A,5
GO:0002705,GO:0002705,positive regulation of leukocyte mediated immunity,3/317,82/12743,0.334247534876402,0.620030901899208,0.55335749622686,B2M/VAMP8/NPPA,3
GO:0044773,GO:0044773,mitotic DNA damage checkpoint,3/317,82/12743,0.334247534876402,0.620030901899208,0.55335749622686,SOX4/NOP53/CDKN1A,3
GO:0061387,GO:0061387,regulation of extent of cell growth,3/317,82/12743,0.334247534876402,0.620030901899208,0.55335749622686,MAP1B/MACF1/VEGFA,3
GO:0000075,GO:0000075,cell cycle checkpoint,6/317,190/12743,0.335161784671938,0.620582941629076,0.553850173804384,RPL24/SOX4/DUSP1/MAD1L1/NOP53/CDKN1A,6
GO:0001523,GO:0001523,retinoid metabolic process,2/317,48/12743,0.336217794163533,0.620582941629076,0.553850173804384,RBP1/AKR1B1,2
GO:0006879,GO:0006879,cellular iron ion homeostasis,2/317,48/12743,0.336217794163533,0.620582941629076,0.553850173804384,ATP6AP1/FTH1,2
GO:0014743,GO:0014743,regulation of muscle hypertrophy,2/317,48/12743,0.336217794163533,0.620582941629076,0.553850173804384,IGFBP5/RGS2,2
GO:0042490,GO:0042490,mechanoreceptor differentiation,2/317,48/12743,0.336217794163533,0.620582941629076,0.553850173804384,MYCL/SLITRK6,2
GO:0044784,GO:0044784,metaphase/anaphase transition of cell cycle,2/317,48/12743,0.336217794163533,0.620582941629076,0.553850173804384,DUSP1/MAD1L1,2
GO:0098739,GO:0098739,import across plasma membrane,2/317,48/12743,0.336217794163533,0.620582941629076,0.553850173804384,RGS2/CACNA2D1,2
GO:0070555,GO:0070555,response to interleukin-1,5/317,154/12743,0.337516413436946,0.620582941629076,0.553850173804384,EGR1/PSMB8/RBX1/PSMA6/CD47,5
GO:0048813,GO:0048813,dendrite morphogenesis,4/317,118/12743,0.338010368743944,0.620582941629076,0.553850173804384,YWHAH/CDC42/ARC/CAMK2B,4
GO:0051668,GO:0051668,localization within membrane,4/317,118/12743,0.338010368743944,0.620582941629076,0.553850173804384,CD24/RAC1/GRIK2/ARC,4
GO:0060047,GO:0060047,heart contraction,6/317,191/12743,0.339580764936692,0.620582941629076,0.553850173804384,S100A1/CHGA/RGS2/DSP/CACNA2D1/NPPA,6
GO:0007613,GO:0007613,memory,3/317,83/12743,0.341084023239439,0.620582941629076,0.553850173804384,MDK/SGK1/ARC,3
GO:0021761,GO:0021761,limbic system development,3/317,83/12743,0.341084023239439,0.620582941629076,0.553850173804384,MDK/MFSD2A/CNTNAP2,3
GO:0032675,GO:0032675,regulation of interleukin-6 production,3/317,83/12743,0.341084023239439,0.620582941629076,0.553850173804384,SELENOK/HGF/CD47,3
GO:0072527,GO:0072527,pyrimidine-containing compound metabolic process,3/317,83/12743,0.341084023239439,0.620582941629076,0.553850173804384,NTHL1/NME4/CTPS1,3
GO:0001890,GO:0001890,placenta development,4/317,119/12743,0.343677416008916,0.620582941629076,0.553850173804384,SPINT2/BSG/MME/JUNB,4
GO:0031669,GO:0031669,cellular response to nutrient levels,6/317,192/12743,0.344006102991624,0.620582941629076,0.553850173804384,HSP90B1/HSPA5/WIPI2/MAP1LC3B/CDKN1A/JUN,6
GO:0043393,GO:0043393,regulation of protein binding,6/317,192/12743,0.344006102991624,0.620582941629076,0.553850173804384,B2M/LRPAP1/PARK7/TMBIM6/HSPA5/PCBD1,6
GO:0071383,GO:0071383,cellular response to steroid hormone stimulus,6/317,192/12743,0.344006102991624,0.620582941629076,0.553850173804384,RHOA/CALR/PARK7/YWHAH/SCGB2A1/DDX17,6
GO:0003170,GO:0003170,heart valve development,2/317,49/12743,0.345328459304368,0.620582941629076,0.553850173804384,SOX4/ELN,2
GO:0016233,GO:0016233,telomere capping,2/317,49/12743,0.345328459304368,0.620582941629076,0.553850173804384,TERF2IP/HIST1H4C,2
GO:0021872,GO:0021872,forebrain generation of neurons,2/317,49/12743,0.345328459304368,0.620582941629076,0.553850173804384,RHOA/ASCL1,2
GO:0034308,GO:0034308,primary alcohol metabolic process,2/317,49/12743,0.345328459304368,0.620582941629076,0.553850173804384,PARK7/AKR1B1,2
GO:0051306,GO:0051306,mitotic sister chromatid separation,2/317,49/12743,0.345328459304368,0.620582941629076,0.553850173804384,DUSP1/MAD1L1,2
GO:0051952,GO:0051952,regulation of amine transport,2/317,49/12743,0.345328459304368,0.620582941629076,0.553850173804384,CHGA/RGS2,2
GO:0060420,GO:0060420,regulation of heart growth,2/317,49/12743,0.345328459304368,0.620582941629076,0.553850173804384,BASP1/RGS2,2
GO:0072091,GO:0072091,regulation of stem cell proliferation,2/317,49/12743,0.345328459304368,0.620582941629076,0.553850173804384,EPCAM/VEGFA,2
GO:0086001,GO:0086001,cardiac muscle cell action potential,2/317,49/12743,0.345328459304368,0.620582941629076,0.553850173804384,DSP/CACNA2D1,2
GO:0097756,GO:0097756,negative regulation of blood vessel diameter,2/317,49/12743,0.345328459304368,0.620582941629076,0.553850173804384,CHGA/RHOA,2
GO:0019058,GO:0019058,viral life cycle,8/317,267/12743,0.346817610250601,0.620582941629076,0.553850173804384,HSPA1A/PPIB/VAMP8/HSPA1B/RPSA/CDC42/PPIA/SNX3,8
GO:0007507,GO:0007507,heart development,12/317,418/12743,0.347147900894458,0.620582941629076,0.553850173804384,CALR/SOX4/TCF25/BASP1/RGS2/DSP/ELN/CDKN1A/ASCL1/JUN/NPPA/VEGFA,12
GO:0016079,GO:0016079,synaptic vesicle exocytosis,3/317,84/12743,0.347915564871872,0.620582941629076,0.553850173804384,PFN2/SYT1/PCLO,3
GO:0042471,GO:0042471,ear morphogenesis,3/317,84/12743,0.347915564871872,0.620582941629076,0.553850173804384,RPL38/SLITRK6/TSHZ1,3
GO:0090287,GO:0090287,regulation of cellular response to growth factor stimulus,6/317,193/12743,0.348437178622785,0.620582941629076,0.553850173804384,HSPA1A/CD63/PEG10/PDCD6/HSPA5/VEGFA,6
GO:2001234,GO:2001234,negative regulation of apoptotic signaling pathway,6/317,193/12743,0.348437178622785,0.620582941629076,0.553850173804384,HSPA1A/MIF/PARK7/HSPA1B/TMBIM6/HGF,6
GO:0001963,GO:0001963,synaptic transmission, dopaminergic,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,PARK7,1
GO:0002320,GO:0002320,lymphoid progenitor cell differentiation,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,SOX4,1
GO:0003071,GO:0003071,renal system process involved in regulation of systemic arterial blood pressure,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,RHOA,1
GO:0003283,GO:0003283,atrial septum development,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,SOX4,1
GO:0006891,GO:0006891,intra-Golgi vesicle-mediated transport,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,GABARAPL2,1
GO:0006978,GO:0006978,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,CDKN1A,1
GO:0007095,GO:0007095,mitotic G2 DNA damage checkpoint,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,NOP53,1
GO:0008211,GO:0008211,glucocorticoid metabolic process,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,YWHAH,1
GO:0009074,GO:0009074,aromatic amino acid family catabolic process,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,PCBD1,1
GO:0009264,GO:0009264,deoxyribonucleotide catabolic process,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,NTHL1,1
GO:0010155,GO:0010155,regulation of proton transport,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,PARK7,1
GO:0010667,GO:0010667,negative regulation of cardiac muscle cell apoptotic process,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,MDK,1
GO:0014829,GO:0014829,vascular smooth muscle contraction,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,RHOA,1
GO:0019184,GO:0019184,nonribosomal peptide biosynthetic process,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,GGCT,1
GO:0019934,GO:0019934,cGMP-mediated signaling,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,NPPA,1
GO:0021895,GO:0021895,cerebral cortex neuron differentiation,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,ASCL1,1
GO:0032288,GO:0032288,myelin assembly,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,CD9,1
GO:0032928,GO:0032928,regulation of superoxide anion generation,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,PON3,1
GO:0035162,GO:0035162,embryonic hemopoiesis,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,VEGFA,1
GO:0035728,GO:0035728,response to hepatocyte growth factor,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,HGF,1
GO:0036336,GO:0036336,dendritic cell migration,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,CALR,1
GO:0039535,GO:0039535,regulation of RIG-I signaling pathway,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,NOP53,1
GO:0042053,GO:0042053,regulation of dopamine metabolic process,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,PARK7,1
GO:0042069,GO:0042069,regulation of catecholamine metabolic process,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,PARK7,1
GO:0048799,GO:0048799,animal organ maturation,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,RHOA,1
GO:0050913,GO:0050913,sensory perception of bitter taste,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,AZGP1,1
GO:0060445,GO:0060445,branching involved in salivary gland morphogenesis,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,HGF,1
GO:0060716,GO:0060716,labyrinthine layer blood vessel development,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,JUNB,1
GO:0061081,GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,MIF,1
GO:0061437,GO:0061437,renal system vasculature development,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,EGR1,1
GO:0061440,GO:0061440,kidney vasculature development,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,EGR1,1
GO:0070734,GO:0070734,histone H3-K27 methylation,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,HIST1H1C,1
GO:0072576,GO:0072576,liver morphogenesis,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,MDK,1
GO:0086011,GO:0086011,membrane repolarization during action potential,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,CACNA2D1,1
GO:0090050,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,VEGFA,1
GO:0090190,GO:0090190,positive regulation of branching involved in ureteric bud morphogenesis,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,VEGFA,1
GO:0090201,GO:0090201,negative regulation of release of cytochrome c from mitochondria,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,HGF,1
GO:0101023,GO:0101023,vascular endothelial cell proliferation,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,MDK,1
GO:1900120,GO:1900120,regulation of receptor binding,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,B2M,1
GO:1901524,GO:1901524,regulation of mitophagy,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,TOMM7,1
GO:1901984,GO:1901984,negative regulation of protein acetylation,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,PARK7,1
GO:1903204,GO:1903204,negative regulation of oxidative stress-induced neuron death,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,PARK7,1
GO:1905208,GO:1905208,negative regulation of cardiocyte differentiation,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,RGS2,1
GO:1905562,GO:1905562,regulation of vascular endothelial cell proliferation,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,MDK,1
GO:2000679,GO:2000679,positive regulation of transcription regulatory region DNA binding,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,PARK7,1
GO:2001267,GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,1/317,17/12743,0.348527665966371,0.620582941629076,0.553850173804384,PARK7,1
GO:1904951,GO:1904951,positive regulation of establishment of protein localization,10/317,344/12743,0.352908771645915,0.628072789142111,0.560534620102527,MDK/MIF/SOX4/TOMM7/YWHAH/RAC1/PPIA/SERP1/SELENOK/YWHAG,10
GO:0003208,GO:0003208,cardiac ventricle morphogenesis,2/317,50/12743,0.354398139969022,0.628094505495971,0.560554001244922,SOX4/DSP,2
GO:0032272,GO:0032272,negative regulation of protein polymerization,2/317,50/12743,0.354398139969022,0.628094505495971,0.560554001244922,TBCD/PFN2,2
GO:0032515,GO:0032515,negative regulation of phosphoprotein phosphatase activity,2/317,50/12743,0.354398139969022,0.628094505495971,0.560554001244922,BOD1/PPP1R15A,2
GO:0038034,GO:0038034,signal transduction in absence of ligand,2/317,50/12743,0.354398139969022,0.628094505495971,0.560554001244922,HSPA1A/HSPA1B,2
GO:0070830,GO:0070830,bicellular tight junction assembly,2/317,50/12743,0.354398139969022,0.628094505495971,0.560554001244922,RAB13/TBCD,2
GO:0072528,GO:0072528,pyrimidine-containing compound biosynthetic process,2/317,50/12743,0.354398139969022,0.628094505495971,0.560554001244922,NME4/CTPS1,2
GO:0097192,GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,2/317,50/12743,0.354398139969022,0.628094505495971,0.560554001244922,HSPA1A/HSPA1B,2
GO:1904427,GO:1904427,positive regulation of calcium ion transmembrane transport,2/317,50/12743,0.354398139969022,0.628094505495971,0.560554001244922,S100A1/CACNA2D1,2
GO:0031424,GO:0031424,keratinization,3/317,85/12743,0.354740143588644,0.628094505495971,0.560554001244922,DSP/KRT12/KRT10,3
GO:0072009,GO:0072009,nephron epithelium development,3/317,85/12743,0.354740143588644,0.628094505495971,0.560554001244922,CD24/BASP1/VEGFA,3
GO:1903034,GO:1903034,regulation of response to wounding,4/317,121/12743,0.355017534121784,0.628094505495971,0.560554001244922,MDK/CD9/GRN/CDKN1A,4
GO:2001257,GO:2001257,regulation of cation channel activity,4/317,121/12743,0.355017534121784,0.628094505495971,0.560554001244922,S100A1/GEM/CACNA2D1/NPPA,4
GO:0010639,GO:0010639,negative regulation of organelle organization,9/317,307/12743,0.355614872658733,0.628617638393388,0.561020880410818,HSPA1A/TERF2IP/TBCD/TSPO/PFN2/DUSP1/HGF/MAD1L1/MAP1B,9
GO:0060249,GO:0060249,anatomical structure homeostasis,10/317,345/12743,0.356233655567232,0.628617638393388,0.561020880410818,B2M/CLDN18/TERF2IP/RAC1/HIST1H4C/ATP6AP1/AKR1B1/ALDOA/AZGP1/VEGFA,10
GO:0043583,GO:0043583,ear development,5/317,158/12743,0.35728045002792,0.628617638393388,0.561020880410818,RPL38/MYCL/PSAP/SLITRK6/TSHZ1,5
GO:0008544,GO:0008544,epidermis development,8/317,270/12743,0.358102009549982,0.628617638393388,0.561020880410818,FABP5/MYCL/PSAP/IGFBP5/DSP/KRT12/KRT10/SLITRK6,8
GO:0000280,GO:0000280,nuclear division,9/317,308/12743,0.359142759808246,0.628617638393388,0.561020880410818,RHOA/HSPA1A/CALR/RPL24/BOD1/HSPA1B/DUSP1/MAD1L1/UBE2S,9
GO:0035265,GO:0035265,organ growth,4/317,122/12743,0.360688159618938,0.628617638393388,0.561020880410818,BASP1/SERP1/RGS2/NPPA,4
GO:1990845,GO:1990845,adaptive thermogenesis,4/317,122/12743,0.360688159618938,0.628617638393388,0.561020880410818,FABP5/GADD45G/MFAP2/VEGFA,4
GO:0002040,GO:0002040,sprouting angiogenesis,3/317,86/12743,0.36155579707583,0.628617638393388,0.561020880410818,S100A1/RHOA/VEGFA,3
GO:0044774,GO:0044774,mitotic DNA integrity checkpoint,3/317,86/12743,0.36155579707583,0.628617638393388,0.561020880410818,SOX4/NOP53/CDKN1A,3
GO:0007163,GO:0007163,establishment or maintenance of cell polarity,5/317,159/12743,0.362230198746086,0.628617638393388,0.561020880410818,FSCN1/SPINT2/RHOA/CDC42/MAP1B,5
GO:0042594,GO:0042594,response to starvation,5/317,159/12743,0.362230198746086,0.628617638393388,0.561020880410818,HSPA5/WIPI2/MAP1LC3B/CDKN1A/JUN,5
GO:0007600,GO:0007600,sensory perception,10/317,347/12743,0.362896734038611,0.628617638393388,0.561020880410818,FABP5/UCHL1/RPL38/PSAP/OR51E1/MME/KRT12/NCAM2/SLITRK6/AZGP1,10
GO:0044772,GO:0044772,mitotic cell cycle phase transition,14/317,500/12743,0.363349635030197,0.628617638393388,0.561020880410818,RPL24/TUBA1A/SOX4/KHDRBS1/DUSP1/MAD1L1/PSMB8/RBX1/NOP53/PSMA6/CDKN1A/YWHAG/UBE2S/TUBB4B,14
GO:0001895,GO:0001895,retina homeostasis,2/317,51/12743,0.363423241966997,0.628617638393388,0.561020880410818,B2M/AZGP1,2
GO:0015837,GO:0015837,amine transport,2/317,51/12743,0.363423241966997,0.628617638393388,0.561020880410818,CHGA/RGS2,2
GO:0015914,GO:0015914,phospholipid transport,2/317,51/12743,0.363423241966997,0.628617638393388,0.561020880410818,MFSD2A/NPC2,2
GO:0030279,GO:0030279,negative regulation of ossification,2/317,51/12743,0.363423241966997,0.628617638393388,0.561020880410818,MDK/IGFBP5,2
GO:0042440,GO:0042440,pigment metabolic process,2/317,51/12743,0.363423241966997,0.628617638393388,0.561020880410818,TSPO/TMEM14C,2
GO:0046365,GO:0046365,monosaccharide catabolic process,2/317,51/12743,0.363423241966997,0.628617638393388,0.561020880410818,PGAM2/ALDOA,2
GO:0051453,GO:0051453,regulation of intracellular pH,2/317,51/12743,0.363423241966997,0.628617638393388,0.561020880410818,GRN/ATP6V0E2,2
GO:0120192,GO:0120192,tight junction assembly,2/317,51/12743,0.363423241966997,0.628617638393388,0.561020880410818,RAB13/TBCD,2
GO:1905818,GO:1905818,regulation of chromosome separation,2/317,51/12743,0.363423241966997,0.628617638393388,0.561020880410818,DUSP1/MAD1L1,2
GO:0009152,GO:0009152,purine ribonucleotide biosynthetic process,7/317,234/12743,0.364299959180684,0.628617638393388,0.561020880410818,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA/NME4/NPPA,7
GO:0001914,GO:0001914,regulation of T cell mediated cytotoxicity,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,B2M,1
GO:0001945,GO:0001945,lymph vessel development,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,VEGFA,1
GO:0001964,GO:0001964,startle response,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,SLITRK6,1
GO:0002026,GO:0002026,regulation of the force of heart contraction,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,CHGA,1
GO:0006706,GO:0006706,steroid catabolic process,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,YWHAH,1
GO:0007026,GO:0007026,negative regulation of microtubule depolymerization,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,MAP1B,1
GO:0008045,GO:0008045,motor neuron axon guidance,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,ALCAM,1
GO:0010560,GO:0010560,positive regulation of glycoprotein biosynthetic process,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,RAMP1,1
GO:0014912,GO:0014912,negative regulation of smooth muscle cell migration,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,IGFBP5,1
GO:0030431,GO:0030431,sleep,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,FOS,1
GO:0032366,GO:0032366,intracellular sterol transport,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,NPC2,1
GO:0032367,GO:0032367,intracellular cholesterol transport,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,NPC2,1
GO:0034311,GO:0034311,diol metabolic process,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,PCBD1,1
GO:0035235,GO:0035235,ionotropic glutamate receptor signaling pathway,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,GRIK2,1
GO:0042772,GO:0042772,DNA damage response, signal transduction resulting in transcription,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,CDKN1A,1
GO:0043555,GO:0043555,regulation of translation in response to stress,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,PPP1R15A,1
GO:0048665,GO:0048665,neuron fate specification,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,ASCL1,1
GO:0051043,GO:0051043,regulation of membrane protein ectodomain proteolysis,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,TIMP1,1
GO:0051084,GO:0051084,'de novo' posttranslational protein folding,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,DNAJB1,1
GO:0051589,GO:0051589,negative regulation of neurotransmitter transport,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,RGS2,1
GO:0051900,GO:0051900,regulation of mitochondrial depolarization,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,TSPO,1
GO:0060008,GO:0060008,Sertoli cell differentiation,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,RAB13,1
GO:0070932,GO:0070932,histone H3 deacetylation,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,SFPQ,1
GO:0071677,GO:0071677,positive regulation of mononuclear cell migration,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,S100A14,1
GO:0099625,GO:0099625,ventricular cardiac muscle cell membrane repolarization,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,CACNA2D1,1
GO:0140115,GO:0140115,export across plasma membrane,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,NPPA,1
GO:1900273,GO:1900273,positive regulation of long-term synaptic potentiation,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,MME,1
GO:1902165,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,MIF,1
GO:1903055,GO:1903055,positive regulation of extracellular matrix organization,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,FSCN1,1
GO:2000144,GO:2000144,positive regulation of DNA-templated transcription, initiation,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,JUN,1
GO:2000778,GO:2000778,positive regulation of interleukin-6 secretion,1/317,18/12743,0.364755603251351,0.628617638393388,0.561020880410818,SELENOK,1
GO:0098813,GO:0098813,nuclear chromosome segregation,6/317,197/12743,0.366206599491543,0.630170070947013,0.562406376179341,BOD1/CDC42/GEM/DUSP1/MAD1L1/SFPQ,6
GO:0032874,GO:0032874,positive regulation of stress-activated MAPK cascade,4/317,123/12743,0.366357565585329,0.630170070947013,0.562406376179341,GADD45G/GADD45B/RPS3/VEGFA,4
GO:0048469,GO:0048469,cell maturation,4/317,123/12743,0.366357565585329,0.630170070947013,0.562406376179341,CNTNAP2/CDKN1A/ASCL1/VEGFA,4
GO:0050731,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,4/317,123/12743,0.366357565585329,0.630170070947013,0.562406376179341,CD24/MIF/HGF/VEGFA,4
GO:0022037,GO:0022037,metencephalon development,3/317,87/12743,0.368360616680021,0.633009759543343,0.564940706269851,MDK/HSPA5/ASCL1,3
GO:0060996,GO:0060996,dendritic spine development,3/317,87/12743,0.368360616680021,0.633009759543343,0.564940706269851,CDC42/ARC/CAMK2B,3
GO:0003015,GO:0003015,heart process,6/317,198/12743,0.370657209186218,0.635249394686726,0.566939508090225,S100A1/CHGA/RGS2/DSP/CACNA2D1/NPPA,6
GO:0034504,GO:0034504,protein localization to nucleus,6/317,198/12743,0.370657209186218,0.635249394686726,0.566939508090225,APOD/CALR/CLDN18/PARK7/NOP53/CDKN1A,6
GO:0006414,GO:0006414,translational elongation,4/317,124/12743,0.372024579349915,0.635249394686726,0.566939508090225,EEF2/MRPS24/MRPL33/RPLP1,4
GO:0050773,GO:0050773,regulation of dendrite development,4/317,124/12743,0.372024579349915,0.635249394686726,0.566939508090225,RHOA/YWHAH/ARC/CAMK2B,4
GO:0070304,GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,4/317,124/12743,0.372024579349915,0.635249394686726,0.566939508090225,GADD45G/GADD45B/RPS3/VEGFA,4
GO:0009156,GO:0009156,ribonucleoside monophosphate biosynthetic process,5/317,161/12743,0.372134430292057,0.635249394686726,0.566939508090225,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA,5
GO:0090276,GO:0090276,regulation of peptide hormone secretion,5/317,161/12743,0.372134430292057,0.635249394686726,0.566939508090225,GRP/SOX4/SLC25A6/RAC1/SERP1,5
GO:0010803,GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,2/317,52/12743,0.37240037411146,0.635249394686726,0.566939508090225,HSPA1A/HSPA1B,2
GO:0014910,GO:0014910,regulation of smooth muscle cell migration,2/317,52/12743,0.37240037411146,0.635249394686726,0.566939508090225,MDK/IGFBP5,2
GO:0034508,GO:0034508,centromere complex assembly,2/317,52/12743,0.37240037411146,0.635249394686726,0.566939508090225,CENPV/HIST1H4C,2
GO:0006869,GO:0006869,lipid transport,7/317,236/12743,0.372448642738532,0.635249394686726,0.566939508090225,APOD/MFSD2A/NPC2/PSAP/MIF/TSPO/NME4,7
GO:0072503,GO:0072503,cellular divalent inorganic cation homeostasis,8/317,274/12743,0.373208535255053,0.635249394686726,0.566939508090225,HSP90B1/CALR/CD24/TMBIM6/GTF2I/GRIK2/CACNA2D1/CALCB,8
GO:0006909,GO:0006909,phagocytosis,6/317,199/12743,0.375109927290337,0.635249394686726,0.566939508090225,CALR/CDC42/RAC1/BRK1/SNX3/CD47,6
GO:0022612,GO:0022612,gland morphogenesis,3/317,88/12743,0.375152747145253,0.635249394686726,0.566939508090225,MDK/IGFBP5/HGF,3
GO:0034763,GO:0034763,negative regulation of transmembrane transport,3/317,88/12743,0.375152747145253,0.635249394686726,0.566939508090225,FABP5/GEM/RGS2,3
GO:0051928,GO:0051928,positive regulation of calcium ion transport,3/317,88/12743,0.375152747145253,0.635249394686726,0.566939508090225,S100A1/TSPO/CACNA2D1,3
GO:0090101,GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,3/317,88/12743,0.375152747145253,0.635249394686726,0.566939508090225,HSPA1A/PEG10/HSPA5,3
GO:0006754,GO:0006754,ATP biosynthetic process,4/317,125/12743,0.377688048676954,0.635249394686726,0.566939508090225,ATP5F1E/ATP5ME/PGAM2/ALDOA,4
GO:0050866,GO:0050866,negative regulation of cell activation,4/317,125/12743,0.377688048676954,0.635249394686726,0.566939508090225,MDK/CD9/GRN/MAD1L1,4
GO:0007423,GO:0007423,sensory organ development,11/317,390/12743,0.378582764391166,0.635249394686726,0.566939508090225,RPL38/RPL24/MYCL/PSAP/MFAP2/MEIS2/SLITRK6/ASCL1/TSHZ1/JUN/VEGFA,11
GO:0000303,GO:0000303,response to superoxide,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,PARK7,1
GO:0001783,GO:0001783,B cell apoptotic process,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,MIF,1
GO:0001956,GO:0001956,positive regulation of neurotransmitter secretion,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,SYT1,1
GO:0002021,GO:0002021,response to dietary excess,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,PCSK1N,1
GO:0002230,GO:0002230,positive regulation of defense response to virus by host,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,SELENOK,1
GO:0002385,GO:0002385,mucosal immune response,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,RPL39,1
GO:0007413,GO:0007413,axonal fasciculation,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,NCAM2,1
GO:0007628,GO:0007628,adult walking behavior,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,UCHL1,1
GO:0009651,GO:0009651,response to salt stress,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,AKR1B1,1
GO:0010664,GO:0010664,negative regulation of striated muscle cell apoptotic process,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,MDK,1
GO:0019731,GO:0019731,antibacterial humoral response,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,RPL39,1
GO:0019835,GO:0019835,cytolysis,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,ROMO1,1
GO:0031114,GO:0031114,regulation of microtubule depolymerization,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,MAP1B,1
GO:0031664,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,MIF,1
GO:0033198,GO:0033198,response to ATP,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,HSP90B1,1
GO:0034110,GO:0034110,regulation of homotypic cell-cell adhesion,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,CD9,1
GO:0039529,GO:0039529,RIG-I signaling pathway,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,NOP53,1
GO:0040020,GO:0040020,regulation of meiotic nuclear division,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,CALR,1
GO:0045671,GO:0045671,negative regulation of osteoclast differentiation,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,CLDN18,1
GO:0045987,GO:0045987,positive regulation of smooth muscle contraction,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,RHOA,1
GO:0046386,GO:0046386,deoxyribose phosphate catabolic process,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,NTHL1,1
GO:0048025,GO:0048025,negative regulation of mRNA splicing, via spliceosome,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,SRSF9,1
GO:0048730,GO:0048730,epidermis morphogenesis,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,IGFBP5,1
GO:0055022,GO:0055022,negative regulation of cardiac muscle tissue growth,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,RGS2,1
GO:0060149,GO:0060149,negative regulation of posttranscriptional gene silencing,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,NEAT1,1
GO:0060384,GO:0060384,innervation,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,SLITRK6,1
GO:0060706,GO:0060706,cell differentiation involved in embryonic placenta development,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,SPINT2,1
GO:0060967,GO:0060967,negative regulation of gene silencing by RNA,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,NEAT1,1
GO:0061003,GO:0061003,positive regulation of dendritic spine morphogenesis,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,CAMK2B,1
GO:0061117,GO:0061117,negative regulation of heart growth,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,RGS2,1
GO:0071243,GO:0071243,cellular response to arsenic-containing substance,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,ZFAND2A,1
GO:0071514,GO:0071514,genetic imprinting,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,DIRAS3,1
GO:0071542,GO:0071542,dopaminergic neuron differentiation,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,VEGFA,1
GO:0090312,GO:0090312,positive regulation of protein deacetylation,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,VEGFA,1
GO:0106030,GO:0106030,neuron projection fasciculation,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,NCAM2,1
GO:0120033,GO:0120033,negative regulation of plasma membrane bounded cell projection assembly,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,PFN2,1
GO:1901889,GO:1901889,negative regulation of cell junction assembly,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,APOD,1
GO:1903319,GO:1903319,positive regulation of protein maturation,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,SOX4,1
GO:1903861,GO:1903861,positive regulation of dendrite extension,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,SYT1,1
GO:1904738,GO:1904738,vascular associated smooth muscle cell migration,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,IGFBP5,1
GO:1904752,GO:1904752,regulation of vascular associated smooth muscle cell migration,1/317,19/12743,0.380580552074088,0.635249394686726,0.566939508090225,IGFBP5,1
GO:0014015,GO:0014015,positive regulation of gliogenesis,2/317,53/12743,0.381326340398875,0.635249394686726,0.566939508090225,MDK/TSPO,2
GO:0016101,GO:0016101,diterpenoid metabolic process,2/317,53/12743,0.381326340398875,0.635249394686726,0.566939508090225,RBP1/AKR1B1,2
GO:0032760,GO:0032760,positive regulation of tumor necrosis factor production,2/317,53/12743,0.381326340398875,0.635249394686726,0.566939508090225,MIF/SELENOK,2
GO:0050886,GO:0050886,endocrine process,2/317,53/12743,0.381326340398875,0.635249394686726,0.566939508090225,RHOA/MME,2
GO:0061045,GO:0061045,negative regulation of wound healing,2/317,53/12743,0.381326340398875,0.635249394686726,0.566939508090225,CD9/CDKN1A,2
GO:0008630,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,3/317,89/12743,0.381930386300919,0.635372391833319,0.5670492790595,MIF/RPS3/CDKN1A,3
GO:0032635,GO:0032635,interleukin-6 production,3/317,89/12743,0.381930386300919,0.635372391833319,0.5670492790595,SELENOK/HGF/CD47,3
GO:0072089,GO:0072089,stem cell proliferation,3/317,89/12743,0.381930386300919,0.635372391833319,0.5670492790595,EPCAM/ASCL1/VEGFA,3
GO:0008015,GO:0008015,blood circulation,10/317,353/12743,0.382973893876739,0.636813667200221,0.568335570639418,S100A1/CHGA/RHOA/MME/RGS2/SGK1/DSP/ELN/CACNA2D1/NPPA,10
GO:0015893,GO:0015893,drug transport,4/317,126/12743,0.383346841969033,0.637139110900912,0.568626018600682,RTBDN/PARK7/SLC25A6/RGS2,4
GO:0042391,GO:0042391,regulation of membrane potential,8/317,277/12743,0.384570949723161,0.638878264443052,0.570178156803286,PARK7/YWHAH/TSPO/DSP/GRIK2/CACNA2D1/JUN/NPPA,8
GO:0062012,GO:0062012,regulation of small molecule metabolic process,10/317,354/12743,0.3863302194642,0.641290494516698,0.572330994008315,FABP5/TFF3/RHOA/PARK7/IGFBP5/ODC1/EGR1/TSPO/PSMB8/PSMA6,10
GO:0002064,GO:0002064,epithelial cell development,5/317,164/12743,0.386990635205883,0.641290494516698,0.572330994008315,SPINT2/RAB13/PSAP/SLITRK6/CDKN1A,5
GO:0015711,GO:0015711,organic anion transport,9/317,316/12743,0.387497344295229,0.641290494516698,0.572330994008315,RTBDN/MFSD2A/CA9/NPC2/PSAP/MIF/SLC25A6/RGS2/SYT1,9
GO:0017015,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,3/317,90/12743,0.388691784703951,0.641290494516698,0.572330994008315,HSPA1A/PEG10/HSPA5,3
GO:0046822,GO:0046822,regulation of nucleocytoplasmic transport,3/317,90/12743,0.388691784703951,0.641290494516698,0.572330994008315,APOD/PARK7/KHDRBS1,3
GO:0048565,GO:0048565,digestive tract development,3/317,90/12743,0.388691784703951,0.641290494516698,0.572330994008315,CLDN18/CDKN1A/ASCL1,3
GO:0008064,GO:0008064,regulation of actin polymerization or depolymerization,4/317,127/12743,0.388999848446861,0.641290494516698,0.572330994008315,RHOA/BRK1/PFN2/ELN,4
GO:0006977,GO:0006977,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,2/317,54/12743,0.390198132450094,0.641290494516698,0.572330994008315,SOX4/CDKN1A,2
GO:0010633,GO:0010633,negative regulation of epithelial cell migration,2/317,54/12743,0.390198132450094,0.641290494516698,0.572330994008315,RHOA/PFN2,2
GO:0030641,GO:0030641,regulation of cellular pH,2/317,54/12743,0.390198132450094,0.641290494516698,0.572330994008315,GRN/ATP6V0E2,2
GO:0031016,GO:0031016,pancreas development,2/317,54/12743,0.390198132450094,0.641290494516698,0.572330994008315,SOX4/MEIS2,2
GO:0035308,GO:0035308,negative regulation of protein dephosphorylation,2/317,54/12743,0.390198132450094,0.641290494516698,0.572330994008315,BOD1/PPP1R15A,2
GO:0045454,GO:0045454,cell redox homeostasis,2/317,54/12743,0.390198132450094,0.641290494516698,0.572330994008315,PDIA3/PDIA6,2
GO:1903557,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,2/317,54/12743,0.390198132450094,0.641290494516698,0.572330994008315,MIF/SELENOK,2
GO:1990266,GO:1990266,neutrophil migration,2/317,54/12743,0.390198132450094,0.641290494516698,0.572330994008315,MDK/RAC1,2
GO:0032869,GO:0032869,cellular response to insulin stimulus,5/317,165/12743,0.391939540191247,0.641290494516698,0.572330994008315,RAB13/ATP6AP1/APRT/ATP6V0E2/YWHAG,5
GO:0050657,GO:0050657,nucleic acid transport,5/317,165/12743,0.391939540191247,0.641290494516698,0.572330994008315,KHDRBS1/SRSF9/THOC7/ARC/SFPQ,5
GO:0050658,GO:0050658,RNA transport,5/317,165/12743,0.391939540191247,0.641290494516698,0.572330994008315,KHDRBS1/SRSF9/THOC7/ARC/SFPQ,5
GO:0061013,GO:0061013,regulation of mRNA catabolic process,5/317,165/12743,0.391939540191247,0.641290494516698,0.572330994008315,YBX1/HSPA1A/PSMB8/PSMA6/PABPC4,5
GO:0001501,GO:0001501,skeletal system development,10/317,356/12743,0.393049268559387,0.641290494516698,0.572330994008315,TIMP1/MDK/BMP8B/RPL38/RHOA/PPIB/CLDN18/SOX4/ATP6AP1/SERP1,10
GO:0010950,GO:0010950,positive regulation of endopeptidase activity,4/317,128/12743,0.39464597830659,0.641290494516698,0.572330994008315,RHOA/PDCD6/RPS3/FAM162A,4
GO:0030832,GO:0030832,regulation of actin filament length,4/317,128/12743,0.39464597830659,0.641290494516698,0.572330994008315,RHOA/BRK1/PFN2/ELN,4
GO:0019751,GO:0019751,polyol metabolic process,3/317,91/12743,0.39543524523842,0.641290494516698,0.572330994008315,AKR1B1/NUDT3/PCBD1,3
GO:0051817,GO:0051817,modification of morphology or physiology of other organism involved in symbiotic interaction,3/317,91/12743,0.39543524523842,0.641290494516698,0.572330994008315,PPIB/SLC25A6/JUN,3
GO:0055067,GO:0055067,monovalent inorganic cation homeostasis,3/317,91/12743,0.39543524523842,0.641290494516698,0.572330994008315,GRN/ATP6AP1/ATP6V0E2,3
GO:1903844,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,3/317,91/12743,0.39543524523842,0.641290494516698,0.572330994008315,HSPA1A/PEG10/HSPA5,3
GO:0000188,GO:0000188,inactivation of MAPK activity,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,DUSP1,1
GO:0000305,GO:0000305,response to oxygen radical,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,PARK7,1
GO:0002053,GO:0002053,positive regulation of mesenchymal cell proliferation,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,VEGFA,1
GO:0003181,GO:0003181,atrioventricular valve morphogenesis,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,SOX4,1
GO:0010460,GO:0010460,positive regulation of heart rate,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,NPPA,1
GO:0010614,GO:0010614,negative regulation of cardiac muscle hypertrophy,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,RGS2,1
GO:0019054,GO:0019054,modulation by virus of host process,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,SLC25A6,1
GO:0032743,GO:0032743,positive regulation of interleukin-2 production,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,RPS3,1
GO:0032799,GO:0032799,low-density lipoprotein receptor particle metabolic process,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,MYLIP,1
GO:0033032,GO:0033032,regulation of myeloid cell apoptotic process,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,MIF,1
GO:0034694,GO:0034694,response to prostaglandin,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,GNG2,1
GO:0035902,GO:0035902,response to immobilization stress,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,FOS,1
GO:0036507,GO:0036507,protein demannosylation,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,OS9,1
GO:0036508,GO:0036508,protein alpha-1,2-demannosylation,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,OS9,1
GO:0039531,GO:0039531,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,NOP53,1
GO:0044331,GO:0044331,cell-cell adhesion mediated by cadherin,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,EPCAM,1
GO:0048265,GO:0048265,response to pain,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,TSPO,1
GO:0051882,GO:0051882,mitochondrial depolarization,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,TSPO,1
GO:0051930,GO:0051930,regulation of sensory perception of pain,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,FABP5,1
GO:0062009,GO:0062009,secondary palate development,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,TSHZ1,1
GO:0070229,GO:0070229,negative regulation of lymphocyte apoptotic process,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,MIF,1
GO:0071711,GO:0071711,basement membrane organization,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,SPINT2,1
GO:0090189,GO:0090189,regulation of branching involved in ureteric bud morphogenesis,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,VEGFA,1
GO:0098780,GO:0098780,response to mitochondrial depolarisation,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,TOMM7,1
GO:1901018,GO:1901018,positive regulation of potassium ion transmembrane transporter activity,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,NPPA,1
GO:1903020,GO:1903020,positive regulation of glycoprotein metabolic process,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,RAMP1,1
GO:1903792,GO:1903792,negative regulation of anion transport,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,RGS2,1
GO:1903859,GO:1903859,regulation of dendrite extension,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,SYT1,1
GO:2000178,GO:2000178,negative regulation of neural precursor cell proliferation,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,SPINT2,1
GO:2000191,GO:2000191,regulation of fatty acid transport,1/317,20/12743,0.396012488964415,0.641290494516698,0.572330994008315,MIF,1
GO:0001649,GO:0001649,osteoblast differentiation,5/317,166/12743,0.396885590778849,0.642220747293457,0.573161214479308,IGFBP5/ATP6AP1/HGF/ATRAID/JUNB,5
GO:0006164,GO:0006164,purine nucleotide biosynthetic process,7/317,242/12743,0.396944228229781,0.642220747293457,0.573161214479308,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA/NME4/NPPA,7
GO:0034762,GO:0034762,regulation of transmembrane transport,11/317,396/12743,0.397730058441504,0.643202681105357,0.57403755860014,S100A1/FABP5/CD63/TSPAN13/PARK7/YWHAH/GEM/RGS2/CACNA2D1/CNKSR3/NPPA,11
GO:0021675,GO:0021675,nerve development,2/317,55/12743,0.399012922204786,0.643251773688882,0.574081372140754,RPL24/SLITRK6,2
GO:0050871,GO:0050871,positive regulation of B cell activation,2/317,55/12743,0.399012922204786,0.643251773688882,0.574081372140754,MIF/CDKN1A,2
GO:0060191,GO:0060191,regulation of lipase activity,2/317,55/12743,0.399012922204786,0.643251773688882,0.574081372140754,RHOA/RGS2,2
GO:0072431,GO:0072431,signal transduction involved in mitotic G1 DNA damage checkpoint,2/317,55/12743,0.399012922204786,0.643251773688882,0.574081372140754,SOX4/CDKN1A,2
GO:0120193,GO:0120193,tight junction organization,2/317,55/12743,0.399012922204786,0.643251773688882,0.574081372140754,RAB13/TBCD,2
GO:1902400,GO:1902400,intracellular signal transduction involved in G1 DNA damage checkpoint,2/317,55/12743,0.399012922204786,0.643251773688882,0.574081372140754,SOX4/CDKN1A,2
GO:1903902,GO:1903902,positive regulation of viral life cycle,2/317,55/12743,0.399012922204786,0.643251773688882,0.574081372140754,PPIB/PPIA,2
GO:0030198,GO:0030198,extracellular matrix organization,7/317,244/12743,0.405113997482197,0.64886391180179,0.579090023621069,TIMP1/FSCN1/SPINT2/BSG/MFAP2/ELN/CD47,7
GO:0043901,GO:0043901,negative regulation of multi-organism process,4/317,130/12743,0.40591335462607,0.64886391180179,0.579090023621069,TIMP1/CALR/SNX3/JUN,4
GO:0003013,GO:0003013,circulatory system process,10/317,360/12743,0.406505926563361,0.64886391180179,0.579090023621069,S100A1/CHGA/RHOA/MME/RGS2/SGK1/DSP/ELN/CACNA2D1/NPPA,10
GO:0045732,GO:0045732,positive regulation of protein catabolic process,5/317,168/12743,0.406766147066292,0.64886391180179,0.579090023621069,HSPA1A/MYLIP/RBX1/NOP53/ZFAND2A,5
GO:0051236,GO:0051236,establishment of RNA localization,5/317,168/12743,0.406766147066292,0.64886391180179,0.579090023621069,KHDRBS1/SRSF9/THOC7/ARC/SFPQ,5
GO:1901987,GO:1901987,regulation of cell cycle phase transition,11/317,399/12743,0.407327398630244,0.64886391180179,0.579090023621069,TUBA1A/SOX4/DUSP1/MAD1L1/PSMB8/RBX1/NOP53/PSMA6/CDKN1A/YWHAG/TUBB4B,11
GO:0016575,GO:0016575,histone deacetylation,2/317,56/12743,0.407768054861357,0.64886391180179,0.579090023621069,SFPQ/VEGFA,2
GO:0072413,GO:0072413,signal transduction involved in mitotic cell cycle checkpoint,2/317,56/12743,0.407768054861357,0.64886391180179,0.579090023621069,SOX4/CDKN1A,2
GO:1902402,GO:1902402,signal transduction involved in mitotic DNA damage checkpoint,2/317,56/12743,0.407768054861357,0.64886391180179,0.579090023621069,SOX4/CDKN1A,2
GO:1902403,GO:1902403,signal transduction involved in mitotic DNA integrity checkpoint,2/317,56/12743,0.407768054861357,0.64886391180179,0.579090023621069,SOX4/CDKN1A,2
GO:2000300,GO:2000300,regulation of synaptic vesicle exocytosis,2/317,56/12743,0.407768054861357,0.64886391180179,0.579090023621069,PFN2/SYT1,2
GO:0015931,GO:0015931,nucleobase-containing compound transport,6/317,207/12743,0.410738168905542,0.64886391180179,0.579090023621069,SLC25A6/KHDRBS1/SRSF9/THOC7/ARC/SFPQ,6
GO:0071356,GO:0071356,cellular response to tumor necrosis factor,6/317,207/12743,0.410738168905542,0.64886391180179,0.579090023621069,HSPA1A/CLDN18/HSPA1B/PSMB8/RPS3/PSMA6,6
GO:0000423,GO:0000423,mitophagy,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,TOMM7,1
GO:0002251,GO:0002251,organ or tissue specific immune response,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,RPL39,1
GO:0002691,GO:0002691,regulation of cellular extravasation,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,MDK,1
GO:0002701,GO:0002701,negative regulation of production of molecular mediator of immune response,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,TMBIM6,1
GO:0003171,GO:0003171,atrioventricular valve development,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,SOX4,1
GO:0006293,GO:0006293,nucleotide-excision repair, preincision complex stabilization,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,RBX1,1
GO:0006295,GO:0006295,nucleotide-excision repair, DNA incision, 3'-to lesion,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,RBX1,1
GO:0006541,GO:0006541,glutamine metabolic process,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,CTPS1,1
GO:0007063,GO:0007063,regulation of sister chromatid cohesion,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,SFPQ,1
GO:0010543,GO:0010543,regulation of platelet activation,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,CD9,1
GO:0031954,GO:0031954,positive regulation of protein autophosphorylation,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,VEGFA,1
GO:0032469,GO:0032469,endoplasmic reticulum calcium ion homeostasis,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,TMBIM6,1
GO:0032733,GO:0032733,positive regulation of interleukin-10 production,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,HGF,1
GO:0032897,GO:0032897,negative regulation of viral transcription,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,JUN,1
GO:0034105,GO:0034105,positive regulation of tissue remodeling,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,ATP6AP1,1
GO:0034661,GO:0034661,ncRNA catabolic process,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,TRIR,1
GO:0035886,GO:0035886,vascular smooth muscle cell differentiation,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,VEGFA,1
GO:0042462,GO:0042462,eye photoreceptor cell development,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,VEGFA,1
GO:0042755,GO:0042755,eating behavior,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,UCHL1,1
GO:0044342,GO:0044342,type B pancreatic cell proliferation,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,IGFBP5,1
GO:0044818,GO:0044818,mitotic G2/M transition checkpoint,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,NOP53,1
GO:0045066,GO:0045066,regulatory T cell differentiation,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,MDK,1
GO:0045589,GO:0045589,regulation of regulatory T cell differentiation,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,MDK,1
GO:0046596,GO:0046596,regulation of viral entry into host cell,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,SNX3,1
GO:0046885,GO:0046885,regulation of hormone biosynthetic process,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,EGR1,1
GO:0048679,GO:0048679,regulation of axon regeneration,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,GRN,1
GO:0051457,GO:0051457,maintenance of protein location in nucleus,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,PARK7,1
GO:0051931,GO:0051931,regulation of sensory perception,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,FABP5,1
GO:0060292,GO:0060292,long-term synaptic depression,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,ARC,1
GO:0071459,GO:0071459,protein localization to chromosome, centromeric region,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,BOD1,1
GO:0097066,GO:0097066,response to thyroid hormone,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,AKR1B1,1
GO:0150077,GO:0150077,regulation of neuroinflammatory response,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,GRN,1
GO:1902692,GO:1902692,regulation of neuroblast proliferation,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,VEGFA,1
GO:1903203,GO:1903203,regulation of oxidative stress-induced neuron death,1/317,21/12743,0.411061144234263,0.64886391180179,0.579090023621069,PARK7,1
GO:0010212,GO:0010212,response to ionizing radiation,4/317,131/12743,0.411532527471299,0.64886391180179,0.579090023621069,EGR1/RHOB/HSPA5/CDKN1A,4
GO:0007411,GO:0007411,axon guidance,5/317,169/12743,0.411699188545169,0.64886391180179,0.579090023621069,TUBB2B/RPL24/TUBB3/ALCAM/VEGFA,5
GO:0009124,GO:0009124,nucleoside monophosphate biosynthetic process,5/317,169/12743,0.411699188545169,0.64886391180179,0.579090023621069,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA,5
GO:0030217,GO:0030217,T cell differentiation,5/317,169/12743,0.411699188545169,0.64886391180179,0.579090023621069,B2M/MDK/RHOA/SOX4/EGR1,5
GO:0007178,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,7/317,246/12743,0.413280222415422,0.650785107132476,0.580804628223347,RHOA/HSPA1A/PEG10/FOS/EGR1/HSPA5/JUN,7
GO:0016579,GO:0016579,protein deubiquitination,7/317,246/12743,0.413280222415422,0.650785107132476,0.580804628223347,UCHL1/RHOA/PARK7/PSMB8/NOP53/SNX3/PSMA6,7
GO:0003158,GO:0003158,endothelium development,3/317,94/12743,0.415541803883832,0.652055759075072,0.581938643923818,RHOA/RHOB/BTG1,3
GO:0007052,GO:0007052,mitotic spindle organization,3/317,94/12743,0.415541803883832,0.652055759075072,0.581938643923818,RHOA/HSPA1A/HSPA1B,3
GO:0097711,GO:0097711,ciliary basal body-plasma membrane docking,3/317,94/12743,0.415541803883832,0.652055759075072,0.581938643923818,TUBA1A/YWHAG/TUBB4B,3
GO:1903578,GO:1903578,regulation of ATP metabolic process,3/317,94/12743,0.415541803883832,0.652055759075072,0.581938643923818,RHOA/PARK7/TSPO,3
GO:2000278,GO:2000278,regulation of DNA biosynthetic process,3/317,94/12743,0.415541803883832,0.652055759075072,0.581938643923818,DUSP1/HGF/CDKN1A,3
GO:0003073,GO:0003073,regulation of systemic arterial blood pressure,2/317,57/12743,0.416461042054714,0.652055759075072,0.581938643923818,RHOA/MME,2
GO:0007492,GO:0007492,endoderm development,2/317,57/12743,0.416461042054714,0.652055759075072,0.581938643923818,HSBP1/ARC,2
GO:0014909,GO:0014909,smooth muscle cell migration,2/317,57/12743,0.416461042054714,0.652055759075072,0.581938643923818,MDK/IGFBP5,2
GO:0033047,GO:0033047,regulation of mitotic sister chromatid segregation,2/317,57/12743,0.416461042054714,0.652055759075072,0.581938643923818,DUSP1/MAD1L1,2
GO:0045582,GO:0045582,positive regulation of T cell differentiation,2/317,57/12743,0.416461042054714,0.652055759075072,0.581938643923818,MDK/RHOA,2
GO:0048644,GO:0048644,muscle organ morphogenesis,2/317,57/12743,0.416461042054714,0.652055759075072,0.581938643923818,SERP1/DSP,2
GO:1901379,GO:1901379,regulation of potassium ion transmembrane transport,2/317,57/12743,0.416461042054714,0.652055759075072,0.581938643923818,CD63/NPPA,2
GO:0051168,GO:0051168,nuclear export,5/317,170/12743,0.41662644745353,0.652055759075072,0.581938643923818,CALR/PARK7/KHDRBS1/SRSF9/THOC7,5
GO:0071897,GO:0071897,DNA biosynthetic process,5/317,170/12743,0.41662644745353,0.652055759075072,0.581938643923818,TERF2IP/PPIA/DUSP1/HGF/CDKN1A,5
GO:0007059,GO:0007059,chromosome segregation,7/317,248/12743,0.421439493129075,0.654348417651633,0.583984767440796,BOD1/CDC42/GEM/DUSP1/MAD1L1/RPS3/SFPQ,7
GO:0097485,GO:0097485,neuron projection guidance,5/317,171/12743,0.42154721889569,0.654348417651633,0.583984767440796,TUBB2B/RPL24/TUBB3/ALCAM/VEGFA,5
GO:0061138,GO:0061138,morphogenesis of a branching epithelium,4/317,133/12743,0.422736818825351,0.654348417651633,0.583984767440796,MDK/SPINT2/HGF/VEGFA,4
GO:0006721,GO:0006721,terpenoid metabolic process,2/317,58/12743,0.425089555264487,0.654348417651633,0.583984767440796,RBP1/AKR1B1,2
GO:0070373,GO:0070373,negative regulation of ERK1 and ERK2 cascade,2/317,58/12743,0.425089555264487,0.654348417651633,0.583984767440796,DUSP1/CNKSR3,2
GO:0000715,GO:0000715,nucleotide-excision repair, DNA damage recognition,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,RBX1,1
GO:0000717,GO:0000717,nucleotide-excision repair, DNA duplex unwinding,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,RBX1,1
GO:0002724,GO:0002724,regulation of T cell cytokine production,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,B2M,1
GO:0003180,GO:0003180,aortic valve morphogenesis,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,ELN,1
GO:0003209,GO:0003209,cardiac atrium morphogenesis,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,SOX4,1
GO:0006376,GO:0006376,mRNA splice site selection,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,SRSF9,1
GO:0006862,GO:0006862,nucleotide transport,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,SLC25A6,1
GO:0006972,GO:0006972,hyperosmotic response,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,AKR1B1,1
GO:0007064,GO:0007064,mitotic sister chromatid cohesion,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,BOD1,1
GO:0009620,GO:0009620,response to fungus,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,CHGA,1
GO:0015872,GO:0015872,dopamine transport,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,PARK7,1
GO:0030149,GO:0030149,sphingolipid catabolic process,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,PSAP,1
GO:0032594,GO:0032594,protein transport within lipid bilayer,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,CD24,1
GO:0032735,GO:0032735,positive regulation of interleukin-12 production,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,MDK,1
GO:0035909,GO:0035909,aorta morphogenesis,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,SOX4,1
GO:0036475,GO:0036475,neuron death in response to oxidative stress,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,PARK7,1
GO:0042554,GO:0042554,superoxide anion generation,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,PON3,1
GO:0044743,GO:0044743,protein transmembrane import into intracellular organelle,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,TOMM7,1
GO:0044788,GO:0044788,modulation by host of viral process,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,PPIB,1
GO:0045956,GO:0045956,positive regulation of calcium ion-dependent exocytosis,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,SYT1,1
GO:0046461,GO:0046461,neutral lipid catabolic process,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,FABP5,1
GO:0046464,GO:0046464,acylglycerol catabolic process,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,FABP5,1
GO:0048048,GO:0048048,embryonic eye morphogenesis,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,MFAP2,1
GO:0051125,GO:0051125,regulation of actin nucleation,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,BRK1,1
GO:0060074,GO:0060074,synapse maturation,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,CAMK2B,1
GO:0061036,GO:0061036,positive regulation of cartilage development,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,MDK,1
GO:0070528,GO:0070528,protein kinase C signaling,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,VEGFA,1
GO:0071526,GO:0071526,semaphorin-plexin signaling pathway,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,RAC1,1
GO:0086019,GO:0086019,cell-cell signaling involved in cardiac conduction,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,CACNA2D1,1
GO:0090344,GO:0090344,negative regulation of cell aging,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,MIF,1
GO:1900027,GO:1900027,regulation of ruffle assembly,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,PFN2,1
GO:1900117,GO:1900117,regulation of execution phase of apoptosis,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,RPS3,1
GO:1901522,GO:1901522,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,VEGFA,1
GO:1902254,GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,MIF,1
GO:1903649,GO:1903649,regulation of cytoplasmic transport,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,SNX3,1
GO:1903959,GO:1903959,regulation of anion transmembrane transport,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,RGS2,1
GO:1904666,GO:1904666,regulation of ubiquitin protein ligase activity,1/317,22/12743,0.425736008035374,0.654348417651633,0.583984767440796,UBE2S,1
GO:0002700,GO:0002700,regulation of production of molecular mediator of immune response,3/317,96/12743,0.428827685295872,0.658255990025047,0.587472149212018,B2M/MIF/TMBIM6,3
GO:0016202,GO:0016202,regulation of striated muscle tissue development,3/317,96/12743,0.428827685295872,0.658255990025047,0.587472149212018,RGS2/DDX17/AKIRIN1,3
GO:2000241,GO:2000241,regulation of reproductive process,3/317,96/12743,0.428827685295872,0.658255990025047,0.587472149212018,TIMP1/CALR/DUSP1,3
GO:0006397,GO:0006397,mRNA processing,12/317,445/12743,0.42927439244216,0.658660452765499,0.587833119106725,YBX1/SNRPF/KHDRBS1/SNRNP70/SRSF9/THOC7/SNRPE/TXNL4A/LSM3/SFPQ/LSM5/DDX17,12
GO:0002718,GO:0002718,regulation of cytokine production involved in immune response,2/317,59/12743,0.433651419446501,0.664525512749433,0.593067495164416,B2M/MIF,2
GO:0060291,GO:0060291,long-term synaptic potentiation,2/317,59/12743,0.433651419446501,0.664525512749433,0.593067495164416,MME/ARC,2
GO:0090398,GO:0090398,cellular senescence,2/317,59/12743,0.433651419446501,0.664525512749433,0.593067495164416,CALR/CDKN1A,2
GO:0000910,GO:0000910,cytokinesis,4/317,135/12743,0.433889256511457,0.664606679658581,0.593139934001714,RHOA/CENPV/CDC42/RHOB,4
GO:0043271,GO:0043271,negative regulation of ion transport,3/317,97/12743,0.435430749660134,0.66553074416703,0.593964631643688,TMBIM6/GEM/RGS2,3
GO:1902904,GO:1902904,negative regulation of supramolecular fiber organization,3/317,97/12743,0.435430749660134,0.66553074416703,0.593964631643688,TBCD/PFN2/MAP1B,3
GO:0050807,GO:0050807,regulation of synapse organization,5/317,174/12743,0.436263726480198,0.66553074416703,0.593964631643688,RHOA/TUBA1A/SLITRK6/ARC/CAMK2B,5
GO:0048732,GO:0048732,gland development,9/317,330/12743,0.437327383166204,0.66553074416703,0.593964631643688,MDK/IGFBP5/TSPO/HGF/APRT/MAD1L1/ASCL1/JUN/VEGFA,9
GO:0072522,GO:0072522,purine-containing compound biosynthetic process,7/317,252/12743,0.437723851016697,0.66553074416703,0.593964631643688,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA/NME4/NPPA,7
GO:0043409,GO:0043409,negative regulation of MAPK cascade,4/317,136/12743,0.439443692911631,0.66553074416703,0.593964631643688,UCHL1/RGS2/DUSP1/CNKSR3,4
GO:0050663,GO:0050663,cytokine secretion,4/317,136/12743,0.439443692911631,0.66553074416703,0.593964631643688,MDK/MIF/S100A13/SELENOK,4
GO:1903531,GO:1903531,negative regulation of secretion by cell,4/317,136/12743,0.439443692911631,0.66553074416703,0.593964631643688,CHGA/VAMP8/TMBIM6/ERP29,4
GO:0001912,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,B2M,1
GO:0002437,GO:0002437,inflammatory response to antigenic stimulus,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,PARK7,1
GO:0006458,GO:0006458,'de novo' protein folding,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,DNAJB1,1
GO:0007339,GO:0007339,binding of sperm to zona pellucida,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,ALDOA,1
GO:0009072,GO:0009072,aromatic amino acid family metabolic process,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,PCBD1,1
GO:0015804,GO:0015804,neutral amino acid transport,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,RGS2,1
GO:0021522,GO:0021522,spinal cord motor neuron differentiation,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,SOX4,1
GO:0021680,GO:0021680,cerebellar Purkinje cell layer development,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,HSPA5,1
GO:0031063,GO:0031063,regulation of histone deacetylation,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,VEGFA,1
GO:0032309,GO:0032309,icosanoid secretion,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,MIF,1
GO:0032528,GO:0032528,microvillus organization,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,FSCN1,1
GO:0033028,GO:0033028,myeloid cell apoptotic process,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,MIF,1
GO:0039694,GO:0039694,viral RNA genome replication,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,CDC42,1
GO:0045777,GO:0045777,positive regulation of blood pressure,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,RHOA,1
GO:0050919,GO:0050919,negative chemotaxis,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,RHOA,1
GO:0051180,GO:0051180,vitamin transport,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,RTBDN,1
GO:0051955,GO:0051955,regulation of amino acid transport,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,RGS2,1
GO:0060251,GO:0060251,regulation of glial cell proliferation,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,TSPO,1
GO:0090383,GO:0090383,phagosome acidification,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,ATP6V0E2,1
GO:0098901,GO:0098901,regulation of cardiac muscle cell action potential,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,DSP,1
GO:1903671,GO:1903671,negative regulation of sprouting angiogenesis,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,RHOA,1
GO:2000171,GO:2000171,negative regulation of dendrite development,1/317,23/12743,0.440046336268437,0.66553074416703,0.593964631643688,YWHAH,1
GO:0048524,GO:0048524,positive regulation of viral process,3/317,98/12743,0.442005420248534,0.665902748946599,0.594296633859669,PPIB/PPIA/JUN,3
GO:0048634,GO:0048634,regulation of muscle organ development,3/317,98/12743,0.442005420248534,0.665902748946599,0.594296633859669,RGS2/DDX17/AKIRIN1,3
GO:0055123,GO:0055123,digestive system development,3/317,98/12743,0.442005420248534,0.665902748946599,0.594296633859669,CLDN18/CDKN1A/ASCL1,3
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,2/317,60/12743,0.442144606880537,0.665902748946599,0.594296633859669,B2M/TUBB4B,2
GO:0002028,GO:0002028,regulation of sodium ion transport,2/317,60/12743,0.442144606880537,0.665902748946599,0.594296633859669,YWHAH/CNKSR3,2
GO:0008088,GO:0008088,axo-dendritic transport,2/317,60/12743,0.442144606880537,0.665902748946599,0.594296633859669,UCHL1/SFPQ,2
GO:0032612,GO:0032612,interleukin-1 production,2/317,60/12743,0.442144606880537,0.665902748946599,0.594296633859669,S100A13/EGR1,2
GO:0071260,GO:0071260,cellular response to mechanical stimulus,2/317,60/12743,0.442144606880537,0.665902748946599,0.594296633859669,RAC1/NPPA,2
GO:1902803,GO:1902803,regulation of synaptic vesicle transport,2/317,60/12743,0.442144606880537,0.665902748946599,0.594296633859669,PFN2/SYT1,2
GO:1904063,GO:1904063,negative regulation of cation transmembrane transport,2/317,60/12743,0.442144606880537,0.665902748946599,0.594296633859669,GEM/RGS2,2
GO:0007088,GO:0007088,regulation of mitotic nuclear division,4/317,137/12743,0.444982404124168,0.66989603970954,0.597860516516998,HSPA1A/HSPA1B/DUSP1/MAD1L1,4
GO:1901653,GO:1901653,cellular response to peptide,8/317,293/12743,0.445224242869628,0.669979553418297,0.597935049796932,RAB13/ATP6AP1/APRT/AKR1B1/MAP1B/ATP6V0E2/CACNA2D1/YWHAG,8
GO:0042593,GO:0042593,glucose homeostasis,5/317,176/12743,0.446029874776918,0.670911045951054,0.598766376709996,FABP5/PARK7/SOX4/RAC1/IGFBP5,5
GO:1905952,GO:1905952,regulation of lipid localization,3/317,99/12743,0.448550399964253,0.671107794847235,0.59894196872685,MIF/TSPO/HILPDA,3
GO:0032147,GO:0032147,activation of protein kinase activity,7/317,255/12743,0.449894458696031,0.671107794847235,0.59894196872685,GADD45G/PARK7/ERP29/HGF/GADD45B/RPLP1/VEGFA,7
GO:0099504,GO:0099504,synaptic vesicle cycle,4/317,138/12743,0.450504514325299,0.671107794847235,0.59894196872685,SNCB/PFN2/SYT1/PCLO,4
GO:0001570,GO:0001570,vasculogenesis,2/317,61/12743,0.450567231227621,0.671107794847235,0.59894196872685,JUNB/VEGFA,2
GO:0006906,GO:0006906,vesicle fusion,2/317,61/12743,0.450567231227621,0.671107794847235,0.59894196872685,CALR/SYT1,2
GO:0031100,GO:0031100,animal organ regeneration,2/317,61/12743,0.450567231227621,0.671107794847235,0.59894196872685,HGF/CDKN1A,2
GO:0031571,GO:0031571,mitotic G1 DNA damage checkpoint,2/317,61/12743,0.450567231227621,0.671107794847235,0.59894196872685,SOX4/CDKN1A,2
GO:0044819,GO:0044819,mitotic G1/S transition checkpoint,2/317,61/12743,0.450567231227621,0.671107794847235,0.59894196872685,SOX4/CDKN1A,2
GO:0050688,GO:0050688,regulation of defense response to virus,2/317,61/12743,0.450567231227621,0.671107794847235,0.59894196872685,SELENOK/NOP53,2
GO:0051851,GO:0051851,modification by host of symbiont morphology or physiology,2/317,61/12743,0.450567231227621,0.671107794847235,0.59894196872685,PPIB/JUN,2
GO:1905954,GO:1905954,positive regulation of lipid localization,2/317,61/12743,0.450567231227621,0.671107794847235,0.59894196872685,MIF/HILPDA,2
GO:0009743,GO:0009743,response to carbohydrate,5/317,177/12743,0.450897546471463,0.671107794847235,0.59894196872685,RHOA/SOX4/RAC1/EGR1/MAP1B,5
GO:0033500,GO:0033500,carbohydrate homeostasis,5/317,177/12743,0.450897546471463,0.671107794847235,0.59894196872685,FABP5/PARK7/SOX4/RAC1/IGFBP5,5
GO:0001782,GO:0001782,B cell homeostasis,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,MIF,1
GO:0001975,GO:0001975,response to amphetamine,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,RGS2,1
GO:0010165,GO:0010165,response to X-ray,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,CDKN1A,1
GO:0010742,GO:0010742,macrophage derived foam cell differentiation,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,SELENOK,1
GO:0010837,GO:0010837,regulation of keratinocyte proliferation,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,MDK,1
GO:0010922,GO:0010922,positive regulation of phosphatase activity,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,PPP1R15A,1
GO:0010939,GO:0010939,regulation of necrotic cell death,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,TSPO,1
GO:0031338,GO:0031338,regulation of vesicle fusion,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,SYT1,1
GO:0032892,GO:0032892,positive regulation of organic acid transport,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,MIF,1
GO:0034142,GO:0034142,toll-like receptor 4 signaling pathway,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,S100A14,1
GO:0043921,GO:0043921,modulation by host of viral transcription,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,JUN,1
GO:0044068,GO:0044068,modulation by symbiont of host cellular process,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,SLC25A6,1
GO:0045601,GO:0045601,regulation of endothelial cell differentiation,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,BTG1,1
GO:0048384,GO:0048384,retinoic acid receptor signaling pathway,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,CALR,1
GO:0050685,GO:0050685,positive regulation of mRNA processing,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,SNRNP70,1
GO:0050931,GO:0050931,pigment cell differentiation,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,CD63,1
GO:0051984,GO:0051984,positive regulation of chromosome segregation,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,SFPQ,1
GO:0052312,GO:0052312,modulation of transcription in other organism involved in symbiotic interaction,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,JUN,1
GO:0052472,GO:0052472,modulation by host of symbiont transcription,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,JUN,1
GO:0055094,GO:0055094,response to lipoprotein particle,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,CD9,1
GO:0060428,GO:0060428,lung epithelium development,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,ASCL1,1
GO:0060765,GO:0060765,regulation of androgen receptor signaling pathway,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,PARK7,1
GO:0060969,GO:0060969,negative regulation of gene silencing,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,NEAT1,1
GO:0071715,GO:0071715,icosanoid transport,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,MIF,1
GO:0090077,GO:0090077,foam cell differentiation,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,SELENOK,1
GO:1901571,GO:1901571,fatty acid derivative transport,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,MIF,1
GO:1901661,GO:1901661,quinone metabolic process,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,AKR1B1,1
GO:1902410,GO:1902410,mitotic cytokinetic process,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,RHOA,1
GO:2000758,GO:2000758,positive regulation of peptidyl-lysine acetylation,1/317,24/12743,0.454001156347281,0.671107794847235,0.59894196872685,SOX4,1
GO:0019079,GO:0019079,viral genome replication,3/317,100/12743,0.455064438968603,0.671850783610731,0.599605062131764,PPIB/CDC42/PPIA,3
GO:0042552,GO:0042552,myelination,3/317,100/12743,0.455064438968603,0.671850783610731,0.599605062131764,CD9/PSAP/HGF,3
GO:0043666,GO:0043666,regulation of phosphoprotein phosphatase activity,3/317,100/12743,0.455064438968603,0.671850783610731,0.599605062131764,HSP90B1/BOD1/PPP1R15A,3
GO:0071407,GO:0071407,cellular response to organic cyclic compound,11/317,414/12743,0.455322471011254,0.671955781315869,0.599698769182569,HSP90B1/RHOA/CALR/PARK7/GNG2/YWHAH/IGFBP5/EGR1/HSPA5/SCGB2A1/DDX17,11
GO:0050803,GO:0050803,regulation of synapse structure or activity,5/317,178/12743,0.455754112111592,0.672041030779808,0.599774851567779,RHOA/TUBA1A/SLITRK6/ARC/CAMK2B,5
GO:0070372,GO:0070372,regulation of ERK1 and ERK2 cascade,5/317,178/12743,0.455754112111592,0.672041030779808,0.599774851567779,MIF/ATP6AP1/DUSP1/JUN/CNKSR3,5
GO:0002440,GO:0002440,production of molecular mediator of immune response,4/317,139/12743,0.456009169118805,0.672141436237026,0.599864460186064,B2M/CHGA/MIF/TMBIM6,4
GO:0034660,GO:0034660,ncRNA metabolic process,12/317,454/12743,0.456789234099773,0.673015285487166,0.600644342336544,RPS27/TRIT1/RPS2/RPS28/RPL14/TRIR/RPS19/RPL35A/RPL27/NOP53/RPS14/DDX17,12
GO:0008306,GO:0008306,associative learning,2/317,62/12743,0.45891754179026,0.675597282037667,0.602948690623178,FOS/MEIS2,2
GO:0044783,GO:0044783,G1 DNA damage checkpoint,2/317,62/12743,0.45891754179026,0.675597282037667,0.602948690623178,SOX4/CDKN1A,2
GO:0002244,GO:0002244,hematopoietic progenitor cell differentiation,4/317,140/12743,0.461495535478522,0.677248600295628,0.604422438679767,EEF2/SOX4/PSMB8/PSMA6,4
GO:0010970,GO:0010970,transport along microtubule,4/317,140/12743,0.461495535478522,0.677248600295628,0.604422438679767,UCHL1/CDC42/MAP1B/SFPQ,4
GO:0046328,GO:0046328,regulation of JNK cascade,4/317,140/12743,0.461495535478522,0.677248600295628,0.604422438679767,GADD45G/GADD45B/RPS3/GRIK2,4
GO:0050796,GO:0050796,regulation of insulin secretion,4/317,140/12743,0.461495535478522,0.677248600295628,0.604422438679767,SOX4/SLC25A6/RAC1/SERP1,4
GO:0099111,GO:0099111,microtubule-based transport,4/317,140/12743,0.461495535478522,0.677248600295628,0.604422438679767,UCHL1/CDC42/MAP1B/SFPQ,4
GO:0030330,GO:0030330,DNA damage response, signal transduction by p53 class mediator,3/317,101/12743,0.461546333998411,0.677248600295628,0.604422438679767,MIF/SOX4/CDKN1A,3
GO:0046330,GO:0046330,positive regulation of JNK cascade,3/317,101/12743,0.461546333998411,0.677248600295628,0.604422438679767,GADD45G/GADD45B/RPS3,3
GO:1900180,GO:1900180,regulation of protein localization to nucleus,3/317,101/12743,0.461546333998411,0.677248600295628,0.604422438679767,APOD/CLDN18/PARK7,3
GO:0070646,GO:0070646,protein modification by small protein removal,7/317,259/12743,0.466045009639129,0.681140735734987,0.60789604348737,UCHL1/RHOA/PARK7/PSMB8/NOP53/SNX3/PSMA6,7
GO:1901699,GO:1901699,cellular response to nitrogen compound,13/317,497/12743,0.466828817188289,0.681140735734987,0.60789604348737,HSP90B1/RAB13/GNG2/IGFBP5/EGR1/ATP6AP1/APRT/AKR1B1/HSPA5/MAP1B/ATP6V0E2/CACNA2D1/YWHAG,13
GO:0015908,GO:0015908,fatty acid transport,2/317,63/12743,0.467193917969274,0.681140735734987,0.60789604348737,MFSD2A/MIF,2
GO:0030301,GO:0030301,cholesterol transport,2/317,63/12743,0.467193917969274,0.681140735734987,0.60789604348737,NPC2/TSPO,2
GO:0051304,GO:0051304,chromosome separation,2/317,63/12743,0.467193917969274,0.681140735734987,0.60789604348737,DUSP1/MAD1L1,2
GO:0055017,GO:0055017,cardiac muscle tissue growth,2/317,63/12743,0.467193917969274,0.681140735734987,0.60789604348737,RGS2/NPPA,2
GO:0031365,GO:0031365,N-terminal protein amino acid modification,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,SOX4,1
GO:0039528,GO:0039528,cytoplasmic pattern recognition receptor signaling pathway in response to virus,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,NOP53,1
GO:0040018,GO:0040018,positive regulation of multicellular organism growth,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,PPIB,1
GO:0044319,GO:0044319,wound healing, spreading of cells,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,RHOA,1
GO:0046466,GO:0046466,membrane lipid catabolic process,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,PSAP,1
GO:0048147,GO:0048147,negative regulation of fibroblast proliferation,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,FTH1,1
GO:0050433,GO:0050433,regulation of catecholamine secretion,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,CHGA,1
GO:0055026,GO:0055026,negative regulation of cardiac muscle tissue development,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,RGS2,1
GO:0060416,GO:0060416,response to growth hormone,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,IGFBP5,1
GO:0086005,GO:0086005,ventricular cardiac muscle cell action potential,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,DSP,1
GO:0090505,GO:0090505,epiboly involved in wound healing,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,RHOA,1
GO:2000765,GO:2000765,regulation of cytoplasmic translation,1/317,25/12743,0.467609272821683,0.681140735734987,0.60789604348737,EEF2,1
GO:0042133,GO:0042133,neurotransmitter metabolic process,3/317,102/12743,0.467994927667003,0.681426393261594,0.608150983576997,RAC1/TSPO/CD47,3
GO:0001763,GO:0001763,morphogenesis of a branching structure,4/317,142/12743,0.472410177202145,0.687114323946965,0.613227277473201,MDK/SPINT2/HGF/VEGFA,4
GO:0007051,GO:0007051,spindle organization,4/317,142/12743,0.472410177202145,0.687114323946965,0.613227277473201,RHOA/HSPA1A/HSPA1B/RPS3,4
GO:0034612,GO:0034612,response to tumor necrosis factor,6/317,221/12743,0.472474717328762,0.687114323946965,0.613227277473201,HSPA1A/CLDN18/HSPA1B/PSMB8/RPS3/PSMA6,6
GO:0060070,GO:0060070,canonical Wnt signaling pathway,7/317,261/12743,0.474080555841459,0.687927173075875,0.613952718991367,MDK/SOX4/EGR1/PSMB8/RBX1/IGFBP2/PSMA6,7
GO:0030879,GO:0030879,mammary gland development,3/317,103/12743,0.474409107750524,0.687927173075875,0.613952718991367,IGFBP5/APRT/VEGFA,3
GO:0006513,GO:0006513,protein monoubiquitination,2/317,64/12743,0.47539486391103,0.687927173075875,0.613952718991367,PDCD6/RBX1,2
GO:0006970,GO:0006970,response to osmotic stress,2/317,64/12743,0.47539486391103,0.687927173075875,0.613952718991367,TSPO/AKR1B1,2
GO:0034109,GO:0034109,homotypic cell-cell adhesion,2/317,64/12743,0.47539486391103,0.687927173075875,0.613952718991367,CD9/DSP,2
GO:0045621,GO:0045621,positive regulation of lymphocyte differentiation,2/317,64/12743,0.47539486391103,0.687927173075875,0.613952718991367,MDK/RHOA,2
GO:0046470,GO:0046470,phosphatidylcholine metabolic process,2/317,64/12743,0.47539486391103,0.687927173075875,0.613952718991367,FABP5/MFSD2A,2
GO:0051702,GO:0051702,interaction with symbiont,2/317,64/12743,0.47539486391103,0.687927173075875,0.613952718991367,PPIB/JUN,2
GO:0051881,GO:0051881,regulation of mitochondrial membrane potential,2/317,64/12743,0.47539486391103,0.687927173075875,0.613952718991367,PARK7/TSPO,2
GO:0048285,GO:0048285,organelle fission,9/317,341/12743,0.476235336576012,0.687927173075875,0.613952718991367,RHOA/HSPA1A/CALR/RPL24/BOD1/HSPA1B/DUSP1/MAD1L1/UBE2S,9
GO:0007272,GO:0007272,ensheathment of neurons,3/317,104/12743,0.480787806461261,0.687927173075875,0.613952718991367,CD9/PSAP/HGF,3
GO:0007605,GO:0007605,sensory perception of sound,3/317,104/12743,0.480787806461261,0.687927173075875,0.613952718991367,RPL38/PSAP/SLITRK6,3
GO:0008366,GO:0008366,axon ensheathment,3/317,104/12743,0.480787806461261,0.687927173075875,0.613952718991367,CD9/PSAP/HGF,3
GO:0010508,GO:0010508,positive regulation of autophagy,3/317,104/12743,0.480787806461261,0.687927173075875,0.613952718991367,PARK7/TOMM7/SVIP,3
GO:0001913,GO:0001913,T cell mediated cytotoxicity,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,B2M,1
GO:0002183,GO:0002183,cytoplasmic translational initiation,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,EIF3L,1
GO:0003091,GO:0003091,renal water homeostasis,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,AKR1B1,1
GO:0003176,GO:0003176,aortic valve development,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,ELN,1
GO:0003338,GO:0003338,metanephros morphogenesis,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,BASP1,1
GO:0006099,GO:0006099,tricarboxylic acid cycle,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,MDH2,1
GO:0006775,GO:0006775,fat-soluble vitamin metabolic process,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,RBP1,1
GO:0010259,GO:0010259,multicellular organism aging,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,SERP1,1
GO:0014014,GO:0014014,negative regulation of gliogenesis,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,TSPO,1
GO:0018198,GO:0018198,peptidyl-cysteine modification,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,PARK7,1
GO:0031343,GO:0031343,positive regulation of cell killing,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,B2M,1
GO:0032148,GO:0032148,activation of protein kinase B activity,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,PARK7,1
GO:0032731,GO:0032731,positive regulation of interleukin-1 beta production,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,EGR1,1
GO:0032941,GO:0032941,secretion by tissue,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,VAMP8,1
GO:0035774,GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,RAC1,1
GO:0044058,GO:0044058,regulation of digestive system process,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,SGK1,1
GO:0045736,GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,CDKN1A,1
GO:0046621,GO:0046621,negative regulation of organ growth,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,RGS2,1
GO:0051339,GO:0051339,regulation of lyase activity,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,PARK7,1
GO:0060674,GO:0060674,placenta blood vessel development,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,JUNB,1
GO:0070911,GO:0070911,global genome nucleotide-excision repair,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,RBX1,1
GO:0071402,GO:0071402,cellular response to lipoprotein particle stimulus,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,CD9,1
GO:0071709,GO:0071709,membrane assembly,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,PSAP,1
GO:0090504,GO:0090504,epiboly,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,RHOA,1
GO:1901020,GO:1901020,negative regulation of calcium ion transmembrane transporter activity,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,GEM,1
GO:1901381,GO:1901381,positive regulation of potassium ion transmembrane transport,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,NPPA,1
GO:2000142,GO:2000142,regulation of DNA-templated transcription, initiation,1/317,26/12743,0.480879272862218,0.687927173075875,0.613952718991367,JUN,1
GO:0030216,GO:0030216,keratinocyte differentiation,4/317,144/12743,0.483242199661197,0.689508455773118,0.615363962578571,PSAP/DSP/KRT12/KRT10,4
GO:0071216,GO:0071216,cellular response to biotic stimulus,4/317,144/12743,0.483242199661197,0.689508455773118,0.615363962578571,RHOA/MIF/TSPO/HSPA5,4
GO:0003300,GO:0003300,cardiac muscle hypertrophy,2/317,65/12743,0.483519003339091,0.689508455773118,0.615363962578571,RGS2/NPPA,2
GO:0021766,GO:0021766,hippocampus development,2/317,65/12743,0.483519003339091,0.689508455773118,0.615363962578571,MDK/MFSD2A,2
GO:0030004,GO:0030004,cellular monovalent inorganic cation homeostasis,2/317,65/12743,0.483519003339091,0.689508455773118,0.615363962578571,GRN/ATP6V0E2,2
GO:0043266,GO:0043266,regulation of potassium ion transport,2/317,65/12743,0.483519003339091,0.689508455773118,0.615363962578571,CD63/NPPA,2
GO:0060998,GO:0060998,regulation of dendritic spine development,2/317,65/12743,0.483519003339091,0.689508455773118,0.615363962578571,ARC/CAMK2B,2
GO:1903312,GO:1903312,negative regulation of mRNA metabolic process,2/317,65/12743,0.483519003339091,0.689508455773118,0.615363962578571,YBX1/SRSF9,2
GO:0032388,GO:0032388,positive regulation of intracellular transport,5/317,184/12743,0.484626723863774,0.69081406514285,0.616529176650438,VAMP8/TOMM7/KHDRBS1/SYT1/NPPA,5
GO:0051494,GO:0051494,negative regulation of cytoskeleton organization,3/317,105/12743,0.487129999709535,0.693832150933351,0.619222720458196,TBCD/PFN2/MAP1B,3
GO:0061337,GO:0061337,cardiac conduction,3/317,105/12743,0.487129999709535,0.693832150933351,0.619222720458196,DSP/CACNA2D1/NPPA,3
GO:0006694,GO:0006694,steroid biosynthetic process,4/317,145/12743,0.488625370713248,0.695604617383492,0.620804589352136,CNBP/EGR1/TSPO/AKR1B1,4
GO:0003007,GO:0003007,heart morphogenesis,5/317,185/12743,0.489389015668138,0.695604617383492,0.620804589352136,SOX4/DSP/ELN/JUN/VEGFA,5
GO:0000288,GO:0000288,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,2/317,66/12743,0.491565074564457,0.695604617383492,0.620804589352136,LSM3/LSM5,2
GO:0006919,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,2/317,66/12743,0.491565074564457,0.695604617383492,0.620804589352136,PDCD6/FAM162A,2
GO:0090174,GO:0090174,organelle membrane fusion,2/317,66/12743,0.491565074564457,0.695604617383492,0.620804589352136,CALR/SYT1,2
GO:0098869,GO:0098869,cellular oxidant detoxification,2/317,66/12743,0.491565074564457,0.695604617383492,0.620804589352136,SELENOW/PARK7,2
GO:1902117,GO:1902117,positive regulation of organelle assembly,2/317,66/12743,0.491565074564457,0.695604617383492,0.620804589352136,FSCN1/RHOA,2
GO:1900542,GO:1900542,regulation of purine nucleotide metabolic process,3/317,106/12743,0.493434706355643,0.695604617383492,0.620804589352136,RHOA/PARK7/TSPO,3
GO:0003009,GO:0003009,skeletal muscle contraction,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,EEF2,1
GO:0003230,GO:0003230,cardiac atrium development,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,SOX4,1
GO:0003382,GO:0003382,epithelial cell morphogenesis,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,SPINT2,1
GO:0006335,GO:0006335,DNA replication-dependent nucleosome assembly,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,HIST1H4C,1
GO:0006968,GO:0006968,cellular defense response,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,LGALS3BP,1
GO:0007435,GO:0007435,salivary gland morphogenesis,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,HGF,1
GO:0009394,GO:0009394,2'-deoxyribonucleotide metabolic process,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,NTHL1,1
GO:0010586,GO:0010586,miRNA metabolic process,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,DDX17,1
GO:0010765,GO:0010765,positive regulation of sodium ion transport,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,CNKSR3,1
GO:0032715,GO:0032715,negative regulation of interleukin-6 production,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,HGF,1
GO:0034314,GO:0034314,Arp2/3 complex-mediated actin nucleation,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,BRK1,1
GO:0034723,GO:0034723,DNA replication-dependent nucleosome organization,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,HIST1H4C,1
GO:0043537,GO:0043537,negative regulation of blood vessel endothelial cell migration,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,RHOA,1
GO:0050432,GO:0050432,catecholamine secretion,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,CHGA,1
GO:0050686,GO:0050686,negative regulation of mRNA processing,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,SRSF9,1
GO:0070198,GO:0070198,protein localization to chromosome, telomeric region,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,TERF2IP,1
GO:0072529,GO:0072529,pyrimidine-containing compound catabolic process,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,NTHL1,1
GO:0090200,GO:0090200,positive regulation of release of cytochrome c from mitochondria,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,FAM162A,1
GO:0090218,GO:0090218,positive regulation of lipid kinase activity,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,EEF1A2,1
GO:1904030,GO:1904030,negative regulation of cyclin-dependent protein kinase activity,1/317,27/12743,0.493819531610561,0.695604617383492,0.620804589352136,CDKN1A,1
GO:0007219,GO:0007219,Notch signaling pathway,4/317,146/12743,0.49398569907651,0.695604617383492,0.620804589352136,MDK/YBX1/PGAM2/ASCL1,4
GO:1902532,GO:1902532,negative regulation of intracellular signal transduction,11/317,427/12743,0.496550051544962,0.698941830581103,0.623782944033732,UCHL1/RHOA/HSPA1A/MIF/PARK7/TMBIM6/RGS2/DUSP1/PDCD6/NOP53/CNKSR3,11
GO:0090596,GO:0090596,sensory organ morphogenesis,5/317,187/12743,0.498866013675193,0.700943510062146,0.625569378133203,RPL38/MFAP2/SLITRK6/TSHZ1/VEGFA,5
GO:0009166,GO:0009166,nucleotide catabolic process,4/317,147/12743,0.499322498629567,0.700943510062146,0.625569378133203,PGAM2/NUDT3/ALDOA/NTHL1,4
GO:0000281,GO:0000281,mitotic cytokinesis,2/317,67/12743,0.499531925668767,0.700943510062146,0.625569378133203,RHOA/RHOB,2
GO:0001892,GO:0001892,embryonic placenta development,2/317,67/12743,0.499531925668767,0.700943510062146,0.625569378133203,SPINT2/JUNB,2
GO:0006278,GO:0006278,RNA-dependent DNA biosynthetic process,2/317,67/12743,0.499531925668767,0.700943510062146,0.625569378133203,TERF2IP/PPIA,2
GO:0006805,GO:0006805,xenobiotic metabolic process,2/317,67/12743,0.499531925668767,0.700943510062146,0.625569378133203,PON3/BPHL,2
GO:0045682,GO:0045682,regulation of epidermis development,2/317,67/12743,0.499531925668767,0.700943510062146,0.625569378133203,MYCL/KRT10,2
GO:1902036,GO:1902036,regulation of hematopoietic stem cell differentiation,2/317,67/12743,0.499531925668767,0.700943510062146,0.625569378133203,PSMB8/PSMA6,2
GO:0051222,GO:0051222,positive regulation of protein transport,8/317,308/12743,0.501290200351279,0.702680583383872,0.627119659806469,MDK/MIF/SOX4/TOMM7/RAC1/PPIA/SERP1/SELENOK,8
GO:0030177,GO:0030177,positive regulation of Wnt signaling pathway,4/317,148/12743,0.50463510371683,0.702680583383872,0.627119659806469,SOX4/PSMB8/PSMA6/MACF1,4
GO:0060348,GO:0060348,bone development,4/317,148/12743,0.50463510371683,0.702680583383872,0.627119659806469,RHOA/PPIB/CLDN18/ATP6AP1,4
GO:0002695,GO:0002695,negative regulation of leukocyte activation,3/317,108/12743,0.505927945485724,0.702680583383872,0.627119659806469,MDK/GRN/MAD1L1,3
GO:0017156,GO:0017156,calcium ion regulated exocytosis,3/317,108/12743,0.505927945485724,0.702680583383872,0.627119659806469,PFN2/SYT1/PCLO,3
GO:0000578,GO:0000578,embryonic axis specification,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,BASP1,1
GO:0002369,GO:0002369,T cell cytokine production,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,B2M,1
GO:0006101,GO:0006101,citrate metabolic process,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,MDH2,1
GO:0010656,GO:0010656,negative regulation of muscle cell apoptotic process,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,MDK,1
GO:0010665,GO:0010665,regulation of cardiac muscle cell apoptotic process,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,MDK,1
GO:0018345,GO:0018345,protein palmitoylation,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,SELENOK,1
GO:0030212,GO:0030212,hyaluronan metabolic process,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,HGF,1
GO:0031572,GO:0031572,G2 DNA damage checkpoint,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,NOP53,1
GO:0042181,GO:0042181,ketone biosynthetic process,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,EGR1,1
GO:0045058,GO:0045058,T cell selection,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,RHOA,1
GO:0045738,GO:0045738,negative regulation of DNA repair,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,RPS3,1
GO:0050691,GO:0050691,regulation of defense response to virus by host,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,SELENOK,1
GO:0060421,GO:0060421,positive regulation of heart growth,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,BASP1,1
GO:0070536,GO:0070536,protein K63-linked deubiquitination,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,NOP53,1
GO:0070979,GO:0070979,protein K11-linked ubiquitination,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,UBE2S,1
GO:0071108,GO:0071108,protein K48-linked deubiquitination,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,PARK7,1
GO:0071634,GO:0071634,regulation of transforming growth factor beta production,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,CD24,1
GO:0071868,GO:0071868,cellular response to monoamine stimulus,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,GNG2,1
GO:0071870,GO:0071870,cellular response to catecholamine stimulus,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,GNG2,1
GO:0072604,GO:0072604,interleukin-6 secretion,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,SELENOK,1
GO:0086004,GO:0086004,regulation of cardiac muscle cell contraction,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,DSP,1
GO:0098659,GO:0098659,inorganic cation import across plasma membrane,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,CACNA2D1,1
GO:0099587,GO:0099587,inorganic ion import across plasma membrane,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,CACNA2D1,1
GO:1903580,GO:1903580,positive regulation of ATP metabolic process,1/317,28/12743,0.506438217398501,0.702680583383872,0.627119659806469,PARK7,1
GO:0002702,GO:0002702,positive regulation of production of molecular mediator of immune response,2/317,68/12743,0.50741850985497,0.703226500743492,0.627606873366859,B2M/MIF,2
GO:0006939,GO:0006939,smooth muscle contraction,2/317,68/12743,0.50741850985497,0.703226500743492,0.627606873366859,RHOA/RGS2,2
GO:0010771,GO:0010771,negative regulation of cell morphogenesis involved in differentiation,2/317,68/12743,0.50741850985497,0.703226500743492,0.627606873366859,RHOA/YWHAH,2
GO:0050878,GO:0050878,regulation of body fluid levels,9/317,350/12743,0.507640397323309,0.703262901108785,0.627639359513821,VAMP8/CD9/GNG2/CDC42/RAC1/APRT/AKR1B1/PABPC4/VEGFA,9
GO:0090068,GO:0090068,positive regulation of cell cycle process,6/317,230/12743,0.511226757504656,0.70795847196812,0.63183000440929,RHOA/SOX4/CENPV/CDC42/CDKN1A/SFPQ,6
GO:0006140,GO:0006140,regulation of nucleotide metabolic process,3/317,109/12743,0.512114723596187,0.708369538795034,0.632196868237249,RHOA/PARK7/TSPO,3
GO:0048489,GO:0048489,synaptic vesicle transport,3/317,109/12743,0.512114723596187,0.708369538795034,0.632196868237249,PFN2/SYT1/PCLO,3
GO:0097480,GO:0097480,establishment of synaptic vesicle localization,3/317,109/12743,0.512114723596187,0.708369538795034,0.632196868237249,PFN2/SYT1/PCLO,3
GO:0009410,GO:0009410,response to xenobiotic stimulus,5/317,190/12743,0.512954923336864,0.709080666211349,0.63283152642184,PON3/EGR1/RGS2/BPHL/HSPA5,5
GO:0000819,GO:0000819,sister chromatid segregation,4/317,150/12743,0.515185169229679,0.709080666211349,0.63283152642184,BOD1/DUSP1/MAD1L1/SFPQ,4
GO:0043123,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,4/317,150/12743,0.515185169229679,0.709080666211349,0.63283152642184,S100A4/RHOA/TERF2IP/S100A13,4
GO:0006353,GO:0006353,DNA-templated transcription, termination,2/317,69/12743,0.515223880960178,0.709080666211349,0.63283152642184,SNRPF/SNRPE,2
GO:0050868,GO:0050868,negative regulation of T cell activation,2/317,69/12743,0.515223880960178,0.709080666211349,0.63283152642184,MDK/MAD1L1,2
GO:0016358,GO:0016358,dendrite development,5/317,191/12743,0.517615518992783,0.709080666211349,0.63283152642184,RHOA/YWHAH/CDC42/ARC/CAMK2B,5
GO:0048863,GO:0048863,stem cell differentiation,5/317,191/12743,0.517615518992783,0.709080666211349,0.63283152642184,EPCAM/PDCD6/PSMB8/PSMA6/ASCL1,5
GO:0060560,GO:0060560,developmental growth involved in morphogenesis,5/317,191/12743,0.517615518992783,0.709080666211349,0.63283152642184,MAP1B/SYT1/ALCAM/MACF1/VEGFA,5
GO:0001889,GO:0001889,liver development,3/317,110/12743,0.5182605048133,0.709080666211349,0.63283152642184,MDK/HGF/JUN,3
GO:0071466,GO:0071466,cellular response to xenobiotic stimulus,3/317,110/12743,0.5182605048133,0.709080666211349,0.63283152642184,PON3/EGR1/BPHL,3
GO:0001709,GO:0001709,cell fate determination,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,ASCL1,1
GO:0006294,GO:0006294,nucleotide-excision repair, preincision complex assembly,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,RBX1,1
GO:0006911,GO:0006911,phagocytosis, engulfment,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,CDC42,1
GO:0007019,GO:0007019,microtubule depolymerization,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,MAP1B,1
GO:0007212,GO:0007212,dopamine receptor signaling pathway,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,GNG2,1
GO:0009262,GO:0009262,deoxyribonucleotide metabolic process,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,NTHL1,1
GO:0009303,GO:0009303,rRNA transcription,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,NOP53,1
GO:0010662,GO:0010662,regulation of striated muscle cell apoptotic process,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,MDK,1
GO:0018279,GO:0018279,protein N-linked glycosylation via asparagine,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,RPN1,1
GO:0019692,GO:0019692,deoxyribose phosphate metabolic process,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,NTHL1,1
GO:0021587,GO:0021587,cerebellum morphogenesis,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,HSPA5,1
GO:0032732,GO:0032732,positive regulation of interleukin-1 production,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,EGR1,1
GO:0033344,GO:0033344,cholesterol efflux,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,NPC2,1
GO:0043094,GO:0043094,cellular metabolic compound salvage,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,APRT,1
GO:0043616,GO:0043616,keratinocyte proliferation,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,MDK,1
GO:0045910,GO:0045910,negative regulation of DNA recombination,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,TERF2IP,1
GO:0060443,GO:0060443,mammary gland morphogenesis,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,IGFBP5,1
GO:0071867,GO:0071867,response to monoamine,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,GNG2,1
GO:0071869,GO:0071869,response to catecholamine,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,GNG2,1
GO:0097484,GO:0097484,dendrite extension,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,SYT1,1
GO:1902253,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,1/317,29/12743,0.5187432968389,0.709080666211349,0.63283152642184,MIF,1
GO:0006820,GO:0006820,anion transport,10/317,394/12743,0.519839902577201,0.710309559013698,0.633928273442281,RTBDN/MFSD2A/CA9/NPC2/PSAP/MIF/SLC25A6/TSPO/RGS2/SYT1,10
GO:0044070,GO:0044070,regulation of anion transport,2/317,70/12743,0.522947189125528,0.712929520252663,0.636266503983637,MIF/RGS2,2
GO:0050906,GO:0050906,detection of stimulus involved in sensory perception,2/317,70/12743,0.522947189125528,0.712929520252663,0.636266503983637,OR51E1/AZGP1,2
GO:0072401,GO:0072401,signal transduction involved in DNA integrity checkpoint,2/317,70/12743,0.522947189125528,0.712929520252663,0.636266503983637,SOX4/CDKN1A,2
GO:0072422,GO:0072422,signal transduction involved in DNA damage checkpoint,2/317,70/12743,0.522947189125528,0.712929520252663,0.636266503983637,SOX4/CDKN1A,2
GO:1901570,GO:1901570,fatty acid derivative biosynthetic process,2/317,70/12743,0.522947189125528,0.712929520252663,0.636266503983637,FABP5/MIF,2
GO:1990748,GO:1990748,cellular detoxification,2/317,70/12743,0.522947189125528,0.712929520252663,0.636266503983637,SELENOW/PARK7,2
GO:0006165,GO:0006165,nucleoside diphosphate phosphorylation,3/317,111/12743,0.524364511273085,0.713106841031698,0.636424757035243,PGAM2/ALDOA/NME4,3
GO:0070374,GO:0070374,positive regulation of ERK1 and ERK2 cascade,3/317,111/12743,0.524364511273085,0.713106841031698,0.636424757035243,MIF/ATP6AP1/JUN,3
GO:0002429,GO:0002429,immune response-activating cell surface receptor signaling pathway,7/317,274/12743,0.525450462710835,0.713106841031698,0.636424757035243,CDC42/RAC1/BRK1/PSMB8/RPS3/PSMA6/CD47,7
GO:0051048,GO:0051048,negative regulation of secretion,4/317,152/12743,0.525630973375906,0.713106841031698,0.636424757035243,CHGA/VAMP8/TMBIM6/ERP29,4
GO:1901292,GO:1901292,nucleoside phosphate catabolic process,4/317,152/12743,0.525630973375906,0.713106841031698,0.636424757035243,PGAM2/NUDT3/ALDOA/NTHL1,4
GO:0070371,GO:0070371,ERK1 and ERK2 cascade,5/317,193/12743,0.526880362396101,0.713106841031698,0.636424757035243,MIF/ATP6AP1/DUSP1/JUN/CNKSR3,5
GO:0009165,GO:0009165,nucleotide biosynthetic process,8/317,315/12743,0.526896040840205,0.713106841031698,0.636424757035243,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA/NME4/NPPA/CTPS1,8
GO:0061008,GO:0061008,hepaticobiliary system development,3/317,112/12743,0.530426003438352,0.713106841031698,0.636424757035243,MDK/HGF/JUN,3
GO:0015918,GO:0015918,sterol transport,2/317,71/12743,0.530587676618071,0.713106841031698,0.636424757035243,NPC2/TSPO,2
GO:0051289,GO:0051289,protein homotetramerization,2/317,71/12743,0.530587676618071,0.713106841031698,0.636424757035243,ALDOA/PCBD1,2
GO:0072395,GO:0072395,signal transduction involved in cell cycle checkpoint,2/317,71/12743,0.530587676618071,0.713106841031698,0.636424757035243,SOX4/CDKN1A,2
GO:0001953,GO:0001953,negative regulation of cell-matrix adhesion,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,APOD,1
GO:0002711,GO:0002711,positive regulation of T cell mediated immunity,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,B2M,1
GO:0007520,GO:0007520,myoblast fusion,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,CD9,1
GO:0014002,GO:0014002,astrocyte development,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,GRN,1
GO:0015701,GO:0015701,bicarbonate transport,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,CA9,1
GO:0018196,GO:0018196,peptidyl-asparagine modification,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,RPN1,1
GO:0021575,GO:0021575,hindbrain morphogenesis,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,HSPA5,1
GO:0032330,GO:0032330,regulation of chondrocyte differentiation,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,MDK,1
GO:0032350,GO:0032350,regulation of hormone metabolic process,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,EGR1,1
GO:0042304,GO:0042304,regulation of fatty acid biosynthetic process,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,FABP5,1
GO:0042461,GO:0042461,photoreceptor cell development,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,VEGFA,1
GO:0043516,GO:0043516,regulation of DNA damage response, signal transduction by p53 class mediator,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,MIF,1
GO:0045981,GO:0045981,positive regulation of nucleotide metabolic process,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,PARK7,1
GO:0046189,GO:0046189,phenol-containing compound biosynthetic process,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,PARK7,1
GO:0048066,GO:0048066,developmental pigmentation,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,CD63,1
GO:0048713,GO:0048713,regulation of oligodendrocyte differentiation,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,MDK,1
GO:0050909,GO:0050909,sensory perception of taste,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,AZGP1,1
GO:0071604,GO:0071604,transforming growth factor beta production,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,CD24,1
GO:1900544,GO:1900544,positive regulation of purine nucleotide metabolic process,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,PARK7,1
GO:1901976,GO:1901976,regulation of cell cycle checkpoint,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,DUSP1,1
GO:1902230,GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,MIF,1
GO:1903115,GO:1903115,regulation of actin filament-based movement,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,DSP,1
GO:1903170,GO:1903170,negative regulation of calcium ion transmembrane transport,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,GEM,1
GO:1904646,GO:1904646,cellular response to amyloid-beta,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,CACNA2D1,1
GO:1905314,GO:1905314,semi-lunar valve development,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,ELN,1
GO:2000279,GO:2000279,negative regulation of DNA biosynthetic process,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,DUSP1,1
GO:2000725,GO:2000725,regulation of cardiac muscle cell differentiation,1/317,30/12743,0.530742539791714,0.713106841031698,0.636424757035243,RGS2,1
GO:0016051,GO:0016051,carbohydrate biosynthetic process,4/317,153/12743,0.530813325897308,0.713106841031698,0.636424757035243,PGAM2/MDH2/AKR1B1/ALDOA,4
GO:0009749,GO:0009749,response to glucose,4/317,154/12743,0.535967910229585,0.719493889945988,0.642124991305284,RHOA/SOX4/RAC1/EGR1,4
GO:0015850,GO:0015850,organic hydroxy compound transport,4/317,154/12743,0.535967910229585,0.719493889945988,0.642124991305284,CHGA/NPC2/PARK7/TSPO,4
GO:0046939,GO:0046939,nucleotide phosphorylation,3/317,113/12743,0.53644427931657,0.719588365139581,0.642209307355374,PGAM2/ALDOA/NME4,3
GO:0051260,GO:0051260,protein homooligomerization,7/317,277/12743,0.537046783421684,0.719588365139581,0.642209307355374,MIF/BRK1/ALDOA/SYT1/PCBD1/ARC/DPYSL3,7
GO:0033559,GO:0033559,unsaturated fatty acid metabolic process,2/317,72/12743,0.538144673799845,0.719588365139581,0.642209307355374,FABP5/MIF,2
GO:0034766,GO:0034766,negative regulation of ion transmembrane transport,2/317,72/12743,0.538144673799845,0.719588365139581,0.642209307355374,GEM/RGS2,2
GO:0043535,GO:0043535,regulation of blood vessel endothelial cell migration,2/317,72/12743,0.538144673799845,0.719588365139581,0.642209307355374,RHOA/VEGFA,2
GO:0008202,GO:0008202,steroid metabolic process,6/317,237/12743,0.540624510731627,0.719588365139581,0.642209307355374,CNBP/NPC2/YWHAH/EGR1/TSPO/AKR1B1,6
GO:0032984,GO:0032984,protein-containing complex disassembly,7/317,278/12743,0.54088733263542,0.719588365139581,0.642209307355374,VAMP8/GABARAP/GABARAPL2/MRPS24/MRPL33/MAP1B/MAP1LC3B,7
GO:1901293,GO:1901293,nucleoside phosphate biosynthetic process,8/317,319/12743,0.541317798237426,0.719588365139581,0.642209307355374,ATP5F1E/ATP5ME/PGAM2/APRT/ALDOA/NME4/NPPA/CTPS1,8
GO:0050707,GO:0050707,regulation of cytokine secretion,3/317,114/12743,0.542418673677147,0.719588365139581,0.642209307355374,MDK/MIF/SELENOK,3
GO:1902850,GO:1902850,microtubule cytoskeleton organization involved in mitosis,3/317,114/12743,0.542418673677147,0.719588365139581,0.642209307355374,RHOA/HSPA1A/HSPA1B,3
GO:0000183,GO:0000183,chromatin silencing at rDNA,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,HIST1H4C,1
GO:0001754,GO:0001754,eye photoreceptor cell differentiation,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,VEGFA,1
GO:0006356,GO:0006356,regulation of transcription by RNA polymerase I,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,NOP53,1
GO:0007431,GO:0007431,salivary gland development,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,HGF,1
GO:0009187,GO:0009187,cyclic nucleotide metabolic process,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,NPPA,1
GO:0010039,GO:0010039,response to iron ion,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,B2M,1
GO:0010559,GO:0010559,regulation of glycoprotein biosynthetic process,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,RAMP1,1
GO:0010659,GO:0010659,cardiac muscle cell apoptotic process,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,MDK,1
GO:0016601,GO:0016601,Rac protein signal transduction,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,BRK1,1
GO:0032371,GO:0032371,regulation of sterol transport,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,TSPO,1
GO:0032374,GO:0032374,regulation of cholesterol transport,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,TSPO,1
GO:0042558,GO:0042558,pteridine-containing compound metabolic process,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,PCBD1,1
GO:0043001,GO:0043001,Golgi to plasma membrane protein transport,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,MACF1,1
GO:0044091,GO:0044091,membrane biogenesis,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,PSAP,1
GO:0050856,GO:0050856,regulation of T cell receptor signaling pathway,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,RPS3,1
GO:0072210,GO:0072210,metanephric nephron development,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,EGR1,1
GO:0072350,GO:0072350,tricarboxylic acid metabolic process,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,MDH2,1
GO:1903955,GO:1903955,positive regulation of protein targeting to mitochondrion,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,TOMM7,1
GO:1904036,GO:1904036,negative regulation of epithelial cell apoptotic process,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,MDK,1
GO:2000107,GO:2000107,negative regulation of leukocyte apoptotic process,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,MIF,1
GO:2000272,GO:2000272,negative regulation of signaling receptor activity,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,LRPAP1,1
GO:2000273,GO:2000273,positive regulation of signaling receptor activity,1/317,31/12743,0.54244352420814,0.719588365139581,0.642209307355374,PARK7,1
GO:0043062,GO:0043062,extracellular structure organization,7/317,279/12743,0.544714979883786,0.72060810245617,0.64311938987963,TIMP1/FSCN1/SPINT2/BSG/MFAP2/ELN/CD47,7
GO:0006403,GO:0006403,RNA localization,5/317,197/12743,0.545172462406256,0.72060810245617,0.64311938987963,KHDRBS1/SRSF9/THOC7/ARC/SFPQ,5
GO:0006476,GO:0006476,protein deacetylation,2/317,73/12743,0.545617595239414,0.72060810245617,0.64311938987963,SFPQ/VEGFA,2
GO:0008585,GO:0008585,female gonad development,2/317,73/12743,0.545617595239414,0.72060810245617,0.64311938987963,HSPA5/VEGFA,2
GO:0016925,GO:0016925,protein sumoylation,2/317,73/12743,0.545617595239414,0.72060810245617,0.64311938987963,PARK7/EGR1,2
GO:0048640,GO:0048640,negative regulation of developmental growth,2/317,73/12743,0.545617595239414,0.72060810245617,0.64311938987963,RGS2/CDKN1A,2
GO:0050810,GO:0050810,regulation of steroid biosynthetic process,2/317,73/12743,0.545617595239414,0.72060810245617,0.64311938987963,EGR1/TSPO,2
GO:0051153,GO:0051153,regulation of striated muscle cell differentiation,2/317,73/12743,0.545617595239414,0.72060810245617,0.64311938987963,YBX1/RGS2,2
GO:0051341,GO:0051341,regulation of oxidoreductase activity,2/317,73/12743,0.545617595239414,0.72060810245617,0.64311938987963,S100A1/PARK7,2
GO:0070252,GO:0070252,actin-mediated cell contraction,2/317,73/12743,0.545617595239414,0.72060810245617,0.64311938987963,DSP/CACNA2D1,2
GO:0071158,GO:0071158,positive regulation of cell cycle arrest,2/317,73/12743,0.545617595239414,0.72060810245617,0.64311938987963,SOX4/CDKN1A,2
GO:0072080,GO:0072080,nephron tubule development,2/317,73/12743,0.545617595239414,0.72060810245617,0.64311938987963,CD24/VEGFA,2
GO:0006611,GO:0006611,protein export from nucleus,4/317,157/12743,0.551259875214738,0.725325388810198,0.647329415150717,CALR/PARK7/SRSF9/THOC7,4
GO:0009746,GO:0009746,response to hexose,4/317,157/12743,0.551259875214738,0.725325388810198,0.647329415150717,RHOA/SOX4/RAC1/EGR1,4
GO:2001021,GO:2001021,negative regulation of response to DNA damage stimulus,2/317,74/12743,0.553005935961339,0.725325388810198,0.647329415150717,MIF/RPS3,2
GO:0010658,GO:0010658,striated muscle cell apoptotic process,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,MDK,1
GO:0019048,GO:0019048,modulation by virus of host morphology or physiology,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,SLC25A6,1
GO:0031641,GO:0031641,regulation of myelination,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,HGF,1
GO:0032365,GO:0032365,intracellular lipid transport,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,NPC2,1
GO:0032801,GO:0032801,receptor catabolic process,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,MYLIP,1
GO:0043268,GO:0043268,positive regulation of potassium ion transport,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,NPPA,1
GO:0045104,GO:0045104,intermediate filament cytoskeleton organization,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,DSP,1
GO:0045581,GO:0045581,negative regulation of T cell differentiation,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,MDK,1
GO:0045668,GO:0045668,negative regulation of osteoblast differentiation,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,IGFBP5,1
GO:0045684,GO:0045684,positive regulation of epidermis development,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,KRT10,1
GO:0048255,GO:0048255,mRNA stabilization,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,YBX1,1
GO:0048488,GO:0048488,synaptic vesicle endocytosis,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,SNCB,1
GO:0090503,GO:0090503,RNA phosphodiester bond hydrolysis, exonucleolytic,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,TRIR,1
GO:0140238,GO:0140238,presynaptic endocytosis,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,SNCB,1
GO:1903053,GO:1903053,regulation of extracellular matrix organization,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,FSCN1,1
GO:1904031,GO:1904031,positive regulation of cyclin-dependent protein kinase activity,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,CDKN1A,1
GO:2001258,GO:2001258,negative regulation of cation channel activity,1/317,32/12743,0.553853640855876,0.725325388810198,0.647329415150717,GEM,1
GO:0021537,GO:0021537,telencephalon development,5/317,199/12743,0.554193161710268,0.725325388810198,0.647329415150717,MDK/MFSD2A/RHOA/CNTNAP2/ASCL1,5
GO:0032496,GO:0032496,response to lipopolysaccharide,5/317,199/12743,0.554193161710268,0.725325388810198,0.647329415150717,S100A14/RHOA/MIF/FOS/TSPO,5
GO:0033157,GO:0033157,regulation of intracellular protein transport,5/317,199/12743,0.554193161710268,0.725325388810198,0.647329415150717,APOD/PARK7/TOMM7/OS9/SVIP,5
GO:0048015,GO:0048015,phosphatidylinositol-mediated signaling,3/317,116/12743,0.554233336039392,0.725325388810198,0.647329415150717,RHOA/HGF/NOP53,3
GO:0051147,GO:0051147,regulation of muscle cell differentiation,3/317,116/12743,0.554233336039392,0.725325388810198,0.647329415150717,YBX1/CDC42/RGS2,3
GO:0048608,GO:0048608,reproductive structure development,8/317,323/12743,0.555567700426866,0.726807089896137,0.648651785375427,SPINT2/BSG/RAB13/MME/BASP1/HSPA5/JUNB/VEGFA,8
GO:0071375,GO:0071375,cellular response to peptide hormone stimulus,6/317,241/12743,0.55707875738422,0.728518782392241,0.650179415483947,RAB13/ATP6AP1/APRT/MAP1B/ATP6V0E2/YWHAG,6
GO:0006405,GO:0006405,RNA export from nucleus,3/317,117/12743,0.560072450354411,0.730617271616162,0.652052249143126,KHDRBS1/SRSF9/THOC7,3
GO:0030902,GO:0030902,hindbrain development,3/317,117/12743,0.560072450354411,0.730617271616162,0.652052249143126,MDK/HSPA5/ASCL1,3
GO:2001251,GO:2001251,negative regulation of chromosome organization,3/317,117/12743,0.560072450354411,0.730617271616162,0.652052249143126,TERF2IP/DUSP1/MAD1L1,3
GO:0006892,GO:0006892,post-Golgi vesicle-mediated transport,2/317,75/12743,0.56030926782914,0.730617271616162,0.652052249143126,VAMP8/MACF1,2
GO:0017158,GO:0017158,regulation of calcium ion-dependent exocytosis,2/317,75/12743,0.56030926782914,0.730617271616162,0.652052249143126,PFN2/SYT1,2
GO:0034644,GO:0034644,cellular response to UV,2/317,75/12743,0.56030926782914,0.730617271616162,0.652052249143126,MME/CDKN1A,2
GO:0048525,GO:0048525,negative regulation of viral process,2/317,75/12743,0.56030926782914,0.730617271616162,0.652052249143126,SNX3/JUN,2
GO:0061326,GO:0061326,renal tubule development,2/317,75/12743,0.56030926782914,0.730617271616162,0.652052249143126,CD24/VEGFA,2
GO:0000959,GO:0000959,mitochondrial RNA metabolic process,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,TRIT1,1
GO:0007223,GO:0007223,Wnt signaling pathway, calcium modulating pathway,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,GNG2,1
GO:0014047,GO:0014047,glutamate secretion,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,SYT1,1
GO:0022602,GO:0022602,ovulation cycle process,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,HSPA5,1
GO:0030501,GO:0030501,positive regulation of bone mineralization,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,ATRAID,1
GO:0031018,GO:0031018,endocrine pancreas development,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,SOX4,1
GO:0045103,GO:0045103,intermediate filament-based process,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,DSP,1
GO:0046164,GO:0046164,alcohol catabolic process,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,NUDT3,1
GO:0050775,GO:0050775,positive regulation of dendrite morphogenesis,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,CAMK2B,1
GO:0060976,GO:0060976,coronary vasculature development,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,VEGFA,1
GO:1901998,GO:1901998,toxin transport,1/317,33/12743,0.564980097928387,0.733780148862916,0.654875014635581,HSPA5,1
GO:0031497,GO:0031497,chromatin assembly,3/317,118/12743,0.56586537422251,0.733869415703435,0.654954682399259,HIST1H1C/CENPV/HIST1H4C,3
GO:0051053,GO:0051053,negative regulation of DNA metabolic process,3/317,118/12743,0.56586537422251,0.733869415703435,0.654954682399259,TERF2IP/DUSP1/RPS3,3
GO:0071222,GO:0071222,cellular response to lipopolysaccharide,3/317,118/12743,0.56586537422251,0.733869415703435,0.654954682399259,RHOA/MIF/TSPO,3
GO:0097479,GO:0097479,synaptic vesicle localization,3/317,118/12743,0.56586537422251,0.733869415703435,0.654954682399259,PFN2/SYT1/PCLO,3
GO:0061458,GO:0061458,reproductive system development,8/317,326/12743,0.566133857021316,0.733952836636002,0.655029132879447,SPINT2/BSG/RAB13/MME/BASP1/HSPA5/JUNB/VEGFA,8
GO:0007009,GO:0007009,plasma membrane organization,2/317,76/12743,0.567527236057471,0.734476097823299,0.655496126539906,PSAP/SERP1,2
GO:0016525,GO:0016525,negative regulation of angiogenesis,2/317,76/12743,0.567527236057471,0.734476097823299,0.655496126539906,RHOA/GTF2I,2
GO:0021510,GO:0021510,spinal cord development,2/317,76/12743,0.567527236057471,0.734476097823299,0.655496126539906,SOX4/ASCL1,2
GO:0060218,GO:0060218,hematopoietic stem cell differentiation,2/317,76/12743,0.567527236057471,0.734476097823299,0.655496126539906,PSMB8/PSMA6,2
GO:0006352,GO:0006352,DNA-templated transcription, initiation,5/317,202/12743,0.567558998540507,0.734476097823299,0.655496126539906,HIST1H4C/GTF2I/CDKN1A/JUN/NPPA,5
GO:0034284,GO:0034284,response to monosaccharide,4/317,161/12743,0.571230555356891,0.738126348492632,0.658753857025267,RHOA/SOX4/RAC1/EGR1,4
GO:1901605,GO:1901605,alpha-amino acid metabolic process,4/317,161/12743,0.571230555356891,0.738126348492632,0.658753857025267,PARK7/ODC1/PCBD1/CTPS1,4
GO:0035304,GO:0035304,regulation of protein dephosphorylation,3/317,119/12743,0.571611614521137,0.738126348492632,0.658753857025267,HSP90B1/BOD1/PPP1R15A,3
GO:0048017,GO:0048017,inositol lipid-mediated signaling,3/317,119/12743,0.571611614521137,0.738126348492632,0.658753857025267,RHOA/HGF/NOP53,3
GO:0050954,GO:0050954,sensory perception of mechanical stimulus,3/317,119/12743,0.571611614521137,0.738126348492632,0.658753857025267,RPL38/PSAP/SLITRK6,3
GO:1903900,GO:1903900,regulation of viral life cycle,3/317,119/12743,0.571611614521137,0.738126348492632,0.658753857025267,PPIB/PPIA/SNX3,3
GO:0046545,GO:0046545,development of primary female sexual characteristics,2/317,77/12743,0.574659555849352,0.738533208105603,0.659116966051059,HSPA5/VEGFA,2
GO:2000181,GO:2000181,negative regulation of blood vessel morphogenesis,2/317,77/12743,0.574659555849352,0.738533208105603,0.659116966051059,RHOA/GTF2I,2
GO:0002067,GO:0002067,glandular epithelial cell differentiation,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,ASCL1,1
GO:0008347,GO:0008347,glial cell migration,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,TSPO,1
GO:0019076,GO:0019076,viral release from host cell,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,PPIA,1
GO:0035307,GO:0035307,positive regulation of protein dephosphorylation,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,PPP1R15A,1
GO:0035890,GO:0035890,exit from host,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,PPIA,1
GO:0035891,GO:0035891,exit from host cell,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,PPIA,1
GO:0035987,GO:0035987,endodermal cell differentiation,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,HSBP1,1
GO:0042108,GO:0042108,positive regulation of cytokine biosynthetic process,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,EGR1,1
GO:0043949,GO:0043949,regulation of cAMP-mediated signaling,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,RGS2,1
GO:0046638,GO:0046638,positive regulation of alpha-beta T cell differentiation,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,RHOA,1
GO:0048512,GO:0048512,circadian behavior,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,EGR1,1
GO:0050999,GO:0050999,regulation of nitric-oxide synthase activity,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,S100A1,1
GO:0052126,GO:0052126,movement in host environment,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,PPIA,1
GO:0052192,GO:0052192,movement in environment of other organism involved in symbiotic interaction,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,PPIA,1
GO:0090382,GO:0090382,phagosome maturation,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,ATP6V0E2,1
GO:0097755,GO:0097755,positive regulation of blood vessel diameter,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,RGS2,1
GO:1905898,GO:1905898,positive regulation of response to endoplasmic reticulum stress,1/317,34/12743,0.575829925541031,0.738533208105603,0.659116966051059,PPP1R15A,1
GO:0008406,GO:0008406,gonad development,4/317,162/12743,0.576145574317916,0.738674514861949,0.659243077753963,RAB13/BASP1/HSPA5/VEGFA,4
GO:0072330,GO:0072330,monocarboxylic acid biosynthetic process,6/317,246/12743,0.577256747431132,0.739640770943637,0.660105430008405,FABP5/MIF/PARK7/RBP1/PGAM2/ALDOA,6
GO:0090263,GO:0090263,positive regulation of canonical Wnt signaling pathway,3/317,120/12743,0.577310710227495,0.739640770943637,0.660105430008405,SOX4/PSMB8/PSMA6,3
GO:0051186,GO:0051186,cofactor metabolic process,11/317,454/12743,0.579289849548637,0.741912008951674,0.662132436361819,CYB5A/PARK7/RAC1/GGCT/TSPO/PGAM2/MDH2/AKR1B1/TMEM14C/ALDOA/PCBD1,11
GO:0032368,GO:0032368,regulation of lipid transport,2/317,78/12743,0.581706009154423,0.744741133515011,0.664657338395067,MIF/TSPO,2
GO:0035148,GO:0035148,tube formation,3/317,121/12743,0.582962231653912,0.744927165554738,0.66482336596467,SPINT2/SOX4/VEGFA,3
GO:0051259,GO:0051259,protein complex oligomerization,11/317,456/12743,0.585199710085283,0.744927165554738,0.66482336596467,MIF/RPS19/KHDRBS1/BRK1/HIST1H4C/ALDOA/KRT10/SYT1/PCBD1/ARC/DPYSL3,11
GO:0002228,GO:0002228,natural killer cell mediated immunity,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,TUBB4B,1
GO:0002762,GO:0002762,negative regulation of myeloid leukocyte differentiation,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,CLDN18,1
GO:0006509,GO:0006509,membrane protein ectodomain proteolysis,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,TIMP1,1
GO:0007622,GO:0007622,rhythmic behavior,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,EGR1,1
GO:0009948,GO:0009948,anterior/posterior axis specification,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,BASP1,1
GO:0010883,GO:0010883,regulation of lipid storage,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,HILPDA,1
GO:0019229,GO:0019229,regulation of vasoconstriction,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,RHOA,1
GO:0030195,GO:0030195,negative regulation of blood coagulation,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,CD9,1
GO:0032205,GO:0032205,negative regulation of telomere maintenance,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,TERF2IP,1
GO:0042130,GO:0042130,negative regulation of T cell proliferation,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,MAD1L1,1
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,TUBB4B,1
GO:0043124,GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,RHOA,1
GO:0045687,GO:0045687,positive regulation of glial cell differentiation,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,MDK,1
GO:0046825,GO:0046825,regulation of protein export from nucleus,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,PARK7,1
GO:0048538,GO:0048538,thymus development,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,MAD1L1,1
GO:0050701,GO:0050701,interleukin-1 secretion,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,S100A13,1
GO:0050819,GO:0050819,negative regulation of coagulation,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,CD9,1
GO:0060119,GO:0060119,inner ear receptor cell development,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,SLITRK6,1
GO:1903018,GO:1903018,regulation of glycoprotein metabolic process,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,RAMP1,1
GO:1905207,GO:1905207,regulation of cardiocyte differentiation,1/317,35/12743,0.586409980116803,0.744927165554738,0.66482336596467,RGS2,1
GO:0002703,GO:0002703,regulation of leukocyte mediated immunity,3/317,122/12743,0.588565779688407,0.745685643887164,0.665500283308126,B2M/VAMP8/NPPA,3
GO:0071219,GO:0071219,cellular response to molecule of bacterial origin,3/317,122/12743,0.588565779688407,0.745685643887164,0.665500283308126,RHOA/MIF/TSPO,3
GO:0034502,GO:0034502,protein localization to chromosome,2/317,79/12743,0.588666441544304,0.745685643887164,0.665500283308126,BOD1/TERF2IP,2
GO:0045069,GO:0045069,regulation of viral genome replication,2/317,79/12743,0.588666441544304,0.745685643887164,0.665500283308126,PPIB/PPIA,2
GO:0046928,GO:0046928,regulation of neurotransmitter secretion,2/317,79/12743,0.588666441544304,0.745685643887164,0.665500283308126,PFN2/SYT1,2
GO:0062014,GO:0062014,negative regulation of small molecule metabolic process,2/317,79/12743,0.588666441544304,0.745685643887164,0.665500283308126,RHOA/TSPO,2
GO:1901532,GO:1901532,regulation of hematopoietic progenitor cell differentiation,2/317,79/12743,0.588666441544304,0.745685643887164,0.665500283308126,PSMB8/PSMA6,2
GO:1903038,GO:1903038,negative regulation of leukocyte cell-cell adhesion,2/317,79/12743,0.588666441544304,0.745685643887164,0.665500283308126,MDK/MAD1L1,2
GO:0060562,GO:0060562,epithelial tube morphogenesis,6/317,249/12743,0.589142306701096,0.746025569774723,0.66580365615207,MDK/SPINT2/RHOA/SOX4/RHOB/VEGFA,6
GO:0043543,GO:0043543,protein acylation,5/317,207/12743,0.589372145499074,0.746053825024356,0.665828873047138,TERF2IP/PARK7/SOX4/SELENOK/MDH2,5
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,4/317,166/12743,0.595483577917484,0.749659019432777,0.669046392279073,EPCAM/CLDN18/CD164/ALCAM,4
GO:0021549,GO:0021549,cerebellum development,2/317,80/12743,0.59554075920129,0.749659019432777,0.669046392279073,MDK/HSPA5,2
GO:0061640,GO:0061640,cytoskeleton-dependent cytokinesis,2/317,80/12743,0.59554075920129,0.749659019432777,0.669046392279073,RHOA/RHOB,2
GO:0097327,GO:0097327,response to antineoplastic agent,2/317,80/12743,0.59554075920129,0.749659019432777,0.669046392279073,EGR1/RPL18A,2
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,B2M,1
GO:0003254,GO:0003254,regulation of membrane depolarization,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,TSPO,1
GO:0006576,GO:0006576,cellular biogenic amine metabolic process,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,ODC1,1
GO:0032720,GO:0032720,negative regulation of tumor necrosis factor production,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,TSPO,1
GO:0042149,GO:0042149,cellular response to glucose starvation,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,HSPA5,1
GO:0044003,GO:0044003,modification by symbiont of host morphology or physiology,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,SLC25A6,1
GO:0045022,GO:0045022,early endosome to late endosome transport,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,SNX3,1
GO:0046503,GO:0046503,glycerolipid catabolic process,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,FABP5,1
GO:0048278,GO:0048278,vesicle docking,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,SYT1,1
GO:0050435,GO:0050435,amyloid-beta metabolic process,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,MME,1
GO:0055010,GO:0055010,ventricular cardiac muscle tissue morphogenesis,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,DSP,1
GO:0070228,GO:0070228,regulation of lymphocyte apoptotic process,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,MIF,1
GO:0090311,GO:0090311,regulation of protein deacetylation,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,VEGFA,1
GO:1900047,GO:1900047,negative regulation of hemostasis,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,CD9,1
GO:1902475,GO:1902475,L-alpha-amino acid transmembrane transport,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,RGS2,1
GO:1903793,GO:1903793,positive regulation of anion transport,1/317,36/12743,0.596726948664409,0.749659019432777,0.669046392279073,MIF,1
GO:0006520,GO:0006520,cellular amino acid metabolic process,7/317,293/12743,0.596807820199335,0.749659019432777,0.669046392279073,PARK7/ODC1/BPHL/PSMB8/PSMA6/PCBD1/CTPS1,7
GO:0031331,GO:0031331,positive regulation of cellular catabolic process,7/317,293/12743,0.596807820199335,0.749659019432777,0.669046392279073,HSPA1A/PARK7/TOMM7/SVIP/RBX1/NOP53/ZFAND2A,7
GO:0017038,GO:0017038,protein import,3/317,124/12743,0.599627507496134,0.752674891567249,0.67173796047053,APOD/TOMM7/CDKN1A,3
GO:0042770,GO:0042770,signal transduction in response to DNA damage,3/317,124/12743,0.599627507496134,0.752674891567249,0.67173796047053,MIF/SOX4/CDKN1A,3
GO:0045137,GO:0045137,development of primary sexual characteristics,4/317,167/12743,0.600235861083646,0.753134842117997,0.672148451438593,RAB13/BASP1/HSPA5/VEGFA,4
GO:0007265,GO:0007265,Ras protein signal transduction,7/317,294/12743,0.600412922812289,0.753134842117997,0.672148451438593,RHOA/PARK7/RAC1/BRK1/RHOB/CDKN1A/JUN,7
GO:0070588,GO:0070588,calcium ion transmembrane transport,5/317,210/12743,0.602168649582642,0.754485187815314,0.673353591233754,S100A1/TSPAN13/GEM/CACNA2D1/NPPA,5
GO:0035601,GO:0035601,protein deacylation,2/317,81/12743,0.602328926016676,0.754485187815314,0.673353591233754,SFPQ/VEGFA,2
GO:0035725,GO:0035725,sodium ion transmembrane transport,2/317,81/12743,0.602328926016676,0.754485187815314,0.673353591233754,YWHAH/CNKSR3,2
GO:0099175,GO:0099175,regulation of postsynapse organization,2/317,81/12743,0.602328926016676,0.754485187815314,0.673353591233754,ARC/CAMK2B,2
GO:0007254,GO:0007254,JNK cascade,4/317,168/12743,0.604954634596264,0.75559422717696,0.674343372940597,GADD45G/GADD45B/RPS3/GRIK2,4
GO:0031047,GO:0031047,gene silencing by RNA,4/317,168/12743,0.604954634596264,0.75559422717696,0.674343372940597,NEAT1/HIST1H4C/MEG3/DDX17,4
GO:0006090,GO:0006090,pyruvate metabolic process,3/317,125/12743,0.605085035172016,0.75559422717696,0.674343372940597,BSG/PGAM2/ALDOA,3
GO:0007269,GO:0007269,neurotransmitter secretion,3/317,125/12743,0.605085035172016,0.75559422717696,0.674343372940597,PFN2/SYT1/PCLO,3
GO:0043467,GO:0043467,regulation of generation of precursor metabolites and energy,3/317,125/12743,0.605085035172016,0.75559422717696,0.674343372940597,RHOA/PARK7/NOP53,3
GO:0099643,GO:0099643,signal release from synapse,3/317,125/12743,0.605085035172016,0.75559422717696,0.674343372940597,PFN2/SYT1/PCLO,3
GO:0008542,GO:0008542,visual learning,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,MEIS2,1
GO:0010718,GO:0010718,positive regulation of epithelial to mesenchymal transition,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,MDK,1
GO:0014075,GO:0014075,response to amine,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,RGS2,1
GO:0021795,GO:0021795,cerebral cortex cell migration,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,RHOA,1
GO:0032506,GO:0032506,cytokinetic process,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,RHOA,1
GO:0032663,GO:0032663,regulation of interleukin-2 production,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,RPS3,1
GO:0043489,GO:0043489,RNA stabilization,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,YBX1,1
GO:0044088,GO:0044088,regulation of vacuole organization,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,GRN,1
GO:0045010,GO:0045010,actin nucleation,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,BRK1,1
GO:0070169,GO:0070169,positive regulation of biomineral tissue development,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,ATRAID,1
GO:1904645,GO:1904645,response to amyloid-beta,1/317,37/12743,0.606787352951289,0.75559422717696,0.674343372940597,CACNA2D1,1
GO:0014066,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,2/317,82/12743,0.609030960795183,0.75760079725214,0.676134171736922,HGF/NOP53,2
GO:0050864,GO:0050864,regulation of B cell activation,2/317,82/12743,0.609030960795183,0.75760079725214,0.676134171736922,MIF/CDKN1A,2
GO:0098732,GO:0098732,macromolecule deacylation,2/317,82/12743,0.609030960795183,0.75760079725214,0.676134171736922,SFPQ/VEGFA,2
GO:1902115,GO:1902115,regulation of organelle assembly,4/317,169/12743,0.609639615106593,0.758095612697407,0.676575778494019,FSCN1/RHOA/HSPA1A/HSPA1B,4
GO:0071695,GO:0071695,anatomical structure maturation,3/317,126/12743,0.610493283786723,0.758743224527193,0.677153751074997,RHOA/CNTNAP2/CDKN1A,3
GO:0009896,GO:0009896,positive regulation of catabolic process,8/317,339/12743,0.610582516983913,0.758743224527193,0.677153751074997,HSPA1A/PARK7/TOMM7/MYLIP/SVIP/RBX1/NOP53/ZFAND2A,8
GO:0006473,GO:0006473,protein acetylation,4/317,170/12743,0.614290534809077,0.761479974269727,0.679596211572836,TERF2IP/PARK7/SOX4/MDH2,4
GO:0014013,GO:0014013,regulation of gliogenesis,2/317,83/12743,0.615646934561992,0.761479974269727,0.679596211572836,MDK/TSPO,2
GO:0042303,GO:0042303,molting cycle,2/317,83/12743,0.615646934561992,0.761479974269727,0.679596211572836,IGFBP5/SNRPE,2
GO:0042633,GO:0042633,hair cycle,2/317,83/12743,0.615646934561992,0.761479974269727,0.679596211572836,IGFBP5/SNRPE,2
GO:0043279,GO:0043279,response to alkaloid,2/317,83/12743,0.615646934561992,0.761479974269727,0.679596211572836,SRSF9/HSPA5,2
GO:0051208,GO:0051208,sequestering of calcium ion,2/317,83/12743,0.615646934561992,0.761479974269727,0.679596211572836,HSP90B1/CALR,2
GO:0010517,GO:0010517,regulation of phospholipase activity,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,RGS2,1
GO:0010569,GO:0010569,regulation of double-strand break repair via homologous recombination,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,TERF2IP,1
GO:0019068,GO:0019068,virion assembly,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,PPIA,1
GO:0042220,GO:0042220,response to cocaine,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,HSPA5,1
GO:0045599,GO:0045599,negative regulation of fat cell differentiation,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,CCDC85B,1
GO:0045620,GO:0045620,negative regulation of lymphocyte differentiation,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,MDK,1
GO:0048663,GO:0048663,neuron fate commitment,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,ASCL1,1
GO:0060412,GO:0060412,ventricular septum morphogenesis,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,SOX4,1
GO:0060999,GO:0060999,positive regulation of dendritic spine development,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,CAMK2B,1
GO:0061383,GO:0061383,trabecula morphogenesis,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,RHOA,1
GO:1903428,GO:1903428,positive regulation of reactive oxygen species biosynthetic process,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,PARK7,1
GO:1903556,GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,1/317,38/12743,0.616597553574179,0.761479974269727,0.679596211572836,TSPO,1
GO:0050673,GO:0050673,epithelial cell proliferation,7/317,299/12743,0.618186784460624,0.763180456777453,0.681113837129837,MDK/GRN/IGFBP5/HGF/PDCD6/JUN/VEGFA,7
GO:0015849,GO:0015849,organic acid transport,5/317,214/12743,0.61887579110512,0.763506681202095,0.681404981861939,MFSD2A/PSAP/MIF/RGS2/SYT1,5
GO:0046942,GO:0046942,carboxylic acid transport,5/317,214/12743,0.61887579110512,0.763506681202095,0.681404981861939,MFSD2A/PSAP/MIF/RGS2/SYT1,5
GO:0000077,GO:0000077,DNA damage checkpoint,3/317,128/12743,0.621160940355052,0.766062977899284,0.683686393861948,SOX4/NOP53/CDKN1A,3
GO:0045444,GO:0045444,fat cell differentiation,4/317,172/12743,0.623489196704641,0.767755353130047,0.685196783936866,RGS2/PSMB8/ARL4A/CCDC85B,4
GO:0005975,GO:0005975,carbohydrate metabolic process,11/317,470/12743,0.625511442441082,0.767755353130047,0.685196783936866,APOD/FABP5/TFF3/CYB5A/IGFBP5/SERP1/PGAM2/MDH2/AKR1B1/ALDOA/CHID1,11
GO:0001706,GO:0001706,endoderm formation,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,HSBP1,1
GO:0010596,GO:0010596,negative regulation of endothelial cell migration,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,RHOA,1
GO:0018023,GO:0018023,peptidyl-lysine trimethylation,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,HIST1H1C,1
GO:0030837,GO:0030837,negative regulation of actin filament polymerization,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,PFN2,1
GO:0032007,GO:0032007,negative regulation of TOR signaling,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,PDCD6,1
GO:0032873,GO:0032873,negative regulation of stress-activated MAPK cascade,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,DUSP1,1
GO:0035272,GO:0035272,exocrine system development,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,HGF,1
GO:0035904,GO:0035904,aorta development,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,SOX4,1
GO:0042551,GO:0042551,neuron maturation,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,CNTNAP2,1
GO:0045744,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,RGS2,1
GO:0050885,GO:0050885,neuromuscular process controlling balance,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,PSAP,1
GO:0060193,GO:0060193,positive regulation of lipase activity,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,RHOA,1
GO:0070303,GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,DUSP1,1
GO:0098927,GO:0098927,vesicle-mediated transport between endosomal compartments,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,SNX3,1
GO:1902373,GO:1902373,negative regulation of mRNA catabolic process,1/317,39/12743,0.626163753929707,0.767755353130047,0.685196783936866,YBX1,1
GO:0000070,GO:0000070,mitotic sister chromatid segregation,3/317,129/12743,0.626419911247902,0.767807562542177,0.685243379146053,BOD1/DUSP1/MAD1L1,3
GO:0072659,GO:0072659,protein localization to plasma membrane,5/317,216/12743,0.627073115348976,0.768346233701284,0.6857241257072,BSG/RAMP1/VAMP8/RAB13/MACF1,5
GO:0006066,GO:0006066,alcohol metabolic process,6/317,259/12743,0.627469513587602,0.768569983423315,0.685923815086528,CNBP/NPC2/PARK7/AKR1B1/NUDT3/PCBD1,6
GO:0050792,GO:0050792,regulation of viral process,4/317,173/12743,0.628036478629693,0.769002432109586,0.686309761531372,PPIB/PPIA/SNX3/JUN,4
GO:1901343,GO:1901343,negative regulation of vasculature development,2/317,85/12743,0.628621228797512,0.769456355984697,0.686714873886643,RHOA/GTF2I,2
GO:0051216,GO:0051216,cartilage development,3/317,130/12743,0.631628727546055,0.772874498137532,0.689765455039366,TIMP1/MDK/BMP8B,3
GO:0050730,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,4/317,174/12743,0.632548778680269,0.773128174177486,0.689991852688084,CD24/MIF/HGF/VEGFA,4
GO:0001841,GO:0001841,neural tube formation,2/317,86/12743,0.63497992955279,0.773128174177486,0.689991852688084,SPINT2/SOX4,2
GO:0035335,GO:0035335,peptidyl-tyrosine dephosphorylation,2/317,86/12743,0.63497992955279,0.773128174177486,0.689991852688084,DUSP1/DUSP2,2
GO:0042476,GO:0042476,odontogenesis,2/317,86/12743,0.63497992955279,0.773128174177486,0.689991852688084,BSG/RHOA,2
GO:0046660,GO:0046660,female sex differentiation,2/317,86/12743,0.63497992955279,0.773128174177486,0.689991852688084,HSPA5/VEGFA,2
GO:0070125,GO:0070125,mitochondrial translational elongation,2/317,86/12743,0.63497992955279,0.773128174177486,0.689991852688084,MRPS24/MRPL33,2
GO:0000768,GO:0000768,syncytium formation by plasma membrane fusion,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,CD9,1
GO:0003229,GO:0003229,ventricular cardiac muscle tissue development,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,DSP,1
GO:0007080,GO:0007080,mitotic metaphase plate congression,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,BOD1,1
GO:0021879,GO:0021879,forebrain neuron differentiation,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,ASCL1,1
GO:0031663,GO:0031663,lipopolysaccharide-mediated signaling pathway,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,MIF,1
GO:0032456,GO:0032456,endocytic recycling,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,RAB13,1
GO:0034080,GO:0034080,CENP-A containing nucleosome assembly,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,HIST1H4C,1
GO:0050434,GO:0050434,positive regulation of viral transcription,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,JUN,1
GO:0061641,GO:0061641,CENP-A containing chromatin organization,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,HIST1H4C,1
GO:0140253,GO:0140253,cell-cell fusion,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,CD9,1
GO:2000677,GO:2000677,regulation of transcription regulatory region DNA binding,1/317,40/12743,0.635492004087475,0.773128174177486,0.689991852688084,PARK7,1
GO:0001654,GO:0001654,eye development,6/317,262/12743,0.638559270701619,0.776596947960866,0.693087620931035,RPL24/MFAP2/MEIS2/SLITRK6/JUN/VEGFA,6
GO:0001824,GO:0001824,blastocyst development,2/317,87/12743,0.641253325149796,0.77907982326757,0.695303506718264,TM4SF1/JUNB,2
GO:0006900,GO:0006900,vesicle budding from membrane,2/317,87/12743,0.641253325149796,0.77907982326757,0.695303506718264,PDCD6/SNX3,2
GO:0050777,GO:0050777,negative regulation of immune response,2/317,87/12743,0.641253325149796,0.77907982326757,0.695303506718264,GRN/RPS19,2
GO:0065004,GO:0065004,protein-DNA complex assembly,4/317,176/12743,0.641467670896247,0.77907982326757,0.695303506718264,HIST1H1C/CENPV/HIST1H4C/RBX1,4
GO:0150063,GO:0150063,visual system development,6/317,263/12743,0.642212349045958,0.779720835805545,0.695875589645063,RPL24/MFAP2/MEIS2/SLITRK6/JUN/VEGFA,6
GO:0007632,GO:0007632,visual behavior,1/317,41/12743,0.644588204568013,0.780496664002023,0.696567991180196,MEIS2,1
GO:0042059,GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,1/317,41/12743,0.644588204568013,0.780496664002023,0.696567991180196,CDC42,1
GO:0043392,GO:0043392,negative regulation of DNA binding,1/317,41/12743,0.644588204568013,0.780496664002023,0.696567991180196,JUN,1
GO:0045747,GO:0045747,positive regulation of Notch signaling pathway,1/317,41/12743,0.644588204568013,0.780496664002023,0.696567991180196,ASCL1,1
GO:0071398,GO:0071398,cellular response to fatty acid,1/317,41/12743,0.644588204568013,0.780496664002023,0.696567991180196,GNG2,1
GO:0097366,GO:0097366,response to bronchodilator,1/317,41/12743,0.644588204568013,0.780496664002023,0.696567991180196,RGS2,1
GO:1901016,GO:1901016,regulation of potassium ion transmembrane transporter activity,1/317,41/12743,0.644588204568013,0.780496664002023,0.696567991180196,NPPA,1
GO:1903214,GO:1903214,regulation of protein targeting to mitochondrion,1/317,41/12743,0.644588204568013,0.780496664002023,0.696567991180196,TOMM7,1
GO:0001959,GO:0001959,regulation of cytokine-mediated signaling pathway,3/317,133/12743,0.646952794887233,0.782370739466153,0.698240542827856,HSPA1A/CD24/HSPA1B,3
GO:0006606,GO:0006606,protein import into nucleus,2/317,88/12743,0.647441710684786,0.782370739466153,0.698240542827856,APOD/CDKN1A,2
GO:0032092,GO:0032092,positive regulation of protein binding,2/317,88/12743,0.647441710684786,0.782370739466153,0.698240542827856,B2M/PARK7,2
GO:0048284,GO:0048284,organelle fusion,2/317,88/12743,0.647441710684786,0.782370739466153,0.698240542827856,CALR/SYT1,2
GO:0070126,GO:0070126,mitochondrial translational termination,2/317,88/12743,0.647441710684786,0.782370739466153,0.698240542827856,MRPS24/MRPL33,2
GO:0098693,GO:0098693,regulation of synaptic vesicle cycle,2/317,88/12743,0.647441710684786,0.782370739466153,0.698240542827856,PFN2/SYT1,2
GO:0061448,GO:0061448,connective tissue development,4/317,178/12743,0.650244486764608,0.785493592042597,0.701027587598517,TIMP1/MDK/BMP8B/EGR1,4
GO:0009132,GO:0009132,nucleoside diphosphate metabolic process,3/317,134/12743,0.651959652963624,0.785521826262877,0.701052785725569,PGAM2/ALDOA/NME4,3
GO:0048880,GO:0048880,sensory system development,6/317,266/12743,0.653039016784688,0.785521826262877,0.701052785725569,RPL24/MFAP2/MEIS2/SLITRK6/JUN/VEGFA,6
GO:0001541,GO:0001541,ovarian follicle development,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,VEGFA,1
GO:0006893,GO:0006893,Golgi to plasma membrane transport,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,MACF1,1
GO:0006949,GO:0006949,syncytium formation,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,CD9,1
GO:0015807,GO:0015807,L-amino acid transport,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,RGS2,1
GO:0032623,GO:0032623,interleukin-2 production,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,RPS3,1
GO:0032945,GO:0032945,negative regulation of mononuclear cell proliferation,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,MAD1L1,1
GO:0046530,GO:0046530,photoreceptor cell differentiation,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,VEGFA,1
GO:0046635,GO:0046635,positive regulation of alpha-beta T cell activation,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,RHOA,1
GO:0050672,GO:0050672,negative regulation of lymphocyte proliferation,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,MAD1L1,1
GO:0051145,GO:0051145,smooth muscle cell differentiation,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,VEGFA,1
GO:0061098,GO:0061098,positive regulation of protein tyrosine kinase activity,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,CD24,1
GO:0070534,GO:0070534,protein K63-linked ubiquitination,1/317,42/12743,0.653458110027936,0.785521826262877,0.701052785725569,UBE2S,1
GO:0031124,GO:0031124,mRNA 3'-end processing,2/317,89/12743,0.653545419291311,0.785521826262877,0.701052785725569,SRSF9/THOC7,2
GO:0007416,GO:0007416,synapse assembly,3/317,135/12743,0.656915798337537,0.789308922133505,0.704432646120466,MAP1B/SLITRK6/PCLO,3
GO:1901617,GO:1901617,organic hydroxy compound biosynthetic process,4/317,180/12743,0.658878054438167,0.791402140228938,0.70630077546821,CNBP/PARK7/AKR1B1/PCBD1,4
GO:0003206,GO:0003206,cardiac chamber morphogenesis,2/317,90/12743,0.659564820077388,0.791433754398601,0.706328990090604,SOX4/DSP,2
GO:0006275,GO:0006275,regulation of DNA replication,2/317,90/12743,0.659564820077388,0.791433754398601,0.706328990090604,RAC1/JUN,2
GO:0030048,GO:0030048,actin filament-based movement,2/317,90/12743,0.659564820077388,0.791433754398601,0.706328990090604,DSP/CACNA2D1,2
GO:0009952,GO:0009952,anterior/posterior pattern specification,3/317,136/12743,0.661821184174212,0.79210511201737,0.706928155019089,BASP1/TSHZ1/ARC,3
GO:0031570,GO:0031570,DNA integrity checkpoint,3/317,136/12743,0.661821184174212,0.79210511201737,0.706928155019089,SOX4/NOP53/CDKN1A,3
GO:0051028,GO:0051028,mRNA transport,3/317,136/12743,0.661821184174212,0.79210511201737,0.706928155019089,SRSF9/THOC7/ARC,3
GO:0031648,GO:0031648,protein destabilization,1/317,43/12743,0.662107332854575,0.79210511201737,0.706928155019089,MYLIP,1
GO:0034198,GO:0034198,cellular response to amino acid starvation,1/317,43/12743,0.662107332854575,0.79210511201737,0.706928155019089,CDKN1A,1
GO:0035306,GO:0035306,positive regulation of dephosphorylation,1/317,43/12743,0.662107332854575,0.79210511201737,0.706928155019089,PPP1R15A,1
GO:0043954,GO:0043954,cellular component maintenance,1/317,43/12743,0.662107332854575,0.79210511201737,0.706928155019089,PCLO,1
GO:0046637,GO:0046637,regulation of alpha-beta T cell differentiation,1/317,43/12743,0.662107332854575,0.79210511201737,0.706928155019089,RHOA,1
GO:0070265,GO:0070265,necrotic cell death,1/317,43/12743,0.662107332854575,0.79210511201737,0.706928155019089,TSPO,1
GO:0010923,GO:0010923,negative regulation of phosphatase activity,2/317,91/12743,0.665500316141185,0.795634731136535,0.710078225753359,BOD1/PPP1R15A,2
GO:0050709,GO:0050709,negative regulation of protein secretion,2/317,91/12743,0.665500316141185,0.795634731136535,0.710078225753359,TMBIM6/ERP29,2
GO:0051604,GO:0051604,protein maturation,5/317,226/12743,0.666437695854138,0.796245661960338,0.71062346172465,PCSK1N/CALR/SOX4/MME/SCG5,5
GO:0048839,GO:0048839,inner ear development,3/317,137/12743,0.666675783727571,0.796245661960338,0.71062346172465,MYCL/PSAP/SLITRK6,3
GO:0099173,GO:0099173,postsynapse organization,3/317,137/12743,0.666675783727571,0.796245661960338,0.71062346172465,CDC42/ARC/CAMK2B,3
GO:0000186,GO:0000186,activation of MAPKK activity,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,GADD45B,1
GO:0002709,GO:0002709,regulation of T cell mediated immunity,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,B2M,1
GO:0022029,GO:0022029,telencephalon cell migration,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,RHOA,1
GO:0031341,GO:0031341,regulation of cell killing,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,B2M,1
GO:0033059,GO:0033059,cellular pigmentation,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,CD63,1
GO:0043536,GO:0043536,positive regulation of blood vessel endothelial cell migration,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,VEGFA,1
GO:0050771,GO:0050771,negative regulation of axonogenesis,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,RHOA,1
GO:0050854,GO:0050854,regulation of antigen receptor-mediated signaling pathway,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,RPS3,1
GO:0090342,GO:0090342,regulation of cell aging,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,MIF,1
GO:0098586,GO:0098586,cellular response to virus,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,NOP53,1
GO:1901616,GO:1901616,organic hydroxy compound catabolic process,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,NUDT3,1
GO:2001238,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,1/317,44/12743,0.670541346672299,0.797682376335842,0.711905682767483,PDIA3,1
GO:0006304,GO:0006304,DNA modification,2/317,92/12743,0.671352342662644,0.797855098139572,0.712059831382597,FOS/NTHL1,2
GO:0007498,GO:0007498,mesoderm development,2/317,92/12743,0.671352342662644,0.797855098139572,0.712059831382597,RPL38/VEGFA,2
GO:0043534,GO:0043534,blood vessel endothelial cell migration,2/317,92/12743,0.671352342662644,0.797855098139572,0.712059831382597,RHOA/VEGFA,2
GO:0051188,GO:0051188,cofactor biosynthetic process,6/317,272/12743,0.67408445347736,0.800837280320921,0.714721332382159,GGCT/TSPO/PGAM2/TMEM14C/ALDOA/PCBD1,6
GO:0006814,GO:0006814,sodium ion transport,3/317,139/12743,0.676232613698012,0.801366809752667,0.715193920247751,YWHAH/SGK1/CNKSR3,3
GO:0009314,GO:0009314,response to radiation,8/317,360/12743,0.677093700943294,0.801366809752667,0.715193920247751,FOS/MME/EGR1/RHOB/MEIS2/DUSP1/HSPA5/CDKN1A,8
GO:0006096,GO:0006096,glycolytic process,2/317,93/12743,0.677121365068484,0.801366809752667,0.715193920247751,PGAM2/ALDOA,2
GO:0043200,GO:0043200,response to amino acid,2/317,93/12743,0.677121365068484,0.801366809752667,0.715193920247751,RHOA/TMBIM6,2
GO:0051250,GO:0051250,negative regulation of lymphocyte activation,2/317,93/12743,0.677121365068484,0.801366809752667,0.715193920247751,MDK/MAD1L1,2
GO:0000209,GO:0000209,protein polyubiquitination,6/317,273/12743,0.677511945231827,0.801366809752667,0.715193920247751,MYLIP/PSMB8/RBX1/RNF187/PSMA6/UBE2S,6
GO:0001658,GO:0001658,branching involved in ureteric bud morphogenesis,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,VEGFA,1
GO:0002011,GO:0002011,morphogenesis of an epithelial sheet,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,RHOA,1
GO:0002637,GO:0002637,regulation of immunoglobulin production,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,TMBIM6,1
GO:0007193,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,RGS2,1
GO:0009880,GO:0009880,embryonic pattern specification,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,BASP1,1
GO:0021885,GO:0021885,forebrain cell migration,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,RHOA,1
GO:0036465,GO:0036465,synaptic vesicle recycling,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,SNCB,1
GO:0042310,GO:0042310,vasoconstriction,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,RHOA,1
GO:0046579,GO:0046579,positive regulation of Ras protein signal transduction,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,RAC1,1
GO:0061035,GO:0061035,regulation of cartilage development,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,MDK,1
GO:0070664,GO:0070664,negative regulation of leukocyte proliferation,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,MAD1L1,1
GO:1901185,GO:1901185,negative regulation of ERBB signaling pathway,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,CDC42,1
GO:1902369,GO:1902369,negative regulation of RNA catabolic process,1/317,45/12743,0.67876548976269,0.801366809752667,0.715193920247751,YBX1,1
GO:0007266,GO:0007266,Rho protein signal transduction,3/317,140/12743,0.68093488548384,0.803664121245701,0.717244196341965,RHOA/RAC1/RHOB,3
GO:0051098,GO:0051098,regulation of binding,7/317,318/12743,0.681613345096706,0.804200845297886,0.717723205173254,B2M/LRPAP1/PARK7/TMBIM6/HSPA5/PCBD1/JUN,7
GO:0006757,GO:0006757,ATP generation from ADP,2/317,94/12743,0.68280787726815,0.804756180378245,0.71821882374435,PGAM2/ALDOA,2
GO:0010906,GO:0010906,regulation of glucose metabolic process,2/317,94/12743,0.68280787726815,0.804756180378245,0.71821882374435,TFF3/IGFBP5,2
GO:0007596,GO:0007596,blood coagulation,5/317,231/12743,0.685076571955118,0.804756180378245,0.71821882374435,CD9/GNG2/CDC42/RAC1/PABPC4,5
GO:0006333,GO:0006333,chromatin assembly or disassembly,3/317,141/12743,0.685586452523115,0.804756180378245,0.71821882374435,HIST1H1C/CENPV/HIST1H4C,3
GO:0060759,GO:0060759,regulation of response to cytokine stimulus,3/317,141/12743,0.685586452523115,0.804756180378245,0.71821882374435,HSPA1A/CD24/HSPA1B,3
GO:0010611,GO:0010611,regulation of cardiac muscle hypertrophy,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,RGS2,1
GO:0015909,GO:0015909,long-chain fatty acid transport,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,MIF,1
GO:0032370,GO:0032370,positive regulation of lipid transport,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,MIF,1
GO:0042306,GO:0042306,regulation of protein import into nucleus,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,APOD,1
GO:0043113,GO:0043113,receptor clustering,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,GRIK2,1
GO:0045604,GO:0045604,regulation of epidermal cell differentiation,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,MYCL,1
GO:0050766,GO:0050766,positive regulation of phagocytosis,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,CALR,1
GO:0050795,GO:0050795,regulation of behavior,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,MDK,1
GO:0055008,GO:0055008,cardiac muscle tissue morphogenesis,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,DSP,1
GO:0055021,GO:0055021,regulation of cardiac muscle tissue growth,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,RGS2,1
GO:0061951,GO:0061951,establishment of protein localization to plasma membrane,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,MACF1,1
GO:0070849,GO:0070849,response to epidermal growth factor,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,ASCL1,1
GO:0099072,GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,ARC,1
GO:1901607,GO:1901607,alpha-amino acid biosynthetic process,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,PARK7,1
GO:1990928,GO:1990928,response to amino acid starvation,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,CDKN1A,1
GO:2000756,GO:2000756,regulation of peptidyl-lysine acetylation,1/317,46/12743,0.686784968400683,0.804756180378245,0.71821882374435,SOX4,1
GO:0048568,GO:0048568,embryonic organ development,7/317,320/12743,0.687888951611686,0.805612818310603,0.71898334535121,SPINT2/RPL38/MFAP2/SLITRK6/TSHZ1/JUNB/VEGFA,7
GO:0002792,GO:0002792,negative regulation of peptide secretion,2/317,95/12743,0.688412399958324,0.805612818310603,0.71898334535121,TMBIM6/ERP29,2
GO:0019218,GO:0019218,regulation of steroid metabolic process,2/317,95/12743,0.688412399958324,0.805612818310603,0.71898334535121,EGR1/TSPO,2
GO:2000134,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,2/317,95/12743,0.688412399958324,0.805612818310603,0.71898334535121,SOX4/CDKN1A,2
GO:0050817,GO:0050817,coagulation,5/317,232/12743,0.688719242613199,0.805709624859892,0.719069742060743,CD9/GNG2/CDC42/RAC1/PABPC4,5
GO:0035195,GO:0035195,gene silencing by miRNA,3/317,142/12743,0.690187379328604,0.807164485584363,0.720368158132242,NEAT1/HIST1H4C/MEG3,3
GO:0043122,GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,4/317,188/12743,0.691963448338533,0.808386038229478,0.72145835430011,S100A4/RHOA/TERF2IP/S100A13,4
GO:0002220,GO:0002220,innate immune response activating cell surface receptor signaling pathway,2/317,96/12743,0.693935478993695,0.808386038229478,0.72145835430011,PSMB8/PSMA6,2
GO:0002223,GO:0002223,stimulatory C-type lectin receptor signaling pathway,2/317,96/12743,0.693935478993695,0.808386038229478,0.72145835430011,PSMB8/PSMA6,2
GO:0003231,GO:0003231,cardiac ventricle development,2/317,96/12743,0.693935478993695,0.808386038229478,0.72145835430011,SOX4/DSP,2
GO:0015718,GO:0015718,monocarboxylic acid transport,2/317,96/12743,0.693935478993695,0.808386038229478,0.72145835430011,MFSD2A/MIF,2
GO:0031644,GO:0031644,regulation of neurological system process,2/317,96/12743,0.693935478993695,0.808386038229478,0.72145835430011,FABP5/HGF,2
GO:0042866,GO:0042866,pyruvate biosynthetic process,2/317,96/12743,0.693935478993695,0.808386038229478,0.72145835430011,PGAM2/ALDOA,2
GO:0045580,GO:0045580,regulation of T cell differentiation,2/317,96/12743,0.693935478993695,0.808386038229478,0.72145835430011,MDK/RHOA,2
GO:0071804,GO:0071804,cellular potassium ion transport,2/317,96/12743,0.693935478993695,0.808386038229478,0.72145835430011,CD63/NPPA,2
GO:0071805,GO:0071805,potassium ion transmembrane transport,2/317,96/12743,0.693935478993695,0.808386038229478,0.72145835430011,CD63/NPPA,2
GO:0002260,GO:0002260,lymphocyte homeostasis,1/317,47/12743,0.694604860108723,0.808386038229478,0.72145835430011,MIF,1
GO:0032651,GO:0032651,regulation of interleukin-1 beta production,1/317,47/12743,0.694604860108723,0.808386038229478,0.72145835430011,EGR1,1
GO:0043388,GO:0043388,positive regulation of DNA binding,1/317,47/12743,0.694604860108723,0.808386038229478,0.72145835430011,PARK7,1
GO:0051568,GO:0051568,histone H3-K4 methylation,1/317,47/12743,0.694604860108723,0.808386038229478,0.72145835430011,HIST1H1C,1
GO:1901880,GO:1901880,negative regulation of protein depolymerization,1/317,47/12743,0.694604860108723,0.808386038229478,0.72145835430011,MAP1B,1
GO:0048511,GO:0048511,rhythmic process,5/317,234/12743,0.695918945085512,0.80965327106227,0.72258931855583,MDK/EGR1/HSPA5/SFPQ/JUN,5
GO:0035305,GO:0035305,negative regulation of dephosphorylation,2/317,97/12743,0.69937768382177,0.81288806121541,0.725476263987869,BOD1/PPP1R15A,2
GO:0051193,GO:0051193,regulation of cofactor metabolic process,2/317,97/12743,0.69937768382177,0.81288806121541,0.725476263987869,RAC1/TMEM14C,2
GO:0060402,GO:0060402,calcium ion transport into cytosol,2/317,97/12743,0.69937768382177,0.81288806121541,0.725476263987869,TMBIM6/CACNA2D1,2
GO:0043903,GO:0043903,regulation of symbiosis, encompassing mutualism through parasitism,4/317,190/12743,0.699870122278544,0.813197507948083,0.725752435173342,PPIB/PPIA/SNX3/JUN,4
GO:0007585,GO:0007585,respiratory gaseous exchange,1/317,48/12743,0.702230116830961,0.813573080891816,0.726087621860261,ELN,1
GO:0008333,GO:0008333,endosome to lysosome transport,1/317,48/12743,0.702230116830961,0.813573080891816,0.726087621860261,RHOB,1
GO:0014032,GO:0014032,neural crest cell development,1/317,48/12743,0.702230116830961,0.813573080891816,0.726087621860261,PDCD6,1
GO:0014855,GO:0014855,striated muscle cell proliferation,1/317,48/12743,0.702230116830961,0.813573080891816,0.726087621860261,AKIRIN1,1
GO:0015800,GO:0015800,acidic amino acid transport,1/317,48/12743,0.702230116830961,0.813573080891816,0.726087621860261,SYT1,1
GO:0046427,GO:0046427,positive regulation of JAK-STAT cascade,1/317,48/12743,0.702230116830961,0.813573080891816,0.726087621860261,AKR1B1,1
GO:0050891,GO:0050891,multicellular organismal water homeostasis,1/317,48/12743,0.702230116830961,0.813573080891816,0.726087621860261,AKR1B1,1
GO:0051965,GO:0051965,positive regulation of synapse assembly,1/317,48/12743,0.702230116830961,0.813573080891816,0.726087621860261,SLITRK6,1
GO:0061178,GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,1/317,48/12743,0.702230116830961,0.813573080891816,0.726087621860261,RAC1,1
GO:0007599,GO:0007599,hemostasis,5/317,236/12743,0.703004138772005,0.814207435207911,0.726653762539701,CD9/GNG2/CDC42/RAC1/PABPC4,5
GO:0046890,GO:0046890,regulation of lipid biosynthetic process,3/317,145/12743,0.703687207402348,0.814736074270996,0.727125555780103,FABP5/EGR1/TSPO,3
GO:0006766,GO:0006766,vitamin metabolic process,2/317,98/12743,0.704739605979546,0.814904755064801,0.727276097924753,CYB5A/RBP1,2
GO:0014065,GO:0014065,phosphatidylinositol 3-kinase signaling,2/317,98/12743,0.704739605979546,0.814904755064801,0.727276097924753,HGF/NOP53,2
GO:1902807,GO:1902807,negative regulation of cell cycle G1/S phase transition,2/317,98/12743,0.704739605979546,0.814904755064801,0.727276097924753,SOX4/CDKN1A,2
GO:2000736,GO:2000736,regulation of stem cell differentiation,2/317,98/12743,0.704739605979546,0.814904755064801,0.727276097924753,PSMB8/PSMA6,2
GO:0009615,GO:0009615,response to virus,5/317,237/12743,0.706503699721151,0.81668192942043,0.728862168471845,NPC2/ODC1/SELENOK/NOP53/DDX17,5
GO:0030520,GO:0030520,intracellular estrogen receptor signaling pathway,1/317,49/12743,0.709665568029432,0.817594035314421,0.729676193437773,DDX17,1
GO:0032649,GO:0032649,regulation of interferon-gamma production,1/317,49/12743,0.709665568029432,0.817594035314421,0.729676193437773,CD47,1
GO:0043486,GO:0043486,histone exchange,1/317,49/12743,0.709665568029432,0.817594035314421,0.729676193437773,HIST1H4C,1
GO:0043550,GO:0043550,regulation of lipid kinase activity,1/317,49/12743,0.709665568029432,0.817594035314421,0.729676193437773,EEF1A2,1
GO:0070227,GO:0070227,lymphocyte apoptotic process,1/317,49/12743,0.709665568029432,0.817594035314421,0.729676193437773,MIF,1
GO:0070527,GO:0070527,platelet aggregation,1/317,49/12743,0.709665568029432,0.817594035314421,0.729676193437773,CD9,1
GO:1904589,GO:1904589,regulation of protein import,1/317,49/12743,0.709665568029432,0.817594035314421,0.729676193437773,APOD,1
GO:1904894,GO:1904894,positive regulation of STAT cascade,1/317,49/12743,0.709665568029432,0.817594035314421,0.729676193437773,AKR1B1,1
GO:0030098,GO:0030098,lymphocyte differentiation,5/317,238/12743,0.70997453300107,0.817594035314421,0.729676193437773,B2M/MDK/RHOA/SOX4/EGR1,5
GO:0051101,GO:0051101,regulation of DNA binding,2/317,99/12743,0.710021857649964,0.817594035314421,0.729676193437773,PARK7/JUN,2
GO:0061041,GO:0061041,regulation of wound healing,2/317,99/12743,0.710021857649964,0.817594035314421,0.729676193437773,CD9/CDKN1A,2
GO:0071482,GO:0071482,cellular response to light stimulus,2/317,99/12743,0.710021857649964,0.817594035314421,0.729676193437773,MME/CDKN1A,2
GO:0001701,GO:0001701,in utero embryonic development,6/317,283/12743,0.71050309734349,0.817886210358581,0.729936950200704,YBX1/SPINT2/BRK1/TM4SF1/JUNB/VEGFA,6
GO:0140053,GO:0140053,mitochondrial gene expression,3/317,147/12743,0.712435790601417,0.819848485023077,0.731688216777788,TRIT1/MRPS24/MRPL33,3
GO:0033044,GO:0033044,regulation of chromosome organization,6/317,284/12743,0.713672576622623,0.821008932146665,0.732723878246991,TERF2IP/CENPV/DUSP1/MAD1L1/SFPQ/VEGFA,6
GO:0006415,GO:0006415,translational termination,2/317,100/12743,0.715225070276114,0.821323373395909,0.733004506876723,MRPS24/MRPL33,2
GO:0007292,GO:0007292,female gamete generation,2/317,100/12743,0.715225070276114,0.821323373395909,0.733004506876723,MDK/RGS2,2
GO:0046434,GO:0046434,organophosphate catabolic process,4/317,194/12743,0.715244845559156,0.821323373395909,0.733004506876723,PGAM2/NUDT3/ALDOA/NTHL1,4
GO:0051480,GO:0051480,regulation of cytosolic calcium ion concentration,4/317,194/12743,0.715244845559156,0.821323373395909,0.733004506876723,CD24/TMBIM6/GTF2I/CACNA2D1,4
GO:0035194,GO:0035194,posttranscriptional gene silencing by RNA,3/317,148/12743,0.716735115157649,0.821323373395909,0.733004506876723,NEAT1/HIST1H4C/MEG3,3
GO:0003333,GO:0003333,amino acid transmembrane transport,1/317,50/12743,0.716915923704134,0.821323373395909,0.733004506876723,RGS2,1
GO:0031646,GO:0031646,positive regulation of neurological system process,1/317,50/12743,0.716915923704134,0.821323373395909,0.733004506876723,HGF,1
GO:0032413,GO:0032413,negative regulation of ion transmembrane transporter activity,1/317,50/12743,0.716915923704134,0.821323373395909,0.733004506876723,GEM,1
GO:0035418,GO:0035418,protein localization to synapse,1/317,50/12743,0.716915923704134,0.821323373395909,0.733004506876723,PCLO,1
GO:0051057,GO:0051057,positive regulation of small GTPase mediated signal transduction,1/317,50/12743,0.716915923704134,0.821323373395909,0.733004506876723,RAC1,1
GO:0060675,GO:0060675,ureteric bud morphogenesis,1/317,50/12743,0.716915923704134,0.821323373395909,0.733004506876723,VEGFA,1
GO:0070509,GO:0070509,calcium ion import,1/317,50/12743,0.716915923704134,0.821323373395909,0.733004506876723,CACNA2D1,1
GO:0098930,GO:0098930,axonal transport,1/317,50/12743,0.716915923704134,0.821323373395909,0.733004506876723,UCHL1,1
GO:0006289,GO:0006289,nucleotide-excision repair,2/317,101/12743,0.720349893231219,0.824469234691574,0.735812086184003,RBX1/NTHL1,2
GO:0006865,GO:0006865,amino acid transport,2/317,101/12743,0.720349893231219,0.824469234691574,0.735812086184003,RGS2/SYT1,2
GO:0060964,GO:0060964,regulation of gene silencing by miRNA,2/317,101/12743,0.720349893231219,0.824469234691574,0.735812086184003,NEAT1/HIST1H4C,2
GO:0016441,GO:0016441,posttranscriptional gene silencing,3/317,149/12743,0.720984681859762,0.824933141720511,0.736226108180695,NEAT1/HIST1H4C/MEG3,3
GO:0006336,GO:0006336,DNA replication-independent nucleosome assembly,1/317,51/12743,0.723985777338877,0.826823775583482,0.737913437662968,HIST1H4C,1
GO:0033619,GO:0033619,membrane protein proteolysis,1/317,51/12743,0.723985777338877,0.826823775583482,0.737913437662968,TIMP1,1
GO:0034724,GO:0034724,DNA replication-independent nucleosome organization,1/317,51/12743,0.723985777338877,0.826823775583482,0.737913437662968,HIST1H4C,1
GO:0072171,GO:0072171,mesonephric tubule morphogenesis,1/317,51/12743,0.723985777338877,0.826823775583482,0.737913437662968,VEGFA,1
GO:0006323,GO:0006323,DNA packaging,3/317,150/12743,0.725184671913437,0.826823775583482,0.737913437662968,HIST1H1C/CENPV/HIST1H4C,3
GO:0019362,GO:0019362,pyridine nucleotide metabolic process,3/317,150/12743,0.725184671913437,0.826823775583482,0.737913437662968,PGAM2/MDH2/ALDOA,3
GO:0046496,GO:0046496,nicotinamide nucleotide metabolic process,3/317,150/12743,0.725184671913437,0.826823775583482,0.737913437662968,PGAM2/MDH2/ALDOA,3
GO:0007264,GO:0007264,small GTPase mediated signal transduction,9/317,421/12743,0.725231012940281,0.826823775583482,0.737913437662968,RHOA/DIRAS3/PARK7/CDC42/RAC1/BRK1/RHOB/CDKN1A/JUN,9
GO:0000724,GO:0000724,double-strand break repair via homologous recombination,2/317,102/12743,0.725396992542504,0.826823775583482,0.737913437662968,TERF2IP/SFPQ,2
GO:0006334,GO:0006334,nucleosome assembly,2/317,102/12743,0.725396992542504,0.826823775583482,0.737913437662968,HIST1H1C/HIST1H4C,2
GO:0006406,GO:0006406,mRNA export from nucleus,2/317,102/12743,0.725396992542504,0.826823775583482,0.737913437662968,SRSF9/THOC7,2
GO:0071427,GO:0071427,mRNA-containing ribonucleoprotein complex export from nucleus,2/317,102/12743,0.725396992542504,0.826823775583482,0.737913437662968,SRSF9/THOC7,2
GO:0043588,GO:0043588,skin development,5/317,243/12743,0.72689732599282,0.828271279538569,0.739205288056089,PSAP/IGFBP5/DSP/KRT12/KRT10,5
GO:0000725,GO:0000725,recombinational repair,2/317,103/12743,0.730367049667098,0.829915411732494,0.740672622783293,TERF2IP/SFPQ,2
GO:0001838,GO:0001838,embryonic epithelial tube formation,2/317,103/12743,0.730367049667098,0.829915411732494,0.740672622783293,SPINT2/SOX4,2
GO:0006282,GO:0006282,regulation of DNA repair,2/317,103/12743,0.730367049667098,0.829915411732494,0.740672622783293,TERF2IP/RPS3,2
GO:0046031,GO:0046031,ADP metabolic process,2/317,103/12743,0.730367049667098,0.829915411732494,0.740672622783293,PGAM2/ALDOA,2
GO:0006855,GO:0006855,drug transmembrane transport,1/317,52/12743,0.730879608774708,0.829915411732494,0.740672622783293,RGS2,1
GO:0010660,GO:0010660,regulation of muscle cell apoptotic process,1/317,52/12743,0.730879608774708,0.829915411732494,0.740672622783293,MDK,1
GO:0014031,GO:0014031,mesenchymal cell development,1/317,52/12743,0.730879608774708,0.829915411732494,0.740672622783293,PDCD6,1
GO:0030104,GO:0030104,water homeostasis,1/317,52/12743,0.730879608774708,0.829915411732494,0.740672622783293,AKR1B1,1
GO:0032755,GO:0032755,positive regulation of interleukin-6 production,1/317,52/12743,0.730879608774708,0.829915411732494,0.740672622783293,SELENOK,1
GO:0046824,GO:0046824,positive regulation of nucleocytoplasmic transport,1/317,52/12743,0.730879608774708,0.829915411732494,0.740672622783293,KHDRBS1,1
GO:0048864,GO:0048864,stem cell development,1/317,52/12743,0.730879608774708,0.829915411732494,0.740672622783293,PDCD6,1
GO:0010921,GO:0010921,regulation of phosphatase activity,3/317,152/12743,0.733436707761174,0.831739879697846,0.742300901345153,HSP90B1/BOD1/PPP1R15A,3
GO:0050852,GO:0050852,T cell receptor signaling pathway,3/317,152/12743,0.733436707761174,0.831739879697846,0.742300901345153,PSMB8/RPS3/PSMA6,3
GO:0006486,GO:0006486,protein glycosylation,4/317,199/12743,0.733643159533204,0.831739879697846,0.742300901345153,RAMP1/TMEM258/KRTCAP2/RPN1,4
GO:0007548,GO:0007548,sex differentiation,4/317,199/12743,0.733643159533204,0.831739879697846,0.742300901345153,RAB13/BASP1/HSPA5/VEGFA,4
GO:0043413,GO:0043413,macromolecule glycosylation,4/317,199/12743,0.733643159533204,0.831739879697846,0.742300901345153,RAMP1/TMEM258/KRTCAP2/RPN1,4
GO:0071333,GO:0071333,cellular response to glucose stimulus,2/317,104/12743,0.735260760318192,0.832554552951883,0.743027970835909,SOX4/RAC1,2
GO:0006367,GO:0006367,transcription initiation from RNA polymerase II promoter,3/317,153/12743,0.737489175398451,0.832554552951883,0.743027970835909,GTF2I/CDKN1A/NPPA,3
GO:0019915,GO:0019915,lipid storage,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,HILPDA,1
GO:0021536,GO:0021536,diencephalon development,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,CNTNAP2,1
GO:0030317,GO:0030317,flagellated sperm motility,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,SLIRP,1
GO:0030500,GO:0030500,regulation of bone mineralization,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,ATRAID,1
GO:0031670,GO:0031670,cellular response to nutrient,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,HSP90B1,1
GO:0032611,GO:0032611,interleukin-1 beta production,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,EGR1,1
GO:0032652,GO:0032652,regulation of interleukin-1 production,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,EGR1,1
GO:0043242,GO:0043242,negative regulation of protein complex disassembly,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,MAP1B,1
GO:0043647,GO:0043647,inositol phosphate metabolic process,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,NUDT3,1
GO:0060415,GO:0060415,muscle tissue morphogenesis,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,DSP,1
GO:0097722,GO:0097722,sperm motility,1/317,53/12743,0.737601787012705,0.832554552951883,0.743027970835909,SLIRP,1
GO:0120031,GO:0120031,plasma membrane bounded cell projection assembly,10/317,470/12743,0.737603964159039,0.832554552951883,0.743027970835909,FSCN1/TUBA1A/CDC42/RAC1/BRK1/PFN2/YWHAG/DPYSL3/AKIRIN1/TUBB4B,10
GO:0030900,GO:0030900,forebrain development,6/317,292/12743,0.738172485558009,0.832934741236988,0.743367276565504,MDK/MFSD2A/RHOA/CNTNAP2/ASCL1/DNAJB1,6
GO:0031123,GO:0031123,RNA 3'-end processing,2/317,105/12743,0.74007883333972,0.834300221340951,0.744585923328371,SRSF9/THOC7,2
GO:0060147,GO:0060147,regulation of posttranscriptional gene silencing,2/317,105/12743,0.74007883333972,0.834300221340951,0.744585923328371,NEAT1/HIST1H4C,2
GO:0060966,GO:0060966,regulation of gene silencing by RNA,2/317,105/12743,0.74007883333972,0.834300221340951,0.744585923328371,NEAT1/HIST1H4C,2
GO:0071824,GO:0071824,protein-DNA complex subunit organization,4/317,201/12743,0.740748801103938,0.83479371158892,0.745026347389804,HIST1H1C/CENPV/HIST1H4C/RBX1,4
GO:0072524,GO:0072524,pyridine-containing compound metabolic process,3/317,154/12743,0.741492909143528,0.834934534677958,0.745152027435302,PGAM2/MDH2/ALDOA,3
GO:0071396,GO:0071396,cellular response to lipid,9/317,428/12743,0.742811949288686,0.834934534677958,0.745152027435302,RHOA/CALR/MIF/PARK7/GNG2/YWHAH/TSPO/SCGB2A1/DDX17,9
GO:0009416,GO:0009416,response to light stimulus,5/317,248/12743,0.743101661333152,0.834934534677958,0.745152027435302,FOS/MME/MEIS2/DUSP1/CDKN1A,5
GO:0001708,GO:0001708,cell fate specification,1/317,54/12743,0.744156572947849,0.834934534677958,0.745152027435302,ASCL1,1
GO:0002088,GO:0002088,lens development in camera-type eye,1/317,54/12743,0.744156572947849,0.834934534677958,0.745152027435302,SLITRK6,1
GO:0006305,GO:0006305,DNA alkylation,1/317,54/12743,0.744156572947849,0.834934534677958,0.745152027435302,FOS,1
GO:0006306,GO:0006306,DNA methylation,1/317,54/12743,0.744156572947849,0.834934534677958,0.745152027435302,FOS,1
GO:0007040,GO:0007040,lysosome organization,1/317,54/12743,0.744156572947849,0.834934534677958,0.745152027435302,GRN,1
GO:0033077,GO:0033077,T cell differentiation in thymus,1/317,54/12743,0.744156572947849,0.834934534677958,0.745152027435302,B2M,1
GO:0045685,GO:0045685,regulation of glial cell differentiation,1/317,54/12743,0.744156572947849,0.834934534677958,0.745152027435302,MDK,1
GO:0080171,GO:0080171,lytic vacuole organization,1/317,54/12743,0.744156572947849,0.834934534677958,0.745152027435302,GRN,1
GO:0097194,GO:0097194,execution phase of apoptosis,1/317,54/12743,0.744156572947849,0.834934534677958,0.745152027435302,RPS3,1
GO:0051054,GO:0051054,positive regulation of DNA metabolic process,4/317,202/12743,0.744247584994108,0.834934534677958,0.745152027435302,RAC1/HGF/RPS3/JUN,4
GO:0006633,GO:0006633,fatty acid biosynthetic process,2/317,106/12743,0.744821989627875,0.834934534677958,0.745152027435302,FABP5/MIF,2
GO:0008286,GO:0008286,insulin receptor signaling pathway,2/317,106/12743,0.744821989627875,0.834934534677958,0.745152027435302,ATP6AP1/ATP6V0E2,2
GO:0071326,GO:0071326,cellular response to monosaccharide stimulus,2/317,106/12743,0.744821989627875,0.834934534677958,0.745152027435302,SOX4/RAC1,2
GO:0071331,GO:0071331,cellular response to hexose stimulus,2/317,106/12743,0.744821989627875,0.834934534677958,0.745152027435302,SOX4/RAC1,2
GO:0072331,GO:0072331,signal transduction by p53 class mediator,5/317,250/12743,0.74938290908539,0.83873810964199,0.748546594887281,FHIT/MIF/SOX4/NOP53/CDKN1A,5
GO:0071772,GO:0071772,response to BMP,2/317,107/12743,0.749490961097868,0.83873810964199,0.748546594887281,SPINT2/EGR1,2
GO:0071773,GO:0071773,cellular response to BMP stimulus,2/317,107/12743,0.749490961097868,0.83873810964199,0.748546594887281,SPINT2/EGR1,2
GO:0010827,GO:0010827,regulation of glucose transmembrane transport,1/317,55/12743,0.750548122035683,0.83873810964199,0.748546594887281,FABP5,1
GO:0014068,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,1/317,55/12743,0.750548122035683,0.83873810964199,0.748546594887281,HGF,1
GO:0030193,GO:0030193,regulation of blood coagulation,1/317,55/12743,0.750548122035683,0.83873810964199,0.748546594887281,CD9,1
GO:0035773,GO:0035773,insulin secretion involved in cellular response to glucose stimulus,1/317,55/12743,0.750548122035683,0.83873810964199,0.748546594887281,RAC1,1
GO:0040014,GO:0040014,regulation of multicellular organism growth,1/317,55/12743,0.750548122035683,0.83873810964199,0.748546594887281,PPIB,1
GO:0042475,GO:0042475,odontogenesis of dentin-containing tooth,1/317,55/12743,0.750548122035683,0.83873810964199,0.748546594887281,BSG,1
GO:0070936,GO:0070936,protein K48-linked ubiquitination,1/317,55/12743,0.750548122035683,0.83873810964199,0.748546594887281,RNF187,1
GO:0030031,GO:0030031,cell projection assembly,10/317,476/12743,0.751613609668335,0.839667783330536,0.749376298540802,FSCN1/TUBA1A/CDC42/RAC1/BRK1/PFN2/YWHAG/DPYSL3/AKIRIN1/TUBB4B,10
GO:0090092,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,3/317,157/12743,0.753214134905472,0.841194412856531,0.750738765942963,HSPA1A/PEG10/HSPA5,3
GO:0008643,GO:0008643,carbohydrate transport,2/317,108/12743,0.754086489694323,0.841645740593322,0.751141561328877,FABP5/MFSD2A,2
GO:0060401,GO:0060401,cytosolic calcium ion transport,2/317,108/12743,0.754086489694323,0.841645740593322,0.751141561328877,TMBIM6/CACNA2D1,2
GO:1990778,GO:1990778,protein localization to cell periphery,5/317,252/12743,0.755550114025838,0.842820895409469,0.752190348937285,BSG/RAMP1/VAMP8/RAB13/MACF1,5
GO:0009064,GO:0009064,glutamine family amino acid metabolic process,1/317,56/12743,0.756780486893398,0.842820895409469,0.752190348937285,CTPS1,1
GO:0010657,GO:0010657,muscle cell apoptotic process,1/317,56/12743,0.756780486893398,0.842820895409469,0.752190348937285,MDK,1
GO:0014033,GO:0014033,neural crest cell differentiation,1/317,56/12743,0.756780486893398,0.842820895409469,0.752190348937285,PDCD6,1
GO:0050818,GO:0050818,regulation of coagulation,1/317,56/12743,0.756780486893398,0.842820895409469,0.752190348937285,CD9,1
GO:1900046,GO:1900046,regulation of hemostasis,1/317,56/12743,0.756780486893398,0.842820895409469,0.752190348937285,CD9,1
GO:1903779,GO:1903779,regulation of cardiac conduction,1/317,56/12743,0.756780486893398,0.842820895409469,0.752190348937285,NPPA,1
GO:0016241,GO:0016241,regulation of macroautophagy,3/317,158/12743,0.757025409093778,0.842832562927263,0.752200761818988,UCHL1/TOMM7/ATP6V0E2,3
GO:0010675,GO:0010675,regulation of cellular carbohydrate metabolic process,2/317,109/12743,0.758609326443821,0.84355104502491,0.75284198381844,TFF3/IGFBP5,2
GO:0048754,GO:0048754,branching morphogenesis of an epithelial tube,2/317,109/12743,0.758609326443821,0.84355104502491,0.75284198381844,MDK/VEGFA,2
GO:0072175,GO:0072175,epithelial tube formation,2/317,109/12743,0.758609326443821,0.84355104502491,0.75284198381844,SPINT2/SOX4,2
GO:1905477,GO:1905477,positive regulation of protein localization to membrane,2/317,109/12743,0.758609326443821,0.84355104502491,0.75284198381844,YWHAH/YWHAG,2
GO:0032410,GO:0032410,negative regulation of transporter activity,1/317,57/12743,0.762857619836946,0.846928536221174,0.755856285309169,GEM,1
GO:0032922,GO:0032922,circadian regulation of gene expression,1/317,57/12743,0.762857619836946,0.846928536221174,0.755856285309169,EGR1,1
GO:0035019,GO:0035019,somatic stem cell population maintenance,1/317,57/12743,0.762857619836946,0.846928536221174,0.755856285309169,SOX4,1
GO:0072347,GO:0072347,response to anesthetic,1/317,57/12743,0.762857619836946,0.846928536221174,0.755856285309169,HSPA5,1
GO:1904035,GO:1904035,regulation of epithelial cell apoptotic process,1/317,57/12743,0.762857619836946,0.846928536221174,0.755856285309169,MDK,1
GO:0090501,GO:0090501,RNA phosphodiester bond hydrolysis,2/317,110/12743,0.76306023054809,0.846928536221174,0.755856285309169,TRIR/AZGP1,2
GO:1905475,GO:1905475,regulation of protein localization to membrane,3/317,160/12743,0.76450589328627,0.848100670167875,0.756902376889447,VAMP8/YWHAH/YWHAG,3
GO:0050678,GO:0050678,regulation of epithelial cell proliferation,5/317,255/12743,0.764588114607534,0.848100670167875,0.756902376889447,MDK/GRN/PDCD6/JUN/VEGFA,5
GO:0003006,GO:0003006,developmental process involved in reproduction,10/317,482/12743,0.765107208448607,0.848414686728174,0.757182626498053,MDK/SPINT2/BSG/RAB13/MME/SLIRP/BASP1/HSPA5/JUNB/VEGFA,10
GO:0030168,GO:0030168,platelet activation,2/317,111/12743,0.767439968516438,0.850131108706233,0.758714477516023,CD9/GNG2,2
GO:0048592,GO:0048592,eye morphogenesis,2/317,111/12743,0.767439968516438,0.850131108706233,0.758714477516023,MFAP2/VEGFA,2
GO:0071426,GO:0071426,ribonucleoprotein complex export from nucleus,2/317,111/12743,0.767439968516438,0.850131108706233,0.758714477516023,SRSF9/THOC7,2
GO:0071229,GO:0071229,cellular response to acid chemical,3/317,161/12743,0.768175678183663,0.850131108706233,0.758714477516023,GNG2/EGR1/VEGFA,3
GO:0002286,GO:0002286,T cell activation involved in immune response,1/317,58/12743,0.768783375355761,0.850131108706233,0.758714477516023,MDK,1
GO:0006687,GO:0006687,glycosphingolipid metabolic process,1/317,58/12743,0.768783375355761,0.850131108706233,0.758714477516023,PSAP,1
GO:0034637,GO:0034637,cellular carbohydrate biosynthetic process,1/317,58/12743,0.768783375355761,0.850131108706233,0.758714477516023,AKR1B1,1
GO:0048708,GO:0048708,astrocyte differentiation,1/317,58/12743,0.768783375355761,0.850131108706233,0.758714477516023,GRN,1
GO:2000106,GO:2000106,regulation of leukocyte apoptotic process,1/317,58/12743,0.768783375355761,0.850131108706233,0.758714477516023,MIF,1
GO:0051052,GO:0051052,regulation of DNA metabolic process,7/317,349/12743,0.769835064421928,0.851032305226578,0.759518766219342,TERF2IP/RAC1/DUSP1/HGF/RPS3/CDKN1A/JUN,7
GO:0048562,GO:0048562,embryonic organ morphogenesis,4/317,210/12743,0.770955467796437,0.852008886175282,0.760390333083159,RPL38/MFAP2/SLITRK6/TSHZ1,4
GO:0071166,GO:0071166,ribonucleoprotein complex localization,2/317,112/12743,0.77174931333604,0.852362144836579,0.760705604995796,SRSF9/THOC7,2
GO:0071322,GO:0071322,cellular response to carbohydrate stimulus,2/317,112/12743,0.77174931333604,0.852362144836579,0.760705604995796,SOX4/RAC1,2
GO:0070085,GO:0070085,glycosylation,4/317,211/12743,0.774135593876837,0.853109263950112,0.761372384604331,RAMP1/TMEM258/KRTCAP2/RPN1,4
GO:0006081,GO:0006081,cellular aldehyde metabolic process,1/317,59/12743,0.774561512526611,0.853109263950112,0.761372384604331,PARK7,1
GO:0006400,GO:0006400,tRNA modification,1/317,59/12743,0.774561512526611,0.853109263950112,0.761372384604331,TRIT1,1
GO:0006641,GO:0006641,triglyceride metabolic process,1/317,59/12743,0.774561512526611,0.853109263950112,0.761372384604331,FABP5,1
GO:0032609,GO:0032609,interferon-gamma production,1/317,59/12743,0.774561512526611,0.853109263950112,0.761372384604331,CD47,1
GO:0042035,GO:0042035,regulation of cytokine biosynthetic process,1/317,59/12743,0.774561512526611,0.853109263950112,0.761372384604331,EGR1,1
GO:0045739,GO:0045739,positive regulation of DNA repair,1/317,59/12743,0.774561512526611,0.853109263950112,0.761372384604331,RPS3,1
GO:0060411,GO:0060411,cardiac septum morphogenesis,1/317,59/12743,0.774561512526611,0.853109263950112,0.761372384604331,SOX4,1
GO:0072078,GO:0072078,nephron tubule morphogenesis,1/317,59/12743,0.774561512526611,0.853109263950112,0.761372384604331,VEGFA,1
GO:0006733,GO:0006733,oxidoreduction coenzyme metabolic process,3/317,163/12743,0.775375827910651,0.853744594590748,0.761939396621799,PGAM2/MDH2/ALDOA,3
GO:0045619,GO:0045619,regulation of lymphocyte differentiation,2/317,113/12743,0.775989043678733,0.854158178819671,0.762308507149508,MDK/RHOA,2
GO:0003281,GO:0003281,ventricular septum development,1/317,60/12743,0.78019569736807,0.85664392262953,0.764526952982888,SOX4,1
GO:0006695,GO:0006695,cholesterol biosynthetic process,1/317,60/12743,0.78019569736807,0.85664392262953,0.764526952982888,CNBP,1
GO:0008652,GO:0008652,cellular amino acid biosynthetic process,1/317,60/12743,0.78019569736807,0.85664392262953,0.764526952982888,PARK7,1
GO:0046634,GO:0046634,regulation of alpha-beta T cell activation,1/317,60/12743,0.78019569736807,0.85664392262953,0.764526952982888,RHOA,1
GO:0046782,GO:0046782,regulation of viral transcription,1/317,60/12743,0.78019569736807,0.85664392262953,0.764526952982888,JUN,1
GO:0072088,GO:0072088,nephron epithelium morphogenesis,1/317,60/12743,0.78019569736807,0.85664392262953,0.764526952982888,VEGFA,1
GO:1901879,GO:1901879,regulation of protein depolymerization,1/317,60/12743,0.78019569736807,0.85664392262953,0.764526952982888,MAP1B,1
GO:1902653,GO:1902653,secondary alcohol biosynthetic process,1/317,60/12743,0.78019569736807,0.85664392262953,0.764526952982888,CNBP,1
GO:0007249,GO:0007249,I-kappaB kinase/NF-kappaB signaling,4/317,213/12743,0.780391890573494,0.85664392262953,0.764526952982888,S100A4/RHOA/TERF2IP/S100A13,4
GO:0001678,GO:0001678,cellular glucose homeostasis,2/317,115/12743,0.784262799530198,0.860095545361691,0.767607414468175,SOX4/RAC1,2
GO:0009135,GO:0009135,purine nucleoside diphosphate metabolic process,2/317,115/12743,0.784262799530198,0.860095545361691,0.767607414468175,PGAM2/ALDOA,2
GO:0009179,GO:0009179,purine ribonucleoside diphosphate metabolic process,2/317,115/12743,0.784262799530198,0.860095545361691,0.767607414468175,PGAM2/ALDOA,2
GO:0002673,GO:0002673,regulation of acute inflammatory response,1/317,61/12743,0.785689505137077,0.860095545361691,0.767607414468175,PARK7,1
GO:0006360,GO:0006360,transcription by RNA polymerase I,1/317,61/12743,0.785689505137077,0.860095545361691,0.767607414468175,NOP53,1
GO:0016239,GO:0016239,positive regulation of macroautophagy,1/317,61/12743,0.785689505137077,0.860095545361691,0.767607414468175,TOMM7,1
GO:0043507,GO:0043507,positive regulation of JUN kinase activity,1/317,61/12743,0.785689505137077,0.860095545361691,0.767607414468175,RPS3,1
GO:0055024,GO:0055024,regulation of cardiac muscle tissue development,1/317,61/12743,0.785689505137077,0.860095545361691,0.767607414468175,RGS2,1
GO:0072028,GO:0072028,nephron morphogenesis,1/317,61/12743,0.785689505137077,0.860095545361691,0.767607414468175,VEGFA,1
GO:0008203,GO:0008203,cholesterol metabolic process,2/317,116/12743,0.788298404152844,0.86228377475304,0.769560338319967,CNBP/NPC2,2
GO:0042113,GO:0042113,B cell activation,3/317,167/12743,0.789227248646349,0.86228377475304,0.769560338319967,MIF/CDKN1A/CTPS1,3
GO:0051607,GO:0051607,defense response to virus,3/317,167/12743,0.789227248646349,0.86228377475304,0.769560338319967,SELENOK/NOP53/DDX17,3
GO:0009100,GO:0009100,glycoprotein metabolic process,6/317,311/12743,0.790282774797576,0.86228377475304,0.769560338319967,RAMP1/PARK7/OS9/TMEM258/KRTCAP2/RPN1,6
GO:0019216,GO:0019216,regulation of lipid metabolic process,6/317,311/12743,0.790282774797576,0.86228377475304,0.769560338319967,APOD/FABP5/NPC2/EEF1A2/EGR1/TSPO,6
GO:0002708,GO:0002708,positive regulation of lymphocyte mediated immunity,1/317,62/12743,0.791046422568992,0.86228377475304,0.769560338319967,B2M,1
GO:0016126,GO:0016126,sterol biosynthetic process,1/317,62/12743,0.791046422568992,0.86228377475304,0.769560338319967,CNBP,1
GO:0045833,GO:0045833,negative regulation of lipid metabolic process,1/317,62/12743,0.791046422568992,0.86228377475304,0.769560338319967,APOD,1
GO:0048207,GO:0048207,vesicle targeting, rough ER to cis-Golgi,1/317,62/12743,0.791046422568992,0.86228377475304,0.769560338319967,PDCD6,1
GO:0048208,GO:0048208,COPII vesicle coating,1/317,62/12743,0.791046422568992,0.86228377475304,0.769560338319967,PDCD6,1
GO:0070542,GO:0070542,response to fatty acid,1/317,62/12743,0.791046422568992,0.86228377475304,0.769560338319967,GNG2,1
GO:1900006,GO:1900006,positive regulation of dendrite development,1/317,62/12743,0.791046422568992,0.86228377475304,0.769560338319967,CAMK2B,1
GO:1903313,GO:1903313,positive regulation of mRNA metabolic process,1/317,62/12743,0.791046422568992,0.86228377475304,0.769560338319967,SNRNP70,1
GO:2000573,GO:2000573,positive regulation of DNA biosynthetic process,1/317,62/12743,0.791046422568992,0.86228377475304,0.769560338319967,HGF,1
GO:0009185,GO:0009185,ribonucleoside diphosphate metabolic process,2/317,117/12743,0.792267551175425,0.863353090777707,0.770514668235254,PGAM2/ALDOA,2
GO:0007623,GO:0007623,circadian rhythm,3/317,168/12743,0.792577659810896,0.863429299097021,0.770582681691742,EGR1/SFPQ/JUN,3
GO:0007204,GO:0007204,positive regulation of cytosolic calcium ion concentration,3/317,169/12743,0.79588376905254,0.865353721576426,0.772300166419719,CD24/TMBIM6/CACNA2D1,3
GO:0001776,GO:0001776,leukocyte homeostasis,1/317,63/12743,0.796269850062536,0.865353721576426,0.772300166419719,MIF,1
GO:0006821,GO:0006821,chloride transport,1/317,63/12743,0.796269850062536,0.865353721576426,0.772300166419719,TSPO,1
GO:0021954,GO:0021954,central nervous system neuron development,1/317,63/12743,0.796269850062536,0.865353721576426,0.772300166419719,ASCL1,1
GO:0042089,GO:0042089,cytokine biosynthetic process,1/317,63/12743,0.796269850062536,0.865353721576426,0.772300166419719,EGR1,1
GO:0051865,GO:0051865,protein autoubiquitination,1/317,63/12743,0.796269850062536,0.865353721576426,0.772300166419719,RNF187,1
GO:0061333,GO:0061333,renal tubule morphogenesis,1/317,63/12743,0.796269850062536,0.865353721576426,0.772300166419719,VEGFA,1
GO:1903901,GO:1903901,negative regulation of viral life cycle,1/317,63/12743,0.796269850062536,0.865353721576426,0.772300166419719,SNX3,1
GO:0007018,GO:0007018,microtubule-based movement,4/317,219/12743,0.798341321167564,0.867342716711209,0.774075280151018,UCHL1/CDC42/MAP1B/SFPQ,4
GO:0019359,GO:0019359,nicotinamide nucleotide biosynthetic process,2/317,119/12743,0.800009659591178,0.868264122423281,0.774897604903348,PGAM2/ALDOA,2
GO:0019363,GO:0019363,pyridine nucleotide biosynthetic process,2/317,119/12743,0.800009659591178,0.868264122423281,0.774897604903348,PGAM2/ALDOA,2
GO:1902652,GO:1902652,secondary alcohol metabolic process,2/317,119/12743,0.800009659591178,0.868264122423281,0.774897604903348,CNBP/NPC2,2
GO:0002824,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/317,64/12743,0.801363103810973,0.868264122423281,0.774897604903348,B2M,1
GO:0006901,GO:0006901,vesicle coating,1/317,64/12743,0.801363103810973,0.868264122423281,0.774897604903348,PDCD6,1
GO:0042107,GO:0042107,cytokine metabolic process,1/317,64/12743,0.801363103810973,0.868264122423281,0.774897604903348,EGR1,1
GO:0045652,GO:0045652,regulation of megakaryocyte differentiation,1/317,64/12743,0.801363103810973,0.868264122423281,0.774897604903348,HIST1H4C,1
GO:0070167,GO:0070167,regulation of biomineral tissue development,1/317,64/12743,0.801363103810973,0.868264122423281,0.774897604903348,ATRAID,1
GO:1900182,GO:1900182,positive regulation of protein localization to nucleus,1/317,64/12743,0.801363103810973,0.868264122423281,0.774897604903348,PARK7,1
GO:0016331,GO:0016331,morphogenesis of embryonic epithelium,2/317,120/12743,0.803784218054969,0.870624966528356,0.777004581795894,SPINT2/SOX4,2
GO:0007004,GO:0007004,telomere maintenance via telomerase,1/317,65/12743,0.806329417880846,0.87206806777426,0.77829250291368,TERF2IP,1
GO:0007215,GO:0007215,glutamate receptor signaling pathway,1/317,65/12743,0.806329417880846,0.87206806777426,0.77829250291368,GRIK2,1
GO:0009798,GO:0009798,axis specification,1/317,65/12743,0.806329417880846,0.87206806777426,0.77829250291368,BASP1,1
GO:0010522,GO:0010522,regulation of calcium ion transport into cytosol,1/317,65/12743,0.806329417880846,0.87206806777426,0.77829250291368,TMBIM6,1
GO:0019217,GO:0019217,regulation of fatty acid metabolic process,1/317,65/12743,0.806329417880846,0.87206806777426,0.77829250291368,FABP5,1
GO:0016458,GO:0016458,gene silencing,4/317,223/12743,0.809639422220807,0.875384578310917,0.781252381140964,NEAT1/HIST1H4C/MEG3/DDX17,4
GO:0006470,GO:0006470,protein dephosphorylation,5/317,272/12743,0.811085253701591,0.875987728065851,0.781790672760329,HSP90B1/BOD1/PPP1R15A/DUSP1/DUSP2,5
GO:0072525,GO:0072525,pyridine-containing compound biosynthetic process,2/317,122/12743,0.81114434081499,0.875987728065851,0.781790672760329,PGAM2/ALDOA,2
GO:0051149,GO:0051149,positive regulation of muscle cell differentiation,1/317,66/12743,0.811171946239559,0.875987728065851,0.781790672760329,CDC42,1
GO:2000779,GO:2000779,regulation of double-strand break repair,1/317,66/12743,0.811171946239559,0.875987728065851,0.781790672760329,TERF2IP,1
GO:1903827,GO:1903827,regulation of cellular protein localization,9/317,460/12743,0.813303596296888,0.877659510537204,0.783282684464505,APOD/VAMP8/CLDN18/PARK7/TOMM7/YWHAH/OS9/SVIP/YWHAG,9
GO:0016125,GO:0016125,sterol metabolic process,2/317,123/12743,0.814731503720345,0.877659510537204,0.783282684464505,CNBP/NPC2,2
GO:0060968,GO:0060968,regulation of gene silencing,2/317,123/12743,0.814731503720345,0.877659510537204,0.783282684464505,NEAT1/HIST1H4C,2
GO:0016485,GO:0016485,protein processing,3/317,175/12743,0.814809792613549,0.877659510537204,0.783282684464505,PCSK1N/MME/SCG5,3
GO:0043010,GO:0043010,camera-type eye development,4/317,225/12743,0.815092757557169,0.877659510537204,0.783282684464505,RPL24/SLITRK6/JUN/VEGFA,4
GO:0000045,GO:0000045,autophagosome assembly,1/317,67/12743,0.815893764733056,0.877659510537204,0.783282684464505,WIPI2,1
GO:0002456,GO:0002456,T cell mediated immunity,1/317,67/12743,0.815893764733056,0.877659510537204,0.783282684464505,B2M,1
GO:0009953,GO:0009953,dorsal/ventral pattern formation,1/317,67/12743,0.815893764733056,0.877659510537204,0.783282684464505,ASCL1,1
GO:0046632,GO:0046632,alpha-beta T cell differentiation,1/317,67/12743,0.815893764733056,0.877659510537204,0.783282684464505,RHOA,1
GO:0048199,GO:0048199,vesicle targeting, to, from or within Golgi,1/317,67/12743,0.815893764733056,0.877659510537204,0.783282684464505,PDCD6,1
GO:0048477,GO:0048477,oogenesis,1/317,67/12743,0.815893764733056,0.877659510537204,0.783282684464505,MDK,1
GO:0060021,GO:0060021,roof of mouth development,1/317,67/12743,0.815893764733056,0.877659510537204,0.783282684464505,TSHZ1,1
GO:0090114,GO:0090114,COPII-coated vesicle budding,1/317,67/12743,0.815893764733056,0.877659510537204,0.783282684464505,PDCD6,1
GO:0003205,GO:0003205,cardiac chamber development,2/317,124/12743,0.818257798740414,0.879939212226081,0.785317244378917,SOX4/DSP,2
GO:0032787,GO:0032787,monocarboxylic acid metabolic process,9/317,463/12743,0.819092341299963,0.880241675168091,0.785587182757438,FABP5/BSG/MIF/PARK7/RBP1/PON3/PGAM2/PON2/ALDOA,9
GO:0031503,GO:0031503,protein-containing complex localization,4/317,227/12743,0.820417851105712,0.880241675168091,0.785587182757438,SRSF9/THOC7/ARC/SFPQ,4
GO:0001942,GO:0001942,hair follicle development,1/317,68/12743,0.820497873014819,0.880241675168091,0.785587182757438,IGFBP5,1
GO:0006767,GO:0006767,water-soluble vitamin metabolic process,1/317,68/12743,0.820497873014819,0.880241675168091,0.785587182757438,CYB5A,1
GO:0010717,GO:0010717,regulation of epithelial to mesenchymal transition,1/317,68/12743,0.820497873014819,0.880241675168091,0.785587182757438,MDK,1
GO:0022600,GO:0022600,digestive system process,1/317,68/12743,0.820497873014819,0.880241675168091,0.785587182757438,SGK1,1
GO:0044728,GO:0044728,DNA methylation or demethylation,1/317,68/12743,0.820497873014819,0.880241675168091,0.785587182757438,FOS,1
GO:0098876,GO:0098876,vesicle-mediated transport to the plasma membrane,1/317,68/12743,0.820497873014819,0.880241675168091,0.785587182757438,MACF1,1
GO:0000187,GO:0000187,activation of MAPK activity,2/317,125/12743,0.821724022538274,0.880768593030738,0.786057439882202,ERP29/HGF,2
GO:0007033,GO:0007033,vacuole organization,2/317,125/12743,0.821724022538274,0.880768593030738,0.786057439882202,GRN/WIPI2,2
GO:0032543,GO:0032543,mitochondrial translation,2/317,125/12743,0.821724022538274,0.880768593030738,0.786057439882202,MRPS24/MRPL33,2
GO:0002821,GO:0002821,positive regulation of adaptive immune response,1/317,69/12743,0.824987196427387,0.883165193505931,0.788196328176877,B2M,1
GO:0006342,GO:0006342,chromatin silencing,1/317,69/12743,0.824987196427387,0.883165193505931,0.788196328176877,HIST1H4C,1
GO:0050851,GO:0050851,antigen receptor-mediated signaling pathway,3/317,179/12743,0.826586512774342,0.883165193505931,0.788196328176877,PSMB8/RPS3/PSMA6,3
GO:1901615,GO:1901615,organic hydroxy compound metabolic process,7/317,374/12743,0.826913880460967,0.883165193505931,0.788196328176877,CNBP/NPC2/PARK7/SNCB/AKR1B1/NUDT3/PCBD1,7
GO:0046394,GO:0046394,carboxylic acid biosynthetic process,6/317,327/12743,0.827724052655164,0.883165193505931,0.788196328176877,FABP5/MIF/PARK7/RBP1/PGAM2/ALDOA,6
GO:0051650,GO:0051650,establishment of vesicle localization,4/317,230/12743,0.828168845127414,0.883165193505931,0.788196328176877,PFN2/PDCD6/SYT1/PCLO,4
GO:0034728,GO:0034728,nucleosome organization,2/317,127/12743,0.82847943352158,0.883165193505931,0.788196328176877,HIST1H1C/HIST1H4C,2
GO:0035264,GO:0035264,multicellular organism growth,2/317,127/12743,0.82847943352158,0.883165193505931,0.788196328176877,PPIB/SLITRK6,2
GO:0002062,GO:0002062,chondrocyte differentiation,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,MDK,1
GO:0006835,GO:0006835,dicarboxylic acid transport,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,SYT1,1
GO:0007032,GO:0007032,endosome organization,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,SNX3,1
GO:0010927,GO:0010927,cellular component assembly involved in morphogenesis,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,CD9,1
GO:0022404,GO:0022404,molting cycle process,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,IGFBP5,1
GO:0022405,GO:0022405,hair cycle process,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,IGFBP5,1
GO:0042472,GO:0042472,inner ear morphogenesis,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,SLITRK6,1
GO:0044766,GO:0044766,multi-organism transport,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,THOC7,1
GO:0050848,GO:0050848,regulation of calcium-mediated signaling,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,SELENOK,1
GO:0061097,GO:0061097,regulation of protein tyrosine kinase activity,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,CD24,1
GO:0097306,GO:0097306,cellular response to alcohol,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,GNG2,1
GO:0098773,GO:0098773,skin epidermis development,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,IGFBP5,1
GO:1902579,GO:1902579,multi-organism localization,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,THOC7,1
GO:1905037,GO:1905037,autophagosome organization,1/317,70/12743,0.829364587837559,0.883165193505931,0.788196328176877,WIPI2,1
GO:0016053,GO:0016053,organic acid biosynthetic process,6/317,328/12743,0.829876755827089,0.883448900562152,0.788449527534862,FABP5/MIF/PARK7/RBP1/PGAM2/ALDOA,6
GO:0007601,GO:0007601,visual perception,2/317,128/12743,0.831770203254382,0.885202451361606,0.79001451482327,KRT12/SLITRK6,2
GO:0035303,GO:0035303,regulation of dephosphorylation,3/317,181/12743,0.832231639439613,0.885431412780529,0.790218855473261,HSP90B1/BOD1/PPP1R15A,3
GO:0090305,GO:0090305,nucleic acid phosphodiester bond hydrolysis,4/317,232/12743,0.833181015090062,0.885611708566176,0.790379763621903,TRIR/RBX1/NTHL1/AZGP1,4
GO:0006672,GO:0006672,ceramide metabolic process,1/317,71/12743,0.833632829426409,0.885611708566176,0.790379763621903,PSAP,1
GO:0035282,GO:0035282,segmentation,1/317,71/12743,0.833632829426409,0.885611708566176,0.790379763621903,BASP1,1
GO:0043044,GO:0043044,ATP-dependent chromatin remodeling,1/317,71/12743,0.833632829426409,0.885611708566176,0.790379763621903,HIST1H4C,1
GO:0043506,GO:0043506,regulation of JUN kinase activity,1/317,71/12743,0.833632829426409,0.885611708566176,0.790379763621903,RPS3,1
GO:0009411,GO:0009411,response to UV,2/317,129/12743,0.835004066120626,0.886544482487788,0.791212234133015,MME/CDKN1A,2
GO:0021915,GO:0021915,neural tube development,2/317,129/12743,0.835004066120626,0.886544482487788,0.791212234133015,SPINT2/SOX4,2
GO:0043624,GO:0043624,cellular protein complex disassembly,3/317,183/12743,0.837718676602702,0.888719891057735,0.793153715816991,MRPS24/MRPL33/MAP1B,3
GO:0006639,GO:0006639,acylglycerol metabolic process,1/317,72/12743,0.837794634435233,0.888719891057735,0.793153715816991,FABP5,1
GO:0048194,GO:0048194,Golgi vesicle budding,1/317,72/12743,0.837794634435233,0.888719891057735,0.793153715816991,PDCD6,1
GO:0046777,GO:0046777,protein autophosphorylation,3/317,184/12743,0.840403873773353,0.89013537431832,0.794416988777466,JUN/CAMK2B/VEGFA,3
GO:0071103,GO:0071103,DNA conformation change,4/317,235/12743,0.840471107412079,0.89013537431832,0.794416988777466,HIST1H1C/CENPV/HIST1H4C/RBX1,4
GO:0050953,GO:0050953,sensory perception of light stimulus,2/317,131/12743,0.841304202275009,0.89013537431832,0.794416988777466,KRT12/SLITRK6,2
GO:2000045,GO:2000045,regulation of G1/S transition of mitotic cell cycle,2/317,131/12743,0.841304202275009,0.89013537431832,0.794416988777466,SOX4/CDKN1A,2
GO:0006283,GO:0006283,transcription-coupled nucleotide-excision repair,1/317,73/12743,0.841852648868509,0.89013537431832,0.794416988777466,RBX1,1
GO:0006638,GO:0006638,neutral lipid metabolic process,1/317,73/12743,0.841852648868509,0.89013537431832,0.794416988777466,FABP5,1
GO:0042058,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,1/317,73/12743,0.841852648868509,0.89013537431832,0.794416988777466,CDC42,1
GO:0046425,GO:0046425,regulation of JAK-STAT cascade,1/317,73/12743,0.841852648868509,0.89013537431832,0.794416988777466,AKR1B1,1
GO:0060079,GO:0060079,excitatory postsynaptic potential,1/317,73/12743,0.841852648868509,0.89013537431832,0.794416988777466,GRIK2,1
GO:1901606,GO:1901606,alpha-amino acid catabolic process,1/317,73/12743,0.841852648868509,0.89013537431832,0.794416988777466,PCBD1,1
GO:1904659,GO:1904659,glucose transmembrane transport,1/317,73/12743,0.841852648868509,0.89013537431832,0.794416988777466,FABP5,1
GO:0000018,GO:0000018,regulation of DNA recombination,1/317,74/12743,0.845809453154908,0.893268209192684,0.797212942425679,TERF2IP,1
GO:0002377,GO:0002377,immunoglobulin production,1/317,74/12743,0.845809453154908,0.893268209192684,0.797212942425679,TMBIM6,1
GO:0043648,GO:0043648,dicarboxylic acid metabolic process,1/317,74/12743,0.845809453154908,0.893268209192684,0.797212942425679,MDH2,1
GO:1903533,GO:1903533,regulation of protein targeting,1/317,74/12743,0.845809453154908,0.893268209192684,0.797212942425679,TOMM7,1
GO:0006813,GO:0006813,potassium ion transport,2/317,133/12743,0.847386065818306,0.894670457156185,0.798464403312218,CD63/NPPA,2
GO:0014902,GO:0014902,myotube differentiation,1/317,75/12743,0.849667563767419,0.895763897872103,0.799440263733012,CD9,1
GO:0031058,GO:0031058,positive regulation of histone modification,1/317,75/12743,0.849667563767419,0.895763897872103,0.799440263733012,VEGFA,1
GO:0043473,GO:0043473,pigmentation,1/317,75/12743,0.849667563767419,0.895763897872103,0.799440263733012,CD63,1
GO:0071887,GO:0071887,leukocyte apoptotic process,1/317,75/12743,0.849667563767419,0.895763897872103,0.799440263733012,MIF,1
GO:1904892,GO:1904892,regulation of STAT cascade,1/317,75/12743,0.849667563767419,0.895763897872103,0.799440263733012,AKR1B1,1
GO:0021953,GO:0021953,central nervous system neuron differentiation,2/317,134/12743,0.85034707207368,0.896217450631744,0.799845044879747,SOX4/ASCL1,2
GO:2001020,GO:2001020,regulation of response to DNA damage stimulus,3/317,188/12743,0.850764890835175,0.89639501247141,0.800003513070159,TERF2IP/MIF/RPS3,3
GO:0001578,GO:0001578,microtubule bundle formation,1/317,76/12743,0.853429434803551,0.897886689528466,0.801334786525954,MAP1B,1
GO:0001843,GO:0001843,neural tube closure,1/317,76/12743,0.853429434803551,0.897886689528466,0.801334786525954,SPINT2,1
GO:0032508,GO:0032508,DNA duplex unwinding,1/317,76/12743,0.853429434803551,0.897886689528466,0.801334786525954,RBX1,1
GO:0042737,GO:0042737,drug catabolic process,1/317,76/12743,0.853429434803551,0.897886689528466,0.801334786525954,PCBD1,1
GO:0060606,GO:0060606,tube closure,1/317,76/12743,0.853429434803551,0.897886689528466,0.801334786525954,SPINT2,1
GO:0000226,GO:0000226,microtubule cytoskeleton organization,8/317,437/12743,0.856078160628565,0.89990226839902,0.803133625380342,RHOA/HSPA1A/HSPA1B/GABARAP/RAC1/TBCD/RPS3/MAP1B,8
GO:0003002,GO:0003002,regionalization,4/317,242/12743,0.856449541179922,0.89990226839902,0.803133625380342,BASP1/ASCL1/TSHZ1/ARC,4
GO:0006303,GO:0006303,double-strand break repair via nonhomologous end joining,1/317,77/12743,0.857097459526633,0.89990226839902,0.803133625380342,HIST1H4C,1
GO:0008645,GO:0008645,hexose transmembrane transport,1/317,77/12743,0.857097459526633,0.89990226839902,0.803133625380342,FABP5,1
GO:0010833,GO:0010833,telomere maintenance via telomere lengthening,1/317,77/12743,0.857097459526633,0.89990226839902,0.803133625380342,TERF2IP,1
GO:0032204,GO:0032204,regulation of telomere maintenance,1/317,77/12743,0.857097459526633,0.89990226839902,0.803133625380342,TERF2IP,1
GO:1904019,GO:1904019,epithelial cell apoptotic process,1/317,77/12743,0.857097459526633,0.89990226839902,0.803133625380342,MDK,1
GO:0043547,GO:0043547,positive regulation of GTPase activity,5/317,294/12743,0.860081564200601,0.902771744029536,0.805694539434017,RGS7/TBCD/RGS2/JUN/RANBP1,5
GO:0008593,GO:0008593,regulation of Notch signaling pathway,1/317,78/12743,0.860673971869129,0.902954637981198,0.80585776636167,ASCL1,1
GO:0051648,GO:0051648,vesicle localization,4/317,244/12743,0.860758148640213,0.902954637981198,0.80585776636167,PFN2/PDCD6/SYT1/PCLO,4
GO:0014020,GO:0014020,primary neural tube formation,1/317,79/12743,0.864161247898935,0.905467702184981,0.808100594761679,SPINT2,1
GO:0015749,GO:0015749,monosaccharide transmembrane transport,1/317,79/12743,0.864161247898935,0.905467702184981,0.808100594761679,FABP5,1
GO:0099565,GO:0099565,chemical synaptic transmission, postsynaptic,1/317,79/12743,0.864161247898935,0.905467702184981,0.808100594761679,GRIK2,1
GO:1901184,GO:1901184,regulation of ERBB signaling pathway,1/317,79/12743,0.864161247898935,0.905467702184981,0.808100594761679,CDC42,1
GO:0030219,GO:0030219,megakaryocyte differentiation,1/317,80/12743,0.867561507249538,0.907971941357231,0.8103355471069,HIST1H4C,1
GO:0030282,GO:0030282,bone mineralization,1/317,80/12743,0.867561507249538,0.907971941357231,0.8103355471069,ATRAID,1
GO:0045446,GO:0045446,endothelial cell differentiation,1/317,80/12743,0.867561507249538,0.907971941357231,0.8103355471069,BTG1,1
GO:1903076,GO:1903076,regulation of protein localization to plasma membrane,1/317,80/12743,0.867561507249538,0.907971941357231,0.8103355471069,VAMP8,1
GO:0034219,GO:0034219,carbohydrate transmembrane transport,1/317,81/12743,0.870876914514949,0.910646453659465,0.812722462705234,FABP5,1
GO:0051261,GO:0051261,protein depolymerization,1/317,81/12743,0.870876914514949,0.910646453659465,0.812722462705234,MAP1B,1
GO:0051963,GO:0051963,regulation of synapse assembly,1/317,81/12743,0.870876914514949,0.910646453659465,0.812722462705234,SLITRK6,1
GO:0006302,GO:0006302,double-strand break repair,3/317,197/12743,0.871961747958718,0.911252082952798,0.813262967232305,TERF2IP/HIST1H4C/SFPQ,3
GO:0007283,GO:0007283,spermatogenesis,6/317,350/12743,0.872019378282477,0.911252082952798,0.813262967232305,CALR/WFDC2/SLIRP/KHDRBS1/RGS2/PGAM2,6
GO:0006338,GO:0006338,chromatin remodeling,2/317,142/12743,0.872216527799883,0.911252082952798,0.813262967232305,CENPV/HIST1H4C,2
GO:1903317,GO:1903317,regulation of protein maturation,1/317,82/12743,0.874109580610254,0.912964538725701,0.814791278540645,SOX4,1
GO:1902806,GO:1902806,regulation of cell cycle G1/S phase transition,2/317,143/12743,0.874733957316192,0.913351314711504,0.815136463579728,SOX4/CDKN1A,2
GO:0006575,GO:0006575,cellular modified amino acid metabolic process,2/317,144/12743,0.877205736262046,0.91566626651047,0.817202483075591,PARK7/GGCT,2
GO:0006903,GO:0006903,vesicle targeting,1/317,84/12743,0.880334872485751,0.918229896999923,0.819490440247643,PDCD6,1
GO:0034440,GO:0034440,lipid oxidation,1/317,84/12743,0.880334872485751,0.918229896999923,0.819490440247643,APOD,1
GO:0044262,GO:0044262,cellular carbohydrate metabolic process,3/317,201/12743,0.880499589481377,0.918229896999923,0.819490440247643,TFF3/IGFBP5/AKR1B1,3
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,4/317,254/12743,0.880683361573222,0.918229896999923,0.819490440247643,CD24/MIF/HGF/VEGFA,4
GO:0000726,GO:0000726,non-recombinational repair,1/317,85/12743,0.88333146348204,0.919124923652079,0.820289222543455,HIST1H4C,1
GO:0007586,GO:0007586,digestion,1/317,85/12743,0.88333146348204,0.919124923652079,0.820289222543455,SGK1,1
GO:0032006,GO:0032006,regulation of TOR signaling,1/317,85/12743,0.88333146348204,0.919124923652079,0.820289222543455,PDCD6,1
GO:1903825,GO:1903825,organic acid transmembrane transport,1/317,85/12743,0.88333146348204,0.919124923652079,0.820289222543455,RGS2,1
GO:1905039,GO:1905039,carboxylic acid transmembrane transport,1/317,85/12743,0.88333146348204,0.919124923652079,0.820289222543455,RGS2,1
GO:1990823,GO:1990823,response to leukemia inhibitory factor,1/317,85/12743,0.88333146348204,0.919124923652079,0.820289222543455,EIF4A2,1
GO:1990830,GO:1990830,cellular response to leukemia inhibitory factor,1/317,85/12743,0.88333146348204,0.919124923652079,0.820289222543455,EIF4A2,1
GO:0018212,GO:0018212,peptidyl-tyrosine modification,4/317,257/12743,0.886159284465684,0.920832491390683,0.821813171439514,CD24/MIF/HGF/VEGFA,4
GO:0032392,GO:0032392,DNA geometric change,1/317,86/12743,0.886253246234148,0.920832491390683,0.821813171439514,RBX1,1
GO:0043244,GO:0043244,regulation of protein complex disassembly,1/317,86/12743,0.886253246234148,0.920832491390683,0.821813171439514,MAP1B,1
GO:1905269,GO:1905269,positive regulation of chromatin organization,1/317,86/12743,0.886253246234148,0.920832491390683,0.821813171439514,VEGFA,1
GO:2001022,GO:2001022,positive regulation of response to DNA damage stimulus,1/317,86/12743,0.886253246234148,0.920832491390683,0.821813171439514,RPS3,1
GO:0000723,GO:0000723,telomere maintenance,2/317,148/12743,0.886650329802445,0.920978889234264,0.821943826772868,TERF2IP/HIST1H4C,2
GO:0009101,GO:0009101,glycoprotein biosynthetic process,4/317,258/12743,0.887935455392419,0.921661472514518,0.822553010240612,RAMP1/TMEM258/KRTCAP2/RPN1,4
GO:1901136,GO:1901136,carbohydrate derivative catabolic process,2/317,149/12743,0.888904284196222,0.921661472514518,0.822553010240612,PSAP/NTHL1,2
GO:0002706,GO:0002706,regulation of lymphocyte mediated immunity,1/317,87/12743,0.889102082525827,0.921661472514518,0.822553010240612,B2M,1
GO:0007259,GO:0007259,JAK-STAT cascade,1/317,87/12743,0.889102082525827,0.921661472514518,0.822553010240612,AKR1B1,1
GO:0045814,GO:0045814,negative regulation of gene expression, epigenetic,1/317,87/12743,0.889102082525827,0.921661472514518,0.822553010240612,HIST1H4C,1
GO:0048593,GO:0048593,camera-type eye morphogenesis,1/317,87/12743,0.889102082525827,0.921661472514518,0.822553010240612,VEGFA,1
GO:0097553,GO:0097553,calcium ion transmembrane import into cytosol,1/317,87/12743,0.889102082525827,0.921661472514518,0.822553010240612,CACNA2D1,1
GO:0016050,GO:0016050,vesicle organization,4/317,259/12743,0.889687469825494,0.922002437020078,0.82285731001748,CALR/PDCD6/SNX3/SYT1,4
GO:0048232,GO:0048232,male gamete generation,6/317,362/12743,0.891098522733521,0.923198613610089,0.823924858878135,CALR/WFDC2/SLIRP/KHDRBS1/RGS2/PGAM2,6
GO:0009063,GO:0009063,cellular amino acid catabolic process,1/317,88/12743,0.891879787949287,0.923475759699795,0.824172202786026,PCBD1,1
GO:0062013,GO:0062013,positive regulation of small molecule metabolic process,1/317,88/12743,0.891879787949287,0.923475759699795,0.824172202786026,PARK7,1
GO:0044242,GO:0044242,cellular lipid catabolic process,2/317,151/12743,0.893288274242873,0.924667822027967,0.825236079801257,FABP5/PSAP,2
GO:0003279,GO:0003279,cardiac septum development,1/317,89/12743,0.894588133047673,0.925746787077256,0.826199021158473,SOX4,1
GO:2001252,GO:2001252,positive regulation of chromosome organization,2/317,152/12743,0.895419628462629,0.926340594049828,0.826728974647208,SFPQ/VEGFA,2
GO:0046631,GO:0046631,alpha-beta T cell activation,1/317,90/12743,0.897228844429362,0.927678370929984,0.827922897180175,RHOA,1
GO:0097696,GO:0097696,STAT cascade,1/317,90/12743,0.897228844429362,0.927678370929984,0.827922897180175,AKR1B1,1
GO:0016052,GO:0016052,carbohydrate catabolic process,2/317,153/12743,0.897511422542949,0.927703727441605,0.827945527045462,PGAM2/ALDOA,2
GO:0001704,GO:0001704,formation of primary germ layer,1/317,91/12743,0.899803605854786,0.929805680669145,0.829821452215666,HSBP1,1
GO:0045165,GO:0045165,cell fate commitment,2/317,155/12743,0.901578887926788,0.931329039095827,0.831181000267647,RHOA/ASCL1,2
GO:0007030,GO:0007030,Golgi organization,1/317,92/12743,0.902314059296458,0.931329039095827,0.831181000267647,CDC42,1
GO:0060078,GO:0060078,regulation of postsynaptic membrane potential,1/317,92/12743,0.902314059296458,0.931329039095827,0.831181000267647,GRIK2,1
GO:1903510,GO:1903510,mucopolysaccharide metabolic process,1/317,92/12743,0.902314059296458,0.931329039095827,0.831181000267647,HGF,1
GO:0002822,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/317,93/12743,0.904761805972849,0.933319567423929,0.832957482324321,B2M,1
GO:0007286,GO:0007286,spermatid development,1/317,93/12743,0.904761805972849,0.933319567423929,0.832957482324321,SLIRP,1
GO:0002526,GO:0002526,acute inflammatory response,1/317,94/12743,0.90714840735677,0.935503310741847,0.834906402500886,PARK7,1
GO:0032200,GO:0032200,telomere organization,2/317,158/12743,0.907399177901758,0.935503310741847,0.834906402500886,TERF2IP/HIST1H4C,2
GO:0006631,GO:0006631,fatty acid metabolic process,4/317,271/12743,0.908916531300165,0.936769383154212,0.836036331118963,FABP5/MIF/PON3/PON2,4
GO:0051321,GO:0051321,meiotic cell cycle,2/317,159/12743,0.909266820498494,0.936769383154212,0.836036331118963,CALR/DUSP1,2
GO:0006732,GO:0006732,coenzyme metabolic process,5/317,324/12743,0.909408942199777,0.936769383154212,0.836036331118963,CYB5A/PGAM2/MDH2/ALDOA/PCBD1,5
GO:0000082,GO:0000082,G1/S transition of mitotic cell cycle,3/317,217/12743,0.90980425181136,0.936908130983053,0.836160159061956,SOX4/KHDRBS1/CDKN1A,3
GO:0043009,GO:0043009,chordate embryonic development,8/317,476/12743,0.910341478254195,0.937192902154591,0.836414308108394,YBX1/SPINT2/SOX4/BRK1/TM4SF1/PDCD6/JUNB/VEGFA,8
GO:0051099,GO:0051099,positive regulation of binding,2/317,160/12743,0.911099237298649,0.93756307125187,0.836744672037391,B2M/PARK7,2
GO:0009108,GO:0009108,coenzyme biosynthetic process,3/317,218/12743,0.911400114833037,0.93756307125187,0.836744672037391,PGAM2/ALDOA/PCBD1,3
GO:0042752,GO:0042752,regulation of circadian rhythm,1/317,96/12743,0.911744227286936,0.93756307125187,0.836744672037391,SFPQ,1
GO:0045598,GO:0045598,regulation of fat cell differentiation,1/317,96/12743,0.911744227286936,0.93756307125187,0.836744672037391,CCDC85B,1
GO:0040029,GO:0040029,regulation of gene expression, epigenetic,4/317,274/12743,0.913234955045565,0.938827470228426,0.837873107168214,DIRAS3/NEAT1/HIST1H4C/MEG3,4
GO:0006281,GO:0006281,DNA repair,8/317,479/12743,0.913684057516607,0.939020636584392,0.838045501883969,TERF2IP/PARK7/HIST1H4C/RPS3/RBX1/NOP53/NTHL1/SFPQ,8
GO:0006664,GO:0006664,glycolipid metabolic process,1/317,97/12743,0.913956378781365,0.939032061080025,0.838055697876266,PSAP,1
GO:0044282,GO:0044282,small molecule catabolic process,5/317,329/12743,0.915959237694507,0.94017332102665,0.83907423541153,PON3/PGAM2/NUDT3/ALDOA/PCBD1,5
GO:0048515,GO:0048515,spermatid differentiation,1/317,98/12743,0.916113252727776,0.94017332102665,0.83907423541153,SLIRP,1
GO:0060359,GO:0060359,response to ammonium ion,1/317,98/12743,0.916113252727776,0.94017332102665,0.83907423541153,HSPA5,1
GO:1903509,GO:1903509,liposaccharide metabolic process,1/317,98/12743,0.916113252727776,0.94017332102665,0.83907423541153,PSAP,1
GO:0006109,GO:0006109,regulation of carbohydrate metabolic process,2/317,163/12743,0.916390991955869,0.940189958927325,0.839089084198957,TFF3/IGFBP5,2
GO:0016042,GO:0016042,lipid catabolic process,3/317,222/12743,0.917530955723781,0.940720243088697,0.839562345636293,FABP5/PSAP/YWHAH,3
GO:0030509,GO:0030509,BMP signaling pathway,1/317,99/12743,0.918216226146937,0.940720243088697,0.839562345636293,EGR1,1
GO:0034968,GO:0034968,histone lysine methylation,1/317,99/12743,0.918216226146937,0.940720243088697,0.839562345636293,HIST1H1C,1
GO:0072329,GO:0072329,monocarboxylic acid catabolic process,1/317,99/12743,0.918216226146937,0.940720243088697,0.839562345636293,PON3,1
GO:1904375,GO:1904375,regulation of protein localization to cell periphery,1/317,99/12743,0.918216226146937,0.940720243088697,0.839562345636293,VAMP8,1
GO:0007173,GO:0007173,epidermal growth factor receptor signaling pathway,1/317,101/12743,0.92226580934912,0.944061954615628,0.842544714931098,CDC42,1
GO:0015698,GO:0015698,inorganic anion transport,1/317,101/12743,0.92226580934912,0.944061954615628,0.842544714931098,TSPO,1
GO:0031929,GO:0031929,TOR signaling,1/317,101/12743,0.92226580934912,0.944061954615628,0.842544714931098,PDCD6,1
GO:0009792,GO:0009792,embryo development ending in birth or egg hatching,8/317,489/12743,0.924070447839134,0.945249770973166,0.843604802555072,YBX1/SPINT2/SOX4/BRK1/TM4SF1/PDCD6/JUNB/VEGFA,8
GO:0008033,GO:0008033,tRNA processing,1/317,102/12743,0.924215005555126,0.945249770973166,0.843604802555072,TRIT1,1
GO:0098781,GO:0098781,ncRNA transcription,1/317,102/12743,0.924215005555126,0.945249770973166,0.843604802555072,NOP53,1
GO:1901796,GO:1901796,regulation of signal transduction by p53 class mediator,2/317,168/12743,0.924559639854304,0.945333306392555,0.843679355211041,MIF/NOP53,2
GO:0002449,GO:0002449,lymphocyte mediated immunity,2/317,169/12743,0.926100668247139,0.94635102718937,0.844587638056716,B2M/TUBB4B,2
GO:0045834,GO:0045834,positive regulation of lipid metabolic process,1/317,103/12743,0.926115475710891,0.94635102718937,0.844587638056716,EEF1A2,1
GO:0051056,GO:0051056,regulation of small GTPase mediated signal transduction,4/317,284/12743,0.926344718965061,0.94635102718937,0.844587638056716,RHOA/CDC42/RAC1/RHOB,4
GO:0048598,GO:0048598,embryonic morphogenesis,7/317,442/12743,0.927288807062235,0.947046381076345,0.845208218877301,SPINT2/RPL38/SOX4/HSBP1/MFAP2/SLITRK6/TSHZ1,7
GO:0002819,GO:0002819,regulation of adaptive immune response,1/317,104/12743,0.927968434112762,0.947471320827997,0.845587463841223,B2M,1
GO:0044843,GO:0044843,cell cycle G1/S phase transition,3/317,230/12743,0.928649420575936,0.947897406862717,0.845967731825653,SOX4/KHDRBS1/CDKN1A,3
GO:0007281,GO:0007281,germ cell development,2/317,172/12743,0.930547836050608,0.949565560772618,0.847456505156267,MDK/SLIRP,2
GO:1903829,GO:1903829,positive regulation of cellular protein localization,4/317,288/12743,0.931070932441068,0.94982973953622,0.84769227614564,PARK7/TOMM7/YWHAH/YWHAG,4
GO:0008584,GO:0008584,male gonad development,1/317,106/12743,0.931536522749059,0.950035120363934,0.847875571881787,RAB13,1
GO:0048193,GO:0048193,Golgi vesicle transport,4/317,289/12743,0.932209006658588,0.950169326445873,0.847995346462783,VAMP8/GABARAPL2/PDCD6/MACF1,4
GO:0016311,GO:0016311,dephosphorylation,6/317,396/12743,0.932556022418972,0.950169326445873,0.847995346462783,HSP90B1/BOD1/PON3/PPP1R15A/DUSP1/DUSP2,6
GO:0035107,GO:0035107,appendage morphogenesis,1/317,107/12743,0.933253933708033,0.950169326445873,0.847995346462783,SOX4,1
GO:0035108,GO:0035108,limb morphogenesis,1/317,107/12743,0.933253933708033,0.950169326445873,0.847995346462783,SOX4,1
GO:0046546,GO:0046546,development of primary male sexual characteristics,1/317,107/12743,0.933253933708033,0.950169326445873,0.847995346462783,RAB13,1
GO:0140013,GO:0140013,meiotic nuclear division,1/317,107/12743,0.933253933708033,0.950169326445873,0.847995346462783,CALR,1
GO:0022412,GO:0022412,cellular process involved in reproduction in multicellular organism,3/317,235/12743,0.934883409397037,0.950797053156102,0.848555572218666,MDK/CD9/SLIRP,3
GO:0006997,GO:0006997,nucleus organization,1/317,108/12743,0.934928395801619,0.950797053156102,0.848555572218666,RPS19,1
GO:0031214,GO:0031214,biomineral tissue development,1/317,108/12743,0.934928395801619,0.950797053156102,0.848555572218666,ATRAID,1
GO:0035023,GO:0035023,regulation of Rho protein signal transduction,1/317,108/12743,0.934928395801619,0.950797053156102,0.848555572218666,RAC1,1
GO:0018022,GO:0018022,peptidyl-lysine methylation,1/317,110/12743,0.938152729770081,0.953536630908522,0.851000556623724,HIST1H1C,1
GO:0060041,GO:0060041,retina development in camera-type eye,1/317,110/12743,0.938152729770081,0.953536630908522,0.851000556623724,RPL24,1
GO:0007224,GO:0007224,smoothened signaling pathway,1/317,111/12743,0.939704663963296,0.954844055101201,0.852167390366287,EVC2,1
GO:0071774,GO:0071774,response to fibroblast growth factor,1/317,112/12743,0.941217775230208,0.956111303179599,0.853298368228217,IER2,1
GO:0043087,GO:0043087,regulation of GTPase activity,5/317,353/12743,0.941936367210145,0.956570971785444,0.853708607569587,RGS7/TBCD/RGS2/JUN/RANBP1,5
GO:0002285,GO:0002285,lymphocyte activation involved in immune response,1/317,113/12743,0.942693031761918,0.957069033940722,0.854153111910203,MDK,1
GO:1903046,GO:1903046,meiotic cell cycle process,1/317,114/12743,0.944131377678899,0.958258696430164,0.855214847147102,CALR,1
GO:0006260,GO:0006260,DNA replication,3/317,244/12743,0.944857582682401,0.958725094480167,0.855631092299407,PTMS/RAC1/JUN,3
GO:0009451,GO:0009451,RNA modification,1/317,115/12743,0.945533733627572,0.959140454963635,0.856001788076761,TRIT1,1
GO:0046474,GO:0046474,glycerophospholipid biosynthetic process,2/317,184/12743,0.945932637793041,0.959274423939629,0.856121351048382,FABP5/MFSD2A,2
GO:0007276,GO:0007276,gamete generation,7/317,465/12743,0.94721424676885,0.960303219721945,0.857039517959882,MDK/CALR/WFDC2/SLIRP/KHDRBS1/RGS2/PGAM2,7
GO:0016571,GO:0016571,histone methylation,1/317,117/12743,0.94823404431202,0.961066080998509,0.857720346939011,HIST1H1C,1
GO:0031056,GO:0031056,regulation of histone modification,1/317,119/12743,0.950800881258584,0.96339604513095,0.859799764456229,VEGFA,1
GO:0046661,GO:0046661,male sex differentiation,1/317,121/12743,0.953240822098645,0.965596155380284,0.861763291588933,RAB13,1
GO:0038127,GO:0038127,ERBB signaling pathway,1/317,122/12743,0.954415173183633,0.966513393688778,0.862581897068559,CDC42,1
GO:0007389,GO:0007389,pattern specification process,4/317,315/12743,0.956431363535401,0.968257786942344,0.864138711543888,BASP1/ASCL1/TSHZ1/ARC,4
GO:0045931,GO:0045931,positive regulation of mitotic cell cycle,1/317,124/12743,0.956676400339139,0.968257786942344,0.864138711543888,MEIS2,1
GO:0006665,GO:0006665,sphingolipid metabolic process,1/317,126/12743,0.958825796014798,0.970160072241261,0.865836439555337,PSAP,1
GO:0030203,GO:0030203,glycosaminoglycan metabolic process,1/317,129/12743,0.961852193137024,0.97294840583219,0.868324936966991,HGF,1
GO:0019722,GO:0019722,calcium-mediated signaling,1/317,131/12743,0.963745545049022,0.974589376779531,0.869789450384016,SELENOK,1
GO:0006022,GO:0006022,aminoglycan metabolic process,1/317,132/12743,0.964656793242763,0.974962376077518,0.870122340175471,HGF,1
GO:0016482,GO:0016482,cytosolic transport,1/317,132/12743,0.964656793242763,0.974962376077518,0.870122340175471,SNX3,1
GO:0045017,GO:0045017,glycerolipid biosynthetic process,2/317,205/12743,0.965376854745687,0.975415905792789,0.870527100755851,FABP5/MFSD2A,2
GO:0019827,GO:0019827,stem cell population maintenance,1/317,134/12743,0.966411359241236,0.975514156410439,0.870614786249621,SOX4,1
GO:0048736,GO:0048736,appendage development,1/317,134/12743,0.966411359241236,0.975514156410439,0.870614786249621,SOX4,1
GO:0060173,GO:0060173,limb development,1/317,134/12743,0.966411359241236,0.975514156410439,0.870614786249621,SOX4,1
GO:0016054,GO:0016054,organic acid catabolic process,2/317,207/12743,0.966830859329734,0.975514156410439,0.870614786249621,PON3/PCBD1,2
GO:0046395,GO:0046395,carboxylic acid catabolic process,2/317,207/12743,0.966830859329734,0.975514156410439,0.870614786249621,PON3/PCBD1,2
GO:0090316,GO:0090316,positive regulation of intracellular protein transport,1/317,136/12743,0.968079083299763,0.976225611349971,0.871249736738075,TOMM7,1
GO:0098727,GO:0098727,maintenance of cell number,1/317,136/12743,0.968079083299763,0.976225611349971,0.871249736738075,SOX4,1
GO:0010256,GO:0010256,endomembrane system organization,4/317,335/12743,0.969337385626388,0.97722038736031,0.872137542105036,PSAP/CDC42/SERP1/SNX3,4
GO:0006310,GO:0006310,DNA recombination,2/317,213/12743,0.97084950971486,0.97847041979953,0.87325315556664,TERF2IP/SFPQ,2
GO:0018205,GO:0018205,peptidyl-lysine modification,4/317,339/12743,0.971448706329902,0.978799915710761,0.873547219994554,PARK7/SOX4/HIST1H1C/EGR1,4
GO:0007369,GO:0007369,gastrulation,1/317,141/12743,0.971896065958117,0.978976283866469,0.873704622860698,HSBP1,1
GO:0006475,GO:0006475,internal protein amino acid acetylation,1/317,142/12743,0.972603013037253,0.979139689686061,0.873850457261727,MDH2,1
GO:1902275,GO:1902275,regulation of chromatin organization,1/317,142/12743,0.972603013037253,0.979139689686061,0.873850457261727,VEGFA,1
GO:0008654,GO:0008654,phospholipid biosynthetic process,2/317,218/12743,0.973836684086127,0.979961145860953,0.874583580289638,FABP5/MFSD2A,2
GO:0018394,GO:0018394,peptidyl-lysine acetylation,1/317,144/12743,0.973964165274322,0.979961145860953,0.874583580289638,SOX4,1
GO:0006479,GO:0006479,protein methylation,1/317,153/12743,0.979301607573709,0.98478021796573,0.878884446046276,HIST1H1C,1
GO:0008213,GO:0008213,protein alkylation,1/317,153/12743,0.979301607573709,0.98478021796573,0.878884446046276,HIST1H1C,1
GO:0006399,GO:0006399,tRNA metabolic process,1/317,156/12743,0.980826166329371,0.986037491038615,0.880006521538892,TRIT1,1
GO:0006888,GO:0006888,ER to Golgi vesicle-mediated transport,1/317,162/12743,0.98354758848513,0.988490708843143,0.882195938966078,PDCD6,1
GO:0044272,GO:0044272,sulfur compound biosynthetic process,1/317,163/12743,0.983962135377286,0.988490708843143,0.882195938966078,GGCT,1
GO:0043414,GO:0043414,macromolecule methylation,2/317,241/12743,0.984172969757273,0.988490708843143,0.882195938966078,FOS/HIST1H1C,2
GO:0098656,GO:0098656,anion transmembrane transport,1/317,164/12743,0.984366269167858,0.988490708843143,0.882195938966078,RGS2,1
GO:0030258,GO:0030258,lipid modification,1/317,167/12743,0.985518767164889,0.98937167493934,0.882982172671139,APOD,1
GO:0006643,GO:0006643,membrane lipid metabolic process,1/317,168/12743,0.985883791879324,0.98946181792467,0.883062622365682,PSAP,1
GO:0060271,GO:0060271,cilium assembly,3/317,320/12743,0.98741287475825,0.990719867361404,0.884185390737884,TUBA1A/YWHAG/TUBB4B,3
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/317,175/12743,0.988194601451281,0.990870784258961,0.884320079180532,B2M,1
GO:0002250,GO:0002250,adaptive immune response,2/317,255/12743,0.988390161989606,0.990870784258961,0.884320079180532,B2M/ALCAM,2
GO:0006650,GO:0006650,glycerophospholipid metabolic process,2/317,255/12743,0.988390161989606,0.990870784258961,0.884320079180532,FABP5/MFSD2A,2
GO:0016197,GO:0016197,endosomal transport,1/317,178/12743,0.989065622232022,0.991271511548403,0.884677715306209,RAB13,1
GO:0044782,GO:0044782,cilium organization,3/317,330/12743,0.989721359897714,0.991652254412565,0.885017515979649,TUBA1A/YWHAG/TUBB4B,3
GO:0046578,GO:0046578,regulation of Ras protein signal transduction,1/317,193/12743,0.992548557713438,0.994207875447147,0.887298324972667,RAC1,1
GO:0006790,GO:0006790,sulfur compound metabolic process,2/317,288/12743,0.994464214327557,0.995817435512076,0.888734805194585,PARK7/GGCT,2
GO:0032259,GO:0032259,methylation,2/317,290/12743,0.994709432802187,0.995817435512076,0.888734805194585,FOS/HIST1H1C,2
GO:0046486,GO:0046486,glycerolipid metabolic process,2/317,303/12743,0.996063312315502,0.99689521374561,0.889696687357183,FABP5/MFSD2A,2
GO:0016570,GO:0016570,histone modification,3/317,380/12743,0.996352878528605,0.996907486309584,0.889707640223003,HIST1H1C/SFPQ/VEGFA,3
GO:0016569,GO:0016569,covalent chromatin modification,3/317,389/12743,0.996984627124096,0.997262029635817,0.890024058657483,HIST1H1C/SFPQ/VEGFA,3
GO:0006644,GO:0006644,phospholipid metabolic process,2/317,335/12743,0.998112415100411,0.998112415100411,0.890783000139391,FABP5/MFSD2A,2
